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Thesis aim 
Antibiotic resistance poses a serious threat to human health to the extent that options 
for the treatment of infections by antibiotic-resistant bacteria are becoming 
increasingly limited. The first step in containing this problem would be to thoroughly 
understand antibiotic resistance with respect to its development, persistence and 
expansion. Hence, the aim of this thesis is to study aspects of antibiotic resistance 
that are still poorly understood, with a focus on environmental antibiotic resistance. 
One important aspect lies in the identification of biological niches and bacterial taxa 
that are important reservoirs of antibiotic resistance. Furthermore, it is important to 
comprehend to what extent resistance is exchanged between reservoirs, and by what 
mechanisms resistance exchange occurs. The most relevant issue in this context is 
the role of the environmental resistome in the occurrence of resistance genes in 
microorganisms causing nosocomial infections. In this thesis, these topics are 
addressed with a particular focus on the human gut microbiota, the sponge 
microbiota, and the marine genus Pseudovibrio. We specifically aimed to identify 
novel antibiotic resistance reservoir species and to investigate the presence of 
resistance determinants in their respective genomes. The research described in this 
thesis expands our knowledge and thereby contributes to finding novel leads to 
combat the emergence of antibiotic resistance. 
 
This Introduction Chapter gives context to the research chapters by reviewing 
relevant scientific literature. The first paragraph provides a historical perspective 
regarding antibiotic discovery and emerging resistance. The second paragraph 
describes the human pathogens that currently pose a major health threat, and the 
text also explains why research into environmental resistance is crucial. This is 
followed by introduction of relevant topics, including horizontal gene transfer, cellular 
targets of antibiotics, antibiotic resistance mechanisms, and methods to study 
antibiotic resistance. Subsequently there is a short overview of literature discussing 
environmental resistance reservoirs followed by a more in-depth description of the 
current knowledge with respect to microbial communities associated with sponges 
and the human gut. Furthermore, the marine bacterial genus Pseudovibrio is 
introduced in more detail as potential reservoir of antibiotic resistance. Finally, an 
outline is given of the remaining chapters in this thesis. 
 
 
Antibiotics – discovery and emerging resistance 
Since their introduction in the 1930s, antibiotics have played a central role in modern 
health- and veterinary care, where they act by killing or arresting growth of bacteria 
while the cells of the human or animal host remain unharmed. In the pre-antibiotic 
era, when treatment of bacterial infections included rinsing with alcohol, maggot 
debridement therapy [1, 2], patient isolation [3] and treatment with chemical 
compounds, these infections were life-threatening, and treatment was often not 
successful. The first clinically applied antibiotics were the sulfonamides in 1935, 
penicillin in 1941, and streptomycin in 1943 [4]. Following the introduction of these 
antibiotics, bacterial infection-related mortality (e.g. bacterial pneumoniae and 
tuberculosis) dropped sharply [5]. The 1950s and 1960s marked the Golden Age of 
antibiotic discovery in which most important classes of antibiotics in use today were 
discovered. In subsequent decades, natural antibiotics from most important classes 
were optimized for potency, and their properties were improved by modification of the 
chemical structure [6]. Nowadays, physicians do not only rely on antibiotics to treat 
infections, but also to severely reduce risks of infections when performing 
complicated operations. In addition, antibiotics are administered prophylactically to 
patients that are admitted to intensive care units [7]. 
Already during the Golden Age of antimicrobial discovery, antibiotic resistant 
strains were being encountered [4]. However, initial reports about horizontal gene 
transfer (HGT) were still regarded sceptically [8], that is, resistance was considered 
to be limited to the specific strain in which it was detected. In subsequent decades, 
more pathogens developed multidrug resistance, and scientists started to appreciate 
the high impact of HGT, and specifically conjugation, in resistance dissemination [4]. 
This emergence of antibiotic resistance was mainly attributed to high antibiotic use 
and resulted in some once-treatable infections becoming difficult or impossible to 
cure [9]. Not only did resistance emerge, but also fewer new antibiotics entered the 
market that could complement the current repertoire [10]. Outbreaks of strains 
resistant to last resort antibiotics such as the Klebsiella pneumoniae outbreak in the 
Maasstad hospital in Rotterdam started occurring more frequently [11-13]. Today, 
antibiotic resistance is considered a global threat that presents a great social and 
economic burden on societies. The CDC estimated that in the United States alone in 
2013 two million infections and 23,000 deaths were attributable to antibiotic 
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resistance [14]. As a response to these concerning developments, policy makers are 
now increasingly taking action. On March 27th, 2015, the Obama administration 
launched an action plan for combating antibiotic-resistant bacteria, and on February 
4th, 2016, it was announced that the Dutch Ministry of Health increased the budget 
for research on antibiotic resistance by €16 million [15]. 
The antibiotic resistance crisis and prospective research 
The rise in multidrug-resistant bacterial infections by major pathogens has led the 
WHO to declare that we are currently in a global antibiotic resistance crisis with 
potentially devastating costs to human society [16]. The Gram-positive pathogen 
posing the greatest threat to human health is methicillin-resistant Staphylococcus 
aureus, which in the USA alone is attributed ~11,000 deaths per year [17, 18]. 
Another group of Gram-positive pathogens representing a major therapeutic 
challenge are the Vancomycin-resistant enterococci [18-20]. Among Gram-negative 
pathogens, infections by extended-spectrum β-lactamase-producing and/or 
carbapenem-resistant Enterobacteriaceae, (mostly Klebsiella pneumoniae) [17, 18, 
21], multidrug-resistant (MDR) Streptococcus pneumoniae [17, 18], MDR 
Mycobacterium tuberculosis [17, 22], MDR Pseudomonas aeruginosa [18, 23] and 
MDR Acinetobacter spp. [18] resulted in the highest mortality rates. MDR pathogens 
are a global concern because highly mobile individuals can lead to epidemic 
pathogenic spread [24, 25]. At present, transmissible resistance to nearly all clinical 
antibiotics has been found in human pathogens indicating the importance of 
understanding resistance dissemination [18]. For example, the first mobilizable gene 
conferring resistance to colistin (mcr-1), which is considered to be a last resort 
antibiotic [26], was found recently in E. coli strain SHP45 that was isolated from a pig 
[27]. Ever since the description of mcr-1, animal-to-human transmission of the gene 
has already been detected in China [28], Denmark [29], Laos [30] and Thailand [28, 
30]. Hence, even though carbapenem-resistant Enterobacteriaceae can still be 
treated with colistin, there is now the imminent threat that these bacteria acquire the 
mcr-1 gene, resulting in pan-resistant infections becoming truly untreatable [27]. 
Antibiotic stewardship [31, 32], prudent application of antibiotics in food animals [33, 
34], and application of novel antibiotics [35, 36] are important strategies to curb the 
emergence of antibiotic resistance in pathogens. However, in order to develop 
effective strategies for preventing and controlling resistance spread, it is also 
 
 
essential to understand in-depth to what extent, and via which mechanisms, both 
human-associated and environmental bacteria contribute to resistance dissemination. 
Knowledge with regards to the role of environmental bacteria in acquisition and 
spread of antibiotic resistance is still very limited [37-39] even though the majority of 
resistance genes are expected to have originated from non-human sources [40]. The 
notion that environmental bacteria are highly relevant is further supported by them 
being a rich and assorted reservoir of resistance genes that may be heterologously 
expressed in human pathogens [41-44]. As such, there is the need to identify 
important relevant resistance reservoirs (e.g. bacteria in animals, soil or aquatic 
environments), and to assess the transferability of environmental resistance to 
human pathogens. In specific, the dynamics of resistance gene dissemination, the 
mechanisms of resistance gene transfer, and the conditions that promote resistance 
transfer need to be investigated [40, 45]. Responding to these major research 
challenges, and with the ambition to generate novel insights into these processes, 
the Evolution and Transfer of Antibiotic Resistance (EvoTAR) project was initiated 
within the Seventh Framework Programme of the European Commission, including 
the research described in this thesis. 
Horizontal gene transfer 
HGT is considered the main mode of inheritance by which antibiotic resistance genes 
are disseminated and by which pathogenic bacteria develop resistance to clinical 
antibiotics [46-48]. HGT is defined as exchange of genetic material between 
organisms beyond transfer through procreation. In bacteria, the three mechanisms 
through which HGT can occur are conjugation, transformation and transduction [49, 
50]. Conjugation is the transfer of genetic material from the donor to the recipient 
through a pilus. Transformation is incorporation of exogenous DNA taken up directly 
from the environment. Transduction is the delivery of exogenous genetic material into 
the cell by a phage. HGT mechanisms principally exchange resistance genes located 
on plasmids whereas lateral exchange of chromosomally located resistance genes 
occurs less frequently [51, 52]. Aggregation of resistance genes on plasmids allows 
for bacteria to become simultaneously resistant to multiple antibiotics from a single 
DNA transfer event [53, 54]. Analysis of fully sequenced bacterial genomes revealed 
that a substantial fraction of open reading frames have been horizontally transferred 
indicating the importance of HGT in bacterial diversification [55, 56]. The rate at 
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which genetic exchange between bacteria occurs is limited by their genetic 
dissimilarity and spatial distribution. However, even though HGT events 
predominantly occur between closely related species, bacterial recombination can 
extend across bacterial phyla and even across the domains of life [57-59]. Therefore, 
any resistance gene harboured by a bacterium can potentially provide resistance to 
another bacterium that was previously susceptible as long as the cellular machinery 
is compatible. The horizontal spread of resistance-harbouring plasmids through 
conjugation is the most important mechanism by which pathogenic bacteria in the 
clinic acquire resistance [51, 60]. 
Antibiotic targets and antibiotic resistance 
Antibiotics kill (bactericidal drugs) or inhibit (bacteriostatic drugs) growth of bacteria 
by disrupting essential processes or cellular components. Nearly all antibiotics target 
one of the following processes: DNA replication, nucleotide biosynthesis, 
transcription, cell wall synthesis, cell wall stability or protein production [61]. In 2010, 
the classes of antibiotics that were administered to patients most often were the β-
lactams (e.g. ampicillin), macrolides (e.g. erythromycin), fluoroquinolones (e.g. 
ciprofloxacin), tetracyclines (e.g. tetracycline), amphenicols (e.g. chloramphenicol), 
aminoglycosides (e.g. kanamycin), and trimethoprim [62]. Β-lactams by definition 
contain a four-membered β-lactam ring in their molecular structure and block cross-
linking of peptidoglycan layers of bacterial cell walls. B-lactams are comprised of the 
subclasses penicillins, cephalosporins, monobactams, and carbapenems [63]. 
Tetracyclines and aminoglycosides inhibit translation by targeting the 30S ribosome 
while macrolides target the 50S ribosome [61]. Fluoroquinolones impair DNA 
replication by interfering with DNA supercoiling [64]. Trimethoprim inhibits synthesis 
of nucleotides by binding to dihydrofolate reductase [65]. Said antibiotics are effective 
against both Gram-positive and Gram-negative bacteria. However, some antibiotics 
can be classified based on whether they primarily target Gram-positive or Gram-
negative bacteria. Polymyxins (e.g. colistin), which exclusively target Gram-negative 
bacteria, disturb the cell membrane resulting in leakage of cell contents and 
eventually cell death [66]. Glycopeptides (e.g. vancomycin) and oxazolidinones (e.g. 
linezolid) predominantly affect Gram-positive bacteria by inhibition of cell wall cross-
linking and protein synthesis, respectively [44, 67, 68]. 
 
 
Bacterial resistance to an antibiotic can be described as intrinsic or as 
acquired. In the case of intrinsic resistance, the bacterium naturally does not possess 
the target site for the drug. Alternatively, low permeability of the cell wall to the drug 
may prevent the drug from reaching its target. In the case of acquired resistance the 
bacterium is naturally susceptible, and resistance can be acquired by four general 
mechanisms: (i) modification or inactivation of the antibiotic, (ii) reduction of the 
binding capacity of the antibiotics by target site alteration, (iii) modification of a 
metabolic pathway to circumvent the effects, and (iv) reduction of the intracellular 
antibiotic concentration by efflux or decreased membrane permeability [69, 70]. A 
bacterium can acquire resistance either by mutations in the bacterial chromosome, or 
by procurement of an exogenous resistance gene. Resistance genes are often 
located on mobile genetic elements that facilitate HGT such as plasmids, 
transposons and integrons. Figure 1.1 shows the mechanisms of acquired resistance 
to the most important classes of antibiotics. 
 
Figure 1.1 Schematic representation of the mechanisms by which bacteria can become antibiotic 
resistant. This figure was adapted from [69]. 
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Methods to study antibiotic resistance 
Methods to study antibiotic resistance can be separated into those that are uniquely 
suitable to study resistance in bacteria in pure culture, and to those that are suitable 
to study resistance in bacterial communities but may also be applied to study 
resistance in bacteria in pure culture. 
The main advantages of studying bacteria in pure culture are that identified 
resistance genes can be assigned to a single bacterium rather than to a community, 
and that the bacteria can be characterized. Characterization includes performing 
resistance profiling, studying how antibiotics affect cell physiology and morphology, 
and investigating if bacteria themselves produce antibiotics. Transposon 
mutagenesis can be used to identify the genes conferring resistance if the cellular 
machinery of the bacterium in question is compatible with this method [7]. 
Alternatively, the bacterial genome can be sequenced, and putative resistance genes 
can be identified based on similarity to known resistance genes [71]. In vitro evolution 
experiments can be performed to investigate how antibiotic resistance evolves under 
different experimental conditions [72]. Pure bacterial cultures also permit bacterium-
to-bacterium HGT (e.g. conjugation) experiments [73]. 
Methods for studying antibiotic resistance at the community level can be 
separated into three approaches that each study a different biological information 
tier, namely (i) metagenomics; the study of collective DNA, (ii) metatranscriptomics; 
the study of collective RNA, and (iii) metaproteomics; the study of collective proteins 
(Figure 1.2). All three approaches can be applied culture-independently. The most 
commonly used approach to study the bacterial resistome, i.e. the collection of all 
resistance genes in a bacterial community [74], is metagenomics. Metagenomics in 
the context of the resistome involves the deep sequencing of community DNA, and 
subsequent mapping of the (assembled) reads to an antibiotic resistance gene 
database [69]. Occasionally researchers apply “targeted” metagenomics, which uses 
community DNA for microarray hybridization [75, 76] or (quantitative) PCR [77, 78]; 
the disadvantage being that the number of resistance genes that can be detected is 
limited to the size of the experiment and similarity to known resistance genes. 
Functional metagenomics involves the expression of community DNA in a surrogate 
host (usually Escherichia coli). For this purpose, fragmented community DNA is 
ligated into a vector, either as <5 kbp fragments into a routine vector, or as ~40 kbp 
 
 
fragments into a fosmid vector. Subsequently, transformation of E. coli with the 
ligation mixture yields a library that is then plated out on media containing antibiotics. 
Resistant clones are picked and their inserts, which confer resistance, are sequenced 
[69, 79, 80]. Functional metagenomics is more time- and resource-consuming than 
the previously mentioned methods but has the advantage that identified resistance 
genes are confirmed to be functional, and that novel resistance genes (i.e. resistance 
genes with no significant similarity to those already deposited in the resistance gene 
databases) can be identified. Metatranscriptomic and metaproteomic approaches 
have not yet been used as dedicated tools to study antibiotic resistance though these 
approaches have been used to selectively draw conclusions about active resistance 
in environmental samples [81, 82]. The research in Chapter 2 of this thesis applies 
metatranscriptomics to study antibiotic resistance in a range of ecological niches. 
 
Figure 1.2 Different methodological approaches for the study of the resistome of bacterial 
communities. 
Microbial cultivation methods 
It is generally accepted that only a small fraction (~1%) of the total bacterial diversity 
can be readily cultivated in the laboratory ‒ often referred to as the ‘great plate count 
anomaly’ [83, 84]. Historically, isolation of uncultured bacterial species was mainly 
achieved by application of diverse growth media. However, in recent years, this 
strategy has had reduced success, especially regarding well-studied biological niches 
such as the human gut microbiota. For example, it took as much as 88 culture 
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conditions and 12,700 different picked colonies to only isolate 11 new bacterial 
species from a human faecal sample [85]. On the other hand, in a recent study 90% 
of species-level bacterial abundance in 6 human faecal samples was cultivated, 
thereby challenging the notion that the isolation of novel gut bacteria by classical 
cultivation methods has plateaued [86]. Bacteria will resist in vitro growth if essential 
aspects of their natural environment are not properly replicated. Essential aspects for 
bacterial growth can be divided in abiotic (including, but not restricted to, pH, 
nutrients, temperature, oxygen concentration and light intensity) and biotic (i.e. 
microbe-microbe and host-microbe interactions) factors, where biotic factors are 
typically much more difficult to mimic in vitro. Bacteria depending on other 
organisms to remove toxic end products or to supply essential growth factors [87] 
are examples of biotic factors. 
Nowadays, an increasing number of innovative culturing techniques are being 
applied, either involving implementation of non-traditional in vitro conditions ‒ at least 
in the initial stages of bacterial isolation ‒ or involving cultivation conditions 
specifically designed to isolate a target bacterium. Non-traditional methods include 
co-culturing and community culturing, which have already been successfully applied 
to cultivate previously uncultured bacteria [88]. Another novel cultivation method is 
the application of multi-well micro culture chips such as the MicroDish Culture Chip 
(MDCC) [89]. MDCCs allow bacterial colonies to grow at an unprecedented density 
on a porous aluminium oxide support through which small molecules (i.e. nutrients 
and growth factors) can diffuse (Figure 1.3). Bacterial cultivation of novel species has 
also been achieved by application of devices with >250 small growth chambers. 
Growth chambers with liquid media were inoculated with on average one bacterial 
cell from the sample of interest. Subsequently, the chambers, which have semi-
permeable membranes that only allow passing of small molecules, were placed in the 
natural environment of the bacteria [35, 90, 91]. These are only a few examples of 
innovative cultivation methods; however, more comprehensive reports can be found 
in various excellent review papers on this topic [87, 92, 93]. Isolation of uncultured 
bacterial species with a targeted approach requires at least some knowledge with 
respect to its metabolic requirements and necessary growth conditions. Predictions 
about these aspects may be derived from the full genome sequence of the target 
bacterium, or from a (partial) genome reconstructed from metagenomic data [94]. 
Even though this approach has promise, so far very few studies have been published 
that use genomic information to achieve cultivation [95, 96]. 
Figure 1.3 MicroDish Cultivation Chips (MDCCs) consist of a porous aluminium oxide support with on
top an acrylic polymer laminate containing discrete round compartments. MDCCs are available with up
to 180,000 compartments allowing for high-throughput cultivation of bacteria. (A) Cross-sectional 
diagram of a small part of the MDCC. (B) Photograph of an MDCC placed on top of blood agar. The 
pictures are from [89].
Environmental reservoirs of antibiotic resistance 
Resistance genes have been detected in a broad range of biological niches
associated with complex microbial communities [97]. Resistance genes in these so-
called reservoirs can theoretically spread into other environments and previously
non-resistant microbial populations, including human pathogens. Soil is the most
recognized reservoir, but also activated sludge [98], wastewater effluent [99], animals
[100, 101], oceans [102], lakes [97] and rivers [103] were found to harbour diverse 
clinically relevant resistance genes (Figure 1.4). Studies have shown that microbial 
resistomes cluster by ecological niche, and even within an ecological niche 
independent microbial communities appear to contain particular subsets of resistance 
genes [99, 104-106]. The fact that antibiotic resistance functions are largely 
constrained by ecology suggests that niches should be evaluated independently as
potential resistance reservoirs. It is still unknown which niches are the greatest
contributors to antibiotic resistance in human pathogens [105, 107]. Functional
antibiotic resistance genes have been identified in isolated caves and permafrost soil
indicating that resistant genes are ancient and predate the era of application of
antibiotics in human health care [108, 109]. Despite the high diversity of resistance 
genes in the miscellaneous environmental niches, only few cases have been 
documented involving transfer of environmental resistance genes to human 
pathogens. For example, the CTX-M β-lactamases that have been emerging in
Gram-negative pathogens [110] are known to have originated from environmental
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Kluyvera spp. [111]. As another example, the quinolone resistance-conferring qnrA 
gene was shown to have originated from Shewanella algae residing in marine and 
fresh water [112, 113]. Furthermore, in soil, aminoglycoside, tetracycline, 
sulfonamide, amphenicol and β-lactam resistance genes were identified that shared 
100% nucleotide identity with genes in known pathogens [43]. A perfect nucleotide 
identity either indicates that soil bacteria are a direct resistance source that can be 
harnessed by human pathogens, or it indicates that human pathogens or their genes 
have spread into other environments. To sum up, even though it is clear that 
environmental resistance has a clinical impact, little is yet known with respect to 
resistance exchange mechanisms and frequencies. 
One ecological niche that has been little-studied with regards to antibiotic 
resistance is the marine environment [102]. Given its microbial diversity, putatively 
comprising ~90% of total prokaryotic biomass on earth [114, 115], this niche is 
expected to harbour diverse antibiotic resistance functions. 
 
Figure 1.4 Potential routes of resistance gene dissemination. The arrows indicate possible routes 
through which antibiotic resistance can be disseminated. This figure was adapted from [69]. 
Sponge microbiota and antibiotic resistance 
Sponges arose 600-700 million years ago and since that time have been consistent 
members of benthic communities in the aquatic environment [116]. Their diet consists 
of plankton and organic debris that they filter from surrounding water. Although 
sponges actively feed on microorganisms, they frequently simultaneously harbour 
dense and highly diverse microbial communities that co-exist with the host in a 
symbiotic relationship [117, 118]. Various roles have been suggested by which the 
 
 
associated microbiota may benefit the sponge host, including in anti-predation [119], 
antifouling [119], nitrogen fixation [120], nitrification [121], carbon fixation [122] and 
defense against microbial pathogens [123]. 
Sponges can be divided according to the bacterial cell density in their tissues 
where they either have a bacterial concentration within the range of that in 
surrounding sea water (low-microbial-abundance sponges), or the bacterial 
concentration is increased by 2-4 orders of magnitude (high-microbial-abundance 
sponges) [124]. In high-microbial-abundance sponges, the microbial community can 
comprise as much as 40% of the sponge volume [125]. A meta-analysis of publicly 
available 16S rRNA gene sequences of sponge-associated bacteria showed that, 
overall, Proteobacteria, Actinobacteria, Bacteroidetes, Chloroflexi and Firmicutes are 
the dominant bacterial phyla [123]. However, there is great variation in sponge-
associated microbiota, and remarkably, bacterial communities seem to be largely 
host species-specific, with only few bacterial taxa shared between sponge species 
[126-128]. Only a small fraction of sponge-associated bacteria is currently amenable 
to cultivation [125], and this mainly includes bacteria from the phyla Proteobacteria, 
Firmicutes, Bacteroidetes and Actinobacteria [129-131]. 
Sponges, and in particular their associated microbes [132], are recognized as 
the richest source of bioactive compounds in the marine environment [133]. 
Accordingly, over the last decades, sponges have been receiving increasing interest 
from pharmaceutical and biotechnological industries as sources of drugs against e.g. 
cancer, viruses, inflammations and infections [134, 135]. Mining of unexplored 
sponge species has shown to consistently yield new bioactive compounds with novel 
chemical structures [136]. However, the discovery of novel drug leads is hampered 
by only a small fraction of sponge-associated bacteria being currently cultivable in the 
laboratory. Furthermore, logistical obstacles often preclude collecting large quantities 
of sponge material to be used in experiments [137]. In the natural environment, these 
bioactive compounds often provide important defensive capabilities to a static 
organism that is otherwise easily preyed upon [138]. Given that some sponges 
contain complex microbial communities that can produce diverse antimicrobials, it 
could be speculated that sponge holobionts also contain diverse antibiotic resistance 
genes. As a consequence, it is tempting to speculate that sponges might be a 
reservoir of yet unknown resistance genes that may be harnessed by bacteria in 
other environments. So far, research on functional antibiotic resistance genes in 
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sponge microbiota has been limited to a Bacillus sp. isolated from the sponge 
Haliclona simulans. The Bacillus sp. was found to contain two small plasmids, one of 
which harboured the tet(L) tetracycline resistance gene [139] whereas the other 
harboured the erm(T) erythromycin resistance gene [140]. Tetracycline and 
erythromycin antibiotics are both commonly used in the clinics [141], and as such, 
these findings indicate that sponges are potential sources of emerging resistance. A 
recent study detected the mecA, mupA, tetL and qnrB resistance genes in the 
sponge Petromica citrina by PCR with gene-specific primers [142]. With the 
uncovered bacterial diversity in these metazoans it is likely that both a large diversity 
of antibiotics as well as their concomitant resistance genes may be mapped. 
The marine bacterial genus Pseudovibrio 
Members of the α-proteobacterial genus Pseudovibrio have been isolated exclusively 
from marine habitats, that is, those habitats that depend on salt water from the sea. 
The first published type species was Pseudovibrio denitrificans in 2004 [143], and 
since then the genus has been expanded to include six species [144, 145]. 
Interestingly, studies have shown that Pseudovibrio spp. comprise most of the 
cultivable fraction of various sponge species [146-148], while never simultaneously 
being isolated from nor detected in surrounding sea water [149, 150]. This led to the 
hypothesis that Pseudovibrio spp. have a symbiotic relationship with sponges [151]. 
The finding that Pseudovibrio was transferred via the germline in the sponge Mycale 
laxissima [150] strengthened this hypothesis. Besides sponges, Pseudovibrio spp. 
have been isolated from ascidians [152], a flatworm [144], tunicates [153, 154] and 
corals [155, 156]. Even though Pseudovibrio spp. appear to be enriched in various 
marine animals, they have also been isolated from sea water [143, 157]. Members of 
this genus have received high scientific interest as a source of novel clinically 
relevant bioactive compounds with potent broad-spectrum antimicrobial activity [158, 
159]. To date, three antimicrobial compounds have been identified. Pseudovibrio 
ascidiaceicola F423T was found to produce phenazine [160], the coral-associated 
Pseudovibrio strain PaH3.28 was found to produce the peptide pseudovibrocin [156], 
and the algae-associated Pseudovibrio sp. D323 was found to produce tropodithietic 
acid [161]. Numerous scientific articles speculate on the symbiotic role that 
Pseudovibrio spp. may have in sponges. Roles that have been suggested include 
functions in nutrient uptake [149], denitrification [162, 163], sponge health [164, 165], 
 
 
modulation of the host immune system [151], and host defense [161, 166]. Although 
it is now well-established that microbes are important for sponge health, the exact 
mechanisms behind the beneficial interactions remain to be elucidated [123]. 
The human gut microbiota and antibiotic resistance 
The human digestive tract contains a community of microorganisms, collectively 
referred to as the human gut microbiota. The term gut microbiome is less defined but 
almost always includes the genes and genomes of the gut microbiota [167]. Anoxic 
conditions in the gut dictate that gut residents are predominantly anaerobic or 
facultatively anaerobic [168]. The number of microorganisms in the human digestive 
tract is estimated to have the same order of magnitude as the number of human body 
cells (i.e. 3-4 × 1013) [169], and is dominated by the bacterial phyla Firmicutes, 
Bacteroidetes, Proteobacteria, Actinobacteria [170]. Bacteria from other bacterial 
phyla, fungi, viruses, and archaea are also present but at a lower relative abundance 
[170, 171]. A stable gut microbiota is essential for the health of the human host with 
beneficial roles in e.g. colonization resistance, nutrition, metabolism of non-digestible 
dietary compounds and xenobiotics, proliferation and differentiation of intestinal 
mucosal epithelial cells, and homeostasis of the immune system [172-175]. 
Administration of antibiotics can result in gut microbiota dysbiosis with antibiotic-
induced alterations potentially persisting years after treatment [176]. Besides 
negatively affecting the health of the human host, antibiotic treatment will also enrich 
the gut microbiota with resistant bacteria and resistance genes [177]. In fact, once an 
antibiotic resistance determinant has been introduced into the gut microbiota, it will 
generally continue to persist at some low level, and reintroduction of the antibiotic will 
reselect resistant strains despite months or even years of non-use [178]. As a result, 
administration of antibiotics will lead to a greater resistance reservoir in the gut that 
may be harnessed by pathogenic bacteria. This causal relation was also observed in 
a study that assessed faecal metagenomes of 252 individuals to show that the 
resistome correlated more strongly with antibiotics that were on the market longer 
[104]. It is important to note that also in the gut microbiota from isolated human 
populations (i.e. remote populations that are unexposed to the effects of 
anthropogenic antibiotic pressure) resistance genes have been detected [179-181], 
suggesting either the presence of ancestral resistance genes, or the spread of 
resistance genes to remote areas [177]. 
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Chapter 1 
 
The high density and diversity of bacteria in the gut microbiota provides ample 
opportunity for exchange of resistance genes between different taxa to occur. 
Resistance gene transfer from commensal gut bacteria to opportunistic pathogens 
appears to be relatively rare [80]. More often, gut commensals appear to function as 
reservoir-species of resistance genes that may be acquired by incoming pathogens. 
For example, Bacteroidetes have been suggested to be an important resistance 
reservoir as they can acquire DNA from a wide range of bacterial taxa [182]. The 
carbapenem-resistance-conferring β-lactamase NDM-1 was first detected in the 
opportunistic pathogen Klebsiella pneumoniae in 2008, but is now hosted by various 
gut commensals belonging to the Enterobacteriaceae [183]. This is alarming because 
carbapenems are often the last resort in the treatment of infections by Gram-negative 
pathogens [184]. Furthermore, Sommer and colleagues [185] identified functional 
resistance genes in cultured aerobic isolates, where nearly half of these genes was 
100% identical to resistance genes harboured by major human pathogens. These 
results, and those of other studies [186-188], support the notion that the gut 
microbiota is not merely a resistance reservoir but also a mixing vessel that 
contributes to the generation of (multi-)antibiotic resistant pathogens. 
Thesis outline 
Chapter 2 studies the expression of resistance genes in natural environments i.e. 
those environments that have not been subjected to anthropogenic antibiotic 
pressure in the recent past. In addition, local antibiotic biosynthesis is assessed by 
investigating the expression of relevant secondary metabolite gene clusters. The 
ecological niches that were investigated are sea bacterioplankton, a marine sponge, 
forest soil, sub-seafloor sediment and the gut microbiota of humans, mice and pigs. 
In all studied ecological niches resistance genes were found to be expressed, albeit 
with niche-specific differences. Resistance gene expression could not be linked to 
antibiotic biosynthesis. 
Chapter 3 describes a high-throughput cultivation experiment in which the 
cultivable bacterial fraction was studied from the Mediterranean sponges Aplysina 
aerophoba, Corticium candelabrum and Petrosia ficiformis. Bacterial populations 
growing on different agar media were analysed by 16S ribosomal RNA (rRNA) gene 
amplicon sequencing. The results showed that previously uncultured bacteria can be 
cultivated by conventional plating. Notably, many species were cultivated from the 
phylum Actinobacteria, which are important sources of novel bioactive compounds.
Thirty-one different bacterial strains were cultivated up to pure culture from agar 
media containing (combinations of) antibiotics, and further phenotypically
characterized. 
In Chapter 4 the presence and diversity of functional resistance genes in the 
sponges A. aerophoba, C. candelabrum and P. ficiformis is investigated. Small-insert 
libraries were prepared in Escherichia coli with sponge holobiont DNA, as well as
with pooled DNA from the 31 bacterial isolates obtained from these sponges as
described in Chapter 3. The study revealed diverse and/or novel resistance genes
that conferred resistance to ampicillin, D-cycloserine, gentamicin, amikacin,
trimethoprim, chloramphenicol and rifampicin. 
Chapter 5 entails a comparative genomics study of the marine bacterial genus 
Pseudovibrio. Thirty-one Pseudovibrio genomes were analysed, including those of 
five type strains, as well as 18 isolates obtained in the cultivation experiment 
described in Chapter 3. The phylogeny of the Pseudovibrio strains was resolved, and 
features regarding symbiosis, secondary metabolite biosynthesis and antibiotic
resistance were studied. Various findings support the hypothesis that Pseudovibrio
spp. are symbionts of sponges.
Chapter 6 describes a cultivation experiment that aims to investigate yet 
unexplored bacterial taxa of the human gut as reservoirs of antibiotic resistance. 
Therefore, faecal samples from 20 intensive care patients that received antibiotic
treatment were inoculated anaerobically on a porous aluminium oxide chip on top of
agar media. Subsequently, the bacterial growth communities were analysed by 16S 
rRNA gene amplicon sequencing. We detected growth of >10 novel species at ≥2% 
relative abundance. A multi-drug resistant Ruminococcaceae sp. was obtained by
targeted isolation.
Chapter 7 summarizes and discusses the work described in this thesis. The 
results are related to current knowledge in the fields of antibiotic resistance and 
bacterial cultivation. The major challenges that should be addressed as part of future 
research are discussed. 
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Abstract 
Antibiotic resistance genes are found in a broad range of ecological niches 
associated with complex microbiota. Here we investigated if resistance genes are not 
only present, but also transcribed under natural conditions. Furthermore, we 
examined the potential for antibiotic production by assessing the expression of 
associated secondary metabolite biosynthesis gene clusters. Metatranscriptome 
datasets from intestinal microbiota of four human adults, one human infant, 15 mice 
and six pigs, of which only the latter have received antibiotics prior to the study, as 
well as from sea bacterioplankton, a marine sponge, forest soil and sub-seafloor 
sediment, were investigated. We found that resistance genes are expressed in all 
studied ecological niches, albeit with niche-specific differences in relative expression 
levels and diversity of transcripts. For example, in mouse and human infant 
microbiota predominantly tetracycline resistance genes were expressed while in 
human adult microbiota the spectrum of expressed genes was more diverse, and 
also included -lactam, aminoglycoside and macrolide resistance genes. Resistance 
gene expression could result from the presence of natural antibiotics in the 
environment, although we could not link it to expression of corresponding secondary 
metabolites biosynthesis clusters. Alternatively, resistance gene expression could be 
constitutive, or these genes serve alternative roles besides antibiotic resistance. 
 
 
Introduction 
Antibiotic resistance genes are ubiquitous in bacterial communities in various 
ecological niches [97]. Metagenomic studies have revealed the presence of 
resistance determinants in environments as different as soil, gut, sea water, caves 
and glaciers [108, 109, 185, 189-192]. Bacterial communities in these and other 
ecological niches contain particular subsets of antibiotic resistance determinants, and 
can thus be seen as natural reservoirs from where they can theoretically spread into 
other environments and previously non-resistant microbial populations, including 
pathogens, in a process called horizontal gene transfer [45, 57, 193, 194]. The 
advantage that resistance genes confer to microorganisms exposed to anthropogenic 
antibiotic pressure is undisputed. However, the role of resistance genes in bacteria in 
environments not directly affected by application of antibiotics is less clear [19], and 
is not limited to antimicrobial defence. Bacteria can possess proteins that provide 
antibiotic resistance beyond their primary function [195]. For instance, Providencia 
stuartii possesses an enzyme involved in the acetylation of peptidoglycan, and the 
similarity of its substrate to certain aminoglycosides causes this enzyme to also 
provide antibiotic resistance [196].  
Despite a growing body of knowledge about the distribution of antibiotic 
resistance genes in natural environments (i.e. those environments in which the 
human impact is limited), little is known about their expression, even though gene 
expression is a better proxy for functional activity than gene content [197]. We 
therefore hypothesized that a comprehensive metatranscriptome analysis could 
provide additional knowledge about resistance gene functioning and regulation. Due 
to the technical difficulties associated with processing of RNA samples, few 
metatranscriptome studies of microbial communities have been published [198-200]. 
However, recent advances, particularly in the field of next generation sequencing 
technologies, have resulted in increased availability of large metatranscriptome 
datasets (>106 reads). In order to investigate the actual expression of resistance 
genes in natural environments, we evaluated both in-house generated as well as 
public metatranscriptomes. We investigated the expression levels and richness of 
genes conferring resistance to ten types of antibiotics, and furthermore assessed 
local production of these antibiotics by investigating the expression of relevant 
secondary metabolite gene clusters. 
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Results 
Cumulative relative expression of antibiotic resistance genes 
Reads from metatranscriptome datasets from seven different ecological niches 
(human, mouse and pig intestinal microbiota, sea bacterioplankton, a marine sponge, 
forest soil and sub-seafloor sediment) were compared with genes from the resistance 
determinants database (RED-DB, www.fibim.unisi.it/REDDB) using megaBLAST. Per 
niche, a cumulative total was obtained for reads mapping to the different resistance 
genes, with the requirement that ≥3 reads aligned per gene. In order to allow for 
comparison of gene expression in different datasets, we determined the relative 
abundance of resistance gene transcripts as a percentage of the total number of non-
ribosomal RNA reads. Expression of resistance genes was detected in all seven 
ecological niches (Figure 2.1), of which only the pig microbiota was knowingly 
exposed to antibiotics (i.e. a mixture of neomycin and procaine benzylpenicilline) 
approximately two to four weeks prior to taking the samples used for RNA extraction. 
Highest relative expression levels were observed in the sea bacterioplankton sample 
(0.7%), whereas resistance gene transcripts comprised less than 0.06% of the reads 
in the other investigated niches. For human adults and pigs relative abundance of 
resistance gene transcripts was in the same order of magnitude (0.009% ± 0.014 and 
0.028% ± 0.012 [s.d.], respectively), whereas it was more than 15-fold lower in mice 
(4.4 x 10-4 % ± 6.8 x 10-4) and the human infant (5.7 x 10-4 %). 
Expression of genes conferring resistance to ten types of antibiotics 
The distribution of reads aligning to resistance genes that confer resistance to ten 
different types of antibiotics was analysed. Genes in the RED-DB are grouped 
according to resistance to the following types of antibiotics: aminoglycosides, β-
lactams, chloramphenicol, glycopeptides, macrolides, oxazolidinones, quinolones, 
sulphonamides, tetracyclines and trimethoprim. Expression of genes involved in 
resistance to most types of antibiotics (6/10) was detected at least in one of the 
datasets analysed, with the exception of genes conferring resistance to quinolone, 
oxazolidinone, sulphonamide and trimethoprim antibiotics (Figure 2.2). In human gut 
microbiota β-lactam, aminoglycoside, macrolide and tetracycline resistance genes 
were expressed. In mice intestinal content samples, in which the cumulative relative 
expression of resistance genes was the lowest for all gut-associated niches 
examined here, primarily tetracycline resistance genes were found to be expressed. 
 
 
 
Figure 2.1 Relative cumulative expression of antibiotic resistance genes in different ecological niches. 
The relative expression is based on the total of number of reads that aligned to genes of the RED-DB, 
and calculated as a percentage of the non-ribosomal RNA reads. Error bars represent one standard 
deviation. 
One-way ANOSIM showed that resistance profiles were not significantly different 
between different mammalian hosts when comparing the groups of human adults, 
mice and pigs (global R = 0.089 p = 0.197. A comparison of antibiotic resistance 
gene expression profiles of the microbiota of individual human adults, pigs and mice 
indicated there are substantial inter-individual differences within the groups (Figure 
2.3). In the intestinal samples obtained from the human infant, only the expression of 
a tetracycline resistance gene was detected. The profiles of expressed resistance 
genes observed in forest soil and sub-seafloor sediment communities stood out 
because expression of chloramphenicol resistance genes made up ≥20% of the 
cumulative total whereas in the other ecological niches they were not detected. In 
sea bacterioplankton and the marine sponge the expression of two β-lactam 
resistance genes was detected, namely blaTEM-1 and blaTEM-116. These genes share 
97% nucleotide identity and therefore it is possible that in reality only a single β-
lactam resistance gene is being expressed that is closely related to the two known 
genes. In sea bacterioplankton as much as 0.7% of the non-ribosomal transcripts 
aligned with the two blaTEM genes.  
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Figure 2.2 Resistance gene expression profiles for different ecological niches investigated for 
resistance to ten types of antibiotics. Genes conferring resistance to quinolone, oxazolidinone and 
trimethoprim antibiotics were not detected. The numbers in parentheses correspond to the total 
number of reads that aligned to resistance genes. 
Richness of expressed antibiotic resistance genes 
Read mapping was performed against single gene representatives of gene clusters 
defined by a 97% sequence identity threshold, in the following referred to as unique 
genes, and as a result, the number of detected genes can be taken as a measure for 
resistance gene richness. In human adult and pig microbiota the highest numbers of 
unique resistance genes were detected, namely 34 and 41 respectively. In the sea 
bacterioplankton and sponge metatranscriptomes, only two different resistance 
genes were detected. Detected resistance genes were classified according to which 
type of antibiotics they confer resistance (Figure 2.4, Table S2.2). It should be noted 
that the number of unique genes detected per niche is influenced by dataset size, 
sampling date, and the number of sampling sites from which data was analysed. 
Rarefaction curves in most cases (19/29) did not reach an asymptote, which 
suggests that resistance gene richness is underestimated to some extent (Figure 
S2.1). Regression analysis was performed to further investigate this feature for the  
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Figure 2.3 Heat map representing relative expression levels of resistance genes in the gut microbiota
of individual humans, pigs and mice. Resistance genes are grouped based on resistance to ten types 
of antibiotics.
human and pig microbiota, as for these only the rarefaction curve of human adult 
individual 1 reached saturation (Table S2.1), and because the highest number of 
unique resistance genes was detected in these niches. Regression analysis equation 
two provided the best fit, of which the results indicate that in most cases (8/10) the 
detected number of resistance genes is less than one gene different with respect to 
the expected number of resistance genes at infinite sample size. Therefore the 
datasets are expected to be sufficiently large to detect most of the resistance genes
that were expressed.
Expression of secondary metabolite biosynthesis (SMB) clusters 
We also investigated whether the expression of antibiotic resistance genes can be 
associated with local antibiotic biosynthesis. To this end, we used the antibiotics and 
secondary metabolite analysis shell (antiSMASH) pipeline, which focuses on the 
production of secondary metabolites, amongst which are also antibiotics [201]. Profile 
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Figure 2.2 Resistance gene expression profiles for different ecological niches investigated for 
resistance to ten types of antibiotics. Genes conferring resistance to quinolone, oxazolidinone and 
trimethoprim antibiotics were not detected. The numbers in parentheses correspond to the total 
number of reads that aligned to resistance genes. 
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bacterioplankton and sponge metatranscriptomes, only two different resistance 
genes were detected. Detected resistance genes were classified according to which 
type of antibiotics they confer resistance (Figure 2.4, Table S2.2). It should be noted 
that the number of unique genes detected per niche is influenced by dataset size, 
sampling date, and the number of sampling sites from which data was analysed. 
Rarefaction curves in most cases (19/29) did not reach an asymptote, which 
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S2.1). Regression analysis was performed to further investigate this feature for the  
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Chloramphenicol
Glycopeptides
Tetracyclines
Macrolides
Aminoglycosides
β-lactams
Figure 2.3 Heat map representing relative expression levels of resistance genes in the gut microbiota
of individual humans, pigs and mice. Resistance genes are grouped based on resistance to ten types 
of antibiotics.
human and pig microbiota, as for these only the rarefaction curve of human adult 
individual 1 reached saturation (Table S2.1), and because the highest number of 
unique resistance genes was detected in these niches. Regression analysis equation 
two provided the best fit, of which the results indicate that in most cases (8/10) the 
detected number of resistance genes is less than one gene different with respect to 
the expected number of resistance genes at infinite sample size. Therefore the 
datasets are expected to be sufficiently large to detect most of the resistance genes
that were expressed.
Expression of secondary metabolite biosynthesis (SMB) clusters 
We also investigated whether the expression of antibiotic resistance genes can be 
associated with local antibiotic biosynthesis. To this end, we used the antibiotics and 
secondary metabolite analysis shell (antiSMASH) pipeline, which focuses on the 
production of secondary metabolites, amongst which are also antibiotics [201]. Profile 
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Figure 2.4 Richness of expressed resistance genes detected in the different ecological niches, based 
on the number of unique genes that were detected while using RED-DB entries clustered according to 
a 97% identity threshold. 
hidden Markov Models (hMMs) from antiSMASH of domains of enzymes involved in 
the construction of the backbones of various types of antibiotics were used to 
investigate antibiotic biosynthesis. We investigated genes responsible for the 
biosynthesis of type I and II polyketides, non-ribosomal peptides and 
aminoglycosides/aminocyclitols (see Table S2.3 for the domains and the complete 
results), which can be involved in, respectively, the biosynthesis of macrolides, 
tetracyclines, β-lactams and aminoglycosides (Figure 2.5). In the gut microbiota of 
humans (adult and infant), pigs and mice, the marine sponge and sub-seafloor 
sediment, very little expression of SMB genes was detected. The lowest relative 
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expression of SMB genes was found in human individual one, for whom only a single 
domain was detected by just five reads, suggesting that expression of SMB genes 
was very low. The expression of SMB genes in sea bacterioplankton and forest soil 
was at least an order of magnitude higher than in the other investigated 
environments. No associations between the expression of specific SMB clusters and 
resistance genes were uncovered, and their cumulative expression levels varied per 
ecological niche (Figure. S2.2). 
 
Figure 2.5 Cumulative relative expression of secondary metabolite biosynthesis domains involved in 
the production of type I polyketides, type II polyketides, non-ribosomal peptides and aminoglycosides. 
Error bars represent one standard deviation. 
Discussion 
Our explorative metatranscriptome analysis showed that antibiotic resistance genes 
are not only present, but also expressed in a broad variety of natural environments, 
exemplified here by samples derived from the intestinal tract of humans, mice, as 
well as from sea bacterioplankton, a marine sponge, forest soil and sub-seafloor 
sediment. Differences with respect to resistance gene expression profiles were 
observed between the ecological niches, and resistance genes richness was highest 
in human and pig microbiota. We find within-niche variability in resistance gene 
expression in gut microbiota of individual human adults, pigs and mice, which is 
consistent with metagenome-level studies wherein inter-individual variation in 
resistance potential was observed [104, 202]. It should be noted that the resistance 
profiles observed in this study are not necessarily representative for specific habitats 
since even samples from the same habitat but taken at different locations have been 
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expression of SMB genes was found in human individual one, for whom only a single 
domain was detected by just five reads, suggesting that expression of SMB genes 
was very low. The expression of SMB genes in sea bacterioplankton and forest soil 
was at least an order of magnitude higher than in the other investigated 
environments. No associations between the expression of specific SMB clusters and 
resistance genes were uncovered, and their cumulative expression levels varied per 
ecological niche (Figure. S2.2). 
 
Figure 2.5 Cumulative relative expression of secondary metabolite biosynthesis domains involved in 
the production of type I polyketides, type II polyketides, non-ribosomal peptides and aminoglycosides. 
Error bars represent one standard deviation. 
Discussion 
Our explorative metatranscriptome analysis showed that antibiotic resistance genes 
are not only present, but also expressed in a broad variety of natural environments, 
exemplified here by samples derived from the intestinal tract of humans, mice, as 
well as from sea bacterioplankton, a marine sponge, forest soil and sub-seafloor 
sediment. Differences with respect to resistance gene expression profiles were 
observed between the ecological niches, and resistance genes richness was highest 
in human and pig microbiota. We find within-niche variability in resistance gene 
expression in gut microbiota of individual human adults, pigs and mice, which is 
consistent with metagenome-level studies wherein inter-individual variation in 
resistance potential was observed [104, 202]. It should be noted that the resistance 
profiles observed in this study are not necessarily representative for specific habitats 
since even samples from the same habitat but taken at different locations have been 
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known to differ more than 100-fold in terms of relative expression levels of individual 
resistance genes [203]. On the other hand, microbial resistomes have been shown to 
cluster by habitat when soil, human and water resistomes were compared [105]. 
Expression of resistance genes against tetracyclines and β-lactams was most 
abundant in the gut microbiota of mammals and bacterial communities residing in 
aquatic environments, respectively. In the human gut microbiota specifically, 
resistance genes against β-lactams, macrolides and tetracyclines cumulatively 
comprised >90% of the total expression. Resistance genes against these types of 
antibiotics were also most abundant in metagenome datasets of human gut 
microbiota [202]. We did not detect the expression of resistance genes against 
quinolone, oxazolidinone, sulphonamide and trimethoprim antibiotics. These 
antibiotics are all synthetic, and therefore these results might indicate that there has 
not yet been sufficient time for the corresponding resistance genes to spread into 
environmental reservoirs [108]. In the pig microbiota β-lactam and aminoglycoside 
resistance genes were detected, which might have resulted from these animals 
having received neomycin and procaine benzylpenicilline two to four weeks prior to 
sampling. 
The expression of polyketide type I and II, non-ribosomal peptide, and 
aminoglycoside/aminocyclitol biosynthesis genes, which can potentially be involved 
in antibiotic biosynthesis, was detected in forest soil and sea bacterioplankton. This is 
consistent with previous reports [204-206]. In turn, in gut microbiota there was very 
little indication for potential antibiotic biosynthesis. Therefore, since antibiotic 
pressure seems to be absent in the sampled gut microbiota, it can be argued that 
antibiotic resistance gene expression in gut microbiota is either constitutive or 
controlled at least in part independently of the presence of antibiotics. Past studies 
already indicated that that expression of antibiotic resistance genes can be increased 
following mutations or movement of genetic elements [207]. As such, under antibiotic 
pressure, resistance genes that are constitutively expressed at low levels could 
become more active. For example, the expression of the ampC gene, which was 
detected in all human adults, has been shown to vary depending on a single mutation 
in the gene promoter [208].  
There are two limitations to the undertaken approach to detect the expression 
of resistance genes that warrant consideration. The first limitation is that the number 
of characterized and deposited resistance genes in the RED-DB differs per ecological 
 
 
niche. As a consequence the number of expressed resistance genes can be 
underestimated if habitats have been studied less extensively. The second limitation 
is that we require the detection of 200 bp sequences instead of full-length resistance 
genes, and that as a result genes might be detected with other functional roles that 
share homology with resistance genes. Still, the cut-offs we used were conservative 
compared to those applied in previous studies [190, 209]. 
In human adult gut microbiota a large fraction of expressed resistance genes 
confer resistance to macrolide antibiotics. For this reason, and also since there is no 
indication of macrolide biosynthesis (in three out of four of the human adults), it can 
be suggested that the expression of macrolide resistance genes is either a result of 
prior anthropogenic antibiotic pressure as a result of which these genes are still 
constitutively expressed at a low level, or that the corresponding proteins serve other 
roles besides antibiotic resistance. A number of alternative physiological and 
metabolic functions have been proposed for two genes in M. tuberculosis that confer 
resistance to aminoglycosides, such as immune modulation and alleviation of cellular 
stress [210]. Nevertheless, the general consensus in literature is that the presence of 
antibiotic resistance genes in the gut microbiota is the result of anthropogenic 
antibiotic use, and there are numerous studies to support this claim [104, 211, 212]. 
In contrary to what was observed in humans and pigs in this study, in mice gut 
microbiota no macrolide resistance genes were found to be expressed, a result that 
could well be explained by lower exposure of mice to macrolide antibiotics, or 
antibiotics in general. This might also explain the overall lower levels and diversity of 
resistance gene expression detected in the gut microbiota of these animals. In the 
gut microbiota of the human infant expression of two tetracycline resistance genes 
was detected, as opposed to a variety of resistance genes in human adults. This 
could be because intestinal microbiota of babies generally have lower species 
diversity [211] and therefore species that contain resistance genes have not 
colonized the gut at levels that would allow detection of their transcripts. Remarkably, 
the human infant had not been exposed to antibiotics prior to the sampling and hence 
the observed naïve expression of tetracycline resistance genes indicates that 
antibiotics are not needed to trigger expression of cognate resistance genes. Indeed, 
one of the two transcribed tetracycline resistance genes shows high identity with the 
tetM gene which is known to be constitutively expressed but highly mobile as found in 
various conjugative transposons, such as Tn916 [212, 213]. 
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quinolone, oxazolidinone, sulphonamide and trimethoprim antibiotics. These 
antibiotics are all synthetic, and therefore these results might indicate that there has 
not yet been sufficient time for the corresponding resistance genes to spread into 
environmental reservoirs [108]. In the pig microbiota β-lactam and aminoglycoside 
resistance genes were detected, which might have resulted from these animals 
having received neomycin and procaine benzylpenicilline two to four weeks prior to 
sampling. 
The expression of polyketide type I and II, non-ribosomal peptide, and 
aminoglycoside/aminocyclitol biosynthesis genes, which can potentially be involved 
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niche. As a consequence the number of expressed resistance genes can be 
underestimated if habitats have been studied less extensively. The second limitation 
is that we require the detection of 200 bp sequences instead of full-length resistance 
genes, and that as a result genes might be detected with other functional roles that 
share homology with resistance genes. Still, the cut-offs we used were conservative 
compared to those applied in previous studies [190, 209]. 
In human adult gut microbiota a large fraction of expressed resistance genes 
confer resistance to macrolide antibiotics. For this reason, and also since there is no 
indication of macrolide biosynthesis (in three out of four of the human adults), it can 
be suggested that the expression of macrolide resistance genes is either a result of 
prior anthropogenic antibiotic pressure as a result of which these genes are still 
constitutively expressed at a low level, or that the corresponding proteins serve other 
roles besides antibiotic resistance. A number of alternative physiological and 
metabolic functions have been proposed for two genes in M. tuberculosis that confer 
resistance to aminoglycosides, such as immune modulation and alleviation of cellular 
stress [210]. Nevertheless, the general consensus in literature is that the presence of 
antibiotic resistance genes in the gut microbiota is the result of anthropogenic 
antibiotic use, and there are numerous studies to support this claim [104, 211, 212]. 
In contrary to what was observed in humans and pigs in this study, in mice gut 
microbiota no macrolide resistance genes were found to be expressed, a result that 
could well be explained by lower exposure of mice to macrolide antibiotics, or 
antibiotics in general. This might also explain the overall lower levels and diversity of 
resistance gene expression detected in the gut microbiota of these animals. In the 
gut microbiota of the human infant expression of two tetracycline resistance genes 
was detected, as opposed to a variety of resistance genes in human adults. This 
could be because intestinal microbiota of babies generally have lower species 
diversity [211] and therefore species that contain resistance genes have not 
colonized the gut at levels that would allow detection of their transcripts. Remarkably, 
the human infant had not been exposed to antibiotics prior to the sampling and hence 
the observed naïve expression of tetracycline resistance genes indicates that 
antibiotics are not needed to trigger expression of cognate resistance genes. Indeed, 
one of the two transcribed tetracycline resistance genes shows high identity with the 
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various conjugative transposons, such as Tn916 [212, 213]. 
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Surprisingly, in sea bacterioplankton, the expression of AR genes was more than one 
order of magnitude higher than in any other ecological niche. It was comprised of two 
highly similar β-lactamase genes, namely blaTEM-1 and blaTEM-116. The same two 
genes were also found to be expressed in a metatranscriptome dataset from the 
marine sponge Crambe crambe. The blaTEM-1 gene is commonly present in cloning 
vectors, and therefore lab contamination can be suspected; however, this possibility 
is disputed by the fact that the gene is detected in two separate marine 
metatranscriptome datasets that have been independently generated. The functional 
role of a β-lactamase in a marine environment is yet unknown. A substrate for this 
enzyme might be periplasmic or cell-wall bound, as excreted β-lactams could quickly 
be diluted to negligible concentrations in the open sea. On the other hand, the         
β-lactamase could also have an extra-cellular role if the bacteria occasionally reside 
in places with a high cell density (micro niches), such as corals or sponges.        
Roles of these resistance genes in (the disruption of) cell signalling and antimicrobial 
activity can be hypothesized [19]. Another possibility is that these β-lactamases    
have no role in the aquatic environment but that they appeared through        
resistance gene dissemination, such as via human-derived sewage or animal faeces 
[100].  
Acquired resistance to antibiotics is often associated with a fitness cost, which 
translates itself into a reduced bacterial growth rate. It has therefore been proposed 
that in an antibiotic-naïve environment in the long term, resistant strains will be 
outcompeted by susceptible strains [214, 215]. Still, Andersson and Hughes (2010) 
argued that reversal to a susceptible state proceeds so slowly, if at all, that the fitness 
cost has no practical importance. Moreover, it cannot be excluded that resistance 
genes co-localize, i.e. they are genetically linked, or that compensatory mutations 
have occurred that abolish fitness costs. It has been shown that selection for 
resistant bacteria occurs at antibiotic concentrations far below the minimal inhibitory 
concentration [216]. This suggests that resistance can be maintained in bacterial 
populations even if antibiotics are produced locally at a low concentration, or as a 
result of anthropogenic intervention. 
In summary, a broad diversity of resistance genes was found expressed under 
natural conditions in the gut microbiota of mammals, as well as in aquatic and 
terrestrial bacterial communities, with niche-specific differences in relative expression 
levels and diversity of transcripts. Although the expression of antibiotic resistance 
genes could not be associated with expression of relevant secondary metabolite 
biosynthesis clusters, we do see a rich functional reservoir of resistance genes that 
could be accessible by human pathogens.
Materials and methods 
Metatranscriptome data 
In addition to in-house generated metatranscriptome datasets, literature was
searched for available metatranscriptome datasets that contain at least 1 x 106 reads 
(see Table S2.4 for all datasets included in this study and their accession numbers). 
The analysed metatranscriptome data were generated from the intestinal microbiota 
of four human adults, one human infant, six pigs and 15 mice, as well as from the 
orange-red encrusting sponge (Crambe crambe), forest soil [217], sub-seafloor
sediment [218] and sea bacterioplankton [219]. Except for the pig microbiota, none of
the environments that were sampled did experience anthropogenic antibiotic
pressure. The pig microbiota metatranscriptome data were included because pigs
regularly receive antibiotics during intensive farming, and as such expression of 
resistance genes in this niche is of particular interest [220]. The human adult 
metatranscriptome data were obtained from ileostoma effluent samples of four 
human adults [221], as described by Leimena et al. [222]. The metatranscriptome 
data of the human infant was generated from faecal samples collected from a Finnish 
baby girl at three time points in the first six months of life (at the ages of 131 [sample 
2B], 165 [samples 2D_1 and 2D_2] and 171 [sample 2E] days). Multiple time points
were included (data from multiple time points was studied as a single entity) because 
the gut microbiota of human babies is very dynamic [211, 223]. Approximately 0.5 g 
of each faecal sample was processed with the RNAlater protocol [224] and stored at -
70 °C prior to RNA isolation. RNA isolation was done with a protocol based on 
mechanical disruption [224], after which the quality and yield of the RNA was 
assessed with the NanoDrop 1000 Spectrophotometer (Thermo Scientific). 
Sequencing was performed on a Illumina HiSeq 2500 instrument. An additional pre-
sequencing rRNA removal step with the Rib-Zero kit (Epicentre) was included for
sample 2D_2 . The pig metatranscriptome data were those generated from proximal 
colon samples of pig 2,pig 4, pig 5, pig 6, pig 8 and pig 10 from a study by Haenen et
al. [225], and in this study these pigs are addressed as pigs 1 to 6, respectively. It is 
important to note that the pigs received Neopen (MSD Animal Health) intramuscularly
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Surprisingly, in sea bacterioplankton, the expression of AR genes was more than one 
order of magnitude higher than in any other ecological niche. It was comprised of two 
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genes were also found to be expressed in a metatranscriptome dataset from the 
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is disputed by the fact that the gene is detected in two separate marine 
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enzyme might be periplasmic or cell-wall bound, as excreted β-lactams could quickly 
be diluted to negligible concentrations in the open sea. On the other hand, the         
β-lactamase could also have an extra-cellular role if the bacteria occasionally reside 
in places with a high cell density (micro niches), such as corals or sponges.        
Roles of these resistance genes in (the disruption of) cell signalling and antimicrobial 
activity can be hypothesized [19]. Another possibility is that these β-lactamases    
have no role in the aquatic environment but that they appeared through        
resistance gene dissemination, such as via human-derived sewage or animal faeces 
[100].  
Acquired resistance to antibiotics is often associated with a fitness cost, which 
translates itself into a reduced bacterial growth rate. It has therefore been proposed 
that in an antibiotic-naïve environment in the long term, resistant strains will be 
outcompeted by susceptible strains [214, 215]. Still, Andersson and Hughes (2010) 
argued that reversal to a susceptible state proceeds so slowly, if at all, that the fitness 
cost has no practical importance. Moreover, it cannot be excluded that resistance 
genes co-localize, i.e. they are genetically linked, or that compensatory mutations 
have occurred that abolish fitness costs. It has been shown that selection for 
resistant bacteria occurs at antibiotic concentrations far below the minimal inhibitory 
concentration [216]. This suggests that resistance can be maintained in bacterial 
populations even if antibiotics are produced locally at a low concentration, or as a 
result of anthropogenic intervention. 
In summary, a broad diversity of resistance genes was found expressed under 
natural conditions in the gut microbiota of mammals, as well as in aquatic and 
terrestrial bacterial communities, with niche-specific differences in relative expression 
levels and diversity of transcripts. Although the expression of antibiotic resistance 
genes could not be associated with expression of relevant secondary metabolite 
biosynthesis clusters, we do see a rich functional reservoir of resistance genes that 
could be accessible by human pathogens.
Materials and methods 
Metatranscriptome data 
In addition to in-house generated metatranscriptome datasets, literature was
searched for available metatranscriptome datasets that contain at least 1 x 106 reads 
(see Table S2.4 for all datasets included in this study and their accession numbers). 
The analysed metatranscriptome data were generated from the intestinal microbiota 
of four human adults, one human infant, six pigs and 15 mice, as well as from the 
orange-red encrusting sponge (Crambe crambe), forest soil [217], sub-seafloor
sediment [218] and sea bacterioplankton [219]. Except for the pig microbiota, none of
the environments that were sampled did experience anthropogenic antibiotic
pressure. The pig microbiota metatranscriptome data were included because pigs
regularly receive antibiotics during intensive farming, and as such expression of 
resistance genes in this niche is of particular interest [220]. The human adult 
metatranscriptome data were obtained from ileostoma effluent samples of four 
human adults [221], as described by Leimena et al. [222]. The metatranscriptome 
data of the human infant was generated from faecal samples collected from a Finnish 
baby girl at three time points in the first six months of life (at the ages of 131 [sample 
2B], 165 [samples 2D_1 and 2D_2] and 171 [sample 2E] days). Multiple time points
were included (data from multiple time points was studied as a single entity) because 
the gut microbiota of human babies is very dynamic [211, 223]. Approximately 0.5 g 
of each faecal sample was processed with the RNAlater protocol [224] and stored at -
70 °C prior to RNA isolation. RNA isolation was done with a protocol based on 
mechanical disruption [224], after which the quality and yield of the RNA was 
assessed with the NanoDrop 1000 Spectrophotometer (Thermo Scientific). 
Sequencing was performed on a Illumina HiSeq 2500 instrument. An additional pre-
sequencing rRNA removal step with the Rib-Zero kit (Epicentre) was included for
sample 2D_2 . The pig metatranscriptome data were those generated from proximal 
colon samples of pig 2,pig 4, pig 5, pig 6, pig 8 and pig 10 from a study by Haenen et
al. [225], and in this study these pigs are addressed as pigs 1 to 6, respectively. It is 
important to note that the pigs received Neopen (MSD Animal Health) intramuscularly
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Surprisingly, in s a bacteri plankton, the expression of AR genes was mor
than ne order of magni ude higher t an in any other ecological niche. It was
compri ed of two highly similar β-lactamase genes, namely blaTEM-1 and blaTEM-116.
The ame two genes were also found to be expressed in a metatranscriptom
datas t fr m the marine sponge Crambe crambe. The blaTEM-1 gene is commo ly
present in cloning vectors, and therefore lab contamination can be suspected,
however, this possibility is disputed by the fact tha  the gene is detec d in two
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generated. The functional role of a β-lactamase in a marine environment is yet
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bacteria occasionally reside in places with a high cell density (mi ro niches), such as
coral  or sponges. Roles of these resistance genes in (the disruption of) cel
signalling and antimicrobial activity ca  be hypothes zed [19]. Another possibility i
that these β-lactamases have no role in the aqua ic environment but that they
appe red through resist nce gene dissemination, such as via human-deriv d
sewage or animal faeces [100].  
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prior to sampling. The mice metatranscriptome data were generated from cecum 
samples of 15 mice from a study by Hugenholtz et al. [226], and both pig and mice 
samples were processed and sequenced as described in this study. The sponge 
(Crambe crambe) metatranscriptome data were obtained from a sample that was 
collected as described before [227]. A one cm3 piece of sponge tissue was fixed in 
ten volumes of RNALater. Subsequently, RNA was extracted with a modified 
guanidium thiocyanate phenol-chloroform extraction method [228] where 100 mg of 
tissue sample was homogenized in Solution D with glass beads in a Precellys 24 
tissue homogenizer (Bertin Technologies) prior to extraction. The total RNA was 
treated with the Dynabeads® mRNA Purification Kit (Life Technologies) to remove 
sponge mRNA. One µg of the resulting RNA sample was treated with both the Epibio 
Ribo-Zero rRNA (Illumina) removal kit for Human/mouse/rat and the Epibio Ribo-Zero 
rRNA (Illumina) removal kit for meta-bacteria in order remove sponge rRNA and 
bacterial rRNA, respectively. Ten ng of resulting enriched bacterial mRNA was 
reverse transcribed and amplified with the Ovation RNASeq system (Nugen). 
Sequencing was performed on a Illumina HiSeq 1000 instrument at Macrogen. In 
order to perform a thorough analysis for the sub-seafloor sediment, available 
metatranscriptome data from all six depths (≥5 metres below the seafloor) was 
analysed. 
Calculation of the fraction of non-ribosomal RNA reads 
In order to allow for comparison of relative transcript abundance across different 
datasets, we determined the number of non-ribosomal RNA reads for each 
metatranscriptome, applying the SortMeRNA pipeline [229], and using the included 
rRNA database and default filtering settings.  
Analysis of resistance gene expression 
To determine the expression of antibiotic resistance genes, the metatranscriptome 
reads were compared with the genes present in the resistance determinants 
database (RED-DB, www.fibim.unisi.it/REDDB). Genes in the RED-DB are grouped 
according to the type of antibiotic they confer resistance to, which makes the 
database suitable for our purpose. Relying on the FASTA headers of resistance 
genes (i.e. if FASTA headers matched the string “fusion”), fusion proteins of 
resistance genes together with sequences unrelated to antibiotic resistance were 
removed from the database. Subsequently, the redundancy of the RED-DB was 
 
 
reduced by clustering of entries with CD-HIT-EST [230] according to a ≥97% 
nucleotide identity threshold, reducing it in size to 4,537 genes. Thereafter, 
megaBLAST [231] was used to align the metatranscriptome reads against the non-
redundant RED-DB with a nucleotide identity of ≥90% and an alignment length of ≥60 
bp as alignment thresholds. For a gene to be considered expressed at least three 
reads were required to align with a cumulative covered gene length of ≥200 bp. 
These cut-offs are more stringent than those used in previous studies [190, 209]. 
When these cut-offs were made less stringent, no notable increase in the expression 
of antibiotic resistance genes was observed, indicating the robustness of this 
approach (data not shown). The hit list of resistance genes was manually inspected. 
Housekeeping genes that are targets of antibiotics and can become resistance genes 
through mutations (e.g. DNA gyrase and RNA polymerase subunit B) were removed, 
as well as genes that cannot always be directly associated with a resistance 
phenotype (e.g. ribF [232]] and sanA [233]]). One-way analysis of similarities [234] 
(ANOSIM, Bray-Curtis distance measure, 999 permutations) was performed with the 
PRIMER 6 software package (Clarke, K.R., Gorley, R.N., 2006. PRIMER v6: User 
Manual/Tutorial. PRIMER-E, Plymouth) to test for significant differences between the 
expression profiles in human adults, mice and pigs, using the cumulative relative 
expression levels of resistance genes against each of the 10 types of antibiotics. 
Rarefaction curves were prepared using the QIIME script multiple_rarefactions.py. 
The average number of resistance genes that were detected by >3 reads in the 
rarefied OTU tables was calculated after 1,000 iterations of subsampling. Rarefaction 
curves were plotted and regression analysis was performed using two different 
equations [235]. 
�� ���������‐bx�� � � � � � � � � � ������
�� ���������‐bx^c�� � � � � � � � � � ������
where x is the sample size (number of reads sampled), y the observed number of 
resistance genes and a the number of resistance genes to be expected with infinite 
sample size. 
Expression of secondary metabolite biosynthesis cluster genes 
Various secondary metabolite biosynthesis (SMB) gene clusters encode proteins 
needed to produce antibiotics, and therefore their expression can give information 
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of antibiotic resistance genes was observed, indicating the robustness of this 
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through mutations (e.g. DNA gyrase and RNA polymerase subunit B) were removed, 
as well as genes that cannot always be directly associated with a resistance 
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(ANOSIM, Bray-Curtis distance measure, 999 permutations) was performed with the 
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expression profiles in human adults, mice and pigs, using the cumulative relative 
expression levels of resistance genes against each of the 10 types of antibiotics. 
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about the potential presence of naturally produced antibiotics in a given ecological 
niche. For the construction of the antibiotics and secondary metabolite analysis shell 
(antiSMASH) [201], a list of core domains was compiled, which are exclusively 
present in genes in specific types of SMB clusters. Profile Hidden Markov Models 
(pHMMs) are available for these domains. In order to detect the expression of SMB 
clusters, metatranscriptome reads were translated to protein sequences in all six 
open reading frames. Subsequently, the HMMer3 tool (http://hmmer.janelia.org/) was 
used to detect the core domains specific to the different SMB clusters. The SMB 
clusters for which expression was investigated included those involved in synthesis of 
non-ribosomal peptides, polyketides type I and II and 
aminoglycosides/aminocyclitols. Thresholds for domain detection were the trusted 
cut-offs supplied with the pHMMs, and when those were not available an E-value of 
1.0 x 10-7 was used. Core domains were required to be detected by at least three 
reads in order for them to be considered expressed. 
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Supplementary information 
Supplementary Tables and Figures 
Tables S2.2, S2.3 and S2.4 are available on the website of Scientific Reports; doi: 
10.1038/srep11981. 
Table S2.1 Regression analysis was done to fit the rarefaction curves using 2 equations: ሺͳሻൌሺͳ
ԟ Ǧሻ and ሺʹሻ  ൌ  ሺͳ ԟ Ǧ̰ሻ. Constant a indicates the number of resistance genes to be 
expected with infinite sample size. In the case of human 1 no good fit was obtained for equation f1. 
Sample No. of resistance 
genes detected 
a (f1) b (f1) r2 a (f2) b (f2) c (f2) r2
Human 1 5 n.a. n.a. n.a. 5.245 2.05*10-15 2.485 0.9997 
Human 2 20 20.34 6.76*10-07 0.9962 20.34 6.49*10-07 1.003 0.9962 
Human 3 19 18.76 1.14*10-06 0.9064 24.19 7.25*10-05 0.677 0.9974 
Human 4 20  20.93 1.89*10-07 0.9956 20.67 1.49*10-06  0.857 0.9986 
Pig 1 35 33.86 1.27*10-06 0.9621 35.971 9.73*10-05 0.676 0.9996 
Pig 2 25 24.77 1.78*10-06 0.9973 24.456 6.73*10-07 1.075 0.9983 
Pig 3 25 26.05 1.46*10-06 0.9862 32.344 3.24*10-05 0.742 0.9972 
Pig 4 25 30.02 8.36*10-07 0.9957 26.251 8.34*10-08 1.185 0.9987 
Pig 5 31 30.10 1.15*10-06 0.9893 31.884 1.25*10-05 0.818 0.9967 
Pig 6 27 25.15 1.42*10-06 0.9763 27.235 2.05*10-05 0.791 0.9857 
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about the potential presence of naturally produced antibiotics in a given ecological 
niche. For the construction of the antibiotics and secondary metabolite analysis shell 
(antiSMASH) [201], a list of core domains was compiled, which are exclusively 
present in genes in specific types of SMB clusters. Profile Hidden Markov Models 
(pHMMs) are available for these domains. In order to detect the expression of SMB 
clusters, metatranscriptome reads were translated to protein sequences in all six 
open reading frames. Subsequently, the HMMer3 tool (http://hmmer.janelia.org/) was 
used to detect the core domains specific to the different SMB clusters. The SMB 
clusters for which expression was investigated included those involved in synthesis of 
non-ribosomal peptides, polyketides type I and II and 
aminoglycosides/aminocyclitols. Thresholds for domain detection were the trusted 
cut-offs supplied with the pHMMs, and when those were not available an E-value of 
1.0 x 10-7 was used. Core domains were required to be detected by at least three 
reads in order for them to be considered expressed. 
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B) 
Figure S2.1 Rarefaction curves for all investigated ecological niches: (A) for datasets with 
<20,000,000 non-ribosomal RNA reads (B) for datasets with >20,000,000 non-ribosomal RNA reads. 
Figure S2.2 Relative cumulative expression of antibiotic resistance genes plotted against the 
cumulative relative expression of secondary metabolite biosynthesis domains involved in the 
production of type I polyketides, type II polyketides, non-ribosomal peptides and aminoglycosides. 
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Abstract 
Sponges often harbour a dense and diverse microbial community. Presently, a large 
discrepancy exists between the cultivable bacterial fraction from sponges and the 
community in its natural environment. Here, we aimed to acquire additional insights 
into cultivability of (previously uncultured) bacteria from three sponge species, 
namely Aplysina aerophoba, Corticium candelabrum and Petrosia ficiformis, by 
studying bacterial growth on five media in the form of 60 communities scraped from 
plates without antibiotics, as well as in the form of individual isolates that were grown 
on these media supplemented with antibiotics. We applied (double-)barcoded 16S 
rRNA gene amplicon sequencing for species identification. We show that previously 
uncultured bacteria can be cultivated using conventional plating and that application 
of antibiotics in the media can serve to capture a greater bacterial diversity. 
Moreover, we present criteria to address an important caveat of the plate scraping 
method whereby bacteria may be detected that did not actually grow. Fourteen out of 
27 cultivated novel taxa (<95% identity of the 16S rRNA gene amplicon to reported 
species) belong to Actinobacteria, which indicates the presence of a large untapped 
reservoir of bioactive compounds. Three Flavobacteriaceae spp. were isolated that 
potentially constitute two new genera and one new species. 
Introduction 
Sponges arose 600-700 million years ago and have been consistent members of 
benthic communities ever since [116]. Their diet consists of organic debris and 
plankton collected from the surrounding water through filter feeding. Even though 
sponges actively feed on microorganisms, they often simultaneously harbour dense 
and diverse microbial communities that co-exist with the host in a mutualistic 
relationship, and together are referred to as the sponge holobiont [117]. 
Sponges are generally distinguished according to the bacterial cell density in 
their tissues where they either have a bacterial concentration within the range of
surrounding sea water (low-microbial-abundance sponges), or the bacterial
concentration is increased by 2-4 orders of magnitude (high-microbial-abundance 
sponges) [124]. A comprehensive survey of publicly available 16S rRNA gene 
sequences of sponge-associated bacteria showed that, overall, (in descending order 
of relative abundance) Proteobacteria, Actinobacteria, Bacteroidetes, Chloroflexi and 
Firmicutes are the dominant bacterial phyla [123]. However, there is great variation 
between sponge-associated microbial communities, and remarkably, bacterial
communities seem to be largely host species-specific, with only few bacterial 
lineages shared between sponge species [126-128]. Furthermore, host species-
specific microbiota were found to be relatively stable in time, and [236] over wide 
bathymetric and geographic gradients [237]. Sponge-specific bacteria are of
particular interest in the study of the complex host-symbiont relationship since they
may represent the oldest animal-microbe symbioses on Earth [238]. 
However, little is known regarding the metabolic functions and possible host-
microbe interactions of sponge-associated bacteria. Functional roles that have been 
ascribed to sponge microbes are carbon fixation [239], nitrogen cycling [125, 240] 
and host defence [241-243]. Host defence is suggested in most cases to be the 
result of microbe-derived bioactive compounds, and in the last decade their potential 
pharmaceutical application has sparked numerous studies [134, 135]. The classical 
non-ribosomal polyketide synthethase (NRPS) and polyketide synthase (PKS)
pathways responsible for secondary metabolite production in soil microbes have also
been found in sponge bacteria, including novel variations that appear to be restricted 
to symbiotic bacteria [244-246]. Still, bioactive compounds from sponge-associated
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Abstract 
Sponges often harbour a dense and diverse microbial community. Presently, a large 
discrepancy exists between the cultivable bacterial fraction from sponges and the 
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namely Aplysina aerophoba, Corticium candelabrum and Petrosia ficiformis, by 
studying bacterial growth on five media in the form of 60 communities scraped from 
plates without antibiotics, as well as in the form of individual isolates that were grown 
on these media supplemented with antibiotics. We applied (double-)barcoded 16S 
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Moreover, we present criteria to address an important caveat of the plate scraping 
method whereby bacteria may be detected that did not actually grow. Fourteen out of 
27 cultivated novel taxa (<95% identity of the 16S rRNA gene amplicon to reported 
species) belong to Actinobacteria, which indicates the presence of a large untapped 
reservoir of bioactive compounds. Three Flavobacteriaceae spp. were isolated that 
potentially constitute two new genera and one new species. 
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benthic communities ever since [116]. Their diet consists of organic debris and 
plankton collected from the surrounding water through filter feeding. Even though 
sponges actively feed on microorganisms, they often simultaneously harbour dense 
and diverse microbial communities that co-exist with the host in a mutualistic 
relationship, and together are referred to as the sponge holobiont [117]. 
Sponges are generally distinguished according to the bacterial cell density in 
their tissues where they either have a bacterial concentration within the range of
surrounding sea water (low-microbial-abundance sponges), or the bacterial
concentration is increased by 2-4 orders of magnitude (high-microbial-abundance 
sponges) [124]. A comprehensive survey of publicly available 16S rRNA gene 
sequences of sponge-associated bacteria showed that, overall, (in descending order 
of relative abundance) Proteobacteria, Actinobacteria, Bacteroidetes, Chloroflexi and 
Firmicutes are the dominant bacterial phyla [123]. However, there is great variation 
between sponge-associated microbial communities, and remarkably, bacterial
communities seem to be largely host species-specific, with only few bacterial 
lineages shared between sponge species [126-128]. Furthermore, host species-
specific microbiota were found to be relatively stable in time, and [236] over wide 
bathymetric and geographic gradients [237]. Sponge-specific bacteria are of
particular interest in the study of the complex host-symbiont relationship since they
may represent the oldest animal-microbe symbioses on Earth [238]. 
However, little is known regarding the metabolic functions and possible host-
microbe interactions of sponge-associated bacteria. Functional roles that have been 
ascribed to sponge microbes are carbon fixation [239], nitrogen cycling [125, 240] 
and host defence [241-243]. Host defence is suggested in most cases to be the 
result of microbe-derived bioactive compounds, and in the last decade their potential 
pharmaceutical application has sparked numerous studies [134, 135]. The classical 
non-ribosomal polyketide synthethase (NRPS) and polyketide synthase (PKS)
pathways responsible for secondary metabolite production in soil microbes have also
been found in sponge bacteria, including novel variations that appear to be restricted 
to symbiotic bacteria [244-246]. Still, bioactive compounds from sponge-associated
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bacteria are rather unexplored, a phenomenon that can be attributed to sponge-
associated bacteria being difficult to culture. 
Cultivation of sponge-associated bacteria is desirable in order to obtain a 
comprehensive understanding of their biology and ecological role [93]. However, 
there is still a large discrepancy between the cultivable bacterial fraction from 
sponges and the community in its natural environment [129, 130]. To address this 
gap between presence in the natural environment and cultivation, we extensively 
studied the cultivability of sponge-associated bacteria from three Mediterranean high-
microbial-abundance sponges, namely Aplysina aerophoba, Petrosia ficiformis and 
Corticium candelabrum, by collecting total colony material obtained under different 
cultivation conditions, and performing community analysis via sequencing. In 
addition, colonies were picked from media supplemented with different antibiotics in 
an effort to select for different bacterial species. 
Materials and methods 
Sample collection  
Tissue samples were collected from one individual per sponge species. Samples 
from P. ficiformis (Pf1) and C. candelabrum (CC1) were collected on June 5th 2008 
from Punta de Santa Ana, Blanes (41°40’33’’N, 2°48’10”E) at 10 m depth and 
identified by M.J. Uriz. A. aerophoba (AA3) samples were collected on January 15th 
2012 from Cala Montgo (42°06’52.20”N, 03°10’06.52”E) at 12 m depth and identified 
by D. Sipkema. Specimens were brought to the surface in plastic ziplock bags. The 
sponge samples were rinsed three times with sterile artificial sea water (ASW, 33 g/l 
synthetic sea salt [Instant Ocean Reef Crystals, Aquarium Systems, Sarrebourg, 
France]) and were cut into pieces of ~0.1 cm3. Half of the pieces was stored in 100% 
ethanol, while the other half was homogenized with mortar and pestle, and two tissue 
volumes of sterile artificial sea water were added to obtain a homogeneous cell 
suspension. This suspension was aliquoted in 1.2 ml fractions, and each fraction was 
mixed with 0.6 ml 50% sterile glycerol in ASW before storage at -80 °C. 
Cultivation conditions  
Isolation of bacteria on media with antibiotics 
Material from the original glycerol stocks was 10-fold diluted in ASW and 
subsequently 75 µl was used to inoculate one plate of each combination of five 
media and 13 combinations of antibiotics. Fifty µl was in contact with agar whereas 
 
 
the other 25 µl was inoculated on a 0.2 µm GTTP isopore membrane filter (Millipore) 
that was placed on top of the agar. The following five media were used: (I) 37.40 g/l 
marine broth 2216 (Difco) in Milli-Q; (II) 3.74 g/l marine broth 2216 (Difco) in Milli-Q ; 
(III) 22 g/l BBL Mueller Hinton broth (BD) in ASW; (IV) 2.2 g/l BBL Mueller Hinton 
broth (BD) in ASW; (V) 1 g/l porcine stomach mucin (Sigma) in ASW. All media 
contained 15 g/l noble agar (Sigma-Aldrich). Media III to V were supplemented with 1 
ml/l trace metal solution [247], 1 ml/l phosphate solution [247] and 1 ml/l vitamin 
solution (BME vitamins, Sigma), with the pH adjusted to 7.7 before autoclaving. 
Solutions of phosphate, vitamins and antibiotics were filter-sterilized (0.2 μm) and 
added after autoclaving in order to prevent precipitation or inactivation. The following 
13 (combinations of) antibiotics were added: (I) 15 μg/ml polymyxin B and 15 μg/ml 
linezolid; (II) 15 μg/ml polymyxin B and 15 μg/ml daptomycin; (III) 15 μg/ml polymyxin 
B and 50 μg/ml vancomycin; (IV) 15 μg/ml polymyxin B and 50 μg/ml penicillin; (V) 15 
μg/ml erythromycin; (VI) 15 μg/ml ciprofloxacin; (VII) 100 μg/ml cefotaxime; (VIII) 50 
μg/ml tetracycline; (IX) 50 μg/ml chloramphenicol; (X) 95 μg/ml sulfamethoxazole and 
5 μg/ml trimethoprim; (XI) 15 μg/ml lincomycin; (XII) 100 μg/ml kanamycin; (XIII) 7.5 
μg/ml rifampicin. Plates were incubated in the dark at 20 °C for three months. 
Colonies were picked twice per week in the first month and subsequently once per 
week. At most three colonies of the same morphology were picked per plate. 
Colonies were transferred to a fresh plate and colony material from these plates was 
used for preparation of glycerol stocks. Colonies appearing on filters were 
immediately stored in glycerol. Glycerol stocks were prepared by transferring colony 
material to 96-well plates containing 25% glycerol in ASW, and stored at -80 °C. In 
addition, colony material was transferred to 96-well plates containing nuclease-free 
water (Promega) to be used as direct template for 16S rRNA gene PCR. 
Bacterial growth on media without antibiotics  
Material from the original glycerol stocks of A. aerophoba, P. ficiformis and C. 
candelabrum was respectively 100-fold, 10-fold and 2-fold diluted in ASW based on 
prior CFU counts, and subsequently plated on six plates of each of the five media 
described previously. Seventy-five µl of diluted material was inoculated on each plate 
(50 µl in contact with agar and 25 µl on a filter membrane on top of the agar). The 
plates were stored at 20 °C in the dark. Colony material from each combination of 
media and sponges was harvested 15 days (3 plates) and 30 days (the remaining 3 
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bacteria are rather unexplored, a phenomenon that can be attributed to sponge-
associated bacteria being difficult to culture. 
Cultivation of sponge-associated bacteria is desirable in order to obtain a 
comprehensive understanding of their biology and ecological role [93]. However, 
there is still a large discrepancy between the cultivable bacterial fraction from 
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cultivation conditions, and performing community analysis via sequencing. In 
addition, colonies were picked from media supplemented with different antibiotics in 
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synthetic sea salt [Instant Ocean Reef Crystals, Aquarium Systems, Sarrebourg, 
France]) and were cut into pieces of ~0.1 cm3. Half of the pieces was stored in 100% 
ethanol, while the other half was homogenized with mortar and pestle, and two tissue 
volumes of sterile artificial sea water were added to obtain a homogeneous cell 
suspension. This suspension was aliquoted in 1.2 ml fractions, and each fraction was 
mixed with 0.6 ml 50% sterile glycerol in ASW before storage at -80 °C. 
Cultivation conditions  
Isolation of bacteria on media with antibiotics 
Material from the original glycerol stocks was 10-fold diluted in ASW and 
subsequently 75 µl was used to inoculate one plate of each combination of five 
media and 13 combinations of antibiotics. Fifty µl was in contact with agar whereas 
 
 
the other 25 µl was inoculated on a 0.2 µm GTTP isopore membrane filter (Millipore) 
that was placed on top of the agar. The following five media were used: (I) 37.40 g/l 
marine broth 2216 (Difco) in Milli-Q; (II) 3.74 g/l marine broth 2216 (Difco) in Milli-Q ; 
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contained 15 g/l noble agar (Sigma-Aldrich). Media III to V were supplemented with 1 
ml/l trace metal solution [247], 1 ml/l phosphate solution [247] and 1 ml/l vitamin 
solution (BME vitamins, Sigma), with the pH adjusted to 7.7 before autoclaving. 
Solutions of phosphate, vitamins and antibiotics were filter-sterilized (0.2 μm) and 
added after autoclaving in order to prevent precipitation or inactivation. The following 
13 (combinations of) antibiotics were added: (I) 15 μg/ml polymyxin B and 15 μg/ml 
linezolid; (II) 15 μg/ml polymyxin B and 15 μg/ml daptomycin; (III) 15 μg/ml polymyxin 
B and 50 μg/ml vancomycin; (IV) 15 μg/ml polymyxin B and 50 μg/ml penicillin; (V) 15 
μg/ml erythromycin; (VI) 15 μg/ml ciprofloxacin; (VII) 100 μg/ml cefotaxime; (VIII) 50 
μg/ml tetracycline; (IX) 50 μg/ml chloramphenicol; (X) 95 μg/ml sulfamethoxazole and 
5 μg/ml trimethoprim; (XI) 15 μg/ml lincomycin; (XII) 100 μg/ml kanamycin; (XIII) 7.5 
μg/ml rifampicin. Plates were incubated in the dark at 20 °C for three months. 
Colonies were picked twice per week in the first month and subsequently once per 
week. At most three colonies of the same morphology were picked per plate. 
Colonies were transferred to a fresh plate and colony material from these plates was 
used for preparation of glycerol stocks. Colonies appearing on filters were 
immediately stored in glycerol. Glycerol stocks were prepared by transferring colony 
material to 96-well plates containing 25% glycerol in ASW, and stored at -80 °C. In 
addition, colony material was transferred to 96-well plates containing nuclease-free 
water (Promega) to be used as direct template for 16S rRNA gene PCR. 
Bacterial growth on media without antibiotics  
Material from the original glycerol stocks of A. aerophoba, P. ficiformis and C. 
candelabrum was respectively 100-fold, 10-fold and 2-fold diluted in ASW based on 
prior CFU counts, and subsequently plated on six plates of each of the five media 
described previously. Seventy-five µl of diluted material was inoculated on each plate 
(50 µl in contact with agar and 25 µl on a filter membrane on top of the agar). The 
plates were stored at 20 °C in the dark. Colony material from each combination of 
media and sponges was harvested 15 days (3 plates) and 30 days (the remaining 3 
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plates) post-incubation by plate washing with the help of an L-shaped spreader. 
Colony material on top of agar and filter membranes was collected separately in 3 ml 
phosphate buffered saline (PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
KH2PO4) each. 2.5 ml was stored for gDNA isolation at -20 °C. The rest was mixed 
with 0.5 ml 50% glycerol (in ASW) and stored at -80 °C for cultivation. 
DNA extraction and 16S rRNA gene amplicon sequencing 
DNA extraction  
The DNeasy Blood & Tissue Kit (Qiagen) was used to extract total DNA from 0.4 cm3 
of sponge tissue as well as from colony material stored in PBS (the fractions that 
were washed from the plates without antibiotics), according to the manufacturer’s 
protocol for animal tissue. The DNA concentration was determined by NanoDrop 
(Thermo Scientific). DNA samples were stored at -20 °C in AE buffer. 
Barcoded 16S rRNA gene amplicon 454-pyrosequencing 
Barcoded 16S rRNA gene amplicon 454-pyrosequencing was done (1) to analyse 
bacterial communities present in the sponge samples, (2) to identify bacterial 
colonies that were picked from media containing antibiotics, and (3) to analyse 
bacterial communities retrieved by scraping from media without antibiotics. PCR was 
performed to amplify an approximately 311 bp fragment comprising the V1 and V2 
regions of the 16S rRNA gene. For this purpose the extracted DNA of the samples 
was diluted to 10-20 ng/μl. In case of identification of bacterial colonies cell material 
in nuclease-free water served as template. The composite forward primer consisted 
of titanium sequencing adaptor A, a barcode [248] and degenerate primer 27F-DegS 
[249] (Table S3.1). Reverse priming was done by an equimolar mixture of primers 
338R-I and 338R-II [250], each attached to titanium sequencing adaptor B. For the 
identification of individually picked colonies a barcode was also included in the 
reverse primer (for each colony a unique combination of barcodes was used). PCR 
conditions and library preparation are described in the Supplementary Materials and 
Methods. Five libraries were sent for sequencing that contained samples particular to 
this study (Table S3.1). 
Demultiplexing, quality-filtering, denoising and taxonomy assignment of 454-
pyrosequencing data
454-pyrosequencing reads were processed with QIIME [251]. Firstly, libraries were 
demultiplexed according to the forward primer barcodes. Reads were retained if the 
average Phred quality score was >25, no homopolymer stretches >6 nucleotides
were present, the read length was ≥200 bp, and no mismatches were present in the 
5’-end primers. For 454-pyrosequencing reads that were double-barcoded (i.e. those 
generated from picked colonies), an additional demultiplexing step based on the 
reverse barcode was performed. Subsequently, reads were denoised by Acacia [252] 
using default settings. Next, open reference operational taxonomic unit (OTU) picking 
and taxonomic assignment was performed by uclust [253] based on a 97% identity
threshold and the representative sequences of the 97% identity clustered SILVA 111 
database as a reference. The representative sequence from each OTU was picked,
which is the centroid that was used for OTU picking. Potentially chimeric OTUs were
identified using ChimeraSlayer and the downloadable Greengenes 
core_set_aligned.fasta.imputed, and were excluded from downstream analysis. 
Finally, OTU tables were generated that tabulate which OTUs, orders or phyla were
detected in each sample, and by how many reads. 
Analyses and visualisation of bacterial diversity 
Diversity and clustering analyses of bacterial communities 
For sponge bacterial communities, rarefaction curves were calculated with QIIME
scripts. Hierarchical clustering was performed using R package ‘Vegan’ based on
OTU-level relative abundance data obtained from bacterial communities in sponge 
tissues as well as those scraped from agar plates. Canonical (constrained) 
correspondence analysis (CCA) as implemented in Canoco 5 [254] was used to 
investigate which experimental variables best explain the variation in species
composition regarding OTU-level relative abundance data obtained from the bacterial
communities scraped from agar plates. SIMPER [255] was used with respect to 
square rooted OTU-level relative abundance data to break down the contribution of
each OTU to the observed dissimilarity between sample groups. ARB [256] was used 
to construct a 16S rRNA gene-based phylogenetic tree of bacterial isolates (>800 bp
sequences were obtained by Sanger sequencing, see below), their closest type 
strain (based on BLASTn, bitscore sorted) and the nearest neighbour in the Silva 
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DNA extraction  
The DNeasy Blood & Tissue Kit (Qiagen) was used to extract total DNA from 0.4 cm3 
of sponge tissue as well as from colony material stored in PBS (the fractions that 
were washed from the plates without antibiotics), according to the manufacturer’s 
protocol for animal tissue. The DNA concentration was determined by NanoDrop 
(Thermo Scientific). DNA samples were stored at -20 °C in AE buffer. 
Barcoded 16S rRNA gene amplicon 454-pyrosequencing 
Barcoded 16S rRNA gene amplicon 454-pyrosequencing was done (1) to analyse 
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identification of individually picked colonies a barcode was also included in the 
reverse primer (for each colony a unique combination of barcodes was used). PCR 
conditions and library preparation are described in the Supplementary Materials and 
Methods. Five libraries were sent for sequencing that contained samples particular to 
this study (Table S3.1). 
Demultiplexing, quality-filtering, denoising and taxonomy assignment of 454-
pyrosequencing data
454-pyrosequencing reads were processed with QIIME [251]. Firstly, libraries were 
demultiplexed according to the forward primer barcodes. Reads were retained if the 
average Phred quality score was >25, no homopolymer stretches >6 nucleotides
were present, the read length was ≥200 bp, and no mismatches were present in the 
5’-end primers. For 454-pyrosequencing reads that were double-barcoded (i.e. those 
generated from picked colonies), an additional demultiplexing step based on the 
reverse barcode was performed. Subsequently, reads were denoised by Acacia [252] 
using default settings. Next, open reference operational taxonomic unit (OTU) picking 
and taxonomic assignment was performed by uclust [253] based on a 97% identity
threshold and the representative sequences of the 97% identity clustered SILVA 111 
database as a reference. The representative sequence from each OTU was picked,
which is the centroid that was used for OTU picking. Potentially chimeric OTUs were
identified using ChimeraSlayer and the downloadable Greengenes 
core_set_aligned.fasta.imputed, and were excluded from downstream analysis. 
Finally, OTU tables were generated that tabulate which OTUs, orders or phyla were
detected in each sample, and by how many reads. 
Analyses and visualisation of bacterial diversity 
Diversity and clustering analyses of bacterial communities 
For sponge bacterial communities, rarefaction curves were calculated with QIIME
scripts. Hierarchical clustering was performed using R package ‘Vegan’ based on
OTU-level relative abundance data obtained from bacterial communities in sponge 
tissues as well as those scraped from agar plates. Canonical (constrained) 
correspondence analysis (CCA) as implemented in Canoco 5 [254] was used to 
investigate which experimental variables best explain the variation in species
composition regarding OTU-level relative abundance data obtained from the bacterial
communities scraped from agar plates. SIMPER [255] was used with respect to 
square rooted OTU-level relative abundance data to break down the contribution of
each OTU to the observed dissimilarity between sample groups. ARB [256] was used 
to construct a 16S rRNA gene-based phylogenetic tree of bacterial isolates (>800 bp
sequences were obtained by Sanger sequencing, see below), their closest type 
strain (based on BLASTn, bitscore sorted) and the nearest neighbour in the Silva 
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guide tree (release 115). The analyses are described in detail in the Supplementary 
Materials and Methods. 
Regrowth, identification and resistance profiling of picked isolates 
Regrowth from glycerol stocks and identification 
Isolates stored at -80 °C were selected for regrowth based on their specific isolation 
media via the procedure described in the results section, and subsequently 
maintained on marine agar if this medium could support their growth. Bacterial 
cultures were passaged until pure, and their identity was confirmed by 16S rRNA 
gene Sanger sequencing using the 27F and 1492R general bacterial primers [257]. 
PCR products were sent to GATC Biotech with sequencing primers 27F, 1492R or 
907R [258]. Read ends were trimmed with DNA Baser version 3.5.4.2 until there 
were 99% good bases (quality value >21) in a 20-base window. For each isolate at 
minimum the V1 and V2 regions of the 16S rRNA gene were sequenced, and the 
read (after trimming) was required to be at least 800 bp in length. The Sanger read 
pertaining to an isolate needed to be >97% identical to the representative read of the 
target OTU for it to be considered the corresponding strain. Three attempts for 
cultivation up to pure culture were made per selected OTU, where possible from 
distinct wells in the 96-well plates. 
Resistance profiling of pure isolates 
Isolates were tested for resistance to all antibiotics used in the cultivation experiment 
(at identical concentrations), as well as for resistance to ampicillin (50 μg/ml) and 
imipenem (10 μg/ml). The isolates were pregrown in liquid culture (same media but 
without noble agar), and subsequently inoculated on agar media supplemented with 
antibiotics. Antibiotic resistance was evaluated three, four and eight days post-
inoculation while using growth on media without antibiotics as a reference. Bacteria 
were categorized to be ‘resistant’, ‘intermediately resistant’, or ‘susceptible’. 
Nucleotide sequence accession numbers 
The partial 16S rRNA gene sequences of pure isolates were deposited under 
accession numbers KP769416 to KP769446. The 16S rRNA gene amplicon 
sequences were deposited in the ENA SRA database under accession number 
PRJEB4784 (Table S3.1). 
Results 
Bacterial diversity in sponge samples and their cultivable fraction 
The cultivable bacterial fraction from A. aerophoba, P. ficiformis and C. candelabrum
was studied on five media in the form of 60 communities scraped from plates without
antibiotics, and in the form of individual isolates picked from media supplemented 
with (combinations of) different antibiotics (Figure 3.1). Agar media were 
supplemented with two antibiotics if they predominantly affect the growth of either 
Gram-negative or Gram-positive bacteria. 
In total 679 colonies were picked from plates with antibiotics: 556 (81.9%) from
A. aerophoba, 95 (14.0%) from P. ficiformis and 28 (4.1%) from C. candelabrum. 
Qualified 454-pyrosequencing sequence data yielded 716,939 reads that clustered 
into 2,282 OTUs. 41,548 reads were assigned to 542 out of 679 picked colonies, a 
discrepancy that can largely be explained by the fact that 120 red colonies were 
found to belong to the Penicillium genus (data not shown). Furthermore, 660,721 
reads were assigned to the 60 bacterial communities collected by scraping from agar 
media without antibiotics and 14,670 reads were assigned to the three sponge 
samples. Table S3.2 shows the number of colonies that were picked or scraped in
this experiment sorted according to sponge species and media that were used. 
Shannon indices for sponge samples indicated that C. candelabrum (H‘ = 3.96
± 0.01 [s.d.]) contained the least diverse microbiota when compared to A. aerophoba
(H‘ = 5.29 ± 0.04 [s.d.]), and P. ficiformis (H‘ = 4.54). Proteobacteria, Nitrospirae,
Chloroflexi, Bacteroidetes, Actinobacteria and Acidobacteria were present in all three
sponges at >0.1% relative abundance (Figure 3.2). A. aerophoba was distinct
because nearly 50% of the bacteria present belonged to the Chloroflexi. Conversely, 
the microbiota profiles of C. candelabrum and P. ficiformis were characterized by
high relative abundances of Proteobacteria and Nitrospirae. It is noteworthy that in 
the microbiota of P. ficiformis >20% of the bacteria belonged to Bacteroidetes
whereas in the other two sponges their relative abundance was <1%. Rarefaction 
analysis demonstrated that the current sequencing depth did not capture the 
complete bacterial diversity in the sponge samples. (Figure S3.1). 
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guide tree (release 115). The analyses are described in detail in the Supplementary 
Materials and Methods. 
Regrowth, identification and resistance profiling of picked isolates 
Regrowth from glycerol stocks and identification 
Isolates stored at -80 °C were selected for regrowth based on their specific isolation 
media via the procedure described in the results section, and subsequently 
maintained on marine agar if this medium could support their growth. Bacterial 
cultures were passaged until pure, and their identity was confirmed by 16S rRNA 
gene Sanger sequencing using the 27F and 1492R general bacterial primers [257]. 
PCR products were sent to GATC Biotech with sequencing primers 27F, 1492R or 
907R [258]. Read ends were trimmed with DNA Baser version 3.5.4.2 until there 
were 99% good bases (quality value >21) in a 20-base window. For each isolate at 
minimum the V1 and V2 regions of the 16S rRNA gene were sequenced, and the 
read (after trimming) was required to be at least 800 bp in length. The Sanger read 
pertaining to an isolate needed to be >97% identical to the representative read of the 
target OTU for it to be considered the corresponding strain. Three attempts for 
cultivation up to pure culture were made per selected OTU, where possible from 
distinct wells in the 96-well plates. 
Resistance profiling of pure isolates 
Isolates were tested for resistance to all antibiotics used in the cultivation experiment 
(at identical concentrations), as well as for resistance to ampicillin (50 μg/ml) and 
imipenem (10 μg/ml). The isolates were pregrown in liquid culture (same media but 
without noble agar), and subsequently inoculated on agar media supplemented with 
antibiotics. Antibiotic resistance was evaluated three, four and eight days post-
inoculation while using growth on media without antibiotics as a reference. Bacteria 
were categorized to be ‘resistant’, ‘intermediately resistant’, or ‘susceptible’. 
Nucleotide sequence accession numbers 
The partial 16S rRNA gene sequences of pure isolates were deposited under 
accession numbers KP769416 to KP769446. The 16S rRNA gene amplicon 
sequences were deposited in the ENA SRA database under accession number 
PRJEB4784 (Table S3.1). 
Results 
Bacterial diversity in sponge samples and their cultivable fraction 
The cultivable bacterial fraction from A. aerophoba, P. ficiformis and C. candelabrum
was studied on five media in the form of 60 communities scraped from plates without
antibiotics, and in the form of individual isolates picked from media supplemented 
with (combinations of) different antibiotics (Figure 3.1). Agar media were 
supplemented with two antibiotics if they predominantly affect the growth of either 
Gram-negative or Gram-positive bacteria. 
In total 679 colonies were picked from plates with antibiotics: 556 (81.9%) from
A. aerophoba, 95 (14.0%) from P. ficiformis and 28 (4.1%) from C. candelabrum. 
Qualified 454-pyrosequencing sequence data yielded 716,939 reads that clustered 
into 2,282 OTUs. 41,548 reads were assigned to 542 out of 679 picked colonies, a 
discrepancy that can largely be explained by the fact that 120 red colonies were 
found to belong to the Penicillium genus (data not shown). Furthermore, 660,721 
reads were assigned to the 60 bacterial communities collected by scraping from agar 
media without antibiotics and 14,670 reads were assigned to the three sponge 
samples. Table S3.2 shows the number of colonies that were picked or scraped in
this experiment sorted according to sponge species and media that were used. 
Shannon indices for sponge samples indicated that C. candelabrum (H‘ = 3.96
± 0.01 [s.d.]) contained the least diverse microbiota when compared to A. aerophoba
(H‘ = 5.29 ± 0.04 [s.d.]), and P. ficiformis (H‘ = 4.54). Proteobacteria, Nitrospirae,
Chloroflexi, Bacteroidetes, Actinobacteria and Acidobacteria were present in all three
sponges at >0.1% relative abundance (Figure 3.2). A. aerophoba was distinct
because nearly 50% of the bacteria present belonged to the Chloroflexi. Conversely, 
the microbiota profiles of C. candelabrum and P. ficiformis were characterized by
high relative abundances of Proteobacteria and Nitrospirae. It is noteworthy that in 
the microbiota of P. ficiformis >20% of the bacteria belonged to Bacteroidetes
whereas in the other two sponges their relative abundance was <1%. Rarefaction 
analysis demonstrated that the current sequencing depth did not capture the 
complete bacterial diversity in the sponge samples. (Figure S3.1). 
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Figure 3.1 Flow diagram of the experiment. Bacterial diversity in samples from three different sponges 
(A. aerophoba, P. ficiformis and C. candelabrum) was compared to their cultivable fraction. Sponge 
samples were inoculated directly onto agar and on filter membranes on top of the agar. Resistance 
profiles were determined of 31 different isolates. 
Figure 3.2 Phyla that were detected in the sponge samples (S), on media without antibiotics (M-) and 
on media with antibiotics (M+). Phyla with a relative abundance <0.1% are not shown. The relative 
abundance values are based on the combined reads of the different experimental groups.
Bacteria isolated in the absence of antibiotics 
Bacterial communities on the five agar media without antibiotics was dominated by 
Proteobacteria (>50% relative abundance) for the three sponge species investigated 
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(Figure 3.2), which in most cases was attributed to OTU denovo1749 (>50% relative 
abundance in 44 out of 60 scraped fractions), an α-proteobacterium affiliated to the 
Pseudovibrio genus. Notably, OTU1749 was not detected in the sponges samples.
On plates inoculated with C. candelabrum samples also Firmicutes were relatively
abundant with 34% of the total reads. 
Hierarchical clustering was performed to investigate dissimilarity at the OTU 
level between communities present in the sponge samples and those present on 
media without antibiotics (Figure 3.3). A. aerophoba-derived communities retrieved 
by scraping from plates and filters formed one large cluster because all samples
featured a relatively high abundance of members belonging to the genus Ruegeria 
(OTU HE574879) (Table S3.3). Within this cluster, as a general rule, higher similarity
was observed between samples that were retrieved from the same medium (Figure 
3.3). Retrieved communities derived from P. ficiformis and C. candelabrum formed 
two mixed branches containing each >10 samples for which separate clustering can 
be ascribed to a relatively high abundance of a subset of 6 specific OTUs in 1 of the 
2 branches. These signature OTUs constitute Microbulbifer spp. (5 OTUs) and a 
Pseudovibrio sp. (1 OTU). Samples within both of these branches showed further 
grouping according to cultivation medium. The remaining samples in the dendrogram 
are the original sponge communities and 12 communities derived from P. ficiformis
and C. candelabrum that were highly dissimilar to each other. All except one of these 
12 communities were comprised of <10 visible colonies.
CCA of OTU-level relative abundance data from the scraped bacterial 
communities indicated that the explanatory variables medium I (marine agar), 
medium II (marine agar, 10-fold diluted nutrients), sponge C. candelabrum and 
medium III (Mueller Hinton agar) could explain respectively 7.0% (p = 0.012), 4.5% (p 
= 0.002), 3.9% (p = 0.002) and 2.6% (p = 0.022) of the total variation in diversity
using forward selection. Most variation could not be accounted for by the explanatory
variables that were evaluated. Similarity percentage analysis (SIMPER) analyses 
indicated that most dissimilarity in terms of bacterial growth scraped from each 
sponge species could be explained by different levels of average relative abundance 
of OTU denovo1749 (Pseudovibrio sp.). In scraped communities derived from P. 
ficiformis the average relative abundance of OTU denovo1749 was 89%, while the 
corresponding values for A. aerophoba and C. candelabrum were 77% and 63%, 
respectively. Other top contributors to dissimilarity were OTU HE574879 (Ruegeria
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Figure 3.1 Flow diagram of the experiment. Bacterial diversity in samples from three different sponges 
(A. aerophoba, P. ficiformis and C. candelabrum) was compared to their cultivable fraction. Sponge 
samples were inoculated directly onto agar and on filter membranes on top of the agar. Resistance 
profiles were determined of 31 different isolates. 
Figure 3.2 Phyla that were detected in the sponge samples (S), on media without antibiotics (M-) and 
on media with antibiotics (M+). Phyla with a relative abundance <0.1% are not shown. The relative 
abundance values are based on the combined reads of the different experimental groups.
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(Figure 3.2), which in most cases was attributed to OTU denovo1749 (>50% relative 
abundance in 44 out of 60 scraped fractions), an α-proteobacterium affiliated to the 
Pseudovibrio genus. Notably, OTU1749 was not detected in the sponges samples.
On plates inoculated with C. candelabrum samples also Firmicutes were relatively
abundant with 34% of the total reads. 
Hierarchical clustering was performed to investigate dissimilarity at the OTU 
level between communities present in the sponge samples and those present on 
media without antibiotics (Figure 3.3). A. aerophoba-derived communities retrieved 
by scraping from plates and filters formed one large cluster because all samples
featured a relatively high abundance of members belonging to the genus Ruegeria 
(OTU HE574879) (Table S3.3). Within this cluster, as a general rule, higher similarity
was observed between samples that were retrieved from the same medium (Figure 
3.3). Retrieved communities derived from P. ficiformis and C. candelabrum formed 
two mixed branches containing each >10 samples for which separate clustering can 
be ascribed to a relatively high abundance of a subset of 6 specific OTUs in 1 of the 
2 branches. These signature OTUs constitute Microbulbifer spp. (5 OTUs) and a 
Pseudovibrio sp. (1 OTU). Samples within both of these branches showed further 
grouping according to cultivation medium. The remaining samples in the dendrogram 
are the original sponge communities and 12 communities derived from P. ficiformis
and C. candelabrum that were highly dissimilar to each other. All except one of these 
12 communities were comprised of <10 visible colonies.
CCA of OTU-level relative abundance data from the scraped bacterial 
communities indicated that the explanatory variables medium I (marine agar), 
medium II (marine agar, 10-fold diluted nutrients), sponge C. candelabrum and 
medium III (Mueller Hinton agar) could explain respectively 7.0% (p = 0.012), 4.5% (p 
= 0.002), 3.9% (p = 0.002) and 2.6% (p = 0.022) of the total variation in diversity
using forward selection. Most variation could not be accounted for by the explanatory
variables that were evaluated. Similarity percentage analysis (SIMPER) analyses 
indicated that most dissimilarity in terms of bacterial growth scraped from each 
sponge species could be explained by different levels of average relative abundance 
of OTU denovo1749 (Pseudovibrio sp.). In scraped communities derived from P. 
ficiformis the average relative abundance of OTU denovo1749 was 89%, while the 
corresponding values for A. aerophoba and C. candelabrum were 77% and 63%, 
respectively. Other top contributors to dissimilarity were OTU HE574879 (Ruegeria
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sp.) that was present with higher relative abundance, and OTU GQ118701 
(Microbulbifer sp.) that was present with lower relative abundance, on plates 
inoculated with material from A. aerophoba, as compared to plates inoculated with 
samples from the other two sponges. In addition, OTU JN579972 (Bacillus sp.) 
contributed to the dissimilarity by a higher relative abundance on plates inoculated 
with C. candelabrum. Comparison by SIMPER of bacterial communities retrieved 
directly from agar and those obtained on filter membranes showed that there are no 
bacterial taxa that highly favour one growth surface over the other i.e. no taxon 
occurred with great differences in relative abundance that also substantially (>2%) 
contributed to the dissimilarity. 
Bacterial growth on the scraped plates was investigated for novel cultivable 
bacteria. Seventy-nine novel OTUs (≤95% identity of the representative read to the 
16S rRNA gene of the closest type strain) that were identified. However, 13 of these 
79 OTUs had a lower relative abundance in the scraped communities as compared to 
the inoculum (Figure S3.2). Therefore, it might be that these OTUs did not grow but 
instead were derived from sponge material that persisted on the agar media. To 
address this issue we applied three criteria to conclude bacteria growth: (i) OTUs 
needed to increase in relative abundance as compared to the inoculum, (ii) OTUs 
needed to have a relative abundance of ≥0.2%, and (iii) the scraped community 
required ≥20 visible colonies. Adopting these criteria, we retained as many as 27 
novel cultivable OTUs from the scraped communities of which the representative 
read has ≤95% identity to the 16S rRNA gene of the closest type strain (Table 3.1). 
At the phylum-level the 27 OTUs belong to the Proteobacteria (10 OTUs [8 α- and 2 
γ-]), Firmicutes (2 OTUs), Bacteroidetes (1 OTU) and Actinobacteria (14 OTUs). Most 
(19/27) novel OTUs grew on Mueller-Hinton-based agar media. Five of the novel 
OTUs (AJ347026, denovo528, denovo574, GU118526 and denovo98) were detected 
in the inoculum (sponge sample) as well (Table S3.3). 
Bacteria isolated in the presence of antibiotics 
Bacterial colonies were identified by double-barcoded 454-pyrosequencing. Reads 
were allocated to 542 out of 679 picked colonies, and amongst these colonies a total 
of 211 OTUs were detected. An OTU was only assigned if it represented >50% of 
reads obtained for that colony, which resulted in 47 OTUs being assigned to 425 
picked colonies (Figure S3.3). This assignment strategy was used in order to address 
the high number of OTUs that were detected by only one or a few reads, and in
almost all cases comprised the minority of reads assigned to a colony (Figure S3.4). 
In this way we adopt a conservative approach and limit ourselves to strains from
OTUs that are most likely truly represented by growing bacteria and discard potential 
sequence artefacts, even though OTUs detected by one or a few reads can still be 
informative about bacterial presence [259]. On average, a similar number of OTUs 
were assigned to colonies picked directly from agar media (2.56 ± 2.10 [s.d]) as 
compared to those picked from filters on top of agar media (2.33 ± 1.80 [s.d.]). For 31 
of 47 OTUs that were assigned to colonies, a representative isolate was successfully
regrown from the glycerol stocks up to pure culture. OTU denovo1749 (Pseudovibrio 
sp.) was assigned to isolates obtained from all three sponge species, and from two 
sponge species a representative isolate belonging to this OTU was successfully
cultured up to pure culture. Isolates are assumed to be different strains if they belong 
to the same OTU but are obtained from different sponges, and hence both strains 
were included in subsequent analyses. 
For each of the 31 pure cultures the 16S rRNA gene was sequenced to a 
length of at least 800 bp. A phylogenetic tree was constructed (Figure 3.4) based on 
16S rRNA gene sequences from the isolates we obtained in pure culture, their most
closely related type strain, and their closest neighbour in the Silva guide tree. These 
isolates belonged to the Firmicutes (n=5), Actinobacteria (n=6), Proteobacteria 
(n=15) and Bacteroidetes (n=5). The most closely related type strains could be 
separated into those isolated from the marine environment (n=15), and those isolated 
mostly from soil, air and plants (n=12). A similar distribution was observed for the 
closest neighbours where 18 out of 27 sequences originated from the marine 
environment. Three isolates belonging to the family of Flavobacteriaceae were
isolated that potentially constitute two new genera and one new species. These 
strains exhibited the highest 16S rRNA gene sequence identity to Kriegella aquimaris
(denovo1540, 94.9% identity), Gaetbulibacter marinus (denovo1624, 95.6% identity)
and Lacinutrix algicola (denovo1558, 96.7% identity). 
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sp.) that was present with higher relative abundance, and OTU GQ118701 
(Microbulbifer sp.) that was present with lower relative abundance, on plates 
inoculated with material from A. aerophoba, as compared to plates inoculated with 
samples from the other two sponges. In addition, OTU JN579972 (Bacillus sp.) 
contributed to the dissimilarity by a higher relative abundance on plates inoculated 
with C. candelabrum. Comparison by SIMPER of bacterial communities retrieved 
directly from agar and those obtained on filter membranes showed that there are no 
bacterial taxa that highly favour one growth surface over the other i.e. no taxon 
occurred with great differences in relative abundance that also substantially (>2%) 
contributed to the dissimilarity. 
Bacterial growth on the scraped plates was investigated for novel cultivable 
bacteria. Seventy-nine novel OTUs (≤95% identity of the representative read to the 
16S rRNA gene of the closest type strain) that were identified. However, 13 of these 
79 OTUs had a lower relative abundance in the scraped communities as compared to 
the inoculum (Figure S3.2). Therefore, it might be that these OTUs did not grow but 
instead were derived from sponge material that persisted on the agar media. To 
address this issue we applied three criteria to conclude bacteria growth: (i) OTUs 
needed to increase in relative abundance as compared to the inoculum, (ii) OTUs 
needed to have a relative abundance of ≥0.2%, and (iii) the scraped community 
required ≥20 visible colonies. Adopting these criteria, we retained as many as 27 
novel cultivable OTUs from the scraped communities of which the representative 
read has ≤95% identity to the 16S rRNA gene of the closest type strain (Table 3.1). 
At the phylum-level the 27 OTUs belong to the Proteobacteria (10 OTUs [8 α- and 2 
γ-]), Firmicutes (2 OTUs), Bacteroidetes (1 OTU) and Actinobacteria (14 OTUs). Most 
(19/27) novel OTUs grew on Mueller-Hinton-based agar media. Five of the novel 
OTUs (AJ347026, denovo528, denovo574, GU118526 and denovo98) were detected 
in the inoculum (sponge sample) as well (Table S3.3). 
Bacteria isolated in the presence of antibiotics 
Bacterial colonies were identified by double-barcoded 454-pyrosequencing. Reads 
were allocated to 542 out of 679 picked colonies, and amongst these colonies a total 
of 211 OTUs were detected. An OTU was only assigned if it represented >50% of 
reads obtained for that colony, which resulted in 47 OTUs being assigned to 425 
picked colonies (Figure S3.3). This assignment strategy was used in order to address 
the high number of OTUs that were detected by only one or a few reads, and in
almost all cases comprised the minority of reads assigned to a colony (Figure S3.4). 
In this way we adopt a conservative approach and limit ourselves to strains from
OTUs that are most likely truly represented by growing bacteria and discard potential 
sequence artefacts, even though OTUs detected by one or a few reads can still be 
informative about bacterial presence [259]. On average, a similar number of OTUs 
were assigned to colonies picked directly from agar media (2.56 ± 2.10 [s.d]) as 
compared to those picked from filters on top of agar media (2.33 ± 1.80 [s.d.]). For 31 
of 47 OTUs that were assigned to colonies, a representative isolate was successfully
regrown from the glycerol stocks up to pure culture. OTU denovo1749 (Pseudovibrio 
sp.) was assigned to isolates obtained from all three sponge species, and from two 
sponge species a representative isolate belonging to this OTU was successfully
cultured up to pure culture. Isolates are assumed to be different strains if they belong 
to the same OTU but are obtained from different sponges, and hence both strains 
were included in subsequent analyses. 
For each of the 31 pure cultures the 16S rRNA gene was sequenced to a 
length of at least 800 bp. A phylogenetic tree was constructed (Figure 3.4) based on 
16S rRNA gene sequences from the isolates we obtained in pure culture, their most
closely related type strain, and their closest neighbour in the Silva guide tree. These 
isolates belonged to the Firmicutes (n=5), Actinobacteria (n=6), Proteobacteria 
(n=15) and Bacteroidetes (n=5). The most closely related type strains could be 
separated into those isolated from the marine environment (n=15), and those isolated 
mostly from soil, air and plants (n=12). A similar distribution was observed for the 
closest neighbours where 18 out of 27 sequences originated from the marine 
environment. Three isolates belonging to the family of Flavobacteriaceae were
isolated that potentially constitute two new genera and one new species. These 
strains exhibited the highest 16S rRNA gene sequence identity to Kriegella aquimaris
(denovo1540, 94.9% identity), Gaetbulibacter marinus (denovo1624, 95.6% identity)
and Lacinutrix algicola (denovo1558, 96.7% identity). 
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Figure 3.3 Hierarchical clustering using Bray-Curtis distance based on 16S rRNA gene amplicons 
generated from three sponge samples (A. aerophoba , P. ficiformis and C. candelabrum) and 
corresponding communities retrieved by scraping from agar media. Bacterial communities were 
investigated on marine agar (squares), marine agar 10-fold diluted (open squares), Mufeller-Hinton 
agar (circles), Mueller-Hinton 10-fold diluted (open circles) and mucin agar (open triangles). Samples 
were either inoculated in direct contact with agar (A) or on top of a filter (F), and were harvested 15 
and 30 days post-inoculation. The sponge samples (inocula) are indicated with continuous colour bars. 
Hierarchical clustering was performed at the OTU-level (97% identity clusters). The heatmap 
corresponds to relative abundance values of order-level phylogenetic groups (>0.01% relative 
abundance in at least one sample). 
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Chapter 3 
 
Figure 3.3 Hierarchical clustering using Bray-Curtis distance based on 16S rRNA gene amplicons 
generated from three sponge samples (A. aerophoba , P. ficiformis and C. candelabrum) and 
corresponding communities retrieved by scraping from agar media. Bacterial communities were 
investigated on marine agar (squares), marine agar 10-fold diluted (open squares), Mufeller-Hinton 
agar (circles), Mueller-Hinton 10-fold diluted (open circles) and mucin agar (open triangles). Samples 
were either inoculated in direct contact with agar (A) or on top of a filter (F), and were harvested 15 
and 30 days post-inoculation. The sponge samples (inocula) are indicated with continuous colour bars. 
Hierarchical clustering was performed at the OTU-level (97% identity clusters). The heatmap 
corresponds to relative abundance values of order-level phylogenetic groups (>0.01% relative 
abundance in at least one sample). 
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Furthermore, for each of the 31 pure cultures antibiotic resistance was investigated 
against the antibiotics used in the cultivation experiment, plus ampicillin and 
imipenem (Table 3.2). Resistance was most frequent against tetracycline, polymyxin 
B and kanamycin, whereas no single isolate was resistant to rifampicin or imipenem. 
Generally, if isolates were susceptible to a certain antibiotic, then the corresponding 
OTU was not detected on media supplemented with this antibiotic in the original 
cultivation experiment from which they were derived. Except for Bradyrhizobium 
pachyrhizi (OTU: FJ624884), isolates were always simultaneously resistant to both 
antibiotics belonging to the penicillin group of β-lactam antibiotics i.e. ampicillin and 
penicillin. Eleven Gram-negative bacteria were sensitive to vancomycin and/or 
daptomycin, whereas these antibiotics primarily target Gram-positive bacteria (Table 
3.2). 
Publicly available genomes were obtained for six bacteria of the same species 
as our isolates and investigated in terms of resistance gene composition (Table S3.4) 
[105]. We detected putative β-lactam resistance genes in all tested genomes even 
though only Acinetobacter radioresistens was found to be resistant to a β-lactam 
antibiotic (penicillin). A. radioresistens was also found to be resistant to both 
chloramphenicol and erythromycin. In each of six publicly available A. radioresistens 
genomes we detected genes encoding a chloramphenicol transferase, membrane 
fusion protein MacA, and inner membrane protein MacB, which could provide 
resistance to the aforementioned antibiotics. In three genomes (from Sphinogobium 
xenophagum, Leisingera aquimarina and Bacillus stratosphericus) MFS efflux pump 
genes were detected, which could explain why our corresponding isolates are 
tetracycline-resistant. 
Comparison of bacterial presence in sponge samples and their cultivable 
fraction 
We found that for P. ficiformis and C. candelabrum, respectively, 45 and 19 OTUs 
were detected in the sponge samples that were also present in the scraped fractions 
(Figure 3.5). In the case of A. aerophoba only two OTUs (GU940713 and EU803928) 
were retrieved in the scraped fraction, and those were classified at the genus level to 
Propionibacterium and Halomonas. Table S3.5 provides taxonomic information 
regarding the OTUs that overlap for the different datasets. For all three sponges, an 
OTU was never detected both in the sponge samples and on media supplemented 
with antibiotics, without it also being detected in communities scraped from media 
without antibiotics. This is in line with the expectation that the addition of antibiotics
and the picking strategy (whereby merely visual growth was considered) prohibits 
capturing the full diversity of the cultivable fraction on media containing antibiotics. 
Eight OTUs were detected in the bacterial communities of all sponge species 
(Figure 3.5). In addition, 78 OTUs were shared exclusively between A. aerophoba
and P. ficiformis, whereas very few OTUs were shared between either of these two 
sponges and C. candelabrum (2 and 0 OTUs, respectively). The highest number of
OTUs was detected in the combined scraped communities, which could be a product
of this experimental group constituting the bulk of the reads (92.2%) (Table S3.3). 
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Figure 3.5 Venn diagrams that illustrate the relationship between OTUs that were detected in the 
three sponge samples, colonies picked from agar media supplemented with a wide variety of 
antibiotics, and bacteria retrieved by scraping from agar media without antibiotics. Panel A compares
the overlap in terms OTUs in the samples of the three different sponge species (A. aerophoba, P.
ficiformis and C. candelabrum). Panel B, C and D compare the overlap in terms of OTUs between the
sponge samples and their cultivable fractions
Discussion 
Bacterial profiles of the sponge hosts 
In studying bacterial culturability it is essential to know which bacterial species are 
present in the original samples. Therefore, the bacterial community profiles of the 
sponges studied here, i.e. A. aerophoba, C. candelabrum and P. ficiformis were
determined. In the microbiota of Aplysina spp. the sponge-specific candidate phylum 
Poribacteria was originally discovered [260], of which just recently a member was 
genomically characterized after single-cell sorting [261, 262]. Poribacteria could not 
be detected in this study due to insufficient similarity of the 454-pyrosequencing 
forward primer to the 16S rRNA gene target. Only 8 out of 972 OTUs detected in the
sponge samples were shared between all three sponges indicating that, as 
suggested by past studies [126, 263], bacterial colonization is highly sponge species-
specific. 
Bacterial diversity captured by scraping bacterial biomass from agar media 
Twenty-seven novel OTUs (defined as those for which the representative read has
<95% identity to the 16S rRNA gene of the closest type strain) were cultivated, albeit
at ≤3% relative abundance. Fourteen out of 27 novel OTUs belong to the phylum
Actinobacteria, members of which are known producers of secondary metabolites
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Figure 3.5 Venn diagrams that illustrate the relationship between OTUs that were detected in the 
three sponge samples, colonies picked from agar media supplemented with a wide variety of 
antibiotics, and bacteria retrieved by scraping from agar media without antibiotics. Panel A compares
the overlap in terms OTUs in the samples of the three different sponge species (A. aerophoba, P.
ficiformis and C. candelabrum). Panel B, C and D compare the overlap in terms of OTUs between the
sponge samples and their cultivable fractions
Discussion 
Bacterial profiles of the sponge hosts 
In studying bacterial culturability it is essential to know which bacterial species are 
present in the original samples. Therefore, the bacterial community profiles of the 
sponges studied here, i.e. A. aerophoba, C. candelabrum and P. ficiformis were
determined. In the microbiota of Aplysina spp. the sponge-specific candidate phylum 
Poribacteria was originally discovered [260], of which just recently a member was 
genomically characterized after single-cell sorting [261, 262]. Poribacteria could not 
be detected in this study due to insufficient similarity of the 454-pyrosequencing 
forward primer to the 16S rRNA gene target. Only 8 out of 972 OTUs detected in the
sponge samples were shared between all three sponges indicating that, as 
suggested by past studies [126, 263], bacterial colonization is highly sponge species-
specific. 
Bacterial diversity captured by scraping bacterial biomass from agar media 
Twenty-seven novel OTUs (defined as those for which the representative read has
<95% identity to the 16S rRNA gene of the closest type strain) were cultivated, albeit
at ≤3% relative abundance. Fourteen out of 27 novel OTUs belong to the phylum
Actinobacteria, members of which are known producers of secondary metabolites
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[125, 244, 264]. These strains are therefore particularly interesting for obtaining novel 
bioactive compounds with potential pharmaceutical applications. Five OTUs that met 
the criteria for growth were detected of which the 454-pyrosequencing read exhibited 
<89% sequence similarity with the closest type strain, and these strains (3 
Actinobacteria and 2 Proteobacteria) potentially belong to novel orders [265]. Three 
of these five OTUs (OTUs AJ347026, GU118536 and denovo528) were detected in 
bacterial biomass retrieved from agar media as well as in the original sponge 
samples, indicating a role in the sponge host. Consequently, they are of particular 
interest in the study of host-symbiont relations. OTU AJ347026 is especially relevant 
for these studies since it is highly novel (82.2% sequence similarity of the 454-
pyrosequencing read to the 16S rRNA gene of the closest type strain), and it was 
already previously assigned to a sponge-specific clade [266]. OTU GU118536 was 
detected earlier in the coral Montastraea faveolata by cultivation-independent 
methods [267]. We detected no growth of novel Chloroflexi, Nitrospirae and 
Bacteroidetes, which are typically considered harder to cultivate by conventional 
plating methodologies such as those applied in this study. Our study is the first 
cultivation study for C. candelabrum, but nevertheless, most novel bacteria were 
detected in the cultivable fraction from A. aerophoba, warranting further investigation 
into those samples. It should be noted that since we did not obtain strains belonging 
to the novel OTUs (Table 3.1) in pure culture, there is the possibility that some are 
dependent on other strains for growth or some compounds from the sponges, and 
might therefore not be readily cultivable up to pure cultures by the methods applied 
here [268]. 
One issue of analysing bacterial growth by scraping from agar media is that 
cell material from the inoculum can still be present, and as a result bacteria may be 
detected that did not actually grow. This is an important caveat of the plate scraping 
method that needs to be considered in growth experiments that use high throughput 
16S rRNA gene sequencing. We acknowledge that this phenomenon could have 
occurred in our experiments when in one scraped community that was comprised of 
only two visible colonies as much as 188 OTUs were detected. In addition, in some 
scraped communities comprised of <10 colonies OTUs were detected that were also 
present in the sponge samples, but at lower relative abundance. For example, an 
OTU (DQ889875) that corresponded to a novel δ-proteobacterium was present with 
12% relative abundance in the P. ficiformis sample, whereas it was present at a 
relative abundance of 2.7% in a P. ficiformis scraped community that consisted of 2 
colonies. We assume that this bacterium did not grow, even though we cannot
exclude the possibility that micro-colonies appeared that were invisible to the naked
eye. In order to address this issue we have applied conservative criteria before 
concluding bacterial growth. A separate issue is that glycerol-frozen sponge samples
were used and as such bacteria that do not survive the freeze-thawing process are 
not recovered. 
Bacterial diversity captured by picking of individual isolates 
Bacterial sponge isolates typically belong to the Actinobacteria, Bacteroidetes,
Firmicutes or α-, β- and γ-Proteobacteria [148, 269]. Here, each of 47 isolates
obtained from media supplemented with antibiotics belongs to these four phyla, and 
only in two cases the bacterium (or a similar strain from the same OTU) was also
detected in the original sponge sample. OTU1749 was assigned to 223 colonies 
even though in the sponges samples this OTU was not detected, suggesting that 
Pseudovibrio spp. have a strong growth advantage on the applied cultivation media.
Pseudovibrio spp. have been repeatedly isolated from marine sponges without being 
detected by cultivation-independent techniques [150, 270]. These results imply that in 
sponges a vast number of different bacterial species reside that are not detected at 
read depths of at least 3,000-7,000 reads. Therefore, the presence of additional 
uncovered bacterial diversity is still to be expected. 
To isolate a diverse range of bacteria we also applied a polycarbonate filter
that could mimic the inner structures of the filter-feeding sponge, an extended 
incubation period, poor and selective media, and supplementation of antibiotics. We 
found that the application of a polycarbonate filter did not complement conventional 
plating with respect to retrieved bacterial diversity. Two bacterial strains were picked 
no earlier than 34 days post-incubation. These were a Mycobacterium peregrinum
(OTU FJ382132) and a bacterium that potentially belongs to a new genus in the 
Flavobacteriaceae family (OTU denovo1540). After transfer to fresh media visible 
colonies grew after a week, which indicates that their initially slower growth might 
have been hampered due to adjustment to in vitro conditions. The Flavobacteriaceae
sp. was originally isolated on mucin agar, but was also found to grow on marine agar.
Two other strains, namely a Bradyrhizobium pachyrhizi (OTU FJ624884) and another
novel Flavobacteriaceae sp. (OTU denovo1558), were isolated on 10-fold diluted 
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sponges a vast number of different bacterial species reside that are not detected at 
read depths of at least 3,000-7,000 reads. Therefore, the presence of additional 
uncovered bacterial diversity is still to be expected. 
To isolate a diverse range of bacteria we also applied a polycarbonate filter
that could mimic the inner structures of the filter-feeding sponge, an extended 
incubation period, poor and selective media, and supplementation of antibiotics. We 
found that the application of a polycarbonate filter did not complement conventional 
plating with respect to retrieved bacterial diversity. Two bacterial strains were picked 
no earlier than 34 days post-incubation. These were a Mycobacterium peregrinum
(OTU FJ382132) and a bacterium that potentially belongs to a new genus in the 
Flavobacteriaceae family (OTU denovo1540). After transfer to fresh media visible 
colonies grew after a week, which indicates that their initially slower growth might 
have been hampered due to adjustment to in vitro conditions. The Flavobacteriaceae
sp. was originally isolated on mucin agar, but was also found to grow on marine agar.
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novel Flavobacteriaceae sp. (OTU denovo1558), were isolated on 10-fold diluted 
61
High throughput recovery of previously uncultured bacterial generasponge bacteri 
 
 
 
 
  
 
  
 
 
  
 
 
    
   
  
 
 
62
Chapter 3 
 
marine agar and mucin agar, respectively, and both were unable to grow on 
(undiluted) marine agar. Lastly, on marine agar, a third novel Flavobacteriaceae sp. 
(OTU denovo1624) was isolated which potentially constitutes a new genus. These 
results demonstrate that longer incubation periods and a spectrum of different media 
were effective to capture a broader diversity of bacteria. Pseudovibrio spp. hindered 
the isolation of diverse bacteria by virtue of their fast (over-)growth. Bacteria from this 
genus often dominate cultured fractions of sponge-associated bacterial communities 
[148, 271]. Pseudovibrio spp. were sensitive to kanamycin, which aided in the 
isolation of four different bacterial strains from agar media supplemented with this 
antibiotic that were not retrieved from media supplemented with other antibiotics. In 
general, these results show that refinement of standard cultivation strategies, such as 
supplementation of media with antibiotics, can be used to acquire yet uncovered 
bacterial diversity. The success at acquisition of previously uncultivated bacteria is 
also related to sponges being relatively unexplored [93, 129, 271]. 
Sponge bacteria as a reservoir for antibiotic resistance genes 
Resistance genes have been detected in all biological niches associated with 
complex microbial communities [97]. It is therefore hypothesized that also sponge-
associated bacteria harbour resistance genes that could (eventually) become 
available to human pathogens [272]. The bacteria isolated in this study were resistant 
to a diverse range of antibiotics that are routinely used in the clinic. Publicly available 
genomes of a subset of these species indicated the potential presence of resistance 
genes against tetracyclines, β-lactams, aminoglycosides, chloramphenicol and 
erythromycin, frequently correlating with the observed resistance phenotypes of our 
corresponding strains. However, class A or B β-lactamase resistance genes were 
detected in all investigated public genomes even though resistance to ampicillin 
and/or penicillin was only observed in 1 out of 6 of our corresponding strains. 
Functional (meta-)genomic studies are suggested to identify mechanisms behind the 
observed antibiotic resistance, and to investigate if sponges are a reservoir for 
(novel) antibiotic resistance genes. 
Conclusion 
Using high throughput cultivation we captured a breadth of previously uncultured
sponge-associated bacteria, mainly from A. aerophoba. At the same time, we 
presented criteria to address an important caveat of the plate scraping method 
whereby bacteria may be detected that did not actually grow. We propose 27 OTUs
that are of prime interest due to their novelty alone. Among these, a diverse range of
novel Actinobacteria was cultivated, which shows that previously uncultivated 
bacteria with high biotechnological and pharmaceutical potential are still accessible 
by classic cultivation. One highly novel previously uncultured Actinobacterium was 
cultivated that was also detected in the original sponge sample. This strain appears
to belong to a sponge-specific clade, which makes it particularly interesting in the 
study of host-symbiont relations. In addition, three Flavobacteriaceae spp. were 
cultured up to pure cultures and potentially constitute two new genera and one new 
species.
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were effective to capture a broader diversity of bacteria. Pseudovibrio spp. hindered 
the isolation of diverse bacteria by virtue of their fast (over-)growth. Bacteria from this 
genus often dominate cultured fractions of sponge-associated bacterial communities 
[148, 271]. Pseudovibrio spp. were sensitive to kanamycin, which aided in the 
isolation of four different bacterial strains from agar media supplemented with this 
antibiotic that were not retrieved from media supplemented with other antibiotics. In 
general, these results show that refinement of standard cultivation strategies, such as 
supplementation of media with antibiotics, can be used to acquire yet uncovered 
bacterial diversity. The success at acquisition of previously uncultivated bacteria is 
also related to sponges being relatively unexplored [93, 129, 271]. 
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Resistance genes have been detected in all biological niches associated with 
complex microbial communities [97]. It is therefore hypothesized that also sponge-
associated bacteria harbour resistance genes that could (eventually) become 
available to human pathogens [272]. The bacteria isolated in this study were resistant 
to a diverse range of antibiotics that are routinely used in the clinic. Publicly available 
genomes of a subset of these species indicated the potential presence of resistance 
genes against tetracyclines, β-lactams, aminoglycosides, chloramphenicol and 
erythromycin, frequently correlating with the observed resistance phenotypes of our 
corresponding strains. However, class A or B β-lactamase resistance genes were 
detected in all investigated public genomes even though resistance to ampicillin 
and/or penicillin was only observed in 1 out of 6 of our corresponding strains. 
Functional (meta-)genomic studies are suggested to identify mechanisms behind the 
observed antibiotic resistance, and to investigate if sponges are a reservoir for 
(novel) antibiotic resistance genes. 
Conclusion 
Using high throughput cultivation we captured a breadth of previously uncultured
sponge-associated bacteria, mainly from A. aerophoba. At the same time, we 
presented criteria to address an important caveat of the plate scraping method 
whereby bacteria may be detected that did not actually grow. We propose 27 OTUs
that are of prime interest due to their novelty alone. Among these, a diverse range of
novel Actinobacteria was cultivated, which shows that previously uncultivated 
bacteria with high biotechnological and pharmaceutical potential are still accessible 
by classic cultivation. One highly novel previously uncultured Actinobacterium was 
cultivated that was also detected in the original sponge sample. This strain appears
to belong to a sponge-specific clade, which makes it particularly interesting in the 
study of host-symbiont relations. In addition, three Flavobacteriaceae spp. were 
cultured up to pure cultures and potentially constitute two new genera and one new 
species.
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Supplementary information 
Supplementary Tables and Figures 
Tables S3.1, S3.3, S3.4 and S3.5 are available upon request. 
Table S3.2 Panel A: number of colonies picked from samples of three sponges (A. aerophoba, C. 
candelabrum and P. ficiformis) inoculated on five different agar media supplemented with antibiotics. 
Panel B and C: number of visible colonies scraped from identical samples inoculated on media 
without antibiotics. Cell material was harvested 15 and 30 days post-inoculation. 
 
(A)
Aplysina aerophoba Corticium candelabrum Petrosia ficiformis
Agar Filter Agar Filter Agar Filter
Marine agar 110 53 3 4 21 11
Marine agar (10 X diluted) 60 31 18 1 1 0
Mueller-Hinton agar 51 33 1 0 12 10
Mueller-Hinton agar (10 X diluted) 78 31 1 0 18 4
Mucin agar 57 52 0 0 16 2
(B)
Agar Filter Agar Filter Agar Filter
Marine agar 174 55 17 14 39 24
Marine agar (10 X diluted) 195 160 4 3 2 2
Mueller-Hinton agar 101 37 6 4 11 6
Mueller-Hinton agar (10 X diluted) 226 104 4 4 19 17
Mucin agar 183 100 93 15 18 15
(C)
Aplysina aerophoba Corticium candelabrum Petrosia ficiformis
Agar Filter Agar Filter Agar Filter
Marine agar 252 84 20 14 38 14
Marine agar (10 X diluted) 250 90 7 2 23 3
Mueller-Hinton agar 133 35 1 4 11 9
Mueller-Hinton agar (10 X diluted) 286 91 3 10 28 16
Mucin agar 169 119 93 253 25 14
Aplysina aerophoba Corticium candelabrum Petrosia ficiformis
Material from 3 plates scraped at day 30
Picked isolates
Material from 3 plates scraped at day 15
 
 
 
Figure S3.1 Rarefaction curves in which is plotted the number of OTUs detected in samples from the 
sponges A. aerophoba (yellow), P. ficiformis (blue) and C. candelabrum (red) as a function of the 
number of reads sampled. 
 
Figure S3.2 The relative abundance values of OTUs that were detected with >4 reads in the 
communities scraped from agar media are plotted against the identity of the corresponding read to the 
closest type strain, as determined by BLASTn. The highest relative abundance value is shown if the 
OTU was detected in multiple scraped communities. The OTUs are shown separately for each of the 
three sponges: A. aerophoba (circles), P. ficiformis (diamonds) and C. candelabrum (triangles). Data 
points are marked green if the relative abundance of the OTU in the scraped fraction is higher than in 
the in the sponge sample (the inocolum) or in red if the converse is true.  
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Figure S3.4 For each OTU assigned to a picked colony, its relative abundance was calculated by 
dividing the number of reads with which this OTU was detected by the total number of reads assigned 
to the colony. By this manner a list of relative abundance values was generated, and the distribution of 
these values is shown here. Note that a high number OTUs were assigned to colonies with <10% 
relative abundance (in most cases these OTUs are detected by one read only), which are expected to 
be mostly sequencing artefacts. 
Supplementary Materials and Methods 
Barcoded 16S rRNA gene amplification and library preparation 
Barcodes were included to facilitate parallel processing of multiple samples. PCRs 
were performed in a total volume of 100 μl containing 20 μl 5X Phusion Green HF 
buffer (Thermo Scientific), 2 μl 10 mM dNTPs, 5 μl 10 μM forward primer, 5 μl 10 μM 
reverse primer, 1 μl Phusion Hot start II DNA polymerase (2 U/µl, Thermo Scientific) 
and 2 µl sample (10-20 ng/µl). The PCR program consisted of: initial denaturation of 
30 s at 98 °C; 30 cycles of denaturation at 98 °C for 10 s, annealing at 56 °C for 20 s, 
and extension at 72 °C for 20 s; and final extension at 72 °C for 10 min. At this point 
0
100
200
300
400
500
600
Frequency  
Relative abundance  
.
.
67
3
High throughput recovery of previously uncultured bacterial genera
   
 
 Fi
gu
re
 S
3.
3 
A
n 
O
TU
 w
as
 a
ss
ig
ne
d 
to
 a
 c
ol
on
y 
if 
re
pr
es
en
te
d 
by
 >
50
%
 o
f r
ea
ds
 p
er
ta
in
in
g 
to
 th
at
 is
ol
at
e.
 F
or
 e
ac
h 
of
 th
es
e 
47
 O
TU
s 
is
 s
ho
w
n 
on
 a
ve
ra
ge
 th
e 
da
y 
at
 w
hi
ch
 th
e 
co
rr
es
po
nd
in
g 
is
ol
at
es
 w
er
e 
pi
ck
ed
. T
he
 v
al
ue
 b
et
w
ee
n 
br
ac
ke
ts
 b
eh
in
d 
th
e 
O
TU
 n
am
e 
in
di
ca
te
s 
th
e 
nu
m
be
r 
of
 s
tra
in
s 
th
at
 w
er
e 
pi
ck
ed
 
be
lo
ng
in
g 
to
 th
is
 O
TU
. E
rr
or
 b
ar
s 
re
pr
es
en
tin
g 
st
an
da
rd
 d
ev
ia
tio
ns
 a
re
 g
iv
en
 if
 >
1 
is
ol
at
e 
w
as
 o
bt
ai
ne
d.
 F
or
 O
TU
s 
w
ith
 g
re
en
 b
ar
s 
an
 is
ol
at
e 
w
as
 o
bt
ai
ne
d 
in
 
pu
re
 c
ul
tu
re
 w
he
re
as
 fo
r t
ho
se
 w
ith
 re
d 
ba
rs
 re
gr
ow
th
 w
as
 u
ns
uc
ce
ss
fu
l. 
 
Av
er
ag
e 
da
y 
of
 is
ol
at
e 
pi
ck
in
g
O
TU
0
10
20
30
40
50
60
70
80
A
B
57
25
83
 (1
)
A
J6
33
97
0 
(2
)
A
J8
75
02
3 
(1
)
A
M
70
97
02
 (3
)
A
Y
95
90
53
 (4
)
de
no
vo
10
26
 (2
7)
de
no
vo
12
31
 (1
)
de
no
vo
13
38
 (1
)
de
no
vo
13
45
 (2
)
de
no
vo
15
40
 (2
)
de
no
vo
15
58
 (1
3)
de
no
vo
16
00
 (2
)
de
no
vo
16
24
 (1
)
de
no
vo
16
27
 (1
)
de
no
vo
17
49
 (2
23
)
de
no
vo
17
54
 (1
)
de
no
vo
18
88
 (1
0)
de
no
vo
19
8 
(4
)
de
no
vo
20
37
 (1
)
de
no
vo
47
3 
(4
)
de
no
vo
52
0 
(1
)
de
no
vo
55
2 
(7
)
de
no
vo
60
5 
(4
)
de
no
vo
82
8 
(1
)
D
Q
44
61
09
 (1
)
D
Q
86
00
60
 (1
)
E
F1
23
32
3 
(2
)
FJ
16
91
95
 (3
)
FJ
19
16
74
 (1
)
FJ
20
31
35
 (3
)
FJ
38
21
32
 (1
)
FJ
62
48
84
 (2
6)
FJ
75
19
10
 (1
)
FJ
80
87
21
 (8
)
G
Q
11
87
01
 (4
)
G
U
22
58
20
 (1
)
G
U
94
07
13
 (1
)
H
E5
74
87
9 
(3
)
H
M
59
53
66
 (7
)
H
Q
32
62
90
 (2
)
H
Q
67
10
75
 (6
)
JF
93
74
22
 (4
)
JF
93
74
3 3
 (2
)
JN
03
83
12
 (4
)
JN
57
99
72
 (1
)
JN
87
43
85
 (2
)
U
81
99
0 
(2
4)
sponge bacteri
Fi
gu
re
S3
.3
 A
n
O
TU
w
as
as
si
gn
ed
to
a
co
lo
ny
if
re
pr
es
en
te
d
by
>5
0%
of
re
ad
s
pe
rta
in
in
g
to
th
at
is
ol
at
e.
Fo
re
ac
h
of
th
es
e
47
O
TU
s
is
 s
ho
w
n 
on
av
er
ag
e
th
e
da
y
at
w
hi
ch
th
e
co
rr
es
po
nd
in
g
is
ol
at
es
w
er
e
pi
ck
ed
.T
he
va
lu
e 
be
tw
ee
n
br
ac
ke
ts
be
hi
nd
th
e
O
TU
na
m
e
in
di
ca
te
s
th
e
nu
m
be
r
of
st
ra
in
s
th
at
w
er
e
pi
ck
ed
be
lo
ng
in
g
to
th
is
O
TU
.E
rr
or
ba
rs
re
pr
es
en
tin
g
st
an
da
rd
de
vi
at
io
ns
ar
e
gi
ve
n
if
>1
is
ol
at
e
w
as
ob
ta
in
ed
.F
or
O
TU
s
w
ith
gr
ee
n
ba
rs
an
is
ol
at
e
w
as
ob
ta
in
ed
in
pu
re
cu
ltu
re
w
he
re
as
fo
rt
ho
se
w
ith
 re
d
ba
rs
re
gr
ow
th
w
as
un
su
cc
es
sf
ul
.
Av
er
ag
e 
da
y 
of
 is
ol
at
e 
pi
ck
in
g
O
TU
0
10
20
30
40
50
60
70
80
A
B
57
25
83
(1
)
A
J6
33
97
0
(2
)
A
J8
75
02
3
(1
)
A
M
70
97
02
(3
)
A
Y
95
90
53
(4
)
de
no
vo
10
26
(2
7)
de
no
vo
12
31
(1
)
de
no
vo
13
38
(1
)
de
no
vo
13
45
(2
)
de
no
vo
15
40
(2
)
de
no
vo
15
58
(1
3)
de
no
vo
16
00
(2
)
de
no
vo
16
24
(1
)
de
no
vo
16
27
(1
)
de
no
vo
17
49
(2
23
)
de
no
vo
17
54
(1
)
de
no
vo
18
88
(1
0)
de
no
vo
19
8
(4
)
de
no
vo
20
37
(1
)
de
no
vo
47
3
(4
)
de
no
vo
52
0
(1
)
de
no
vo
55
2
(7
)
de
no
vo
60
5
(4
)
de
no
vo
82
8
(1
)
D
Q
44
61
09
(1
)
D
Q
86
00
60
(1
)
E
F1
23
32
3
(2
)
FJ
16
91
95
(3
)
FJ
19
16
74
(1
)
FJ
20
31
35
(3
)
FJ
38
21
32
(1
)
FJ
62
48
84
(2
6)
FJ
75
19
10
(1
)
FJ
80
87
21
(8
)
G
Q
11
87
01
(4
)
G
U
22
58
20
(1
)
G
U
94
07
13
(1
)
H
E5
74
87
9
(3
)
H
M
59
53
66
(7
)
H
Q
32
62
90
(2
)
H
Q
67
10
75
(6
)
JF
93
74
22
(4
)
JF
93
74
33
(2
)
JN
03
83
12
(4
)
JN
57
99
72
(1
)
JN
87
43
85
(2
)
U
81
99
0
(2
4)
Fi
gu
re
S3
.3
 A
n
O
TU
w
as
as
si
gn
ed
to
a
co
lo
ny
if
re
pr
es
en
te
d
by
>5
0%
of
re
ad
s
pe
rta
in
in
g
to
th
at
is
ol
at
e.
Fo
re
ac
h
of
th
es
e
47
O
TU
s
is
 s
ho
w
n 
on
av
er
ag
e
th
e
da
y
at
w
hi
ch
th
e
co
rr
es
po
nd
in
g
is
ol
at
es
w
er
e
pi
ck
ed
.T
he
va
lu
e 
be
tw
ee
n
br
ac
ke
ts
be
hi
nd
th
e
O
TU
na
m
e
in
di
ca
te
s
th
e
nu
m
be
r
of
st
ra
in
s
th
at
w
er
e
pi
ck
ed
be
lo
ng
in
g
to
th
is
O
TU
.E
rr
or
ba
rs
re
pr
es
en
tin
g
st
an
da
rd
de
vi
at
io
ns
ar
e
gi
ve
n
if
>1
is
ol
at
e
w
as
ob
ta
in
ed
.F
or
O
TU
s
w
ith
gr
ee
n
ba
rs
an
is
ol
at
e
w
as
ob
ta
in
ed
in
pu
re
cu
ltu
re
w
he
re
as
fo
rt
ho
se
w
ith
 re
d
ba
rs
re
gr
ow
th
w
as
un
su
cc
es
sf
ul
.
Av
er
ag
e 
da
y 
of
 is
ol
at
e 
pi
ck
in
g
O
TU
0
10
20
30
40
50
60
70
80
A
B
57
25
83
(1
)
A
J6
33
97
0
(2
)
A
J8
75
02
3
(1
)
A
M
70
97
02
(3
)
A
Y
95
90
53
(4
)
de
no
vo
10
26
(2
7)
de
no
vo
12
31
(1
)
de
no
vo
13
38
(1
)
de
no
vo
13
45
(2
)
de
no
vo
15
40
(2
)
de
no
vo
15
58
(1
3)
de
no
vo
16
00
(2
)
de
no
vo
16
24
(1
)
de
no
vo
16
27
(1
)
de
no
vo
17
49
(2
23
)
de
no
vo
17
54
(1
)
de
no
vo
18
88
(1
0)
de
no
vo
19
8
(4
)
de
no
vo
20
37
(1
)
de
no
vo
47
3
(4
)
de
no
vo
52
0
(1
)
de
no
vo
55
2
(7
)
de
no
vo
60
5
(4
)
de
no
vo
82
8
(1
)
D
Q
44
61
09
(1
)
D
Q
86
00
60
(1
)
E
F1
23
32
3
(2
)
FJ
16
91
95
(3
)
FJ
19
16
74
(1
)
FJ
20
31
35
(3
)
FJ
38
21
32
(1
)
FJ
62
48
84
(2
6)
FJ
75
19
10
(1
)
FJ
80
87
21
(8
)
G
Q
11
87
01
(4
)
G
U
22
58
20
(1
)
G
U
94
07
13
(1
)
H
E5
74
87
9
(3
)
H
M
59
53
66
(7
)
H
Q
32
62
90
(2
)
H
Q
67
10
75
(6
)
JF
93
74
22
(4
)
JF
93
74
33
(2
)
JN
03
83
12
(4
)
JN
57
99
72
(1
)
JN
87
43
85
(2
)
U
81
99
0
(2
4)
366
Chapter 3
   
 
 Fi
gu
re
 S
3.
3 
A
n 
O
TU
 w
as
 a
ss
ig
ne
d 
to
 a
 c
ol
on
y 
if 
re
pr
es
en
te
d 
by
 >
50
%
 o
f r
ea
ds
 p
er
ta
in
in
g 
to
 th
at
 is
ol
at
e.
 F
or
 e
ac
h 
of
 th
es
e 
47
 O
TU
s 
is
 s
ho
w
n 
on
 a
ve
ra
ge
 th
e 
da
y 
at
 w
hi
ch
 th
e 
co
rr
es
po
nd
in
g 
is
ol
at
es
 w
er
e 
pi
ck
ed
. T
he
 v
al
ue
 b
et
w
ee
n 
br
ac
ke
ts
 b
eh
in
d 
th
e 
O
TU
 n
am
e 
in
di
ca
te
s 
th
e 
nu
m
be
r 
of
 s
tra
in
s 
th
at
 w
er
e 
pi
ck
ed
 
be
lo
ng
in
g 
to
 th
is
 O
TU
. E
rr
or
 b
ar
s 
re
pr
es
en
tin
g 
st
an
da
rd
 d
ev
ia
tio
ns
 a
re
 g
iv
en
 if
 >
1 
is
ol
at
e 
w
as
 o
bt
ai
ne
d.
 F
or
 O
TU
s 
w
ith
 g
re
en
 b
ar
s 
an
 is
ol
at
e 
w
as
 o
bt
ai
ne
d 
in
 
pu
re
 c
ul
tu
re
 w
he
re
as
 fo
r t
ho
se
 w
ith
 re
d 
ba
rs
 re
gr
ow
th
 w
as
 u
ns
uc
ce
ss
fu
l. 
 
Av
er
ag
e 
da
y 
of
 is
ol
at
e 
pi
ck
in
g
O
TU
0
10
20
30
40
50
60
70
80
A
B
57
25
83
 (1
)
A
J6
33
97
0 
(2
)
A
J8
75
02
3 
(1
)
A
M
70
97
02
 (3
)
A
Y
95
90
53
 (4
)
de
no
vo
10
26
 (2
7)
de
no
vo
12
31
 (1
)
de
no
vo
13
38
 (1
)
de
no
vo
13
45
 (2
)
de
no
vo
15
40
 (2
)
de
no
vo
15
58
 (1
3)
de
no
vo
16
00
 (2
)
de
no
vo
16
24
 (1
)
de
no
vo
16
27
 (1
)
de
no
vo
17
49
 (2
23
)
de
no
vo
17
54
 (1
)
de
no
vo
18
88
 (1
0)
de
no
vo
19
8 
(4
)
de
no
vo
20
37
 (1
)
de
no
vo
47
3 
(4
)
de
no
vo
52
0 
(1
)
de
no
vo
55
2 
(7
)
de
no
vo
60
5 
(4
)
de
no
vo
82
8 
(1
)
D
Q
44
61
09
 (1
)
D
Q
86
00
60
 (1
)
E
F1
23
32
3 
(2
)
FJ
16
91
95
 (3
)
FJ
19
16
74
 (1
)
FJ
20
31
35
 (3
)
FJ
38
21
32
 (1
)
FJ
62
48
84
 (2
6)
FJ
75
19
10
 (1
)
FJ
80
87
21
 (8
)
G
Q
11
87
01
 (4
)
G
U
22
58
20
 (1
)
G
U
94
07
13
 (1
)
H
E5
74
87
9 
(3
)
H
M
59
53
66
 (7
)
H
Q
32
62
90
 (2
)
H
Q
67
10
75
 (6
)
JF
93
74
22
 (4
)
JF
93
74
3 3
 (2
)
JN
03
83
12
 (4
)
JN
57
99
72
 (1
)
JN
87
43
85
 (2
)
U
81
99
0 
(2
4)
 
 
 
 
Figure S3.4 For each OTU assigned to a picked colony, its relative abundance was calculated by 
dividing the number of reads with which this OTU was detected by the total number of reads assigned 
to the colony. By this manner a list of relative abundance values was generated, and the distribution of 
these values is shown here. Note that a high number OTUs were assigned to colonies with <10% 
relative abundance (in most cases these OTUs are detected by one read only), which are expected to 
be mostly sequencing artefacts. 
Supplementary Materials and Methods 
Barcoded 16S rRNA gene amplification and library preparation 
Barcodes were included to facilitate parallel processing of multiple samples. PCRs 
were performed in a total volume of 100 μl containing 20 μl 5X Phusion Green HF 
buffer (Thermo Scientific), 2 μl 10 mM dNTPs, 5 μl 10 μM forward primer, 5 μl 10 μM 
reverse primer, 1 μl Phusion Hot start II DNA polymerase (2 U/µl, Thermo Scientific) 
and 2 µl sample (10-20 ng/µl). The PCR program consisted of: initial denaturation of 
30 s at 98 °C; 30 cycles of denaturation at 98 °C for 10 s, annealing at 56 °C for 20 s, 
and extension at 72 °C for 20 s; and final extension at 72 °C for 10 min. At this point 
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the identification of picked colonies required an additional step wherein PCR 
products with identical barcodes in the forward primer were pooled equimolarly (at 
maximum 48 different barcodes in the reverse primer were combined with a barcode 
in the forward primer). Either 5, 10 or 20 μl of PCR product was included in the pool, 
depending on agarose gel band intensity. Subsequently (pools of) PCR products 
were purified with the GeneJET PCR Purification Kit (Thermo Scientific) according to 
manufacturers’ instructions. Isopropanol was included in the binding buffer and 
elution buffer was re-applied to the column to increase the DNA yield. The DNA 
concentration of the elute was measured with the Qubit® 2.0 Fluorometer 
(Invitrogen) using the Qubit® dsDNA BR assay according to manufacturers’ 
instructions. An equimolar mixture of at maximum 54 purified PCR products 
containing different forward barcodes was prepared and run on a 1% agarose gel. 
The gel band at ~425 bp was cut from the gel and purified using the DNA Gel 
Extraction Kit (Millipore) according to manufacturers’ instructions. The DNA 
concentration of the mixture was measured by Qubit® 2.0 and sent for 454-
pyrosequencing at GATC Biotech (Konstanz, Germany) on a Roche GS FLX. 
Diversity and clustering analyses of bacterial communities 
Rarefactions	curves	
For sponge bacterial communities, rarefaction curves were calculated with QIIME 
scripts [251] applying 10 iterations per subsampling of the OTU table. Subsamples 
were generated beginning with 100 reads, plus an additional 250 reads were added 
per subsampling step. QIIME was also used to calculate Shannon diversity metrics. 
Therefore, the number of reads in the OTU table per sample was rarefied using 1,000 
iterations to match the sample with the smallest number of reads. The Shannon 
diversity metric was calculated for each of the 1,000 rarefied OTU tables and used to 
calculate an average value per sample. 
Hierarchical	clustering	
Hierarchical clustering was performed using R package ‘Vegan’ based on OTU-level 
relative abundance data obtained from bacterial communities in sponge tissues as 
well as those scraped from agar plates. Firstly, a matrix of Bray-Curtis dissimilarity 
values was created with Vegan function ‘vegdist’. Thereafter, the dissimilarity matrix 
was used for average hierarchical clustering with hclust, and finally, a dendrogram 
was created using the function ‘as.dendrogram’. 
 
 
Canonical	(constrained)	correspondence	analysis	
Canonical (constrained) correspondence analysis as implemented in Canoco 5 [254] 
was used to investigate which experimental variables best explain the variation in 
species composition regarding OTU-level relative abundance data obtained from the 
bacterial communities scraped from agar plates. Interactive-forward-selection 
analysis was selected with ‘sponge species’, ‘day of harvesting’, ‘medium’ and 
‘growth surface’ (agar or filter) as explanatory variables. Explanatory variables at the 
forward selection step were included in order of contribution to the explained variation 
until the value of the adjusted R2 including the current best candidate exceeded the 
threshold based on a model with all predictors. 
SIMPER	
SIMPER analysis [255] was used with respect to square rooted OTU-level relative 
abundance data to break down the contribution of each OTU to the observed 
dissimilarity between sample groups. Pairwise comparisons were performed between 
samples that were grouped based on sponge species, day of harvesting, medium 
and growth surface. 
Phylogenetic	tree	construction	
The tree was constructed in ARB [256] by Maximum likelihood analysis using 1,000 
iterations of rapid bootstrapping. For tree calculation, highly variable positions (1-9) 
were excluded using the bacterial Positional Variability by Parsimony filter, and non-
overlapping regions were excluded (window of inclusion, position 5,331 to 26,803). 
After tree construction, representative pyrosequencing reads belonging to OTUs for 
which unsuccessful attempts were made to obtain a member in pure culture were 
added using “add species to existing tree” with ARB_Parsimony, applying similar 
filtering settings as those used for the base tree.
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Abstract 
Wide application of antibiotics has contributed to the evolution of multi-drug resistant 
human pathogens, resulting in poorer treatment outcomes for infections. In the 
marine environment sea water samples have been investigated as a resistance 
reservoir; however, no studies have methodically examined sponges as a reservoir of 
antibiotic resistance. Sponges could be important in this respect because they often 
contain diverse microbial communities that have the capacity to produce bioactive 
metabolites. Here, we apply functional metagenomics to study the presence and 
diversity of functional resistance genes in the sponges Aplysina aerophoba, Petrosia 
ficiformis and Corticium candelabrum. We obtained 37 insert sequences facilitating 
resistance to D-cycloserine (n=6), gentamicin (n=1), amikacin (n=7), trimethoprim 
(n=17), chloramphenicol (n=1), rifampicin (n=2) and ampicillin (n=3). Fifteen of 37 
inserts harboured resistance genes that shared <90% amino acid identity with known 
gene products, whereas on 13 inserts no resistance gene could be identified with 
high confidence, in which case we predicted resistance to be mainly mediated by 
antibiotic efflux. One marine-specific ampicillin-resistance-conferring β-lactamase 
was identified in the genus Pseudovibrio with 41% global amino acid identity to the 
closest β-lactamase with demonstrated functionality, and subsequently classified into 
a new family termed PSV. Taken together, our results confirm that sponge microbiota 
host diverse and novel resistance genes that may be harnessed phylogenetically 
distinct bacteria. 
Introduction 
In the last decades the massive medical and veterinary use of antibiotics has 
contributed to the selection of multi-drug resistant human pathogens, resulting in 
poorer treatment outcomes upon infection [273]. Bacterial pathogens can evolve 
resistance vertically [274] but mainly acquire resistance through horizontal gene
transfer [275], where resistance genes are obtained either from the indigenous
human microbiota or from environmental microorganisms to which an individual is 
exposed (e.g. via food, water or soil). The current complement of resistance genes
encountered in the human microbiota is suggested to have originated from natural 
environments, likely in part selected by prior anthropogenic antibiotic pressure [4, 
104, 212]. However, microbiota from isolated human populations have also been 
found to carry functional antibiotic resistance (AR) genes [179]. Soil has been 
implicated to be a key environmental reservoir of AR genes, as evidenced by the fact
that AR genes with perfect nucleotide identity to those in human pathogens have 
been described in soil-dwelling bacteria [43]. 
In addition to soil, resistance genes have been found in a broad range of 
environments that contain complex microbial communities such as activated sludge 
[98, 99], caves [108], glaciers [191], rivers [103] and animals [100, 101]. As a result,
all these environments, and probably many more, can act as potential reservoirs for
resistance gene dissemination. It has been shown that AR is a natural phenomenon 
that predates the modern selective pressure of clinical antibiotic use [109], although 
little is known about the exact roles of these genes in their native environments [19]. 
The marine environment is a major genetic reservoir of AR, which despite its
tremendous bacterial diversity has been little studied in the context of AR gene
dissemination [190]. A recent study has identified a range of unclassified resistance 
genes in ocean water, thereby highlighting its importance as an environmental 
reservoir [102]. 
Marine sponges are an ancient lineage of sessile filter-feeding metazoans. 
Many sponges harbour a dense and diverse microbiota comprising up to 40% of the 
total sponge volume, and as such, house a complex ecosystem characterized by
host-microbe and microbe-microbe interactions [123]. Much sponge research has
focused on the sponge microbiota as a source of novel bioactive compounds [276], 
whereas its role as a reservoir of AR genes has received limited attention. Still, the
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fact that sponge microbiota can produce diverse antimicrobials [134, 277] would 
suggest the presence of AR genes. An example of antimicrobials produced by 
sponge bacteria are rifampicin antibiotics, which at first were only known to be 
produced by soil Actinobacteria [278, 279], but more recently have also been found 
to be produced by a sponge-associated Actinobacterium sp. [280]. 
To date, research on functional AR genes in sponge microbiota has been 
limited to a Bacillus sp. isolated from the sponge Haliclona simulans. The Bacillus sp. 
was found to contain two small plasmids, one of which harboured the tetL tetracycline 
resistance gene [139] whereas the other harboured the ermT erythromycin resistance 
gene [140]. The plasmid with the tetL gene was shown to be nearly identical to three 
other tetracycline resistance plasmids identified in the honey bee pathogen 
Paenibacilus larvae pMA67, in the cheese-resident Lactobacillus sakei Rits 9, and in 
Sporosarcina urea pSU1 isolated from soil beneath a chicken farm [139]. 
Furthermore, a TEM β-lactamase encoding gene was detected in a 
metatranscriptome dataset from the sponge Crambe crambe (Chapter 2 of this 
thesis), and the mecA, mupA, qnrB and tetL resistance genes were detected in the 
sponge Petromica citrina by PCR with gene-specific primers [142]. Based on these 
results it is tempting to speculate that the sponge microbiota indeed might act as a 
reservoir of functional AR genes. 
The aim of this study was to systematically assess sponge microbiota as a 
reservoir of AR genes. We screened for functional resistance genes against 14 
clinically relevant antibiotics in three Mediterranean high-microbial-abundance 
sponges, namely Aplysina aerophoba, Petrosia ficiformis and Corticium 
candelabrum. Small-insert libraries were prepared in Escherichia coli with DNA 
isolated from sponge tissue of the three sponges (environmental DNA libraries), as 
well as from pooled DNA isolated from 31 bacterial isolates that were obtained from 
these sponges (sponge isolates DNA library). The 31 bacterial isolates were obtained 
from agar media supplemented with antibiotics as part of a previous high-throughput 
cultivation study (Chapter 3). 
Materials and methods 
Resistance profiling of bacterial isolates 
One small-insert library was prepared from genomic DNA obtained from 31 bacterial 
strains (Table 4.1) isolated from the sponges A. aerophoba, C. candelabrum and P. 
ficiformis. Resistance of these isolates to polymyxin B, erythromycin, ciprofloxacin,
cefotaxime, tetracycline, chloramphenicol, rifampicin, ampicillin and imipenem was 
investigated in a previous study (Chapter 3). Additionally, in this study, resistance of
the isolates was tested to gentamicin (50 μg/ml), D-cycloserine (50 μg/ml), 
chlortetracycline (50 μg/ml), amikacin (100 μg/ml) and trimethoprim (50 μg/ml). 
Preparation of linearized vector pZE21
An E. coli TOP10 strain harbouring the plasmid pZE21 was inoculated into 10 ml LB 
broth with kanamycin (50 μg/ml). The culture was incubated at 37 °C overnight. 
Plasmid isolation was performed with the GeneJET Plasmid Miniprep Kit (Thermo 
Fisher Scientific, Waltham, United States). The DNA concentration was measured by
Qubit® (Thermo Fisher Scientific), and the isolated plasmid was electrophoresed on a 
1% agarose gel for visual inspection. Next, the plasmid was cut by HincII #R0103C 
(NEB, Ipswich, Massachusetts) according to manufacturer’s instructions. 
Subsequently, the plasmid ends were dephosphorylated according to the Protocol for
dephosphorylation of 5’-ends of DNA by rSAP (NEB). Finally, the linearized and
dephosphorylated plasmid DNA was purified with the Clean-up Concentrator kit (A&A 
Biotechnology, Gdynia, Poland). 
Preparation of small-insert libraries 
To prepare a small-insert library with a mixture of genomic DNA from 31 pure culture 
isolates (Table 4.1), we individually isolated DNA with the MasterPure™ DNA 
Purification Kit (Epicentre, Madison, Wisconsin). The DNA concentration was
measured by Qubit® 2.0, and DNA from the different isolates was then pooled at
equivalent mass. DNA from sponge tissue samples was isolated with the DNeasy 
Blood & Tissue Kit (Qiagen, Hilden, Germany). DNA was fragmented by the E210 
sonicator (Covaris, Woburn, Massachusetts) where default operating conditions were 
used to achieve an average fragment size of 2 kbp. The fragmented DNA was
electrophoresed on a 1% agarose gel, and DNA ranging from 0.7-5 kbp was purified 
by using the GeneJet Gel Extraction Kit (Thermo Fisher Scientific). In the final gel 
purification step, DNA was eluted with nuclease-free water instead of elution buffer. 
Subsequently the DNA ends were repaired with the NEBNext® End Repair Module 
(NEB) according to manufacturer’s instructions. The end-repaired DNA was cleaned 
with the Clean-up Concentrator kit (A&A Biotechnology), and elution was performed 
with nuclease-free water. The TaKaRa MightyMix DNA ligation kit (Clontech 
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Furthermore, a TEM β-lactamase encoding gene was detected in a 
metatranscriptome dataset from the sponge Crambe crambe (Chapter 2 of this 
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from agar media supplemented with antibiotics as part of a previous high-throughput 
cultivation study (Chapter 3). 
Materials and methods 
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strains (Table 4.1) isolated from the sponges A. aerophoba, C. candelabrum and P. 
ficiformis. Resistance of these isolates to polymyxin B, erythromycin, ciprofloxacin,
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investigated in a previous study (Chapter 3). Additionally, in this study, resistance of
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chlortetracycline (50 μg/ml), amikacin (100 μg/ml) and trimethoprim (50 μg/ml). 
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Qubit® (Thermo Fisher Scientific), and the isolated plasmid was electrophoresed on a 
1% agarose gel for visual inspection. Next, the plasmid was cut by HincII #R0103C 
(NEB, Ipswich, Massachusetts) according to manufacturer’s instructions. 
Subsequently, the plasmid ends were dephosphorylated according to the Protocol for
dephosphorylation of 5’-ends of DNA by rSAP (NEB). Finally, the linearized and
dephosphorylated plasmid DNA was purified with the Clean-up Concentrator kit (A&A 
Biotechnology, Gdynia, Poland). 
Preparation of small-insert libraries 
To prepare a small-insert library with a mixture of genomic DNA from 31 pure culture 
isolates (Table 4.1), we individually isolated DNA with the MasterPure™ DNA 
Purification Kit (Epicentre, Madison, Wisconsin). The DNA concentration was
measured by Qubit® 2.0, and DNA from the different isolates was then pooled at
equivalent mass. DNA from sponge tissue samples was isolated with the DNeasy 
Blood & Tissue Kit (Qiagen, Hilden, Germany). DNA was fragmented by the E210 
sonicator (Covaris, Woburn, Massachusetts) where default operating conditions were 
used to achieve an average fragment size of 2 kbp. The fragmented DNA was
electrophoresed on a 1% agarose gel, and DNA ranging from 0.7-5 kbp was purified 
by using the GeneJet Gel Extraction Kit (Thermo Fisher Scientific). In the final gel 
purification step, DNA was eluted with nuclease-free water instead of elution buffer. 
Subsequently the DNA ends were repaired with the NEBNext® End Repair Module 
(NEB) according to manufacturer’s instructions. The end-repaired DNA was cleaned 
with the Clean-up Concentrator kit (A&A Biotechnology), and elution was performed 
with nuclease-free water. The TaKaRa MightyMix DNA ligation kit (Clontech 
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Laboratories Inc., Mountain View, United States) was used for ligation of the end-
repaired fragments into the linearized pZE21 vector. Each ligation mixture consisted 
of 2 μl Ligation Mix and 2 μl nuclease-free water containing 600 ng insert DNA and 
120 ng linearized vector (5:1 ratio). The resulting product was used for two 
electroporation reactions at 2 μl each, thereby creating two distinct small-insert 
libraries. At electroporation, 2 μl ligation mixture was added to 50 μl One Shot® 
TOP10 Electrocomp™ E. coli cells (Thermo Fisher Scientific). The sample was 
transferred to a 1 mm cuvet and subjected to an electric pulse at 1.8 kV, 2.5 μF and 
200 Ω. To recover the E. coli cells, 1 ml SOC medium was added, and the sample 
was incubated at 37 °C for 1 h. After recovery, 2 μl of the cell suspension was ten-
fold serially diluted, and plated on LB agar media containing kanamycin (50 μg/ml) in 
order to estimate library size based on CFU counts. For each library, twelve clones 
were picked and colony PCRs were performed with primers pZE21_81_104_57C and 
pZE21_151_174rc_58C [185], which flank the insertion site. The average product 
size (nt), the CFU count (in no. of colonies per μl) and the total volume (in μl) were 
multiplied in order to estimate the library size. In order to achieve library amplification, 
the remainder of the cell suspension after recovery was transferred to 10 ml LB 
medium with kanamycin (50 μg/ml) and incubated overnight at 37 °C. After library 
amplification, another CFU count was performed. The total number of CFUs pre- and 
post-amplification was divided in order to estimate the extent of library expansion. 
Libraries were mixed to contain 20% glycerol and stored in cryotubes at -80 °C. We 
also verified the function of a β-lactamase resistance gene by cloning it into the 
pZE21 vector as a single gene using the methods described in this paragraph, 
starting from the ligation step. The insert DNA consisted of amplicon sequences that 
were obtained by gene-specific PCR. 
Library screening and insert sequencing 
Libraries were plated at 25X (predicted) library coverage (i.e. every clone is expected 
to be present 25 times) on LB agar plates containing one of the following antibiotics: 
ampicillin (20 μg/ml), ciprofloxacin (1 μg/ml), tetracycline (20 μg/ml), chloramphenicol 
(20 μg/ml), polymyxin B (2 μg/ml), trimethoprim (2 μg/ml), erythromycin (200 μg/ml), 
cefotaxime (25 μg/ml) , rifampicin (25 μg/ml), imipenem (20 μg/ml), gentamicin (20 
μg/ml), D-cycloserine (100 μg/ml), chlortetracycline (20 μg/ml) and amikacin (50 
μg/ml). E. coli TOP10 cells without a plasmid were used as negative control. Inserts 
from antibiotic resistant clones were Sanger sequenced from both the 5’ and 3’ flanks
with respectively the pZE21_81_104_57C and pZE21_151_174rc_58C primers. 
Clones were assumed to contain identical inserts if sequences were more than 99%
identical over a stretch of >400 bp. One clone per set of identical clones was selected 
for further analysis. The full-length inserts of these representative clones were 
sequenced by primer walking. Sanger sequencing was performed by flanking primers 
custom-designed with Primer3Plus [281] until GeneStudio version 2.2.0.0 could
assemble a contig that spanned the entire insert. Finally, vector sequences were 
removed by DNA Baser version 3.5.4.2. 
Analysis of inserts conferring resistance 
ORFs were identified by MetaGeneMark [282], and the corresponding nucleotide and 
derived amino acid sequences were extracted. Amino acid sequences were used for
BLASTp [283] against the NCBI non-redundant protein database and the CARD 
database [284]. BLASTn of the sequences against the NCBI nr/nt and CARD 
databases were performed as well. Resistance functions were also predicted with 
HMMER (http://hmmer.org/) using the profile hidden Markov models (pHMMs) of the 
Resfams database as a reference [105]. We defined a resistance gene to be 
identified with high confidence if it was detected at an E-value of <1E-7 by either
BLASTp or BLASTn against the Comprehensive Antibiotic Resistance Database
(CARD), or by employing the pHMMs of the Resfams database. In addition, the 
resistance function needed to match the observed resistance phenotype.
InterProScan [285] was used for classifying proteins into families and for predicting
the presence of domains. Clustal Omega [286] was used to globally align resistance 
genes with their best hit in NCBI’s non-redundant protein database and to calculate 
an amino acid identity value. ISfinder [287] was used to identify IS elements. The 
ACLAME server [288] was used to investigate if parts of the insert sequences were 
previously identified on mobile genetic elements. 
Assignment of inserts conferring resistance to bacterial isolates 
Since one small-insert library was prepared with genomic DNA from 31 different 
sponge-associated bacterial isolates (as opposed to metagenomic DNA), we could 
use insert sequence-specific PCRs to assign inserts to the bacterium of origin. For
this purpose, primers were designed with Primer3Plus [281]. The reaction mixture of 
a given detection PCR consisted of: 10 μl 5X Green GoTaq Reaction Buffer 
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Laboratories Inc., Mountain View, United States) was used for ligation of the end-
repaired fragments into the linearized pZE21 vector. Each ligation mixture consisted 
of 2 μl Ligation Mix and 2 μl nuclease-free water containing 600 ng insert DNA and 
120 ng linearized vector (5:1 ratio). The resulting product was used for two 
electroporation reactions at 2 μl each, thereby creating two distinct small-insert 
libraries. At electroporation, 2 μl ligation mixture was added to 50 μl One Shot® 
TOP10 Electrocomp™ E. coli cells (Thermo Fisher Scientific). The sample was 
transferred to a 1 mm cuvet and subjected to an electric pulse at 1.8 kV, 2.5 μF and 
200 Ω. To recover the E. coli cells, 1 ml SOC medium was added, and the sample 
was incubated at 37 °C for 1 h. After recovery, 2 μl of the cell suspension was ten-
fold serially diluted, and plated on LB agar media containing kanamycin (50 μg/ml) in 
order to estimate library size based on CFU counts. For each library, twelve clones 
were picked and colony PCRs were performed with primers pZE21_81_104_57C and 
pZE21_151_174rc_58C [185], which flank the insertion site. The average product 
size (nt), the CFU count (in no. of colonies per μl) and the total volume (in μl) were 
multiplied in order to estimate the library size. In order to achieve library amplification, 
the remainder of the cell suspension after recovery was transferred to 10 ml LB 
medium with kanamycin (50 μg/ml) and incubated overnight at 37 °C. After library 
amplification, another CFU count was performed. The total number of CFUs pre- and 
post-amplification was divided in order to estimate the extent of library expansion. 
Libraries were mixed to contain 20% glycerol and stored in cryotubes at -80 °C. We 
also verified the function of a β-lactamase resistance gene by cloning it into the 
pZE21 vector as a single gene using the methods described in this paragraph, 
starting from the ligation step. The insert DNA consisted of amplicon sequences that 
were obtained by gene-specific PCR. 
Library screening and insert sequencing 
Libraries were plated at 25X (predicted) library coverage (i.e. every clone is expected 
to be present 25 times) on LB agar plates containing one of the following antibiotics: 
ampicillin (20 μg/ml), ciprofloxacin (1 μg/ml), tetracycline (20 μg/ml), chloramphenicol 
(20 μg/ml), polymyxin B (2 μg/ml), trimethoprim (2 μg/ml), erythromycin (200 μg/ml), 
cefotaxime (25 μg/ml) , rifampicin (25 μg/ml), imipenem (20 μg/ml), gentamicin (20 
μg/ml), D-cycloserine (100 μg/ml), chlortetracycline (20 μg/ml) and amikacin (50 
μg/ml). E. coli TOP10 cells without a plasmid were used as negative control. Inserts 
from antibiotic resistant clones were Sanger sequenced from both the 5’ and 3’ flanks
with respectively the pZE21_81_104_57C and pZE21_151_174rc_58C primers. 
Clones were assumed to contain identical inserts if sequences were more than 99%
identical over a stretch of >400 bp. One clone per set of identical clones was selected 
for further analysis. The full-length inserts of these representative clones were 
sequenced by primer walking. Sanger sequencing was performed by flanking primers 
custom-designed with Primer3Plus [281] until GeneStudio version 2.2.0.0 could
assemble a contig that spanned the entire insert. Finally, vector sequences were 
removed by DNA Baser version 3.5.4.2. 
Analysis of inserts conferring resistance 
ORFs were identified by MetaGeneMark [282], and the corresponding nucleotide and 
derived amino acid sequences were extracted. Amino acid sequences were used for
BLASTp [283] against the NCBI non-redundant protein database and the CARD 
database [284]. BLASTn of the sequences against the NCBI nr/nt and CARD 
databases were performed as well. Resistance functions were also predicted with 
HMMER (http://hmmer.org/) using the profile hidden Markov models (pHMMs) of the 
Resfams database as a reference [105]. We defined a resistance gene to be 
identified with high confidence if it was detected at an E-value of <1E-7 by either
BLASTp or BLASTn against the Comprehensive Antibiotic Resistance Database
(CARD), or by employing the pHMMs of the Resfams database. In addition, the 
resistance function needed to match the observed resistance phenotype.
InterProScan [285] was used for classifying proteins into families and for predicting
the presence of domains. Clustal Omega [286] was used to globally align resistance 
genes with their best hit in NCBI’s non-redundant protein database and to calculate 
an amino acid identity value. ISfinder [287] was used to identify IS elements. The 
ACLAME server [288] was used to investigate if parts of the insert sequences were 
previously identified on mobile genetic elements. 
Assignment of inserts conferring resistance to bacterial isolates 
Since one small-insert library was prepared with genomic DNA from 31 different 
sponge-associated bacterial isolates (as opposed to metagenomic DNA), we could 
use insert sequence-specific PCRs to assign inserts to the bacterium of origin. For
this purpose, primers were designed with Primer3Plus [281]. The reaction mixture of 
a given detection PCR consisted of: 10 μl 5X Green GoTaq Reaction Buffer 
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(Promega, Fitchburg, Wisconsin), 0.2 mM dNTPs (Promega), 1 μM forward primer, 1 
μM reverse primer, 0.5 μl GoTaq G2 DNA polymerase (5 U/µl, Promega), 1 µl 
genomic DNA (10-20 ng/µl), and 32.5 µl nuclease-free water (Promega). The PCR 
program consisted of: initial denaturation of 30 s at 98 °C; 35 cycles of denaturation 
at 98 °C for 10 s, annealing at 57 °C for 20 s, and extension at 72 °C for 20 s; and 
final extension at 72 °C for 10 min. The PCR product was analysed on a 1% agarose 
gel. If neither the initial PCR nor a repetition with a 1 °C reduction in annealing 
temperature yielded a product, then new primers were designed. If an insert 
sequence-specific PCR yielded a product with genomic DNA from multiple isolates, 
then the amplification products were sequenced by Sanger sequencing. Inserts were 
assigned to an isolate if the Sanger sequence was 99-100% identical to the insert 
sequence. 
Nucleotide sequence accession numbers 
The metagenomic insert sequences were deposited under accession numbers 
KU577908 to KU577944. The insert that contained blaPSV-1 as a single gene was 
deposited under accession KU926347. 
Results 
Composition and screening of metagenomic libraries 
In order to investigate the presence and diversity of functional AR genes in sponge 
microbiota, small-insert libraries were prepared in E. coli with a mixture of gDNA from 
31 bacterial strains isolated from the sponges A. aerophoba, P. ficiformis, and C. 
candelabrum (library I-31; 0.8 Gbp), and with DNA directly isolated from the 
same three sponges (libraries Aa; 0.2 Gbp, Cc; 0.8 Gbp, Pf; 1.7 Gbp). 16S 
ribosomal RNA (rRNA) gene amplicon sequence analysis of the bacterial gDNA 
pool that was used to prepare library I-31 confirmed that DNA from all 31 isolates 
was present (data not shown). Amongst these 31 sponge-associated bacteria, 
resistance to 14 out of 16 antibiotics was observed, whereas merely 
intermediate resistance, signifying a reduced growth rate, to imipenem was 
observed. None of the isolates were resistant to rifampicin (Table 4.1). Screening 
of the four different libraries for AR yielded 37 clones with unique inserts 
conferring resistance to D-cycloserine (n=6), gentamicin (n=1), amikacin (n=7), 
trimethoprim (n=17), chloramphenicol (n=1), rifampicin (n=2) and ampicillin (n=3) 
(Table 4.2). No clones were obtained that were resistant to chlortetracycline, 
imipenem. The majority of resistant clones (30 of 37) were derived from library I-31, 
whereas 2 clones, 0 clones and 5 clones were derived from libraries Aa, Cc and Pf, 
respectively. 
Resistance gene diversity and uniqueness 
The unique full-length inserts (mean insert size = 2,974 bp ± 1,627 [s.d.]) were 
sequenced by Sanger sequencing, which occasionally required multiple iterations of 
primer walking. We defined a resistance gene to be identified with high confidence if 
the resistance function was assigned at an E-value of <1E-7, and furthermore the 
resistance function needed to match the observed resistance phenotype.
In total, 26 resistance genes distributed over 24 different inserts were 
identified that met our confidence threshold (Table S4.1). The uniqueness of the 
resistance genes was evaluated by performing a global alignment at the amino acid 
level with the closest BLASTp hit in NCBI’s non-redundant protein database. The 
majority of confidently identified resistance genes obtained from library I-31 (17 of 21) 
were predicted to code for proteins that had >70% identity at the amino acid level 
with known gene products, whereas proteins encoded by the genes (n=5) obtained 
from the metagenomic libraries of environmental sponge DNA had <60% amino acid 
identity with known gene products (Figure 4.1A, B). Overall, most confidently
identified resistance genes (15/26) were predicted to encode trimethoprim-
resistance-conferring dihydrofolate reductases (Figure 4.1C). The confidently
identified AR genes with the lowest similarity to known genes were predicted to code 
for a glycerol-3-phosphate acyltransferase and a GNAT family acetyltransferase with 
respectively 32% and 36% amino acid identity with the closest hit in NCBI’s non-
redundant protein database. Both of these amikacin-resistance-conferring genes
were detected in libraries of environmental sponge DNA. 
For 13 insert sequences a resistance gene could not be identified meeting our 
threshold. Those inserts conferred resistance to amikacin (n=4), D-cycloserine (n=6), 
and trimethoprim (n=3) (Table 4.3, Table S4.2). In these cases, besides BLAST
searches against the CARD and NCBI nr/nt databases and motif detection by 
application of Resfams pHMMs, also protein domain and protein family predications
by InterProScan were evaluated in order to manually predict AR gene presence.
Most (12 of 13) inserts contained multiple open reading frames (ORFs), which 
prevented the unequivocal assignment of resistance functions to individual genes. 
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μM reverse primer, 0.5 μl GoTaq G2 DNA polymerase (5 U/µl, Promega), 1 µl 
genomic DNA (10-20 ng/µl), and 32.5 µl nuclease-free water (Promega). The PCR 
program consisted of: initial denaturation of 30 s at 98 °C; 35 cycles of denaturation 
at 98 °C for 10 s, annealing at 57 °C for 20 s, and extension at 72 °C for 20 s; and 
final extension at 72 °C for 10 min. The PCR product was analysed on a 1% agarose 
gel. If neither the initial PCR nor a repetition with a 1 °C reduction in annealing 
temperature yielded a product, then new primers were designed. If an insert 
sequence-specific PCR yielded a product with genomic DNA from multiple isolates, 
then the amplification products were sequenced by Sanger sequencing. Inserts were 
assigned to an isolate if the Sanger sequence was 99-100% identical to the insert 
sequence. 
Nucleotide sequence accession numbers 
The metagenomic insert sequences were deposited under accession numbers 
KU577908 to KU577944. The insert that contained blaPSV-1 as a single gene was 
deposited under accession KU926347. 
Results 
Composition and screening of metagenomic libraries 
In order to investigate the presence and diversity of functional AR genes in sponge 
microbiota, small-insert libraries were prepared in E. coli with a mixture of gDNA from 
31 bacterial strains isolated from the sponges A. aerophoba, P. ficiformis, and C. 
candelabrum (library I-31; 0.8 Gbp), and with DNA directly isolated from the 
same three sponges (libraries Aa; 0.2 Gbp, Cc; 0.8 Gbp, Pf; 1.7 Gbp). 16S 
ribosomal RNA (rRNA) gene amplicon sequence analysis of the bacterial gDNA 
pool that was used to prepare library I-31 confirmed that DNA from all 31 isolates 
was present (data not shown). Amongst these 31 sponge-associated bacteria, 
resistance to 14 out of 16 antibiotics was observed, whereas merely 
intermediate resistance, signifying a reduced growth rate, to imipenem was 
observed. None of the isolates were resistant to rifampicin (Table 4.1). Screening 
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trimethoprim (n=17), chloramphenicol (n=1), rifampicin (n=2) and ampicillin (n=3) 
(Table 4.2). No clones were obtained that were resistant to chlortetracycline, 
imipenem. The majority of resistant clones (30 of 37) were derived from library I-31, 
whereas 2 clones, 0 clones and 5 clones were derived from libraries Aa, Cc and Pf, 
respectively. 
Resistance gene diversity and uniqueness 
The unique full-length inserts (mean insert size = 2,974 bp ± 1,627 [s.d.]) were 
sequenced by Sanger sequencing, which occasionally required multiple iterations of 
primer walking. We defined a resistance gene to be identified with high confidence if 
the resistance function was assigned at an E-value of <1E-7, and furthermore the 
resistance function needed to match the observed resistance phenotype.
In total, 26 resistance genes distributed over 24 different inserts were 
identified that met our confidence threshold (Table S4.1). The uniqueness of the 
resistance genes was evaluated by performing a global alignment at the amino acid 
level with the closest BLASTp hit in NCBI’s non-redundant protein database. The 
majority of confidently identified resistance genes obtained from library I-31 (17 of 21) 
were predicted to code for proteins that had >70% identity at the amino acid level 
with known gene products, whereas proteins encoded by the genes (n=5) obtained 
from the metagenomic libraries of environmental sponge DNA had <60% amino acid 
identity with known gene products (Figure 4.1A, B). Overall, most confidently
identified resistance genes (15/26) were predicted to encode trimethoprim-
resistance-conferring dihydrofolate reductases (Figure 4.1C). The confidently
identified AR genes with the lowest similarity to known genes were predicted to code 
for a glycerol-3-phosphate acyltransferase and a GNAT family acetyltransferase with 
respectively 32% and 36% amino acid identity with the closest hit in NCBI’s non-
redundant protein database. Both of these amikacin-resistance-conferring genes
were detected in libraries of environmental sponge DNA. 
For 13 insert sequences a resistance gene could not be identified meeting our 
threshold. Those inserts conferred resistance to amikacin (n=4), D-cycloserine (n=6), 
and trimethoprim (n=3) (Table 4.3, Table S4.2). In these cases, besides BLAST
searches against the CARD and NCBI nr/nt databases and motif detection by 
application of Resfams pHMMs, also protein domain and protein family predications
by InterProScan were evaluated in order to manually predict AR gene presence.
Most (12 of 13) inserts contained multiple open reading frames (ORFs), which 
prevented the unequivocal assignment of resistance functions to individual genes. 
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For three of four inserts that conferred resistance to amikacin, we predicted the 
presence of genes encoding aminoglycoside-modifying enzymes. On one of these 
inserts (clone Env_Ami3) a gene was identified that we predicted to code for an 
enzyme that putatively modifies amikacin by phosphorylation. On the other two 
inserts, we predicted genes encoding an aminoglycoside acetyltransferase (clone 
Iso_Ami2) and an aminoglycoside methyltransferase (clone Iso_Ami3). The fourth 
insert conferring amikacin resistance (clone Iso_Ami4) contained a single gene that 
shared 93% amino acid identity with an amino acid transporter, and as such we 
predicted the gene to confer AR via antibiotic efflux. Six inserts conferred resistance 
to D-cycloserine. On all of these six inserts we predicted the presence of genes 
encoding proteins involved in transmembrane transport based on high similarity to 
known transporters. We predicted that three of the six D-cycloserine resistance-
conferring inserts harboured genes encoding transporters that belong to the major 
facilitator superfamily. Three other inserts on which an AR gene could not be 
confidently identified conferred resistance to trimethoprim. On one of these inserts 
(clone Env_Trim4) ), we predicted that a thymidylate synthethase may be responsible 
for the resistance phenotype. The two other inserts conferring trimethoprim 
resistance (clones Iso_trim13 and Iso_trim14) putatively encoded oxidoreductases 
that could confer trimethoprim resistance. 
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Chapter 4 
 
For three of four inserts that conferred resistance to amikacin, we predicted the 
presence of genes encoding aminoglycoside-modifying enzymes. On one of these 
inserts (clone Env_Ami3) a gene was identified that we predicted to code for an 
enzyme that putatively modifies amikacin by phosphorylation. On the other two 
inserts, we predicted genes encoding an aminoglycoside acetyltransferase (clone 
Iso_Ami2) and an aminoglycoside methyltransferase (clone Iso_Ami3). The fourth 
insert conferring amikacin resistance (clone Iso_Ami4) contained a single gene that 
shared 93% amino acid identity with an amino acid transporter, and as such we 
predicted the gene to confer AR via antibiotic efflux. Six inserts conferred resistance 
to D-cycloserine. On all of these six inserts we predicted the presence of genes 
encoding proteins involved in transmembrane transport based on high similarity to 
known transporters. We predicted that three of the six D-cycloserine resistance-
conferring inserts harboured genes encoding transporters that belong to the major 
facilitator superfamily. Three other inserts on which an AR gene could not be 
confidently identified conferred resistance to trimethoprim. On one of these inserts 
(clone Env_Trim4) ), we predicted that a thymidylate synthethase may be responsible 
for the resistance phenotype. The two other inserts conferring trimethoprim 
resistance (clones Iso_trim13 and Iso_trim14) putatively encoded oxidoreductases 
that could confer trimethoprim resistance. 
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Chapter 4 
 
Table 4.2 Small-insert libraries in E. coli were made with DNA isolated from 31 sponge bacteria, and 
with DNA isolated from A. aerophoba, C. candelabrum and P. ficiformis tissue. The libraries were 
screened for resistance to 14 antibiotics. This table shows the number of resistant clones with unique 
inserts for the different metagenomic libraries. No clones were obtained that were resistant to 
chlortetracycline, polymyxin, linezolid, erythromycin, ciprofloxacine, cefotaxime, tetracycline or 
imipenem. 
Metagenomic library 
Cumulative 
library size 
D-
cyclose
rine 
Gentam
icin 
Amikaci
n 
Trimeth
oprim 
Chlora
mpheni
col 
Rifampi
cin 
Ampicil
lin 
31 sponge bacteria (I-31) 0.8 Gbp 6 1 4 13 1 2 3 
A. aerophoba (Aa) 0.2 Gbp 0 0 1 1 0 0 0
C. candelabrum (Cc) 0.8 Gbp 0 0 0 0 0 0 0
P. ficiformis (Pf) 1.7 Gbp 0 0 2 3 0 0 0
Taxonomic assignment of inserts from the library of 31 sponge bacteria 
Resistance genes that were confidently identified in library I-31 were assigned to their 
strain of origin by gene-specific PCRs, where the PCR amplicon covered at least part 
of the predicted resistance gene. Gene presence was checked in all 31 strains used 
for building the library by dedicated PCR reactions, which resulted in confidently 
identified AR genes being assigned to 15 of 31 bacterial strains in library I-31 (Table 
4.1). Insert sequences for which no resistance gene could be identified with high 
confidence were assigned to a strain of origin at the loci given in Table S4.2. We 
discovered that several inserts may contain hybrid sequences, that is, the inserts 
consist of two different DNA fragments that were ligated into the vector. For example, 
the insert of clone Iso_Dcy6 was assigned to Ruegeria spp. in the region between 
513-1,372 bp and assigned to Acinetobacter radioresistens DN138_5C8 in the region 
between 2,240-2,851 bp (Table S4.2). We found that about half of the confidently 
identified resistance genes (11/21) were assigned to Bacillus spp., and Bacillus was 
the only taxon to which gentamicin, amikacin, chloramphenicol and rifampicin 
resistance genes were assigned (Table 4.1, Figure 4.1D). Even though gentamicin, 
amikacin, chloramphenicol, rifampicin and ampicillin resistance genes were assigned 
to Bacillus spp., the strains themselves were not found to be resistant to these 
antibiotics. Resistance genes that were assigned to the remaining taxa comprised 
mostly trimethoprim resistance genes, with an exception being an ampicillin 
resistance gene that was assig ned to Pseudovibrio spp. (Table S4.1). Strains to 
which trimethoprim resistance genes were assigned were not trimethoprim resistant 
themselves in 8 out of 9 cases. 
Novel β-lactamase family identified in Pseudovibrio
The insert sequence of ampicillin-resistant clone Iso_Amp3 contained a gene 
predicted to encode a class A β-lactamase. The gene was assigned to Pseudovibrio
ascidiaceicola DN64_1D03 and Pseudovibrio ascidiaceicola DN64_8G1, and the 
predicted protein shared 58% amino acid identity with the closest hit in the CBMAR 
database [289]. Since this predicted protein displayed high divergence with members 
of known β-lactamase families it is a candidate to be classified into a new family 
[290]. Therefore, we further tested the gene’s function by cloning the gene-specific 
amplicon sequence that was generated with genomic DNA of Pseudovibrio
ascidiaceicola DN64_1D03 as template it into the pZE21 vector. The new clone, 
PSV1 (accession KU926347), was resistant to ampicillin, which confirmed the
functionality of the β-lactamase gene. Remarkably, the coding sequence of the gene 
cloned using the genome-derived amplicon sequences was 75 bp longer than the 
coding sequence of the β-lactamase gene in the original metagenomic insert. Sanger
sequencing of the genome-derived amplicon yielded a gene sequence that shared 
100% nucleotide identity with the gene sequence in clone PSV1. Hence, we
concluded that the longer β-lactamase gene in clone PSV1 is the exact gene that is
present in the genome of Pseudovibrio ascidiaceicola DN64_1D03. We predict that 
even though a frameshift mutation yielded a shorter gene in case of the small-insert
library, the encoded enzyme retained its function. We classified the genome-derived 
(longer) gene into a novel β-lactamase family named PSV after Pseudovibrio. The 
first member was designated blaPSV-1. BLASTp of the gene against the CBMAR 
database showed that LEN and SHV were the closest β-lactamase families. The best
hit from the LEN and SHV families in both cases shared 50% amino acid identity with 
blaPSV-1. The best hits in the NCBI non-redundant protein sequences database (≥76% 
amino acid identity) were exclusively genes in sequenced genomes of Pseudovibrio
spp. (Figure 4.2). Additional resistance testing of clone PSV1 showed that blaPSV-1
conferred resistance to penicillin (50 μg/ml) but not against cefotaxime (20 μg/ml) and 
imipenem (20 μg/ml). 
Resistance gene dissemination 
Horizontal gene transfer is the main mechanism through which resistance genes are
disseminated. Therefore, we investigated our sequences for evidence of gene 
mobilisation. Comparison of the insert sequences with the ACLAME plasmid
83
4
Sponge micobiota are a reservoir of functional antibiotic resistance genes
0.8 Gb
0.2 Gb        
0.8 Gb        
1.7 Gb        
 
 
 
 
 
 
   
 
   
  
   
 
 
 
 
 
 
 
482
Chapter 4 
 
Table 4.2 Small-insert libraries in E. coli were made with DNA isolated from 31 sponge bacteria, and 
with DNA isolated from A. aerophoba, C. candelabrum and P. ficiformis tissue. The libraries were 
screened for resistance to 14 antibiotics. This table shows the number of resistant clones with unique 
inserts for the different metagenomic libraries. No clones were obtained that were resistant to 
chlortetracycline, polymyxin, linezolid, erythromycin, ciprofloxacine, cefotaxime, tetracycline or 
imipenem. 
Metagenomic library 
Cumulative 
library size 
D-
cyclose
rine 
Gentam
icin 
Amikaci
n 
Trimeth
oprim 
Chlora
mpheni
col 
Rifampi
cin 
Ampicil
lin 
31 sponge bacteria (I-31) 0.8 Gbp 6 1 4 13 1 2 3 
A. aerophoba (Aa) 0.2 Gbp 0 0 1 1 0 0 0
C. candelabrum (Cc) 0.8 Gbp 0 0 0 0 0 0 0
P. ficiformis (Pf) 1.7 Gbp 0 0 2 3 0 0 0
Taxonomic assignment of inserts from the library of 31 sponge bacteria 
Resistance genes that were confidently identified in library I-31 were assigned to their 
strain of origin by gene-specific PCRs, where the PCR amplicon covered at least part 
of the predicted resistance gene. Gene presence was checked in all 31 strains used 
for building the library by dedicated PCR reactions, which resulted in confidently 
identified AR genes being assigned to 15 of 31 bacterial strains in library I-31 (Table 
4.1). Insert sequences for which no resistance gene could be identified with high 
confidence were assigned to a strain of origin at the loci given in Table S4.2. We 
discovered that several inserts may contain hybrid sequences, that is, the inserts 
consist of two different DNA fragments that were ligated into the vector. For example, 
the insert of clone Iso_Dcy6 was assigned to Ruegeria spp. in the region between 
513-1,372 bp and assigned to Acinetobacter radioresistens DN138_5C8 in the region 
between 2,240-2,851 bp (Table S4.2). We found that about half of the confidently 
identified resistance genes (11/21) were assigned to Bacillus spp., and Bacillus was 
the only taxon to which gentamicin, amikacin, chloramphenicol and rifampicin 
resistance genes were assigned (Table 4.1, Figure 4.1D). Even though gentamicin, 
amikacin, chloramphenicol, rifampicin and ampicillin resistance genes were assigned 
to Bacillus spp., the strains themselves were not found to be resistant to these 
antibiotics. Resistance genes that were assigned to the remaining taxa comprised 
mostly trimethoprim resistance genes, with an exception being an ampicillin 
resistance gene that was assig ned to Pseudovibrio spp. (Table S4.1). Strains to 
which trimethoprim resistance genes were assigned were not trimethoprim resistant 
themselves in 8 out of 9 cases. 
Novel β-lactamase family identified in Pseudovibrio
The insert sequence of ampicillin-resistant clone Iso_Amp3 contained a gene 
predicted to encode a class A β-lactamase. The gene was assigned to Pseudovibrio
ascidiaceicola DN64_1D03 and Pseudovibrio ascidiaceicola DN64_8G1, and the 
predicted protein shared 58% amino acid identity with the closest hit in the CBMAR 
database [289]. Since this predicted protein displayed high divergence with members 
of known β-lactamase families it is a candidate to be classified into a new family 
[290]. Therefore, we further tested the gene’s function by cloning the gene-specific 
amplicon sequence that was generated with genomic DNA of Pseudovibrio
ascidiaceicola DN64_1D03 as template it into the pZE21 vector. The new clone, 
PSV1 (accession KU926347), was resistant to ampicillin, which confirmed the
functionality of the β-lactamase gene. Remarkably, the coding sequence of the gene 
cloned using the genome-derived amplicon sequences was 75 bp longer than the 
coding sequence of the β-lactamase gene in the original metagenomic insert. Sanger
sequencing of the genome-derived amplicon yielded a gene sequence that shared 
100% nucleotide identity with the gene sequence in clone PSV1. Hence, we
concluded that the longer β-lactamase gene in clone PSV1 is the exact gene that is
present in the genome of Pseudovibrio ascidiaceicola DN64_1D03. We predict that 
even though a frameshift mutation yielded a shorter gene in case of the small-insert
library, the encoded enzyme retained its function. We classified the genome-derived 
(longer) gene into a novel β-lactamase family named PSV after Pseudovibrio. The 
first member was designated blaPSV-1. BLASTp of the gene against the CBMAR 
database showed that LEN and SHV were the closest β-lactamase families. The best
hit from the LEN and SHV families in both cases shared 50% amino acid identity with 
blaPSV-1. The best hits in the NCBI non-redundant protein sequences database (≥76% 
amino acid identity) were exclusively genes in sequenced genomes of Pseudovibrio
spp. (Figure 4.2). Additional resistance testing of clone PSV1 showed that blaPSV-1
conferred resistance to penicillin (50 μg/ml) but not against cefotaxime (20 μg/ml) and 
imipenem (20 μg/ml). 
Resistance gene dissemination 
Horizontal gene transfer is the main mechanism through which resistance genes are
disseminated. Therefore, we investigated our sequences for evidence of gene 
mobilisation. Comparison of the insert sequences with the ACLAME plasmid
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database showed that they were not previously identified on plasmids. Furthermore, 
ISfinder did not identify insertion sequences. We investigated whether the resistance 
genes identified in this study had been observed previously in a different genomic 
context by comparing our sequences with those in the NCBI nr/nt database (Table 
S4.3). A β-lactamase and an ADP-ribosyl transferase (those on clones Iso_Amp2 
and Iso_Rif2, respectively), both of which were assigned to Bacillus aryabhattai 
DN67_5C7, shared very high (≥99%) identity with genes previously found in the non-
marine Bacillus megaterium QM B1551, which suggests a relatively recent 
dissemination event. The insert of clone Iso_Amp2 shared 99% identity with the 
genome of Bacillus megaterium QM B1551 over the full-length insert (1,352 bp). This 
insert produced four other significant alignments with sequences in the NCBI nr/nt 
database at >90% nucleotide identity, all of which belonged to Bacillus megaterium 
strains. The insert of clone Iso_Rif2 was 6,717 bp in length but only the region from 
5,198 to 6,717 bp aligned with the genome of Bacillus megaterium QM B1551. 
Besides the rifampicin-resistance-conferring gene, this region encodes a hypothetical 
protein and a gene that putatively encodes an enzyme involved in site specific 
recombination of plasmids. The gene putatively encoding a recombination enzyme 
was the only gene involved in gene mobilization that was predicted on the inserts. 
Discussion 
Functional metagenomic analysis of sponge-associated bacteria revealed diverse AR 
genes that conferred resistance to ampicillin, D-cycloserine, gentamicin, amikacin, 
trimethoprim, chloramphenicol and rifampicin. Seventeen of 26 confidently identified 
AR genes shared low homology (<90% amino acid identity) with known gene 
products. Therefore, these results show that sponges, like environments that contain 
complex bacterial communities, appear to represent reservoirs of unique AR genes. 
In addition, we obtained 13 inserts that did not contain genes with significant 
similarity to known resistance genes, reinforcing the notion that sponges may act as 
reservoirs of yet unknown mechanisms of AR. Two resistance genes shared ≥99% 
nucleotide identity with AR genes detected outside the marine environment, and 
hence it is tempting to speculate that AR genes are being transmitted between 
sponges and non-marine environments and as such may be exploited by bacteria in 
other non-marine habitats. It has previously been shown that AR genes can be 
genetically linked, leading to co-selection [60, 291]. None of our inserts contained AR  
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Chapter 4 
 
database showed that they were not previously identified on plasmids. Furthermore, 
ISfinder did not identify insertion sequences. We investigated whether the resistance 
genes identified in this study had been observed previously in a different genomic 
context by comparing our sequences with those in the NCBI nr/nt database (Table 
S4.3). A β-lactamase and an ADP-ribosyl transferase (those on clones Iso_Amp2 
and Iso_Rif2, respectively), both of which were assigned to Bacillus aryabhattai 
DN67_5C7, shared very high (≥99%) identity with genes previously found in the non-
marine Bacillus megaterium QM B1551, which suggests a relatively recent 
dissemination event. The insert of clone Iso_Amp2 shared 99% identity with the 
genome of Bacillus megaterium QM B1551 over the full-length insert (1,352 bp). This 
insert produced four other significant alignments with sequences in the NCBI nr/nt 
database at >90% nucleotide identity, all of which belonged to Bacillus megaterium 
strains. The insert of clone Iso_Rif2 was 6,717 bp in length but only the region from 
5,198 to 6,717 bp aligned with the genome of Bacillus megaterium QM B1551. 
Besides the rifampicin-resistance-conferring gene, this region encodes a hypothetical 
protein and a gene that putatively encodes an enzyme involved in site specific 
recombination of plasmids. The gene putatively encoding a recombination enzyme 
was the only gene involved in gene mobilization that was predicted on the inserts. 
Discussion 
Functional metagenomic analysis of sponge-associated bacteria revealed diverse AR 
genes that conferred resistance to ampicillin, D-cycloserine, gentamicin, amikacin, 
trimethoprim, chloramphenicol and rifampicin. Seventeen of 26 confidently identified 
AR genes shared low homology (<90% amino acid identity) with known gene 
products. Therefore, these results show that sponges, like environments that contain 
complex bacterial communities, appear to represent reservoirs of unique AR genes. 
In addition, we obtained 13 inserts that did not contain genes with significant 
similarity to known resistance genes, reinforcing the notion that sponges may act as 
reservoirs of yet unknown mechanisms of AR. Two resistance genes shared ≥99% 
nucleotide identity with AR genes detected outside the marine environment, and 
hence it is tempting to speculate that AR genes are being transmitted between 
sponges and non-marine environments and as such may be exploited by bacteria in 
other non-marine habitats. It has previously been shown that AR genes can be 
genetically linked, leading to co-selection [60, 291]. None of our inserts contained AR  
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Sponge micobiota are a reservoir of functional antibiotic resistance genes
 i  of A . Two resistance genes shared ≥9  
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Figure 4.1 These illustrations provide information about the 26 resistance genes that were 
identified with high confidence (E-value <1.0E-7) using the CARD and Resfams databases as a 
reference. Panels A and B show amino acid identity distributions of these genes with their best 
hit (bitscore sorted) in NCBI’s non-redundant protein database. Panel A applies to resistance genes 
obtained from the library of 31 sponge bacteria whereas panel B applies to resistance genes 
obtained from libraries based on DNA isolated from sponge tissue. Panel C shows the 
mechanisms of action of all 26 resistance genes. Panel D shows the taxonomy assignments of 
the resistance genes obtained from the library of 31 sponge bacteria. 
genes with different resistance functions, which is likely in part due to the small insert 
size of the metagenomic libraries. 
Out of 37 inserts harbouring resistance genes, 30 inserts were obtained from 
the library of 31 sponge bacteria, and 7 inserts were obtained from the libraries of 
sponge tissue even though their cumulative library sizes were 0.8 Gbp and 2.7 Gbp, 
respectively. We expect that this discrepancy can be explained by libraries from 
sponge tissue DNA containing a substantial fraction of sponge DNA. No identical 
resistance genes were obtained from individual isolates and from sponge tissue in 
Figure 4.2 Maximum Likelihood Tree based on protein sequences of: the novel ß-lactamase (blaPSV-1) 
discovered in Pseudovibrio ascidiaceicola DN64_1D03 (blue), the closest homologues of the novel ß-
lactamase in the NCBI non-redundant protein sequences database (red), and the closest homologues 
of the novel ß-lactamase in the CBMAR database (green) (the two closest homologues were picked
for each of the two closest families: blaLEN and blaSHV). In this figure, only the proteins in green and the 
novel ß-lactamase (blaPSV-1) have demonstrated functionality. The tree was constructed in MEGA 
using 1,000 iterations of bootstrapping. Bootstrap values <50 are not shown. The horizontal bar 
indicates the number of substitutions per site.
spite of the individual isolates being previously isolated from the tissue samples. This 
result, and taking into account the high AR gene diversity and limited scale of the 
experiment, suggests the presence of a substantial number of AR genes in sponges
that are not yet identified. The number of AR genes that we identified was also
restricted to those that are compatible with the expression system of the E. coli host, 
and to those that confer AR based on a DNA sequence of at most 5 kbp. From the 
sponge C. candelabrum no resistant clones were obtained, neither from the sponge 
tissue nor from the individual isolates. However, it should be noted that the small-
insert library of 31 bacteria contained only two isolates from C. candelabrum, which 
reduced the chance to identify a resistance gene from this sponge. Furthermore, the 
library of C. candelabrum tissue was 0.8 Gb in size and as such is expected to cover 
only a small fraction of the total unique DNA in this niche. Therefore, absence of
resistance inserts for this sponge species should not be interpreted as an absence of 
AR genes.
Most confidently identified resistance genes (15/26) conferred resistance to 
trimethoprim by encoding the enzyme dihydrofolate reductase. Dihydrofolate 
reductase is a housekeeping enzyme that converts dihydrofolic acid to tetrahydrofolic 
acid. Tetrahydrofolic acid in turn is a required cofactor to convert dUMP to dTMP by
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thymidylate synthase, with dTMP being essential for DNA synthesis. Trimethoprim 
resistance due to additional dihydrofolate reductase genes can occur via (a 
combination of) two mechanisms: (i) the dihydrofolate reductase is overproduced 
leading to higher levels of the enzyme in the cell, and (ii) the heterologously 
introduced dihydrofolate reductase has decreased trimethoprim susceptibility due to 
mutations [65]. The fact that strains to which dihydrofolate reductase genes were 
assigned were themselves in most cases (8/9) not trimethoprim resistant, may have 
resulted from these strains having too little active dihydrofolate reductase to 
compensate for the inhibition by trimethoprim. Resistance in recombinant E. coli 
clones that host a plasmid-encoded dihydrofolate reductase may result from 50-70 
copies of pZE21 plasmid being present per cell [292], thereby substantially increasing 
the concentration of active enzyme. Expression level differences of active enzyme 
could also explain other instances where the host to which an AR gene was assigned 
was itself not resistant. For example, Bacillus stratosphericus DN14_7A9 contained 
functional genes conferring resistance to gentamicin, chloramphenicol, rifampicin and 
ampicillin, but the strain itself was not resistant to these antibiotics. In the natural 
environment, these AR genes can potentially benefit their bacterial hosts in the 
presence of lower levels of antimicrobials than those applied in this study, or even if 
antimicrobials are present at sub-MIC levels [293, 294]. For example, an E. coli strain 
harbouring a single GyrA mutation was shown to outcompete the wild-type strain at a 
ciprofloxacin level of 1/230 the wild-type MIC [216]. 
The most unique confidently identified (predicted) resistance genes were 
those encoding a glycerol-3-phosphate acyltransferase and a GNAT family 
acetyltransferase with respectively 32% and 36% amino acid identity with the closest 
hit in NCBI’s non-redundant protein database. These genes were derived from 
libraries Aa and Pf, respectively. Although aminoglycoside resistance genes might 
serve as defense against locally or self-produced antimicrobials [295], past studies 
have ascribed to these genes various other functional roles besides aminoglycoside 
modification. Aminoglycoside modification would then be accidental. For instance, a 
2’-N-acetyltransferase was shown to be involved in the acetylation of peptidoglycan 
[196]. Reeves et al. [210] suggested roles for aminoglycoside resistance genes in 
immune modulation and alleviation of cellular stress. In addition, aminoglycoside-3'-
phosphotransferases are closely related to protein kinases [296]. For one amikacin-
resistance conferring insert, we predicted that resistance resulted from antibiotic 
efflux. The efflux pump showed high identity with an amino acid transporter that was 
not previously implicated in amikacin resistance. For another six metagenomic inserts 
from our libraries that conferred D-cycloserine resistance, we predicted the presence 
of efflux pumps that were also not previously linked to resistance. These results show 
that sponge-derived bacteria carry genes that provide AR by mechanisms that were
not previously observed. 
One novel β-lactamase (blaPSV-1) was discovered in P. ascidiaceicola
DN64_1D03 that provided resistance to ampicillin and penicillin. Based on high 
amino acid sequence divergence with known β-lactamase families, the gene was
placed in a novel family termed PSV, after Pseudovibrio. To date, all publicly
available sequences that share ≥76% identity with blaPSV-1 at the amino acid level
were found in Pseudovibrio spp. (Figure 4.2), a genus whose members are 
consistently being isolated from sponges and have never been isolated outside the 
marine environment [146-148]. The subsequent closest homologues of the novel β-
lactamase were (predicted) β-lactamases from Ruegeria, a genus comprising marine 
bacteria [297]. Therefore, blaPSV-1 appears to be a marine-specific β-lactamase, and 
may correspondingly have a marine-specific role and/or substrate. In sponges, β-
lactamases could serve as a defense molecule against β-lactam antimicrobials, and 
substances containing a β-lactam ring have been identified in sponges [298]. On the 
other hand, β-lactamases have also been predicted to serve a role in disruption of 
cell signalling [299]. Apart from the biological role of β-lactamases, their evolutionary
origin is also still unclear [300, 301]. 
The majority of confidently identified AR genes (11/21) in library I-31 were 
assigned to Bacillus spp. including AR genes conferring resistance to ampicillin,
chloramphenicol, gentamicin, amikacin and rifampicin. This is in line with the fact 
that, to date, the only sponge isolate that was shown to harbour functional resistance 
genes was Bacillus sp. strain HS24 [139, 140]. These findings suggest that in 
sponges, Bacillus spp. are a reservoir of AR genes. However, sponges filter
thousands of litres of water per day [302], and as a result, sponge-associated 
microorganisms are not always permanent residents of the sponge holobiont. In fact, 
in all three investigated sponges Bacillus spp. represent less than 0.1% of the 
sponge microbiome (Chapter 3 of this thesis). Therefore, we speculate that the 
diverse AR genes detected in the sponge-associated Bacillus spp. do not play a 
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sponge-specific role but rather that these genes serve a more general role in the 
survival of these bacteria in the marine environment. 
A phenomenon we noticed is that in our study, several inserts may contain 
hybrid sequences, that is, the inserts consist of two different DNA fragments that 
were ligated into the same vector. As a consequence, the assignment of inserts to a 
strain of origin can depend on the sequence locus that is amplified by insert 
sequence-specific PCR. We suspect that these hybrid inserts are an artefact of the 
cloning strategy involving ligation of blunt end fragments. Because in the present 
study, one of the libraries was prepared from DNA extracted from 31 bacterial 
isolates, and thus a defined pool of starting DNA was used, detection of hybrid 
inserts was possible. However, based on this finding, for all studies using similar 
cloning methods conclusions about the genetic context of AR genes on metagenomic 
inserts should be done carefully. Here, to ensure that all confidently identified 
resistance genes were assigned to the correct strain, we performed gene-specific 
PCRs (Table S4.1). 
In conclusion, we show that sponges are a reservoir of diverse functional AR 
genes. We detected functional AR genes that show little similarity to known AR 
genes, as well as functional AR genes that are completely novel. One ampicillin 
resistance gene, blaPSV-1, was placed into a novel family of marine-specific β-
lactamases. These results raise questions as to the roles of these genes in bacteria 
residing in arguably the oldest lineage of metazoans [124], the sponges. 
Furthermore, the functionality of our observed AR genes in E. coli shows that they 
can potentially be harnessed by phylogenetically distinct bacteria in other 
environments. 
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Abstract 
Pseudovibrio is a marine bacterial genus, members of which are most often isolated 
from sessile marine animals, and sponges in particular. Even though the metabolic 
versatility of Pseudovibrio spp. allows them to thrive in diverse environments, it is 
hypothesised that they preferentially form mutualistic relationships with their hosts. 
Here, we studied evolutionary and symbiotic relations between Pseudovibrio and 
their eukaryotic hosts by comparative genomics of 31 Pseudovibrio strains of which 
25 were isolated from sponges. All strains were highly similar in terms of core 
metabolic pathways, albeit with substantial differences in overall gene content. Based 
on gene composition Pseudovibrio spp. clustered by geographic region (i.e. 
Caribbean, Mediterranean, Atlantic and Pacific), indicating geographic speciation. 
Furthermore, the fact that isolates from the Mediterranean Sea clustered by sponge 
(i.e. Aplysina aerophoba, Corticium candelabrum and Petrosia ficiformis) suggested 
host-specific adaptation or colonization. Based on gene content, Pseudovibrio 
hongkongensis is only distantly related to the other Pseudovibrio spp. and should not 
be classified as Pseudovibrio. All Pseudovibrio genomes were found to encode a 
large number of proteins with SEL1 and tetratricopeptide repeats, which have been 
suggested to play a role in host colonization. Our analysis showed that for evasion of 
the host immune system, Pseudovibrio spp. may depend on type III, type IV and type 
VI secretion systems that can inject effector molecules directly into eukaryotic cells. 
In addition, the detection of on average seven secondary metabolite biosynthesis 
clusters per genome reinforced the role of Pseudovibrio spp. as potential producers 
of novel bioactive compounds. Tropodithietic acid, bacteriocin and terpene 
biosynthesis clusters were highly conserved within the genus, suggesting an 
essential role in survival e.g. through growth inhibition of bacterial competitors. Taken 
together, these results support the hypothesis that Pseudovibrio spp. form mutualistic 
relationships with sponges. 
Introduction
Pseudovibrio is a genus of Gram-negative, heterotrophic, facultative anaerobic, 
marine α-Proteobacteria. The genus was proposed by Shieh and collegues [143],
and presently six species have been described, including P. denitrificans [143], P. 
ascidiaceicola [152], P. japonicus [157], P. axinellae [303], P. hongkongensis [144] 
and P. stylochi [145]. To date, members have been isolated from sea water [157], 
ascidians [152], a flatworm [145], tunicates [153, 154], corals [155] and sponges
[272]. Members of the genus Pseudovibrio are characterized as motile, rod-shaped 
halophilic bacteria. For energy production, they are capable of O2-dependent
respiration as well as fermentation and/or NO3-- and NO2--dependent (anaerobic) 
respiration. The study of two Pseudovibrio genomes showed that they are 
metabolically versatile, i.e. they are capable of utilising a wide range of organic and
inorganic compounds to meet their carbon, nitrogen, phosphorous and energy 
requirements [151]. 
The relationship between Pseudovibrio and sponges is particularly interesting 
because they have consistently been isolated from different sponge species [146-
148], while never simultaneously being isolated from nor detected in surrounding sea 
water [149, 150]. Although it should be noted that the relative abundance of 
Pseudovibrio spp. in the sponge microbiota is generally low considering that their 
presence is rarely detected by cultivation-independent assays [150], these findings
indicate that Pseudovibrio spp. are enriched in sponges, reinforcing the current 
hypothesis that they are symbionts of sponges. Further support for this hypothesis
comes from the fact that Pseudovibrio spp. were reported to be vertically transmitted 
through sponge larvae of Mycale laxissima [150]. Furthermore, Pseudovibrio spp. 
were suggested to be involved in sponge health as they constituted a lower relative 
abundance in the culturable community of diseased specimen of Rhopaloeides
odorabile [149, 164]. In addition, members of Pseudovibrio were reduced in relative 
abundance in diseased individuals of the sponge Callyspongia aff. biru [165]. 
The symbiotic role of Pseudovibrio in the sponge host is still unclear but it 
could include functions in nutrient uptake [149], denitrification [143, 162, 163], or host 
defense [161, 166]. In addition, genomic data indicated several mechanisms for 
establishing and maintaining symbiosis e.g. by interactions of Pseudovibrio with the
host immune system or cytoskeleton [151, 304, 305]. Pseudovibrio spp. have 
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[272]. Members of the genus Pseudovibrio are characterized as motile, rod-shaped 
halophilic bacteria. For energy production, they are capable of O2-dependent
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respiration. The study of two Pseudovibrio genomes showed that they are 
metabolically versatile, i.e. they are capable of utilising a wide range of organic and
inorganic compounds to meet their carbon, nitrogen, phosphorous and energy 
requirements [151]. 
The relationship between Pseudovibrio and sponges is particularly interesting 
because they have consistently been isolated from different sponge species [146-
148], while never simultaneously being isolated from nor detected in surrounding sea 
water [149, 150]. Although it should be noted that the relative abundance of 
Pseudovibrio spp. in the sponge microbiota is generally low considering that their 
presence is rarely detected by cultivation-independent assays [150], these findings
indicate that Pseudovibrio spp. are enriched in sponges, reinforcing the current 
hypothesis that they are symbionts of sponges. Further support for this hypothesis
comes from the fact that Pseudovibrio spp. were reported to be vertically transmitted 
through sponge larvae of Mycale laxissima [150]. Furthermore, Pseudovibrio spp. 
were suggested to be involved in sponge health as they constituted a lower relative 
abundance in the culturable community of diseased specimen of Rhopaloeides
odorabile [149, 164]. In addition, members of Pseudovibrio were reduced in relative 
abundance in diseased individuals of the sponge Callyspongia aff. biru [165]. 
The symbiotic role of Pseudovibrio in the sponge host is still unclear but it 
could include functions in nutrient uptake [149], denitrification [143, 162, 163], or host 
defense [161, 166]. In addition, genomic data indicated several mechanisms for 
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received particular interest as sources of clinically relevant antimicrobials [158, 159], 
with multiple studies reporting that the genus is highly bioactive [166, 306]. So far, 
Pseudovibrio-derived secondary metabolites that have been identified are phenazine 
[160], tropodithietic acid (TDA) [161, 307] and pseudovibrocin [156]. Pathways of 
polyketide synthases (PKS) and non-ribosomal peptide synthethases (NRPS), and/or 
their hybrids are particularly important in the production of secondary metabolites by 
Pseudovibrio spp. [159, 308, 309], albeit not for TDA synthesis. 
In this study, we compared the genomes of 31 Pseudovibrio isolates, including 
25 sponge isolates and five type strains, implementing the Semantic Annotation 
Pipeline for Prokaryotes [310]. We resolved phylogeny, and studied metabolic 
pathways and secondary metabolite biosynthesis (SMB). In addition, we predicted 
features of antibiotic resistance and host-symbiont interactions, providing new insight 
in the nature of the association between Pseudovibrio spp. and marine sponges. 
Materials and methods 
Sample collection and data deposition of all analysed genomes 
The type strains P. ascidiaceicola DSM 16392T, P. axinellae DSM 24994T, P. 
denitrificans JCM 12308T and P. japonicus NCIMB14279T were obtained from the 
respective culture collections. Sponge-associated Pseudovibrio strains were isolated 
from the sponges C. candelabrum (n=2), P. ficiformis (n=10) and A. aerophoba (n=7) 
as described in Chapter 3 of this thesis. Pseudovibrio sp. AB108, Pseudovibrio sp. 
AB111, Pseudovibrio sp. AB113 and Pseudovibrio sp. BC118 were isolated from 
respectively an Ircinia sp., Chondrilla nucula, Acanthella acuta and Cellepora 
pumicosa, in the Limski Channel in Croatia (45°7´54.56´´N,13°39´13.02´´E). The type 
strain P. hongkongensis UST20140214-015BT was genome sequenced but not 
included in growth experiments. Publicly available genome sequences of 
Pseudovibrio FO-BEG1 (GenBank accession numbers: CP003147 and CP003148), 
Pseudovibrio JE062 (ABXL00000000), Pseudovibrio POLY-S9 (LCWX00000000), 
Stappia stellulata DSM 5886T (AUIM00000000), Nesiotobacter exalbescens LA33BT 
(AUGS00000000), and Labrenzia alexandrii DFL-11T (ACCU00000000) were 
downloaded and re-annotated applying the methods particular to this study. 
DNA isolation and sequencing 
The Pseudovibrio strains were inoculated from glycerol stocks onto marine agar 2216 
(Difco, Detroit, United States). Subsequently, a single colony was grown at 20 °C in 
marine broth 2216 (Difco), and DNA was isolated using the MasterPure™ DNA 
Purification Kit (Epicentre, Madison, United States). Genome sequencing was done
using the Illumina MiSEQ (paired end, 2 x 300 bp reads) at GATC Biotech (Konstanz, 
Germany). The genome of type strain P. hongkongensis UST20140214-015BT was
sequenced on the Illumina Hiseq 2000 (paired end, 2 x 101 bp reads).
Antibiotic resistance 
Resistance profiles were determined by inoculation of pre-grown liquid cultures onto 
marine agar containing one of the following (combination of) antibiotics: 20 μg/ml 
polymyxin B, 20 μg/ml daptomycin, 50 μg/ml vancomycin, 50 μg/ml penicillin, 20
μg/ml erythromycin, 20 μg/ml ciprofloxacin, 100 μg/ml cefotaxime, 50 μg/ml 
tetracycline, 50 μg/ml chloramphenicol, 95 μg/ml sulfamethoxazole and 5 μg/ml 
trimethoprim, 20 μg/ml lincomycin, 100 μg/ml kanamycin, 20 μg/ml rifampicin, 20 
μg/ml linezolid, 50 μg/ml ampicillin, 20 μg/ml imipenem. Antibiotic resistance was
evaluated two days post-inoculation and compared to growth on media without
antibiotics as a reference. We defined three levels of antibiotic resistance: (1) 
‘resistant’; growth of the bacteria was identical to their growth on media without
antibiotics, (2) ‘intermediately resistant’; growth of the bacteria was slower than 
growth on media without antibiotics, and (3) ‘susceptible’; no growth. 
Genome assembly and quality control 
The read quality and presence of Illumina Truseq adapter sequences was
investigated with FASTQC [311], and Illumina Truseq adapter sequences were
removed with Cutadapt [312]. All genomes were assembled with the A5-miseq 
assembler [313] using default settings with as exception the P. hongkongensis 
UST20140214-015BT genome that was assembled by Velvet 1.2.10 [314]. 
Subsequently, Pilon 1.13 [315] was used to improve the assemblies based on the 
assembled scaffolds and error-corrected reads obtained as output from the A5 
assembler. Assemblies were investigated for contamination by BLASTn [283] using 
the NCBI nr/nt database as a reference. Overall, seven <3 kb contigs were removed, 
which were assigned to Clostridia and Bacilli spp. Sequences from Enterobacteria
phage phiX174 were removed as well as DNA of this phage is routinely included as a 
positive control during sequencing. In order to determine the coverage, A5 error-
corrected reads were aligned with the assemblies by Bowtie2 2.2.5 [316] using 
default settings. The resulting SAM file was converted by Samtools 0.1.19 [317] into 
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received particular interest as sources of clinically relevant antimicrobials [158, 159], 
with multiple studies reporting that the genus is highly bioactive [166, 306]. So far, 
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[160], tropodithietic acid (TDA) [161, 307] and pseudovibrocin [156]. Pathways of 
polyketide synthases (PKS) and non-ribosomal peptide synthethases (NRPS), and/or 
their hybrids are particularly important in the production of secondary metabolites by 
Pseudovibrio spp. [159, 308, 309], albeit not for TDA synthesis. 
In this study, we compared the genomes of 31 Pseudovibrio isolates, including 
25 sponge isolates and five type strains, implementing the Semantic Annotation 
Pipeline for Prokaryotes [310]. We resolved phylogeny, and studied metabolic 
pathways and secondary metabolite biosynthesis (SMB). In addition, we predicted 
features of antibiotic resistance and host-symbiont interactions, providing new insight 
in the nature of the association between Pseudovibrio spp. and marine sponges. 
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Germany). The genome of type strain P. hongkongensis UST20140214-015BT was
sequenced on the Illumina Hiseq 2000 (paired end, 2 x 101 bp reads).
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Resistance profiles were determined by inoculation of pre-grown liquid cultures onto 
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evaluated two days post-inoculation and compared to growth on media without
antibiotics as a reference. We defined three levels of antibiotic resistance: (1) 
‘resistant’; growth of the bacteria was identical to their growth on media without
antibiotics, (2) ‘intermediately resistant’; growth of the bacteria was slower than 
growth on media without antibiotics, and (3) ‘susceptible’; no growth. 
Genome assembly and quality control 
The read quality and presence of Illumina Truseq adapter sequences was
investigated with FASTQC [311], and Illumina Truseq adapter sequences were
removed with Cutadapt [312]. All genomes were assembled with the A5-miseq 
assembler [313] using default settings with as exception the P. hongkongensis 
UST20140214-015BT genome that was assembled by Velvet 1.2.10 [314]. 
Subsequently, Pilon 1.13 [315] was used to improve the assemblies based on the 
assembled scaffolds and error-corrected reads obtained as output from the A5 
assembler. Assemblies were investigated for contamination by BLASTn [283] using 
the NCBI nr/nt database as a reference. Overall, seven <3 kb contigs were removed, 
which were assigned to Clostridia and Bacilli spp. Sequences from Enterobacteria
phage phiX174 were removed as well as DNA of this phage is routinely included as a 
positive control during sequencing. In order to determine the coverage, A5 error-
corrected reads were aligned with the assemblies by Bowtie2 2.2.5 [316] using 
default settings. The resulting SAM file was converted by Samtools 0.1.19 [317] into 
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a BAM file, after which the coverage per base was calculated using Bedtools 2.25.0 
[318]. 
Genome annotation 
The genomes of all Pseudovibrio strains were (re-)annotated. In addition, the 
genomes of Labrenzia alexandrii DFL-11T [319], Stappia stellulata DSM 5886T and 
Nesiotobacter exalbescens DSM 16456T were annotated in order to serve as a 
reference. A local installation of Galaxy [320] was used to execute the tools for 
annotation. FASTA files containing the genomic scaffolds were converted to RDF 
format to detect rRNA genes by RNAmmer [321], and to detect tRNA and tmRNA 
genes by ARAGORN [321]. Prodigal [322] was used to predict genes, and 
subsequently the InterPro Database 5.4-47.0 [285] was used to classify the genes 
and to predict domains and sites. At runtime, the following databases were selected: 
TIGRFAM, ProDom, SMART, PROSITE, PfamA, PRINTS, SUPERFAMILY, Coils 
and Gene3d. PRIAM [323], SignalP 4.0 [324], and TMHMM [325] were used to 
respectively detect ECs, signal peptides, and transmembrane protein topology. 
Finally, output from the different tools was merged into a single RDF file for 
subsequent analyses. 
Phylogeny, functional diversity and environmental distribution 
A phylogenetic tree was made in ARB with the 16S rRNA gene sequences from the 
genomes. When multiple 16S rRNA genes were found in a genome that were >99% 
identical, a single gene was picked to be included in the tree. The three closest non-
Pseudovibrio relatives in the Silva guide tree (release 115) from which the genomes 
were publicly available were used as outgroup. Gene alignments were manually 
curated, and a Maximum Likelihood tree was constructed with 1,000 iterations of 
rapid bootstrapping. Average nucleotide identity between the different genomes 
based on BLAST results (ANIb) was calculated using JSpecies v1.2.1 with default 
parameters [326]. The dissimilarity in terms of protein diversity was analysed and 
visualized in a distance tree. To identify homologous proteins shared between the 
genomes, an all-against-all BLASTp was performed, after which OrthAgogue [327], 
and MCL [328] were used to identify orthologous groups of proteins (OGPs). With R 
version 3.2.2. [329], a matrix with the binary distances was created based on the 
presence/absence of the OGPs that are present in >2 genomes. The distance matrix 
was used for complete linkage hierarchical clustering. To assess the uncertainty in 
the hierarchical cluster analysis we used the R package PVC with 10,000 bootstraps. 
Canoco 5 [254] was used to investigate which environmental variables could explain 
the variation in OGPs composition amongst the genomes. The presence of metabolic
pathways was predicted using OGPs that had EC numbers assigned, and using the 
MetaCyc database [330] as a reference. Presence/absence data of OGPs that are 
present in at least three genomes was used as input for SIMPER [255] in order to 
break down the contribution of each OGP to the observed dissimilarity between 
genomes grouped by environmental variables. DIAMOND BLAST v.0.7.12 [331] was
used to assign all protein sequences to Clusters of Orthologous Groups (COGs) with 
the 2014 edition of the COGs database as a reference [332]. The environmental 
distribution of Pseudovibrio spp. was investigated using the IMNGS platform 
(www.imngs.org). Full-length 16S rRNA gene sequences of the type strains were
used as query and the similarity threshold was set at 99% nucleotide identity. 
Annotation of symbiosis-related genes
Interproscan [285, 333] was used to detect the following potentially symbiosis-related 
gene products: ankyrin repeat proteins (IPR020683 and IPR002110), proteins with 
SEL1 repeats (IPR006597), tetratricopeptide repeat proteins (IPR011990,
IPR019734, IPR013105, IPR001440 and IPR011717), Invasion protein B 
(IPR010642), proteins with the TadE-like domain (IPR012495), LuxI (IPR016181) 
and LuxR (IPR020642 and IPR012495). Proteins with SEL1 repeats and 
tetratricopeptide repeats are occasionally wrongly classified due to their high 
similarity. Therefore, we used TPRpred [334] to correctly categorize proteins with 
these repeats using an E-value of 1.0E-7 as cut-off. The presence of Type III 
secretion systems (T3SSs), Type IV secretion systems (T4SSs) and Type VI 
secretion systems (T6SSs) was investigated in the genomes with MultiGeneBlast
[335] using default settings with as query previously identified gene clusters that were 
described by [305] i.e. FO-BEG1_3657-03696 (T3SS), PsW64_00918-00938 (T4SS),
FO-BEG1_01844-01855 (T6SS-I) and FO-BEG1_02827-02846 (T6SS-II). 
Detection of antibiotic resistance genes and SMB clusters 
To predict the capacity for TDA biosynthesis, the presence of tdaABCDEF and tdaH 
genes was assessed. Therefore, BLASTp using the sequences of UniProtKB 
accessions I7F4K4_PHAIB (tdaA), I7E6B2_PHAIB (tdaB), I7ESQ7_PHAIB (tdaC), 
I7F2B2_PHAIB (tdaD), I7DWF3_PHAIB (tdaE), I7ESP4_PHAIB (tdaF) and 
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a BAM file, after which the coverage per base was calculated using Bedtools 2.25.0 
[318]. 
Genome annotation 
The genomes of all Pseudovibrio strains were (re-)annotated. In addition, the 
genomes of Labrenzia alexandrii DFL-11T [319], Stappia stellulata DSM 5886T and 
Nesiotobacter exalbescens DSM 16456T were annotated in order to serve as a 
reference. A local installation of Galaxy [320] was used to execute the tools for 
annotation. FASTA files containing the genomic scaffolds were converted to RDF 
format to detect rRNA genes by RNAmmer [321], and to detect tRNA and tmRNA 
genes by ARAGORN [321]. Prodigal [322] was used to predict genes, and 
subsequently the InterPro Database 5.4-47.0 [285] was used to classify the genes 
and to predict domains and sites. At runtime, the following databases were selected: 
TIGRFAM, ProDom, SMART, PROSITE, PfamA, PRINTS, SUPERFAMILY, Coils 
and Gene3d. PRIAM [323], SignalP 4.0 [324], and TMHMM [325] were used to 
respectively detect ECs, signal peptides, and transmembrane protein topology. 
Finally, output from the different tools was merged into a single RDF file for 
subsequent analyses. 
Phylogeny, functional diversity and environmental distribution 
A phylogenetic tree was made in ARB with the 16S rRNA gene sequences from the 
genomes. When multiple 16S rRNA genes were found in a genome that were >99% 
identical, a single gene was picked to be included in the tree. The three closest non-
Pseudovibrio relatives in the Silva guide tree (release 115) from which the genomes 
were publicly available were used as outgroup. Gene alignments were manually 
curated, and a Maximum Likelihood tree was constructed with 1,000 iterations of 
rapid bootstrapping. Average nucleotide identity between the different genomes 
based on BLAST results (ANIb) was calculated using JSpecies v1.2.1 with default 
parameters [326]. The dissimilarity in terms of protein diversity was analysed and 
visualized in a distance tree. To identify homologous proteins shared between the 
genomes, an all-against-all BLASTp was performed, after which OrthAgogue [327], 
and MCL [328] were used to identify orthologous groups of proteins (OGPs). With R 
version 3.2.2. [329], a matrix with the binary distances was created based on the 
presence/absence of the OGPs that are present in >2 genomes. The distance matrix 
was used for complete linkage hierarchical clustering. To assess the uncertainty in 
the hierarchical cluster analysis we used the R package PVC with 10,000 bootstraps. 
Canoco 5 [254] was used to investigate which environmental variables could explain 
the variation in OGPs composition amongst the genomes. The presence of metabolic
pathways was predicted using OGPs that had EC numbers assigned, and using the 
MetaCyc database [330] as a reference. Presence/absence data of OGPs that are 
present in at least three genomes was used as input for SIMPER [255] in order to 
break down the contribution of each OGP to the observed dissimilarity between 
genomes grouped by environmental variables. DIAMOND BLAST v.0.7.12 [331] was
used to assign all protein sequences to Clusters of Orthologous Groups (COGs) with 
the 2014 edition of the COGs database as a reference [332]. The environmental 
distribution of Pseudovibrio spp. was investigated using the IMNGS platform 
(www.imngs.org). Full-length 16S rRNA gene sequences of the type strains were
used as query and the similarity threshold was set at 99% nucleotide identity. 
Annotation of symbiosis-related genes
Interproscan [285, 333] was used to detect the following potentially symbiosis-related 
gene products: ankyrin repeat proteins (IPR020683 and IPR002110), proteins with 
SEL1 repeats (IPR006597), tetratricopeptide repeat proteins (IPR011990,
IPR019734, IPR013105, IPR001440 and IPR011717), Invasion protein B 
(IPR010642), proteins with the TadE-like domain (IPR012495), LuxI (IPR016181) 
and LuxR (IPR020642 and IPR012495). Proteins with SEL1 repeats and 
tetratricopeptide repeats are occasionally wrongly classified due to their high 
similarity. Therefore, we used TPRpred [334] to correctly categorize proteins with 
these repeats using an E-value of 1.0E-7 as cut-off. The presence of Type III 
secretion systems (T3SSs), Type IV secretion systems (T4SSs) and Type VI 
secretion systems (T6SSs) was investigated in the genomes with MultiGeneBlast
[335] using default settings with as query previously identified gene clusters that were 
described by [305] i.e. FO-BEG1_3657-03696 (T3SS), PsW64_00918-00938 (T4SS),
FO-BEG1_01844-01855 (T6SS-I) and FO-BEG1_02827-02846 (T6SS-II). 
Detection of antibiotic resistance genes and SMB clusters 
To predict the capacity for TDA biosynthesis, the presence of tdaABCDEF and tdaH 
genes was assessed. Therefore, BLASTp using the sequences of UniProtKB 
accessions I7F4K4_PHAIB (tdaA), I7E6B2_PHAIB (tdaB), I7ESQ7_PHAIB (tdaC), 
I7F2B2_PHAIB (tdaD), I7DWF3_PHAIB (tdaE), I7ESP4_PHAIB (tdaF) and 
99
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G8PGC0_PSEUV (tdaH) was performed against the genome-encoded proteins. 
Furthermore, the presence of the genes paaI, paaJ, paaK, cysI and malY was 
analysed by investigating if genome-encoded proteins were assigned the EC 
numbers 3.1.2. (paaI), 2.3.1.174 (paaJ), 6.2.1.30 (paaK), 1.8.1.2 (cysI) and 4.4.1.8. 
(MalY). AntiSMASH version 3.0.4 was used to identify SMB clusters [336]. Antibiotic 
resistance functions were predicted with HMMER (http://hmmer.org/) using the 
pHMMs of the Resfams database [105]. In addition, BLASTp of amino acid 
sequences against the CARD database [284] was performed. 
Results and discussion 
Metadata and genome characteristics 
The genomes of 31 Pseudovibrio strains were analysed (Table 5.1), which included 
five type strains that are currently characterized within the genus. The genomes of 28 
Pseudovibrio strains were sequenced as part of this study whereas the genomes of 
strains Pseudovibrio sp. FO-BEG1, Pseudovibrio sp. JE062 and Pseudovibrio sp. 
POLY-S9 were obtained from previous studies [151, 304]. Out of the 31 Pseudovibrio 
strains, two were isolated from sea water, 25 were isolated from sponges, and four 
were isolated from other sessile marine animals. The genome sizes of all 31 
Pseudovibrio strains, except for P. hongkongensis UST20140214-015BT, were large 
(6 Mb ± 0.6 [s.d.]. The genome of P. hongkongensis was only 3.75 Mb and 
correspondingly, the genome also contained fewer unique protein domains. The GC-
content of the Pseudovibrio strains ranged between 44.6% for Pseudovibrio sp. 
AB108 and 52.4% for Pseudovibrio sp. FO-BEG1, whereas the GC-content of the 
three close relatives were 63.9% for Stappia stellulata DSM 5886T isolated from 
marine sediment [337], 54.6% for Nesiotobacter exalbescens LA33BT isolated from 
water in a hypersaline lake [338], and 57.4% for Labrenzia alexandrii DFL-11T 
isolated from a culture of the dinoflagellate Alexandrium lusitanicum [319].
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G8PGC0_PSEUV (tdaH) was performed against the genome-encoded proteins. 
Furthermore, the presence of the genes paaI, paaJ, paaK, cysI and malY was 
analysed by investigating if genome-encoded proteins were assigned the EC 
numbers 3.1.2. (paaI), 2.3.1.174 (paaJ), 6.2.1.30 (paaK), 1.8.1.2 (cysI) and 4.4.1.8. 
(MalY). AntiSMASH version 3.0.4 was used to identify SMB clusters [336]. Antibiotic 
resistance functions were predicted with HMMER (http://hmmer.org/) using the 
pHMMs of the Resfams database [105]. In addition, BLASTp of amino acid 
sequences against the CARD database [284] was performed. 
Results and discussion 
Metadata and genome characteristics 
The genomes of 31 Pseudovibrio strains were analysed (Table 5.1), which included 
five type strains that are currently characterized within the genus. The genomes of 28 
Pseudovibrio strains were sequenced as part of this study whereas the genomes of 
strains Pseudovibrio sp. FO-BEG1, Pseudovibrio sp. JE062 and Pseudovibrio sp. 
POLY-S9 were obtained from previous studies [151, 304]. Out of the 31 Pseudovibrio 
strains, two were isolated from sea water, 25 were isolated from sponges, and four 
were isolated from other sessile marine animals. The genome sizes of all 31 
Pseudovibrio strains, except for P. hongkongensis UST20140214-015BT, were large 
(6 Mb ± 0.6 [s.d.]. The genome of P. hongkongensis was only 3.75 Mb and 
correspondingly, the genome also contained fewer unique protein domains. The GC-
content of the Pseudovibrio strains ranged between 44.6% for Pseudovibrio sp. 
AB108 and 52.4% for Pseudovibrio sp. FO-BEG1, whereas the GC-content of the 
three close relatives were 63.9% for Stappia stellulata DSM 5886T isolated from 
marine sediment [337], 54.6% for Nesiotobacter exalbescens LA33BT isolated from 
water in a hypersaline lake [338], and 57.4% for Labrenzia alexandrii DFL-11T 
isolated from a culture of the dinoflagellate Alexandrium lusitanicum [319].
Ta
bl
e 
5.
1 
M
et
ad
at
a,
 a
nd
 g
en
om
e 
as
se
m
bl
y 
an
d 
an
no
ta
tio
n 
st
at
is
tic
s 
of
 th
e 
31
 P
se
ud
ov
ib
rio
 s
tra
in
s 
an
d 
th
re
e 
cl
os
e 
re
la
tiv
es
.
G
en
om
e 
m
et
ad
at
a
A
ss
em
bl
y
st
at
is
tic
s
G
en
om
e 
an
no
ta
tio
n 
st
at
is
tic
s
St
ra
in
Is
ol
at
io
n 
so
ur
ce
G
eo
gr
ap
hi
c 
lo
ca
tio
n
N
o.
 o
f
Sc
af
fo
ld
s
G
en
om
e 
Si
ze
 
(M
b)
N
50
 
(M
b)
G
C
 
co
nt
en
t 
(%
)
C
ov
er
ag
e
(X
)
N
o.
 o
f
O
R
Fs
 
N
o.
of
do
m
ai
ns
 
P
se
ud
ov
ib
rio
 h
on
gk
on
ge
ns
is
 
U
S
T2
01
40
21
4-
01
5B
T
Fl
at
w
or
m
S
ty
lo
ch
us
 s
p.
Yu
ng
 S
hu
e 
O
, H
on
g 
K
on
g
39
 
3.
75
 
0.
34
 
51
.7
 
13
1 
3,
51
4
14
,1
60
P
se
ud
ov
ib
rio
 a
sc
id
ia
ce
ic
ol
a 
D
S
M
 1
63
92
T
A
sc
id
ia
n 
P
ol
yc
ito
r p
ro
lif
er
us
B
ea
ch
 o
f B
os
o 
pe
ni
ns
ul
a,
 J
ap
an
 
40
 
5.
88
 
0.
42
 
50
.3
 
17
8 
5,
36
5
20
,9
06
P
se
ud
ov
ib
rio
 a
xi
ne
lla
e 
D
S
M
 2
49
94
T
S
po
ng
e 
A
xi
ne
lla
 d
is
si
m
ili
s
A
 m
ar
in
e 
la
ke
, I
re
la
nd
 
78
 
5.
20
 
0.
39
 
50
.7
 
23
0 
4,
78
6
18
,5
45
P
se
ud
ov
ib
rio
 d
en
itr
ifi
ca
ns
JC
M
 1
23
08
T
S
ea
 w
at
er
N
an
w
an
 B
ay
, T
ai
w
an
27
 
6.
12
 
0.
64
 
50
.7
 
19
9 
5,
42
8
22
,1
65
P
se
ud
ov
ib
rio
 ja
po
ni
cu
s
N
C
IM
B
14
27
9T
S
ea
w
at
er
C
oa
st
 o
f B
os
o 
pe
ni
ns
ul
a,
 J
ap
an
 
17
 
4.
97
 
0.
65
 
50
.9
 
24
5 
4,
55
4
18
,4
27
P
se
ud
ov
ib
rio
sp
. 2
G
02
S
po
ng
e 
P
. f
ic
ifo
rm
is
 
C
oa
st
 o
f B
la
ne
s,
 S
pa
in
 
25
 
5.
87
 
0.
41
 
50
.2
 
24
6 
5,
36
9
20
,7
20
P
se
ud
ov
ib
rio
sp
.2
H
03
S
po
ng
e
P
. f
ic
ifo
rm
is
 
C
oa
st
 o
f B
la
ne
s,
 S
pa
in
 
39
 
6.
00
 
0.
47
 
50
.0
 
23
3 
5,
52
4
21
,5
00
P
se
ud
ov
ib
rio
 s
p.
2H
05
S
po
ng
e
P
. f
ic
ifo
rm
is
 
C
oa
st
 o
f B
la
ne
s,
 S
pa
in
 
28
 
5.
94
 
0.
42
 
50
.1
 
13
7 
5,
38
9
21
,0
34
P
se
ud
ov
ib
rio
sp
.2
H
06
S
po
ng
e
P
. f
ic
ifo
rm
is
 
C
oa
st
 o
f B
la
ne
s,
 S
pa
in
 
21
 
6.
09
 
0.
57
 
50
.7
 
22
1 
5,
47
4
21
,6
87
P
se
ud
ov
ib
rio
 s
p.
 4
B
07
 
S
po
ng
e 
P
. f
ic
ifo
rm
is
 
C
oa
st
 o
f B
la
ne
s,
 S
pa
in
 
52
 
5.
13
 
0.
38
 
50
.4
 
22
6 
4,
69
2
18
,4
78
P
se
ud
ov
ib
rio
sp
.4
H
03
S
po
ng
e
P
. f
ic
ifo
rm
is
 
C
oa
st
 o
f B
la
ne
s,
 S
pa
in
 
26
 
5.
79
 
0.
88
 
50
.3
 
21
2 
5,
29
5
20
,6
71
P
se
ud
ov
ib
rio
sp
.4
H
10
S
po
ng
e
P
. f
ic
ifo
rm
is
 
C
oa
st
 o
f B
la
ne
s,
 S
pa
in
 
14
 
5.
78
 
0.
86
 
50
.8
 
25
0 
5,
21
8
20
,6
26
P
se
ud
ov
ib
rio
sp
. 8
G
08
S
po
ng
e 
P
. f
ic
ifo
rm
is
 
C
oa
st
 o
f B
la
ne
s,
 S
pa
in
 
36
 
5.
94
 
0.
48
 
50
.3
 
16
5 
5,
36
1
21
,2
77
P
se
ud
ov
ib
rio
sp
.8
H
04
S
po
ng
e
P
. f
ic
ifo
rm
is
 
C
oa
st
 o
f B
la
ne
s,
 S
pa
in
 
18
 
5.
68
 
0.
50
 
48
.2
 
29
5 
5,
17
4
20
,3
01
P
se
ud
ov
ib
rio
sp
.8
H
06
S
po
ng
e
P
. f
ic
ifo
rm
is
 
C
oa
st
 o
f B
la
ne
s,
 S
pa
in
 
40
 
6.
06
 
0.
40
 
49
.7
 
26
4 
5,
55
4
21
,7
24
P
se
ud
ov
ib
rio
sp
. 1
F1
2
S
po
ng
e 
A
. a
er
op
ho
ba
G
ul
f o
f R
os
es
, S
pa
in
 
28
 
5.
84
 
0.
49
 
50
.9
 
25
3 
5,
28
9
20
,9
15
P
se
ud
ov
ib
rio
sp
.1
D
03
S
po
ng
e
A
. a
er
op
ho
ba
G
ul
f o
f R
os
es
, S
pa
in
 
22
 
5.
77
 
0.
50
 
50
.3
 
71
1 
5,
23
9
20
,7
44
P
se
ud
ov
ib
rio
sp
.3
C
10
S
po
ng
e
A
. a
er
op
ho
ba
G
ul
f o
f R
os
es
, S
pa
in
 
36
 
6.
05
 
0.
85
 
49
.9
 
31
6 
5,
53
9
21
,1
56
P
se
ud
ov
ib
rio
sp
. 7
F0
8
S
po
ng
e 
A
. a
er
op
ho
ba
G
ul
f o
f R
os
es
, S
pa
in
 
27
 
5.
78
 
0.
48
 
51
.3
 
12
4 
5,
24
3
20
,7
09
P
se
ud
ov
ib
rio
 s
p.
 7
G
12
S
po
ng
e 
A
. a
er
op
ho
ba
G
ul
f o
f R
os
es
, S
pa
in
 
29
 
5.
85
 
0.
45
 
51
.0
 
13
8 
5,
28
8
20
,9
19
P
se
ud
ov
ib
rio
sp
.7
H
02
S
po
ng
e
A
. a
er
op
ho
ba
G
ul
f o
f R
os
es
, S
pa
in
 
28
 
5.
84
 
0.
52
 
50
.9
 
11
9 
5,
28
8
20
,9
00
P
se
ud
ov
ib
rio
sp
.7
H
04
S
po
ng
e
A
. a
er
op
ho
ba
G
ul
f o
f R
os
es
, S
pa
in
 
23
 
5.
59
 
0.
58
 
50
.4
 
11
9 
5,
04
1
19
,8
37
P
se
ud
ov
ib
rio
sp
. 7
A
08
 
S
po
ng
e 
C
. c
an
de
la
br
um
C
oa
st
 o
f B
la
ne
s,
 S
pa
in
 
22
 
5.
76
 
0.
59
 
50
.8
 
12
6 
5,
17
6
20
,5
09
P
se
ud
ov
ib
rio
 s
p.
 2
G
O
5
S
po
ng
e 
C
.c
an
de
la
br
um
C
oa
st
 o
f B
la
ne
s,
 S
pa
in
 
20
 
5.
76
 
0.
59
 
50
.8
 
18
9 
5,
18
2
20
,5
14
P
se
ud
ov
ib
rio
sp
. A
B
10
8 
S
po
ng
e 
Irc
in
ia
 s
p.
Li
m
sk
iC
ha
nn
el
,C
ro
at
ia
49
5.
91
0.
44
44
.6
20
0
5,
36
9
20
,9
13
P
se
ud
ov
ib
rio
sp
. A
B
11
1 
S
po
ng
e 
C
. n
uc
ul
a 
Li
m
sk
iC
ha
nn
el
,C
ro
at
ia
36
5.
92
0.
42
49
.8
22
8
5,
42
3
20
,8
53
P
se
ud
ov
ib
rio
sp
. A
B
11
3 
S
po
ng
e 
A
. a
cu
ta
Li
m
sk
iC
ha
nn
el
,C
ro
at
ia
13
5.
37
0.
88
51
.0
19
1
4,
88
6
19
,3
15
P
se
ud
ov
ib
rio
sp
. B
C
11
8
B
ry
oz
oa
n 
C
. p
um
ic
os
a 
Li
m
sk
iC
ha
nn
el
,C
ro
at
ia
23
5.
81
0.
52
51
.3
23
7
5,
30
4
20
,7
97
P
se
ud
ov
ib
rio
sp
. F
O
-B
E
G
1
A
 s
cl
er
ac
tin
ia
n 
co
ra
l 
C
oa
st
 o
f F
lo
rid
a,
 U
S
A
 
1 
5.
48
 
5.
48
 
52
.4
 
n/
a 
4,
92
6
19
,7
99
P
se
ud
ov
ib
rio
sp
. J
E
06
2 
S
po
ng
e 
M
yc
al
e 
la
xi
ss
im
a 
K
ey
La
rg
o,
 F
lo
rid
a,
 U
S
A
 
19
 
5.
73
 
0.
51
 
52
.1
 
n/
a 
5,
13
8
20
,7
91
P
se
ud
ov
ib
rio
sp
.P
O
LY
-S
9
S
po
ng
e
P
ol
ym
as
tia
 p
en
ic
ill
us
 
C
oa
st
 o
f P
or
tu
ga
l
27
1 
6.
60
 
0.
12
 
51
.0
 
n/
a 
6,
33
1
22
,3
47
S
ta
pp
ia
 s
te
llu
la
ta
D
S
M
 5
88
6T
M
ar
in
e 
se
di
m
en
t
15
 
4.
62
 
0.
69
 
63
.9
 
n/
a 
4,
21
2
17
,4
54
N
es
io
to
ba
ct
er
 e
xa
lb
es
ce
ns
LA
33
B
T
W
at
er
 in
 a
 h
yp
er
sa
lin
e 
la
ke
La
ys
an
 A
to
ll,
 H
aw
ai
ia
n 
Is
la
nd
s 
40
 
4.
15
 
0.
29
 
54
.6
 
n/
a 
3,
77
1
15
,7
93
La
br
en
zi
a 
al
ex
an
dr
ii
D
FL
-1
1T
C
ul
tu
re
 o
f t
he
 d
in
of
la
ge
lla
te
 
A
le
xa
nd
riu
m
lu
si
ta
ni
cu
m
H
el
go
la
nd
, G
er
m
an
y 
6 
5.
50
 
5.
30
 
57
.4
 
n/
a 
5,
12
8
20
,1
68
101
Comparative genomics of the marine genus Pseudovibrio
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Phylogeny and taxonomy 
Phylogeny and diversity of the strains was assessed based on 16S rRNA gene 
sequences retrieved from the respective genomes as well as the presence of 
orthologous groups of proteins (OGPs). Phylogenetic analysis based on 16S rRNA 
gene sequences placed all Pseudovibrio type strains in separate branches of the 
corresponding tree (Figure 5.1). Most Pseudovibrio strains (23 of 31) could be 
classified at the species level to P. ascidiaceicola based on the phylogenetic tree and 
16S rRNA gene identity values (Table S5.1). Further phylogenomic analysis of these 
strains based on the presence of OGPs placed P. hongkongensis UST20140214- 
015BT closer to the non-Pseudovibrio outgroup members as compared to the 16S 
rRNA gene based phylogenetic analysis (Figure 5.2). In addition, the average 
nucleotide identity (ANI) between the P. hongkongensis type strain and all other 
Pseudovibrio spp. strains was <75%, which was comparable to ANI values observed 
for the three outgroup species that all belong to different genera (Table S5.2). As 
such, the data presented here suggest that P. hongkongensis UST20140214-015BT 
should not be considered a typical member of the Pseudovibrio genus and therefore 
might need to be placed in a separate genus. For this reason, it was treated as an 
outgroup member in all subsequent analyses. Furthermore, Pseudovibrio sp. strain 
8H04 and Pseudovibrio sp. strain 4B07 were found in isolated branches in both trees 
(Figure 5.2), and 16S rRNA gene identity values did not allow species classification 
because both these strains shared between 97.6% and 98.6% with the four most 
closely related type strains: Pseudovibrio ascidiaceicola DSM 16392T, Pseudovibrio 
denitrificans JCM 12308T, Pseudovibrio japonicus NCIMB14279T and Pseudovibrio 
axinellae DSM 24994T. This result, and the fact that the ANI values between these 
two strains and the Pseudovibrio spp. type strains are rather divergent (Pseudovibrio 
strain 4B07 and strain 8H04 share respectively 94.3% and 97.1% ANI with the most 
similar type strain), indicates that they likely represent two distinct novel species 
within the Pseudovibrio genus [326]. These strains would not have been recognized 
as a novel species based on 16S rRNA gene similarity only, and hence, 16S rRNA 
gene identity values underrepresent the genomic diversity within Pseudovibrio. This 
is also in line with the observation that P. japonicus NCIMB14279T is closely related 
to P. denitrificans JCM 12308T based on the 16S rRNA gene tree (99% sequence 
identity) even though the two strains were highly dissimilar based on the OGP-based 
tree and ANI (81.4%). It has been shown that ANI can confidently replace DNA–DNA 
hybridization (DDH) values to delineate bacterial species with these two parameters 
showing strong r2 correlation values of >0.93 [339, 340]. The 70% DDH cut-off value
for species delineation corresponds to 94-95% ANI [326]. However, so far no novel 
species have been published that use ANI as central evidence for species definition. 
Figure 5.1 Phylogenetic tree based on 16S rRNA gene sequences from the 31 Pseudovibrio spp. and
three close relatives that were included in the comparative genomics analysis. The Pseudovibrio type 
strains are depicted in blue and the close relatives are depicted in green. The tree was constructed in
ARB by Maximum likelihood analysis using 1,000 iterations of bootstrapping. Bootstrap values <50 are
not shown. The horizontal bar indicates the number of substitutions per site. 
Clustering by metadata and group-differences 
To identify variables that best explain the variation in the distribution of OGPs in the 
genomes, we performed a canonical correspondence analysis (CCA). Strains that 
are members of the outgroup (including P. hongkongensis UST20140214-015BT) 
clustered separately from members of the Pseudovibrio genus (p = 0.002) (Figure 
5.3A). Furthermore, we found clustering by geographic origin (Mediterranean,
Caribbean, Pacific or Atlantic, p = 0.002) (Figure 5.3B). The fact that geographic
origin can partially explain the variation in OGPs suggests that in different geographic
regions adaptation has occurred to different environmental conditions (e.g. 
temperature, salinity, local flora and fauna or nutrient availability). This is underlined 
103
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by the fact that clusters in two out of four geographic regions constituted different
Pseudovibrio species. Most studies find that microbial composition and biogeography 
correlate in the aquatic environment, suggesting selective pressure of at least one 
environmental variable [344]. However, to what extent (trait) selection plays a role in 
the biogeography of Pseudovibrio spp., as opposed to the other suggested major 
processes such as drift, dispersal and mutation, remains to be elucidated. This 
question can be further investigated by attempting to link variation in OGPs to 
environmental variables, and reinforces the need for proper recording of metadata for
environmental samples and derived microbial isolates [341, 342]. We also found that 
Pseudovibrio strains isolated near the coast of Spain clustered by sponge of origin 
(A. aerophoba, C. candelabrum or P. ficiformis, p = 0.006) (Figure 5.3C). This might 
indicate that Pseudovibrio strains harbour (combinations of) functional genes that are 
associated with their ability to preferentially colonize certain sponge species. In turn,
it might indicate that the Pseudovibrio strains selectively evolved in the sponge host
after colonization. There is evidence that Pseudovibrio can be vertically transmitted 
[150], and in general various studies have demonstrated that at least in some cases,
sponge-associated bacteria are transmitted vertically [343-346]. 
In order to identify differences in substrate utilization and product formation 
between the strains, the presence of metabolic pathways was investigated using the 
MetaCyc database as a reference. This database contains experimentally verified 
pathways and enzymes that are predominantly found in microorganisms and plants.
We analysed pathways that contained at least three enzymes (Figure S5.1) and at 
least four enzymes with an EC number (Figure S5.2). In terms of metabolism, all 
members of the Pseudovibrio genus were highly similar i.e. across all genomes the 
same pathways were detected with differences between strains nearly always
amounting to the presence and/or absence of single genes. As opposed to members 
of the outgroups, all Pseudovibrio spp. were predicted to be able to synthesize 
Coenzyme F420. Coenzyme F420 is best known as an essential coenzyme of 
methanogenesis [347]. However, since Pseudovibrio spp. are incapable of
methanogenesis, F420 might be involved in SMB [348, 349] or other metabolic
activities such as aerobic catabolism of 2,4,6-trinitrophenol or as an electron carrier
to an F420-dependent glucose-6-phosphate dehydrogenase [350-352]. In contrast to 
the three non-Pseudovibrio close relatives, all Pseudovibrio strains (including P.
hongkongensis UST20140214-015BT) were predicted to have the capacity to 
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by the fact that clusters in two out of four geographic regions constituted different
Pseudovibrio species. Most studies find that microbial composition and biogeography 
correlate in the aquatic environment, suggesting selective pressure of at least one 
environmental variable [344]. However, to what extent (trait) selection plays a role in 
the biogeography of Pseudovibrio spp., as opposed to the other suggested major 
processes such as drift, dispersal and mutation, remains to be elucidated. This 
question can be further investigated by attempting to link variation in OGPs to 
environmental variables, and reinforces the need for proper recording of metadata for
environmental samples and derived microbial isolates [341, 342]. We also found that 
Pseudovibrio strains isolated near the coast of Spain clustered by sponge of origin 
(A. aerophoba, C. candelabrum or P. ficiformis, p = 0.006) (Figure 5.3C). This might 
indicate that Pseudovibrio strains harbour (combinations of) functional genes that are 
associated with their ability to preferentially colonize certain sponge species. In turn,
it might indicate that the Pseudovibrio strains selectively evolved in the sponge host
after colonization. There is evidence that Pseudovibrio can be vertically transmitted 
[150], and in general various studies have demonstrated that at least in some cases,
sponge-associated bacteria are transmitted vertically [343-346]. 
In order to identify differences in substrate utilization and product formation 
between the strains, the presence of metabolic pathways was investigated using the 
MetaCyc database as a reference. This database contains experimentally verified 
pathways and enzymes that are predominantly found in microorganisms and plants.
We analysed pathways that contained at least three enzymes (Figure S5.1) and at 
least four enzymes with an EC number (Figure S5.2). In terms of metabolism, all 
members of the Pseudovibrio genus were highly similar i.e. across all genomes the 
same pathways were detected with differences between strains nearly always
amounting to the presence and/or absence of single genes. As opposed to members 
of the outgroups, all Pseudovibrio spp. were predicted to be able to synthesize 
Coenzyme F420. Coenzyme F420 is best known as an essential coenzyme of 
methanogenesis [347]. However, since Pseudovibrio spp. are incapable of
methanogenesis, F420 might be involved in SMB [348, 349] or other metabolic
activities such as aerobic catabolism of 2,4,6-trinitrophenol or as an electron carrier
to an F420-dependent glucose-6-phosphate dehydrogenase [350-352]. In contrast to 
the three non-Pseudovibrio close relatives, all Pseudovibrio strains (including P.
hongkongensis UST20140214-015BT) were predicted to have the capacity to 
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synthesize biotin (vitamin B7). It has been suggested that sponges can benefit from 
the presence of bacteria that produce biotin, as they cannot synthesize the vitamin 
themselves [353]. High similarity between the Pseudovibrio spp. strains was also 
found with respect to the number of proteins assigned to COG functional categories 
(Table S5.3). The most pronounced difference between Pseudovibrio strains and the 
outliers was found for COG category “Mobilome: prophages, transposons”, to which 
on average Pseudovibrio strains had twice the number of proteins assigned 
compared to the members of the outgroup. 
Next, differences regarding the presence of individual OGPs was investigated 
with SIMPER in order to investigate which functional capacities define our analysed 
genomes when grouped according to geographic origin, sponge of origin and 
membership of the Pseudovibrio genus (Table S5.4). Genes encoding enzymes that 
have urease activity (EC 3.5.1.5) were exclusively predicted in the outgroup 
members, the three P. denitrificans strains and P. axinellae DSM 24994T. The low 
abundance of nitrogen may be growth limiting in the oceans [354], and regeneration 
of urea (i.e. by urease), which is a waste product of many animals, may alleviate this 
restraint. Following this hypothesis, bacteria in sessile marine animals could enhance 
their growth by using the urea excreted by their host as nitrogen source [355]. 
Alternatively, the bacteria could contribute to the nitrogen budget of the host by 
fixation of environmental urea [356]. Given that the urease gene was detected in only 
a few (3 of 29) Pseudovibrio strains that reside in marine mammals, we do not expect 
it to play an important role in the hosts-symbiont relationship, or this gene only plays 
a role in specific hosts. SIMPER analysis also showed that OGPs corresponding to 
enzymes involved in vitamin B12 (cobalamin) and vitamin B1 (thiamin) biosynthesis 
were found in Pseudovibrio spp., but were absent in the outgroup members. Bacteria 
may be an essential contributor to the nutritional requirements of marine animals 
through production of these essential vitamins that the animals cannot synthesize 
themselves [151]. However, we found that only a few enzymes of the multi-enzyme 
pathway to produce vitamins B1 and B12 were present in Pseudovibrio indicating that 
the vitamins cannot be de novo synthesized. Regarding vitamin B1 biosynthesis, all 
Pseudovibrio strains lack a phosphotransferase (EC number: 2.7.4.7) and a thiazole 
tautomerase (5.3.99.10), both of which catalyse the final step to respectively produce 
pyrimidine and thiazole moieties that are required to form thiamine phosphate. 
Cobalamin cannot be synthesized de novo by Pseudovibrio spp. due to absence of 
essential enzymes such as the adenosylcobinamide phosphate synthase (EC 
number: 6.3.1.10) and the adenosyl-cobric acid synthase (6.3.5.10). No further 
characteristic functional traits could be ascribed to Pseudovibrio genomes grouped 
by environmental variables since a large number of the idiosyncratic OGPs were
hypothetical proteins, or were proteins involved in routine processes. 
Symbiosis 
Eukaryotic-like proteins, virulence factors and quorum sensing 
The interactions that are hypothesized to occur between Pseudovibrio spp. 
and the sponge host are still not well-understood. Eukaryotic-like proteins (ELPs)
were first predicted to play a role in symbiosis when they were discovered to be 
highly prevalent in sponge-associated bacteria [261, 357-359]. Ankyrin-repeat 
proteins (ARPs), which are ELPs, were predicted to interfere with phagocytosis of 
Pseudovibrio by the sponge host [360]. It was also estimated that the average 
number of ARPs per sponge symbiont genome was between 10 and 40 as compared 
to an average of 2.5 ARPs in genomes of other symbiotic bacteria [361]. Our analysis
predicted ARPs in 10 of 25 sponge-associated Pseudovibrio strains, with an overall 
average of 0.96 ± 1.27 ARPs per genome (Figure 5.4), which does rank them among 
known symbiotic bacteria based on their ARPs. Proteins containing SEL1 repeats are 
also predominantly found in eukaryotes, and these proteins have been predicted to 
be symbiotic factors by which resident bacteria can interact with the host cells [304, 
362]. Our analysis predicted on average 6.9 ± 1.5 proteins with SEL1 repeats in the
Pseudovibrio genomes. In the genomes of the Pseudovibrio strains that were not
associated with marine animals (i.e. those isolated from sea water), that is 
Pseudovibrio japonicus NCIMB14279T and Pseudovibrio denitrificans JCM 12308T, 9
and 8 proteins with SEL1 repeats were detected, respectively. ELPs with 
tetratricopeptide repeats (TRPs) have been reported to participate in the delivery of
virulence factors to the host cell [363]. On average we detected 17.6 ± 1.1 proteins
with TRPs in the Pseudovibrio genomes. We also detected on average 14 ± 3.4 
proteins with invasion associated locus B, which has been reported to be involved in 
host cell invasion [364, 365]. Furthermore, in each Pseudovibrio genome two proteins 
were predicted that contain a TadE-like domain, suggesting that these might be 
involved in adherence of Pseudovibrio to the host cells [366]. We investigated 
whether the LuxR/LuxI quorum sensing system was present in the Pseudovibrio
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synthesize biotin (vitamin B7). It has been suggested that sponges can benefit from 
the presence of bacteria that produce biotin, as they cannot synthesize the vitamin 
themselves [353]. High similarity between the Pseudovibrio spp. strains was also 
found with respect to the number of proteins assigned to COG functional categories 
(Table S5.3). The most pronounced difference between Pseudovibrio strains and the 
outliers was found for COG category “Mobilome: prophages, transposons”, to which 
on average Pseudovibrio strains had twice the number of proteins assigned 
compared to the members of the outgroup. 
Next, differences regarding the presence of individual OGPs was investigated 
with SIMPER in order to investigate which functional capacities define our analysed 
genomes when grouped according to geographic origin, sponge of origin and 
membership of the Pseudovibrio genus (Table S5.4). Genes encoding enzymes that 
have urease activity (EC 3.5.1.5) were exclusively predicted in the outgroup 
members, the three P. denitrificans strains and P. axinellae DSM 24994T. The low 
abundance of nitrogen may be growth limiting in the oceans [354], and regeneration 
of urea (i.e. by urease), which is a waste product of many animals, may alleviate this 
restraint. Following this hypothesis, bacteria in sessile marine animals could enhance 
their growth by using the urea excreted by their host as nitrogen source [355]. 
Alternatively, the bacteria could contribute to the nitrogen budget of the host by 
fixation of environmental urea [356]. Given that the urease gene was detected in only 
a few (3 of 29) Pseudovibrio strains that reside in marine mammals, we do not expect 
it to play an important role in the hosts-symbiont relationship, or this gene only plays 
a role in specific hosts. SIMPER analysis also showed that OGPs corresponding to 
enzymes involved in vitamin B12 (cobalamin) and vitamin B1 (thiamin) biosynthesis 
were found in Pseudovibrio spp., but were absent in the outgroup members. Bacteria 
may be an essential contributor to the nutritional requirements of marine animals 
through production of these essential vitamins that the animals cannot synthesize 
themselves [151]. However, we found that only a few enzymes of the multi-enzyme 
pathway to produce vitamins B1 and B12 were present in Pseudovibrio indicating that 
the vitamins cannot be de novo synthesized. Regarding vitamin B1 biosynthesis, all 
Pseudovibrio strains lack a phosphotransferase (EC number: 2.7.4.7) and a thiazole 
tautomerase (5.3.99.10), both of which catalyse the final step to respectively produce 
pyrimidine and thiazole moieties that are required to form thiamine phosphate. 
Cobalamin cannot be synthesized de novo by Pseudovibrio spp. due to absence of 
essential enzymes such as the adenosylcobinamide phosphate synthase (EC 
number: 6.3.1.10) and the adenosyl-cobric acid synthase (6.3.5.10). No further 
characteristic functional traits could be ascribed to Pseudovibrio genomes grouped 
by environmental variables since a large number of the idiosyncratic OGPs were
hypothetical proteins, or were proteins involved in routine processes. 
Symbiosis 
Eukaryotic-like proteins, virulence factors and quorum sensing 
The interactions that are hypothesized to occur between Pseudovibrio spp. 
and the sponge host are still not well-understood. Eukaryotic-like proteins (ELPs)
were first predicted to play a role in symbiosis when they were discovered to be 
highly prevalent in sponge-associated bacteria [261, 357-359]. Ankyrin-repeat 
proteins (ARPs), which are ELPs, were predicted to interfere with phagocytosis of 
Pseudovibrio by the sponge host [360]. It was also estimated that the average 
number of ARPs per sponge symbiont genome was between 10 and 40 as compared 
to an average of 2.5 ARPs in genomes of other symbiotic bacteria [361]. Our analysis
predicted ARPs in 10 of 25 sponge-associated Pseudovibrio strains, with an overall 
average of 0.96 ± 1.27 ARPs per genome (Figure 5.4), which does rank them among 
known symbiotic bacteria based on their ARPs. Proteins containing SEL1 repeats are 
also predominantly found in eukaryotes, and these proteins have been predicted to 
be symbiotic factors by which resident bacteria can interact with the host cells [304, 
362]. Our analysis predicted on average 6.9 ± 1.5 proteins with SEL1 repeats in the
Pseudovibrio genomes. In the genomes of the Pseudovibrio strains that were not
associated with marine animals (i.e. those isolated from sea water), that is 
Pseudovibrio japonicus NCIMB14279T and Pseudovibrio denitrificans JCM 12308T, 9
and 8 proteins with SEL1 repeats were detected, respectively. ELPs with 
tetratricopeptide repeats (TRPs) have been reported to participate in the delivery of
virulence factors to the host cell [363]. On average we detected 17.6 ± 1.1 proteins
with TRPs in the Pseudovibrio genomes. We also detected on average 14 ± 3.4 
proteins with invasion associated locus B, which has been reported to be involved in 
host cell invasion [364, 365]. Furthermore, in each Pseudovibrio genome two proteins 
were predicted that contain a TadE-like domain, suggesting that these might be 
involved in adherence of Pseudovibrio to the host cells [366]. We investigated 
whether the LuxR/LuxI quorum sensing system was present in the Pseudovibrio
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genomes. The enzyme encoded by LuxI catalyses the final step in the production of 
N-acyl homoserine lactone (NHL). NHL can bind to the protein product of LuxR, 
Figure 5.3 Canonical correspondence analysis was used to investigate which environmental variables 
could explain the variation in orthologous protein group composition amongst the genomes. All 
clustering shown in this figure is statistically significant (p <0.01). Panel A shows results based on 
grouping of the genomes according to membership of the Pseudovibrio genus. In panel B the 
Pseudovibrio genomes are grouped according to their geographic origin. In panel C the Pseudovibrio 
strains that were isolated at the coast of Spain are grouped according to their sponge of origin. 
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which together activate transcription of genes involved in NHL biosynthesis (auto-
induction) as well as a wide array of other genes [367, 368]. NHL is secreted by the 
bacterium; therefore, as the population density increases, the concentration of NHL 
will increase, resulting in activation of gene expression across the bacterial 
community. In each Pseudovibrio genome we detected ≥10 copies of the LuxR gene 
whereas in none of the genomes LuxI was detected. An absence of LuxI suggests
that Pseudovibrio strains are dependent on quorum sensing molecules produced by
neighbouring bacteria for expression of LuxR/NHL-controlled genes, which has been 
previously hypothesized based on the genomes of Pseudovibrio sp. FO-BEG1 and
Pseudovibrio sp. JE062 [151, 369]. The genes regulated by quorum sensing may be
involved in production of secondary metabolites (e.g. against microbial competitors or 
host pathogens) or biofilm formation [370, 371]. In 29 of the 31 Pseudovibrio
genomes analysed here we detected a cluster of genes putatively involved in 
biogenesis of proteinaceous extracellular fibres called curli. These extracellular curli 
are involved in biofilm formation, and as such may be contribute to sponge 
colonization [372]. Compared to the Pseudovibrio genomes, the genomes of the 
outgroup members encoded similar numbers of ELPs, LuxR enzymes, proteins with 
invasion associated locus B and proteins containing the TadE-like domain. However,
no outgroup member encoded proteins involved in curli fibre biosynthesis.  
Secretion systems 
The distribution of Type III secretion systems (T3SSs), Type IV secretion systems
(T4SSs) and Type VI secretion systems (T6SSs) was investigated (Figure 5.4), 
because these systems have been ascribed important roles in a range of symbiotic
interactions. As query we used genomic regions of Pseudovibrio genomes in which 
the T3SS, T4SS, T6SS-I and T6SS-I were previously detected [305]. All three types 
of secretion systems allow bacteria to deliver effector molecules into a target cell via 
needle-like structures in the cellular membrane [373-375]. Besides effector
molecules, T4SSs can also translocate genetic material to the target cell. In all 
Pseudovibrio genomes, except the genome of P. japonicus NCIMB14279T, at least 
two of these secretions systems were detected. Interestingly, in P. japonicus
NCIMB14279T not a single of the aforementioned secretion systems was found
indicating that the strain might lack equipment to form symbiotic relations. This notion 
is in line with the fact that P. japonicus NCIMB14279T was isolated from the open 
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genomes. The enzyme encoded by LuxI catalyses the final step in the production of 
N-acyl homoserine lactone (NHL). NHL can bind to the protein product of LuxR, 
Figure 5.3 Canonical correspondence analysis was used to investigate which environmental variables 
could explain the variation in orthologous protein group composition amongst the genomes. All 
clustering shown in this figure is statistically significant (p <0.01). Panel A shows results based on 
grouping of the genomes according to membership of the Pseudovibrio genus. In panel B the 
Pseudovibrio genomes are grouped according to their geographic origin. In panel C the Pseudovibrio 
strains that were isolated at the coast of Spain are grouped according to their sponge of origin. 
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which together activate transcription of genes involved in NHL biosynthesis (auto-
induction) as well as a wide array of other genes [367, 368]. NHL is secreted by the 
bacterium; therefore, as the population density increases, the concentration of NHL 
will increase, resulting in activation of gene expression across the bacterial 
community. In each Pseudovibrio genome we detected ≥10 copies of the LuxR gene 
whereas in none of the genomes LuxI was detected. An absence of LuxI suggests
that Pseudovibrio strains are dependent on quorum sensing molecules produced by
neighbouring bacteria for expression of LuxR/NHL-controlled genes, which has been 
previously hypothesized based on the genomes of Pseudovibrio sp. FO-BEG1 and
Pseudovibrio sp. JE062 [151, 369]. The genes regulated by quorum sensing may be
involved in production of secondary metabolites (e.g. against microbial competitors or 
host pathogens) or biofilm formation [370, 371]. In 29 of the 31 Pseudovibrio
genomes analysed here we detected a cluster of genes putatively involved in 
biogenesis of proteinaceous extracellular fibres called curli. These extracellular curli 
are involved in biofilm formation, and as such may be contribute to sponge 
colonization [372]. Compared to the Pseudovibrio genomes, the genomes of the 
outgroup members encoded similar numbers of ELPs, LuxR enzymes, proteins with 
invasion associated locus B and proteins containing the TadE-like domain. However,
no outgroup member encoded proteins involved in curli fibre biosynthesis.  
Secretion systems 
The distribution of Type III secretion systems (T3SSs), Type IV secretion systems
(T4SSs) and Type VI secretion systems (T6SSs) was investigated (Figure 5.4), 
because these systems have been ascribed important roles in a range of symbiotic
interactions. As query we used genomic regions of Pseudovibrio genomes in which 
the T3SS, T4SS, T6SS-I and T6SS-I were previously detected [305]. All three types 
of secretion systems allow bacteria to deliver effector molecules into a target cell via 
needle-like structures in the cellular membrane [373-375]. Besides effector
molecules, T4SSs can also translocate genetic material to the target cell. In all 
Pseudovibrio genomes, except the genome of P. japonicus NCIMB14279T, at least 
two of these secretions systems were detected. Interestingly, in P. japonicus
NCIMB14279T not a single of the aforementioned secretion systems was found
indicating that the strain might lack equipment to form symbiotic relations. This notion 
is in line with the fact that P. japonicus NCIMB14279T was isolated from the open 
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sea, and that members of this species were so far never isolated from marine 
animals. On the other hand, the notion is contradicted by P. japonicus spp. being 
detected more often in sponge 16S rRNA gene datasets as compared to sea water 
datasets (Figure 5.5). T6SS-I and/or T6SS-II clusters were detected in all 
Pseudovibrio genomes (except P. japonicus NCIMB14279T), and the genes in these 
clusters were all homologous and showed perfectly conserved synteny (Table S5.5). 
The fact that the clusters are conserved in Pseudovibrio strains from diverse 
geographical locations and species suggests that they are important for survival and 
propagation. T3SS clusters were limited to Pseudovibrio strains (27/28) belonging to 
the species P. ascidiaceicola and P. denitrificans, whereas T4SSs were detected in 
only 10 out of all Pseudovibrio genomes. These results suggest Pseudovibrio spp. 
developed different strategies to carve a niche in a competitive environment. Romano 
and collegues [305] carried out a more detailed analysis of these clusters for 
Pseudovibrio sp. FO-BEG1 and Pseudovibrio sp. JE062, as well as for 10 other 
Pseudovibrio strains, by analysing which effector molecules are putatively delivered 
into host cells. It was predicted that T3SSs were mainly used to reduce phagocytosis 
and to block the inflammatory response of the host, that T4SSs were mainly involved 
in DNA mobilization, and that T6SSs might be involved in evasion of the host immune 
response, or they could have an antagonistic role towards other bacteria. Only a 
single secretion system, namely the T4SS in P. hongkongensis UST20140214-
015BT, was detected in the outgroup members. The members of the outgroup 
(except P. hongkongensis UST20140214-015BT) do not belong to genera that are 
implicated in forming symbiotic relations. In addition, all outgroup members, except 
Labrenzia alexandrii DFL-11T that was washed from the dinoflagellate Alexandrium 
lusitanicum [376], were not isolated from a host. Hence, the absence of symbiosis-
related gene clusters in their genomes (e.g. those encoding curli fibre formation and 
secretion systems) likely indicates that these bacteria are not committed to forming 
symbiotic relations. 
Figure 5.4 Symbioses-related proteins, secretions systems and secondary metabolite biosynthesis
(SMB) clusters that were detected in the genomes of the Pseudovibrio spp. and their close relatives.
Squares are coded green if the corresponding protein(s) was detected. Numerical values were
included if functions were detected more than once. The tree on top was made by hierarchical linkage
clustering based on presence/absence of orthologous group of proteins that are present in >2
genomes. Pseudovibrio type strains are depicted in blue and the close relatives are depicted in dark 
green. Hierarchical clustering was performed using 10,000 iterations of bootstrapping.
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sea, and that members of this species were so far never isolated from marine 
animals. On the other hand, the notion is contradicted by P. japonicus spp. being 
detected more often in sponge 16S rRNA gene datasets as compared to sea water 
datasets (Figure 5.5). T6SS-I and/or T6SS-II clusters were detected in all 
Pseudovibrio genomes (except P. japonicus NCIMB14279T), and the genes in these 
clusters were all homologous and showed perfectly conserved synteny (Table S5.5). 
The fact that the clusters are conserved in Pseudovibrio strains from diverse 
geographical locations and species suggests that they are important for survival and 
propagation. T3SS clusters were limited to Pseudovibrio strains (27/28) belonging to 
the species P. ascidiaceicola and P. denitrificans, whereas T4SSs were detected in 
only 10 out of all Pseudovibrio genomes. These results suggest Pseudovibrio spp. 
developed different strategies to carve a niche in a competitive environment. Romano 
and collegues [305] carried out a more detailed analysis of these clusters for 
Pseudovibrio sp. FO-BEG1 and Pseudovibrio sp. JE062, as well as for 10 other 
Pseudovibrio strains, by analysing which effector molecules are putatively delivered 
into host cells. It was predicted that T3SSs were mainly used to reduce phagocytosis 
and to block the inflammatory response of the host, that T4SSs were mainly involved 
in DNA mobilization, and that T6SSs might be involved in evasion of the host immune 
response, or they could have an antagonistic role towards other bacteria. Only a 
single secretion system, namely the T4SS in P. hongkongensis UST20140214-
015BT, was detected in the outgroup members. The members of the outgroup 
(except P. hongkongensis UST20140214-015BT) do not belong to genera that are 
implicated in forming symbiotic relations. In addition, all outgroup members, except 
Labrenzia alexandrii DFL-11T that was washed from the dinoflagellate Alexandrium 
lusitanicum [376], were not isolated from a host. Hence, the absence of symbiosis-
related gene clusters in their genomes (e.g. those encoding curli fibre formation and 
secretion systems) likely indicates that these bacteria are not committed to forming 
symbiotic relations. 
Figure 5.4 Symbioses-related proteins, secretions systems and secondary metabolite biosynthesis
(SMB) clusters that were detected in the genomes of the Pseudovibrio spp. and their close relatives.
Squares are coded green if the corresponding protein(s) was detected. Numerical values were
included if functions were detected more than once. The tree on top was made by hierarchical linkage
clustering based on presence/absence of orthologous group of proteins that are present in >2
genomes. Pseudovibrio type strains are depicted in blue and the close relatives are depicted in dark 
green. Hierarchical clustering was performed using 10,000 iterations of bootstrapping.
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Secondary metabolite biosynthesis clusters 
Pseudovibrio spp. have received high interest as sources of novel bioactive 
compounds, and especially antimicrobials [309]. Not only are novel bioactive 
compounds interesting from a clinical perspective but they may also provide insights 
into possible host-symbiont relations. Sponges in part depend on the production of 
bioactive active compounds by associated microorganisms for defense against 
predation and disease [123, 125]. Tropodithietic acid (TDA) is such a compound that 
has antibacterial activity, and was found to be produced by Pseudovibrio sp. D323 
[161]. TDA has a strong inhibitory activity against a range of marine bacteria, and 
hence is proposed to protect the host from unwanted microbial colonization [307]. It 
has been previously shown that Pseudovibrio sp. FO-BEG1 and Pseudovibrio sp. 
JE062 can produce TDA, which was linked to the presence of the tdaA-tdaF 
biosynthetic gene cluster in the respective genomes [151]. Here we found the tdaA-
tdaF biosynthetic cluster in 27 of 31 Pseudovibrio genomes which would suggest that 
TDA production is an important feature of the genus Pseudovibrio (Figure 5.4). It 
cannot be determined if the three Pseudovibrio strains without the tdaA-tdaF cluster 
also lack TDA resistance as the resistance mechanism is not yet understood; 
however, it is tempting to speculate that these strains can benefit in the sponge from 
co-resident TDA-producing Pseudovibrio spp. Further potential for SMB was 
analysed by application of the antiSMASH pipeline [336]. Eighteen of 43 types of 
SMB clusters defined by antiSMASH were detected in the Pseudovibrio genomes, 
with bacteriocin, NRPS, siderophore, T1pks-t3pks, T3pks-t1pks and terpene SMB 
clusters being detected in >5 genomes (Figure 5.4). At least one bacteriocin 
biosynthesis gene cluster was identified in all Pseudovibrio genomes, except for 
Pseudovibrio axinellae DSM 24994T. The main role of bacteriocins, which are 
ribosomally synthesized antibiotic peptides, is to provide their producers with a 
competitive advantage by inhibiting bacterial growth [377, 378]. Therefore, similar to 
TDA, bacteriocins could serve Pseudovibrio to establish a niche in the sponge host, 
and at the same time protect the host against pathogen invasion. So far, few 
bacteriocins have been identified in the marine environment [379], and only one 
study has identified novel bacteriocins in a sponge [380]. AntiSMASH detected a 
terpene biosynthesis gene cluster in all Pseudovibrio genomes. Recently, via mining 
of bacterial genomes, it has become clear that terpenes are not only regularly 
produced by plants and fungi but also by a large number of bacteria [381]. Terpenes 
may give Pseudovibrio a competitive advantage due to antimicrobial activity [382,
383]. Alternatively, the fragrance of the terpenes might be an addition to sponge-
derived secondary metabolites that are designed to repel predators [243, 384, 385]. 
However, terpenes typically have limited water solubility. For the SMB clusters
detected by antiSMASH in Pseudovibrio spp., no more than 26% of the genes in a 
cluster showed similarity to genes in known clusters. Taken together, these findings
highlight Pseudovibrio spp. as a largely untapped resource for the discovery of novel 
compounds with potentially clinical significance. 
Antibiotic resistance 
Antibiotic resistance profiles were determined for 27 out of 31 Pseudovibrio strains 
that were analysed in this study (Table S5.6). All 27 strains were resistant to 
vancomycin, lincomycin, polymyxin B and D-cycloserine, and these resistance 
phenotypes could not be linked to the presence of known resistance genes.
Therefore, resistance to these antibiotics is probably intrinsic. Twenty-one of 27 
strains were resistant to tetracycline, which could not be linked to the presence of 
resistance genes in the genomes. All strains were either resistant or intermediately
resistant to the β-lactam antibiotics ampicillin and penicillin, which could be explained 
by the class A and class B β-lactamases that were predicted to be encoded in their
genomes (Table S5.7). The predicted class A β-lactamase encoded in 22 
Pseudovibrio ascidiaceicola genomes was highly similar (≥95% amino acid identity)
to blaPSV-1 from P. ascidiaceicola 1D03 of which the resistance function has been 
experimentally verified by functional metagenomics (Chapter 4 of this thesis). Within 
the Pseudovibrio genus, almost all class A β-lactamases clustered by species (Figure 
S5.3). The exception was a distinct class A β-lactamase (8H04_2067) predicted in
Pseudovibrio sp. strain 8H04 of which the closest experimentally verified β-lactamase 
was blaPSV-1. However, as previously deduced, Pseudovibrio sp. strain 8H04 is
expected to represent a distinct novel Pseudovibrio species as well. These results,
together with the absence of associated mobilizing elements, suggest that the class
A β-lactamases are not prone to horizontal gene transfer, and that diversity within 
this group of enzymes is predominately achieved by speciation. The β-lactamases in 
these bacteria could function as a defense against β-lactam antibiotics that are 
produced by other micro-organisms co-inhabiting sessile marine animals. Still, these 
enzymes could also have other roles such as in disruption of cell signalling [299]. 
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Secondary metabolite biosynthesis clusters 
Pseudovibrio spp. have received high interest as sources of novel bioactive 
compounds, and especially antimicrobials [309]. Not only are novel bioactive 
compounds interesting from a clinical perspective but they may also provide insights 
into possible host-symbiont relations. Sponges in part depend on the production of 
bioactive active compounds by associated microorganisms for defense against 
predation and disease [123, 125]. Tropodithietic acid (TDA) is such a compound that 
has antibacterial activity, and was found to be produced by Pseudovibrio sp. D323 
[161]. TDA has a strong inhibitory activity against a range of marine bacteria, and 
hence is proposed to protect the host from unwanted microbial colonization [307]. It 
has been previously shown that Pseudovibrio sp. FO-BEG1 and Pseudovibrio sp. 
JE062 can produce TDA, which was linked to the presence of the tdaA-tdaF 
biosynthetic gene cluster in the respective genomes [151]. Here we found the tdaA-
tdaF biosynthetic cluster in 27 of 31 Pseudovibrio genomes which would suggest that 
TDA production is an important feature of the genus Pseudovibrio (Figure 5.4). It 
cannot be determined if the three Pseudovibrio strains without the tdaA-tdaF cluster 
also lack TDA resistance as the resistance mechanism is not yet understood; 
however, it is tempting to speculate that these strains can benefit in the sponge from 
co-resident TDA-producing Pseudovibrio spp. Further potential for SMB was 
analysed by application of the antiSMASH pipeline [336]. Eighteen of 43 types of 
SMB clusters defined by antiSMASH were detected in the Pseudovibrio genomes, 
with bacteriocin, NRPS, siderophore, T1pks-t3pks, T3pks-t1pks and terpene SMB 
clusters being detected in >5 genomes (Figure 5.4). At least one bacteriocin 
biosynthesis gene cluster was identified in all Pseudovibrio genomes, except for 
Pseudovibrio axinellae DSM 24994T. The main role of bacteriocins, which are 
ribosomally synthesized antibiotic peptides, is to provide their producers with a 
competitive advantage by inhibiting bacterial growth [377, 378]. Therefore, similar to 
TDA, bacteriocins could serve Pseudovibrio to establish a niche in the sponge host, 
and at the same time protect the host against pathogen invasion. So far, few 
bacteriocins have been identified in the marine environment [379], and only one 
study has identified novel bacteriocins in a sponge [380]. AntiSMASH detected a 
terpene biosynthesis gene cluster in all Pseudovibrio genomes. Recently, via mining 
of bacterial genomes, it has become clear that terpenes are not only regularly 
produced by plants and fungi but also by a large number of bacteria [381]. Terpenes 
may give Pseudovibrio a competitive advantage due to antimicrobial activity [382,
383]. Alternatively, the fragrance of the terpenes might be an addition to sponge-
derived secondary metabolites that are designed to repel predators [243, 384, 385]. 
However, terpenes typically have limited water solubility. For the SMB clusters
detected by antiSMASH in Pseudovibrio spp., no more than 26% of the genes in a 
cluster showed similarity to genes in known clusters. Taken together, these findings
highlight Pseudovibrio spp. as a largely untapped resource for the discovery of novel 
compounds with potentially clinical significance. 
Antibiotic resistance 
Antibiotic resistance profiles were determined for 27 out of 31 Pseudovibrio strains 
that were analysed in this study (Table S5.6). All 27 strains were resistant to 
vancomycin, lincomycin, polymyxin B and D-cycloserine, and these resistance 
phenotypes could not be linked to the presence of known resistance genes.
Therefore, resistance to these antibiotics is probably intrinsic. Twenty-one of 27 
strains were resistant to tetracycline, which could not be linked to the presence of 
resistance genes in the genomes. All strains were either resistant or intermediately
resistant to the β-lactam antibiotics ampicillin and penicillin, which could be explained 
by the class A and class B β-lactamases that were predicted to be encoded in their
genomes (Table S5.7). The predicted class A β-lactamase encoded in 22 
Pseudovibrio ascidiaceicola genomes was highly similar (≥95% amino acid identity)
to blaPSV-1 from P. ascidiaceicola 1D03 of which the resistance function has been 
experimentally verified by functional metagenomics (Chapter 4 of this thesis). Within 
the Pseudovibrio genus, almost all class A β-lactamases clustered by species (Figure 
S5.3). The exception was a distinct class A β-lactamase (8H04_2067) predicted in
Pseudovibrio sp. strain 8H04 of which the closest experimentally verified β-lactamase 
was blaPSV-1. However, as previously deduced, Pseudovibrio sp. strain 8H04 is
expected to represent a distinct novel Pseudovibrio species as well. These results,
together with the absence of associated mobilizing elements, suggest that the class
A β-lactamases are not prone to horizontal gene transfer, and that diversity within 
this group of enzymes is predominately achieved by speciation. The β-lactamases in 
these bacteria could function as a defense against β-lactam antibiotics that are 
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Environmental distribution of Pseudovibrio 
Using the IMNGS platform (www.imngs.org) we investigated in which percentage of 
environmental 16S rRNA gene datasets in the SRA database the Pseudovibrio type 
strains were detected (Figure 5.5). IMNGS divides the 16S rRNA gene datasets in 
105 categories according to which biological niche was sampled. The highest 
percentage of datasets containing Pseudovibrio spp. was found for the category sea 
squirts (20.8%), followed by datasets acquired from sponges (13.7%) and symbionts 
(7.6%). Pseudovibrio spp. were only detected in 16S rRNA datasets from marine 
habitats or from generalised categories that can also contain datasets from marine 
habitats. This is consistent with the notion that Pseudovibrio spp. have exclusively 
been isolated from the marine environment i.e. they depend on saltwater to thrive. 
The fact that Pseudovibrio spp. were detected more often in 16S rRNA gene datasets 
from sessile marine animals as opposed to aquatic environments suggests that 
indeed Pseudovibrio spp. form symbiotic relations. P. ascidiaceicola, P. denitrificans 
and P. japonicus were detected in >6% of the 16S rRNA gene datasets from at least 
two categories, whereas P. axinellae and P. hongkongensis were never detected in 
>1% of the datasets of any category. 
Figure 5.5 Percentage of 16S rRNA gene amplicon datasets in the SRA database in which the 
Pseudovibrio type strains were detected. The analysis was performed by the IMNGS platform 
(https://www.imngs.org/about/), which divides the datasets in 105 categories according to which 
biological niche was sampled. Full-length 16S rRNA gene sequences of the type strains were used as 
query. The similarity threshold was set at 99% nucleotide identity. All environmental categories are 
shown in which at least one type strain was detected at >0.1% relative abundance. 
Conclusions 
Our analysis of a total of 31 Pseudovibrio genomes revealed that, discounting 
Pseudovibrio hongkongensis UST20140214-015BT, the Pseudovibrio strains are
highly similar in term of metabolic capacity, with striking differences regarding the 
presence of specific SMB clusters. We identified various genomic elements that are 
highly conserved within the genus, all of which we expect to give Pseudovibrio a 
competitive advantage as a sponge (or other marine animal) symbiont. These 
conserved elements encompassed systems involved in immune evasion (T4SSs and 
T6SSs), SMB clusters which products might serve to inhibit growth of competitors 
(TDA, bacteriocin and terpene biosynthesis clusters), and a range of other symbiosis 
factors. The importance of these elements for Pseudovibrio survival is underscored 
by their conservation across Pseudovibrio spp., and across strains isolated from 
diverse geographic locations. Interestingly, based on gene composition, Pseudovibrio
strains from the Mediterranean Sea clustered by sponge of origin, suggesting host-
specific colonization or adaptation. We also showed that Pseudovibrio spp. are 
predominantly detected in 16S rRNA gene datasets of sessile marine animals. Taken 
together, these results support the hypothesis that Pseudovibrio spp. have evolved 
as symbionts of sponges and other marine invertebrates. 
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available upon request. 
 
Figure S5.3 Maximum Likelihood Tree based on protein sequences of the 28 class A ß-lactamases 
that were predicted in the Pseudovibrio genomes. The locus tags of the proteins are given with 
between brackets the corresponding Pseudovibrio strain.The tree was constructed in MEGA using 
1,000 iterations of bootstrapping. Bootstrap values <50 are not shown. The horizontal bar indicates the 
number of substitutions per site. 
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Abstract 
The emergence of bacterial pathogens that are resistant to clinical antibiotics poses 
an increasing risk to human health. The most important reservoir from which bacterial 
pathogens can acquire resistance is the human gut microbiota. However, to date, a 
large fraction of the gut microbiota remains uncultivated and has been little-studied 
with respect to its reservoir-function. Here, our aim was to isolate yet uncultivated 
resistant gut bacteria by a targeted approach. Therefore, faecal samples from 20 
intensive care patients who had received prophylactic antibiotic treatment (selective 
digestive decontamination [SDD], i.e. tobramycin, polymyxin E, amphotericin B and 
cefotaxime) were inoculated anaerobically on MicroDish porous aluminium oxide 
chips placed on top of poor and rich agar media, (including media supplemented with 
the SDD antibiotics). Biomass growing on the chips was analysed by 16S ribosomal 
RNA gene amplicon sequencing, showing large inter-individual differences in 
bacterial cultivability, and enrichment of a range of taxonomically diverse operational 
taxonomic units (OTUs). Furthermore, growth of Ruminococcaceae (2 OTUs), 
Enterobacteriaceae (6 OTUs) and Lachnospiraceae (4 OTUs) was significantly 
inhibited by the SDD antibiotics. Strains belonging to 16 OTUs were candidates for 
cultivation up to pure culture as they shared ≤95% sequence identity with the closest 
type strain and had a relative abundance of ≥2%. Six of these OTUs were detected 
on media containing SDD antibiotics, and as such were prime candidates to be 
studied with regards to antibiotic resistance. One of these six OTUs was obtained in 
pure culture using targeted isolation. This novel strain, which was initially classified 
as member of the Ruminococcaceae, was later found to share 99% nucleotide 
identity with the recently published Sellimonas intestinalis BR72T. In conclusion, we 
showed that high-throughput screening of growth communities can guide targeted 
isolation of bacteria that may serve as reservoirs of antibiotic resistance. 
Introduction 
The emergence of bacterial pathogens that are resistant to most clinical antibiotics is
an increasing threat to public health. A common route through which pathogens can
acquire resistance is by genetic exchange with human-associated bacteria, and 
especially the gut microbiota. Indeed, it has been shown that the commensal gut
microbiota harbours diverse resistance genes [104, 202], and that these genes can 
be acquired by (opportunistic) pathogens [80]. Horizontal gene transfer (HGT) is 
considered the main mechanism by which resistance genes are disseminated, and it 
has been shown that HGT events occur exceedingly more often in the gut microbiota 
than in other environments with complex bacterial communities [187]. Novel 
resistance determinants are typically described once bacteria are obtained in pure 
culture. On the other hand, resistance genes carried by yet uncultivated gut bacteria 
appear to be largely uncovered, which is reinforced by the observation that functional 
metagenomics studies of human gut microbiota consistently yield novel resistance 
genes [185, 386]. This “black box” of little-studied uncultivated bacteria has been
estimated to constitute 40-70% of gut microbes [387, 388]. Even though application 
of culture-independent methods (e.g. functional metagenomics) has provided us with 
useful insights into uncultivated bacteria, their cultivation will be essential to 
comprehensively study the antibiotic resistance phenotype, and the potential roles 
and mechanisms of these bacteria in antibiotic resistance dissemination. Nowadays,
to isolate members of yet uncultivated taxa, innovative culturing techniques that apply
high-throughput screening and/or better simulate the natural environment of these 
bacteria are increasingly being used. Recent methodical advances include cultivation 
inside chambers placed in the native environment [90, 91], the use of custom-
designed media [95], application of multi-well micro culture chips [89], high-
throughput identification of isolates [85], and microfluidic cultivation [389]. 
Furthermore, a recent study by Rettedal and co-authors combined high-throughput 
sequencing with selective cultivation conditions, allowing to cultivate previously 
uncultured species from the human gut by a targeted approach [390]. To this end,
the authors used, among other criteria, the “most wanted” list of microbial taxa that
has recently been introduced in order to guide efforts towards the cultivation of
human gut bacteria [391]. In short, the most wanted list contains human-associated 
bacterial taxa of which the genome has not yet been sequenced, not considering
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cultivation up to pure culture as they shared ≤95% sequence identity with the closest 
type strain and had a relative abundance of ≥2%. Six of these OTUs were detected 
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pure culture using targeted isolation. This novel strain, which was initially classified 
as member of the Ruminococcaceae, was later found to share 99% nucleotide 
identity with the recently published Sellimonas intestinalis BR72T. In conclusion, we 
showed that high-throughput screening of growth communities can guide targeted 
isolation of bacteria that may serve as reservoirs of antibiotic resistance. 
Introduction 
The emergence of bacterial pathogens that are resistant to most clinical antibiotics is
an increasing threat to public health. A common route through which pathogens can
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especially the gut microbiota. Indeed, it has been shown that the commensal gut
microbiota harbours diverse resistance genes [104, 202], and that these genes can 
be acquired by (opportunistic) pathogens [80]. Horizontal gene transfer (HGT) is 
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has been shown that HGT events occur exceedingly more often in the gut microbiota 
than in other environments with complex bacterial communities [187]. Novel 
resistance determinants are typically described once bacteria are obtained in pure 
culture. On the other hand, resistance genes carried by yet uncultivated gut bacteria 
appear to be largely uncovered, which is reinforced by the observation that functional 
metagenomics studies of human gut microbiota consistently yield novel resistance 
genes [185, 386]. This “black box” of little-studied uncultivated bacteria has been
estimated to constitute 40-70% of gut microbes [387, 388]. Even though application 
of culture-independent methods (e.g. functional metagenomics) has provided us with 
useful insights into uncultivated bacteria, their cultivation will be essential to 
comprehensively study the antibiotic resistance phenotype, and the potential roles 
and mechanisms of these bacteria in antibiotic resistance dissemination. Nowadays,
to isolate members of yet uncultivated taxa, innovative culturing techniques that apply
high-throughput screening and/or better simulate the natural environment of these 
bacteria are increasingly being used. Recent methodical advances include cultivation 
inside chambers placed in the native environment [90, 91], the use of custom-
designed media [95], application of multi-well micro culture chips [89], high-
throughput identification of isolates [85], and microfluidic cultivation [389]. 
Furthermore, a recent study by Rettedal and co-authors combined high-throughput 
sequencing with selective cultivation conditions, allowing to cultivate previously 
uncultured species from the human gut by a targeted approach [390]. To this end,
the authors used, among other criteria, the “most wanted” list of microbial taxa that
has recently been introduced in order to guide efforts towards the cultivation of
human gut bacteria [391]. In short, the most wanted list contains human-associated 
bacterial taxa of which the genome has not yet been sequenced, not considering
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whether members of these taxa from other environments might already have been 
sequenced. High priority most wanted taxa were defined as those of which the 16S 
rRNA centroid read shared less than 90% identity with either the GOLD-Human or 
Human Microbiome Project (HMP) strains, and which were detected in at least 20% 
of samples from any body habitat analysed. Medium priority taxa are those that share 
between 90% and 98% identity with the same habitat prevalence threshold. 
Antibiotics are generally administered upon detection of an infection. In 
addition, in most Dutch hospitals, patients who are admitted to the intensive care unit 
(ICU) receive prophylactic antibiotic therapies, of which selective decontamination of 
the digestive tract (SDD) is currently the most common treatment. SDD combines the 
application of tobramycin, polymyxin E and amphotericin B in the oropharynx and 
gastrointestinal tract with a short systemic administration of a third-generation 
cephalosporin. The therapy aims to eradicate potential pathogens such as 
Staphylococcus aureus, Pseudomonas aeruginosa Enterobacteriaceae and 
pathogenic fungi while maintaining the anaerobic members of the microbiota [392]. 
SDD therapy has been shown to decrease infections and mortality of ICU patients 
[393, 394]. Although a meta-analysis showed that SDD therapy resulted in a 
decrease in resistance carriage with respect to cultivable bacteria [395], a recent 
case study [7] and a more extensive follow-up with 13 ICU patients [396] indicated 
that prophylactic therapy may in fact increase resistance carriage among mostly 
uncultivated anaerobic gut residents. It was speculated that the expanded resistome, 
i.e. the collection of all resistance genes in a bacterial community [74], might thereby 
increase the risk of future pathogens becoming resistant. Indeed, the risk that 
pathogens develop antibiotic resistance is a major concern that has prohibited wide 
implementation of prophylactic therapies [395]. In view of the above, it is clear that 
the role of uncultivated anaerobic bacteria in the emergence of resistance pathogens 
merits deeper investigation. 
In this study, we aimed to identify and isolate potential reservoir strains for 
antibiotic resistance in the anaerobic microbiota of the human gut. Therefore, faecal 
material from 20 Dutch ICU patients was inoculated on poor and rich agar media 
under anoxic conditions. These media were prepared without antibiotics, or 
supplemented with the antibiotics that the patients received as part of their SDD 
therapy. Bacteria were cultivated on the MicroDish porous aluminium oxide (PAO) 
chip that facilitates efficient parallel processing of a large number of samples, and 
reduces potential inhibition of bacterial growth by agar [89]. Chips that were placed 
on top of different media solidified with agar were inoculated with faecal suspensions,
and bacterial biomass was investigated by 16S ribosomal RNA (rRNA) gene
amplicon sequencing, based on which growth patterns were analysed and target 
species were identified for cultivation up to pure culture. Accordingly, we isolated a
close relative of Sellimonas intestinalis BR72T that grew on top of the PAO chip on 
agar media containing tobramycin, cefotaxime and polymyxin E, and that could serve 
as a antibiotic resistance reservoir.
Materials and Methods 
Sample collection  
Faecal samples were collected from 20 patients no later than five days after 
admission to the ICU at Utrecht Medical Center, Utrecht, the Netherlands. During this
period, the patients received SDD therapy [7]. The SDD protocol was reviewed and 
approved by the institutional review board of the University Medical Center Utrecht. 
Faecal samples were collected upon defecation and stored at 4 °C for 30 min to 4 h, 
after which an aliquot of the sample (approximately 0.5 g) was suspended in 5 ml of
anaerobic PBS (pH 7.0). Subsequently, 2 ml of the suspension was transferred to an
anaerobic bottle containing 4 ml of PBS, 25% (v/v) glycerol, 0.5 g resazurin and 0.5 g
cysteine. To preserve anaerobic conditions, a few drops of titanium citrate (100 mM) 
were added to the bottle before storage at -80 °C.
Cultivation conditions 
A high throughput cultivation technique using the MicroDish PAO chip (MicroDish,
Utrecht, the Netherlands) was applied. Faecal bacteria were cultured on ethanol-
sterilized PAO chips on top of two different media: (i) GIFU anaerobic agar media
(GAM) (Hyserve, Uffing, Germany), and (ii) bicarbonate-buffered anaerobic media 
(referred to in the text as CP medium) [397] supplemented with 1.5% (w/v) agar and 
1% (v/v) faecal supernatant. The faecal supernatant was prepared from a pool of
faecal samples obtained from three healthy volunteers who had not received 
antibiotics for at least six months. In brief, equal amounts of faecal sample from the 
three volunteers were added to anaerobic PBS (pH 7.0) to a final concentration of
25% (w/v). Subsequently, the mixture was centrifuged at 14,000 rpm for 30 min, after 
which the supernatant was transferred to an anaerobic bottle (N2/CO2 – 80:20, v/v) 
and autoclaved. All samples were cultivated on agar media both in the presence and 
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whether members of these taxa from other environments might already have been 
sequenced. High priority most wanted taxa were defined as those of which the 16S 
rRNA centroid read shared less than 90% identity with either the GOLD-Human or 
Human Microbiome Project (HMP) strains, and which were detected in at least 20% 
of samples from any body habitat analysed. Medium priority taxa are those that share 
between 90% and 98% identity with the same habitat prevalence threshold. 
Antibiotics are generally administered upon detection of an infection. In 
addition, in most Dutch hospitals, patients who are admitted to the intensive care unit 
(ICU) receive prophylactic antibiotic therapies, of which selective decontamination of 
the digestive tract (SDD) is currently the most common treatment. SDD combines the 
application of tobramycin, polymyxin E and amphotericin B in the oropharynx and 
gastrointestinal tract with a short systemic administration of a third-generation 
cephalosporin. The therapy aims to eradicate potential pathogens such as 
Staphylococcus aureus, Pseudomonas aeruginosa Enterobacteriaceae and 
pathogenic fungi while maintaining the anaerobic members of the microbiota [392]. 
SDD therapy has been shown to decrease infections and mortality of ICU patients 
[393, 394]. Although a meta-analysis showed that SDD therapy resulted in a 
decrease in resistance carriage with respect to cultivable bacteria [395], a recent 
case study [7] and a more extensive follow-up with 13 ICU patients [396] indicated 
that prophylactic therapy may in fact increase resistance carriage among mostly 
uncultivated anaerobic gut residents. It was speculated that the expanded resistome, 
i.e. the collection of all resistance genes in a bacterial community [74], might thereby 
increase the risk of future pathogens becoming resistant. Indeed, the risk that 
pathogens develop antibiotic resistance is a major concern that has prohibited wide 
implementation of prophylactic therapies [395]. In view of the above, it is clear that 
the role of uncultivated anaerobic bacteria in the emergence of resistance pathogens 
merits deeper investigation. 
In this study, we aimed to identify and isolate potential reservoir strains for 
antibiotic resistance in the anaerobic microbiota of the human gut. Therefore, faecal 
material from 20 Dutch ICU patients was inoculated on poor and rich agar media 
under anoxic conditions. These media were prepared without antibiotics, or 
supplemented with the antibiotics that the patients received as part of their SDD 
therapy. Bacteria were cultivated on the MicroDish porous aluminium oxide (PAO) 
chip that facilitates efficient parallel processing of a large number of samples, and 
reduces potential inhibition of bacterial growth by agar [89]. Chips that were placed 
on top of different media solidified with agar were inoculated with faecal suspensions,
and bacterial biomass was investigated by 16S ribosomal RNA (rRNA) gene
amplicon sequencing, based on which growth patterns were analysed and target 
species were identified for cultivation up to pure culture. Accordingly, we isolated a
close relative of Sellimonas intestinalis BR72T that grew on top of the PAO chip on 
agar media containing tobramycin, cefotaxime and polymyxin E, and that could serve 
as a antibiotic resistance reservoir.
Materials and Methods 
Sample collection  
Faecal samples were collected from 20 patients no later than five days after 
admission to the ICU at Utrecht Medical Center, Utrecht, the Netherlands. During this
period, the patients received SDD therapy [7]. The SDD protocol was reviewed and 
approved by the institutional review board of the University Medical Center Utrecht. 
Faecal samples were collected upon defecation and stored at 4 °C for 30 min to 4 h, 
after which an aliquot of the sample (approximately 0.5 g) was suspended in 5 ml of
anaerobic PBS (pH 7.0). Subsequently, 2 ml of the suspension was transferred to an
anaerobic bottle containing 4 ml of PBS, 25% (v/v) glycerol, 0.5 g resazurin and 0.5 g
cysteine. To preserve anaerobic conditions, a few drops of titanium citrate (100 mM) 
were added to the bottle before storage at -80 °C.
Cultivation conditions 
A high throughput cultivation technique using the MicroDish PAO chip (MicroDish,
Utrecht, the Netherlands) was applied. Faecal bacteria were cultured on ethanol-
sterilized PAO chips on top of two different media: (i) GIFU anaerobic agar media
(GAM) (Hyserve, Uffing, Germany), and (ii) bicarbonate-buffered anaerobic media 
(referred to in the text as CP medium) [397] supplemented with 1.5% (w/v) agar and 
1% (v/v) faecal supernatant. The faecal supernatant was prepared from a pool of
faecal samples obtained from three healthy volunteers who had not received 
antibiotics for at least six months. In brief, equal amounts of faecal sample from the 
three volunteers were added to anaerobic PBS (pH 7.0) to a final concentration of
25% (w/v). Subsequently, the mixture was centrifuged at 14,000 rpm for 30 min, after 
which the supernatant was transferred to an anaerobic bottle (N2/CO2 – 80:20, v/v) 
and autoclaved. All samples were cultivated on agar media both in the presence and 
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in the absence of the SDD cocktail of antibiotics (25 µg/ml tobramycin, 5 µg/ml 
polymyxin E and 10 µg/ml cefotaxime; the antifungal drug amphotericin B was not 
included in this study). Five μl faecal suspension was applied per PAO chip. Inocula 
consisted of undiluted and 100-fold diluted cryopreserved faecal suspension. In 
addition, 10-fold sample dilutions were included for three patients (designated 210, 
131 and 148) in order to study the effect of dilution on bacterial growth. PAO chips on 
top of GAM agar and CP agar were harvested two and three days after inoculation 
under anoxic conditions at 37 °C, respectively. Upon harvesting, PAO chips with 
bacterial growth were placed in an Eppendorf tube containing 1 ml of anaerobic PBS 
(pH 7.0). The tube was vortexed for 30 s to dissociate the cells from the PAO chip. 
Subsequently, the suspension was split into two fractions; one fraction was used for 
DNA extraction whereas the other fraction was added to an anaerobic bottle 
containing glycerol (final concentration: 25-30%) in PBS, and stored at -80 °C. 
Biological duplicates were analysed for each growth community. 
DNA extraction and 16S rRNA gene amplicon sequencing 
Barcoded 16S rRNA gene amplicon sequencing was used to investigate the bacterial 
composition of the faecal samples and of the growth communities on the PAO chips. 
The cells in these samples were lysed and (cellular) debris was removed with an 
adapted bead beating protocol [398]. In case of cryo-preserved faecal material, 500 
μl of sample was added to a screw-cap tube that already contained 0.5 g of 0.1 mm 
zirconium beads (Biospec Products, Bartlesville, United States) and three 5 mm 
glass beads (Biospec Products). Subsequently, 300 μl STAR buffer (Roche, Basel, 
Switzerland) was added, after which the contents of the tube was homogenized in 
the Precellys 24 (Bertin Technologies, Montigny-le-Bretonneux, France) at 5.5 ms (3 
rounds of 1 min). The sample was then incubated at 95 °C at 100 rpm for 15 min. 
Particles were spun down at 4 oC at >10,000 g for 5 min, and subsequently the 
supernatant was transferred to a fresh tube for DNA extraction. The DNA yield was 
improved by another two iterations of beat-beating that started with re-suspending 
the pellet in 300 μl STAR buffer. In case of bacteria suspended in PBS (i.e. the 
growth communities), 150 μl of sample was processed by identical methods except 
at a smaller scale. Therefore, 0.25 g of 0.1 mm zirconium beads and three 2.5 mm 
glass beads were added to the screw-cap tube, and STAR buffer was used in 
portions of 150 μl. Following the bead beating protocol, DNA was extracted from 250 
μl of the combined supernatants using the Maxwell 16 Tissue LEV total RNA
purification kit starting from the post lysis step (Promega, Madison, United States).
16S rRNA gene amplification, which also attached the barcodes, was done with a 2-
step PCR protocol (Table S6.1) [399]. The product from the second PCR step was
analysed on a 1% agarose gel and purified using the CleanPCR Kit (GC Biotech, 
Alphen aan den Rijn, Netherlands) according to manufacturers’ instructions. The 
DNA concentration was measured by Qubit® 2.0 (Thermo Fisher Scientific). 
Subsequently the sample was included in a pool that in total contained 48 
equimolarly mixed samples. The pool of samples, which constituted a library, was
sent for Illumina paired end MiSeq sequencing (2 x 300 bp) at GATC Biotech 
(Constance, Germany). In total, eight libraries were sent MiSeq for sequencing. 
Technical replicates at the level of 16S rRNA amplicon sequencing were analysed for
the original faecal samples. 
Processing of 16S rRNA gene amplicon data, statistical analyses and detection
of most wanted and novel species 
The 16S rRNA gene amplicon data were analysed using the NG-tax pipeline [400]. In
short, NG-tax initially defines operational taxonomic units (OTUs) as clusters of 16S 
RNA gene amplicons that share 100% nucleotide identity. Subsequently, the OTUs
are expanded by including 16S RNA gene amplicons with one nucleotide mismatch. 
OTUs at <0.1% relative abundance are discarded. The quality of the sequencing was
analysed by including a mock community sample in each library (Table S6.2). The 
output OTU table and centroid OTU sequences were used as input for detection of
most wanted [391] and novel species. For statistical analysis we used a rarefied OTU 
table with 2,500 reads per sample, where samples with <2,500 reads were excluded.
Pearson correlation coefficients between bacterial communities in inocula (i.e. 
faecal material of ICU patients) and their respective growth communities were 
calculated based on OTU-level data using IBM SPSS statistics 23.0.0.2. Shannon 
diversity, richness and phylogenetic diversity whole tree metrics of bacterial
communities were calculated using QIIME [251]. The two-tailed t-test without 
assuming equal variance was used to investigate if Shannon, richness and whole-
tree phylogenetic diversity values of bacterial communities differed significantly when 
grouped according to experimental variables (e.g. growth medium or
supplementation of the medium with antibiotics). The t-test used averaged values for 
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in the absence of the SDD cocktail of antibiotics (25 µg/ml tobramycin, 5 µg/ml 
polymyxin E and 10 µg/ml cefotaxime; the antifungal drug amphotericin B was not 
included in this study). Five μl faecal suspension was applied per PAO chip. Inocula 
consisted of undiluted and 100-fold diluted cryopreserved faecal suspension. In 
addition, 10-fold sample dilutions were included for three patients (designated 210, 
131 and 148) in order to study the effect of dilution on bacterial growth. PAO chips on 
top of GAM agar and CP agar were harvested two and three days after inoculation 
under anoxic conditions at 37 °C, respectively. Upon harvesting, PAO chips with 
bacterial growth were placed in an Eppendorf tube containing 1 ml of anaerobic PBS 
(pH 7.0). The tube was vortexed for 30 s to dissociate the cells from the PAO chip. 
Subsequently, the suspension was split into two fractions; one fraction was used for 
DNA extraction whereas the other fraction was added to an anaerobic bottle 
containing glycerol (final concentration: 25-30%) in PBS, and stored at -80 °C. 
Biological duplicates were analysed for each growth community. 
DNA extraction and 16S rRNA gene amplicon sequencing 
Barcoded 16S rRNA gene amplicon sequencing was used to investigate the bacterial 
composition of the faecal samples and of the growth communities on the PAO chips. 
The cells in these samples were lysed and (cellular) debris was removed with an 
adapted bead beating protocol [398]. In case of cryo-preserved faecal material, 500 
μl of sample was added to a screw-cap tube that already contained 0.5 g of 0.1 mm 
zirconium beads (Biospec Products, Bartlesville, United States) and three 5 mm 
glass beads (Biospec Products). Subsequently, 300 μl STAR buffer (Roche, Basel, 
Switzerland) was added, after which the contents of the tube was homogenized in 
the Precellys 24 (Bertin Technologies, Montigny-le-Bretonneux, France) at 5.5 ms (3 
rounds of 1 min). The sample was then incubated at 95 °C at 100 rpm for 15 min. 
Particles were spun down at 4 oC at >10,000 g for 5 min, and subsequently the 
supernatant was transferred to a fresh tube for DNA extraction. The DNA yield was 
improved by another two iterations of beat-beating that started with re-suspending 
the pellet in 300 μl STAR buffer. In case of bacteria suspended in PBS (i.e. the 
growth communities), 150 μl of sample was processed by identical methods except 
at a smaller scale. Therefore, 0.25 g of 0.1 mm zirconium beads and three 2.5 mm 
glass beads were added to the screw-cap tube, and STAR buffer was used in 
portions of 150 μl. Following the bead beating protocol, DNA was extracted from 250 
μl of the combined supernatants using the Maxwell 16 Tissue LEV total RNA
purification kit starting from the post lysis step (Promega, Madison, United States).
16S rRNA gene amplification, which also attached the barcodes, was done with a 2-
step PCR protocol (Table S6.1) [399]. The product from the second PCR step was
analysed on a 1% agarose gel and purified using the CleanPCR Kit (GC Biotech, 
Alphen aan den Rijn, Netherlands) according to manufacturers’ instructions. The 
DNA concentration was measured by Qubit® 2.0 (Thermo Fisher Scientific). 
Subsequently the sample was included in a pool that in total contained 48 
equimolarly mixed samples. The pool of samples, which constituted a library, was
sent for Illumina paired end MiSeq sequencing (2 x 300 bp) at GATC Biotech 
(Constance, Germany). In total, eight libraries were sent MiSeq for sequencing. 
Technical replicates at the level of 16S rRNA amplicon sequencing were analysed for
the original faecal samples. 
Processing of 16S rRNA gene amplicon data, statistical analyses and detection
of most wanted and novel species 
The 16S rRNA gene amplicon data were analysed using the NG-tax pipeline [400]. In
short, NG-tax initially defines operational taxonomic units (OTUs) as clusters of 16S 
RNA gene amplicons that share 100% nucleotide identity. Subsequently, the OTUs
are expanded by including 16S RNA gene amplicons with one nucleotide mismatch. 
OTUs at <0.1% relative abundance are discarded. The quality of the sequencing was
analysed by including a mock community sample in each library (Table S6.2). The 
output OTU table and centroid OTU sequences were used as input for detection of
most wanted [391] and novel species. For statistical analysis we used a rarefied OTU 
table with 2,500 reads per sample, where samples with <2,500 reads were excluded.
Pearson correlation coefficients between bacterial communities in inocula (i.e. 
faecal material of ICU patients) and their respective growth communities were 
calculated based on OTU-level data using IBM SPSS statistics 23.0.0.2. Shannon 
diversity, richness and phylogenetic diversity whole tree metrics of bacterial
communities were calculated using QIIME [251]. The two-tailed t-test without 
assuming equal variance was used to investigate if Shannon, richness and whole-
tree phylogenetic diversity values of bacterial communities differed significantly when 
grouped according to experimental variables (e.g. growth medium or
supplementation of the medium with antibiotics). The t-test used averaged values for 
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biological and technical replicates. The QIIME script compare_taxa_summaries.py 
was used to calculate Pearson correlation coefficients of OTU-level taxa between 
mock communities and their theoretical composition. Canonical Correspondence 
Analysis (CCA) as implemented in Canoco 5 [254] was used to investigate which 
variables could best explain the variation in bacterial composition between bacterial 
communities. Linear mixed-effect models were fitted by the R package “lmerTest” 
(https://CRAN.R-project.org/package=lmerTest) [329] in order to analyse how media 
type and addition of antibiotics affected bacterial composition. As input an adapted 
OTU table was used in which values were log1p transformed to meet normality 
assumptions. Furthermore, OTUs were removed from the table if they were detected 
in <5 samples or by <50 reads across all samples. Parameter-specific p-values were 
obtained by using the Satterthwaite approximation. P-values were corrected for 
multiple testing by the function p.adjust in the package “stats”, using methods 
“Bonferroni” and “BH”. Bray-Curtis dissimilarity hierarchical clustering was performed 
using R package ‘Vegan’ based on OTU-level relative abundance data of bacterial 
communities.  
In order to investigate the presence of most wanted taxa [391] and novel 
species, the representative reads of the OTUs were compared by BLASTn [283] to 
the V1-V3 sequence data of the most wanted OTUs, and to the 16S rRNA genes in 
the SILVA database of type strains [401], respectively. A custom Perl script was used 
to parse the BLAST results for the best hits (bitscore sorted). Furthermore, the script 
tabulated the relative abundance of the OTUs and their distribution across all 
samples. 
Targeted cultivation 
Based on analysis of the 16S rRNA gene sequence data of the bacterial growth 
communities, OTUs were selected for targeted isolation. Therefore, the original 
faecal inoculum and the enriched growth fractions that contained the target OTU 
were re-plated under identical conditions, i.e. on PAO chips placed on the same 
media. A dilution series was inoculated to yield single colonies. Per PAO chip, three 
colonies per unique colony morphology were transferred to fresh PAO chips. 
Subsequently, the 16S rRNA gene was amplified using the 27F and 1492R primers 
[257], and the PCR products were Sanger sequenced at GATC Biotech (Cologne, 
Germany) using the 907R primer [258]. The 16S rRNA gene sequences were 
compared by BLASTn to those in the NCBI ribosomal 16S RNA sequences database 
for species identification. Only for target species the near full-length 16S rRNA gene 
was then Sanger sequenced using the 27F and 1492R primers. 
Results 
Bacterial growth on PAO chips 
As inoculum, faecal samples were used from 20 patients that at the time of sampling 
had received SDD treatment for no longer than five days. Three 10-fold serial 
dilutions of the samples, starting at undiluted, were inoculated in duplicate on PAO 
chips on top of GAM and CP agar media, either with or without supplementation of
the SDD antibiotic cocktail. Agar media inoculated at the lowest dilution of faecal 
material and in absence of antibiotics always yielded confluent growth on GAM 
media, whereas on CP media confluent growth was observed on 34 of 40 PAO chips
(Table S6.3). In general, less biomass grew on media if the faecal material was
inoculated at a higher dilution, if the media contained the SDD cocktail of antibiotics, 
and if the faecal material was inoculated on CP media. Growth on most PAO chips
(371 of 480) was confluent as opposed to colonies that could be visually
distinguished (Figure 6.1A). Faecal inocula (in duplicate) and a selection of PAO
chips with bacterial growth, including chips inoculated with undiluted and 100-fold
diluted faecal suspensions, as well as with 10-fold diluted suspensions for three 
samples, were analysed by 16S rRNA gene amplicon sequencing, which amounted 
to a total of 324 samples. The NG-tax pipeline was used to process the sequencing 
data of our samples as well as mock communities with known composition that were 
added to each library [400]. The average Pearson correlation value of OTU-level taxa 
between the included mock communities and their theoretical composition was 0.82 
(min-max 0.77-0.88), supporting the reliability of the applied approach (data not
shown). Samples with 0 reads (n=4) assigned were removed from all further analysis
yielding 319 samples with an average read depth of 40,999 ± 49,592 (s.d.) reads 
(Table S6.4), and 3,832 assigned OTUs. 
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biological and technical replicates. The QIIME script compare_taxa_summaries.py 
was used to calculate Pearson correlation coefficients of OTU-level taxa between 
mock communities and their theoretical composition. Canonical Correspondence 
Analysis (CCA) as implemented in Canoco 5 [254] was used to investigate which 
variables could best explain the variation in bacterial composition between bacterial 
communities. Linear mixed-effect models were fitted by the R package “lmerTest” 
(https://CRAN.R-project.org/package=lmerTest) [329] in order to analyse how media 
type and addition of antibiotics affected bacterial composition. As input an adapted 
OTU table was used in which values were log1p transformed to meet normality 
assumptions. Furthermore, OTUs were removed from the table if they were detected 
in <5 samples or by <50 reads across all samples. Parameter-specific p-values were 
obtained by using the Satterthwaite approximation. P-values were corrected for 
multiple testing by the function p.adjust in the package “stats”, using methods 
“Bonferroni” and “BH”. Bray-Curtis dissimilarity hierarchical clustering was performed 
using R package ‘Vegan’ based on OTU-level relative abundance data of bacterial 
communities.  
In order to investigate the presence of most wanted taxa [391] and novel 
species, the representative reads of the OTUs were compared by BLASTn [283] to 
the V1-V3 sequence data of the most wanted OTUs, and to the 16S rRNA genes in 
the SILVA database of type strains [401], respectively. A custom Perl script was used 
to parse the BLAST results for the best hits (bitscore sorted). Furthermore, the script 
tabulated the relative abundance of the OTUs and their distribution across all 
samples. 
Targeted cultivation 
Based on analysis of the 16S rRNA gene sequence data of the bacterial growth 
communities, OTUs were selected for targeted isolation. Therefore, the original 
faecal inoculum and the enriched growth fractions that contained the target OTU 
were re-plated under identical conditions, i.e. on PAO chips placed on the same 
media. A dilution series was inoculated to yield single colonies. Per PAO chip, three 
colonies per unique colony morphology were transferred to fresh PAO chips. 
Subsequently, the 16S rRNA gene was amplified using the 27F and 1492R primers 
[257], and the PCR products were Sanger sequenced at GATC Biotech (Cologne, 
Germany) using the 907R primer [258]. The 16S rRNA gene sequences were 
compared by BLASTn to those in the NCBI ribosomal 16S RNA sequences database 
for species identification. Only for target species the near full-length 16S rRNA gene 
was then Sanger sequenced using the 27F and 1492R primers. 
Results 
Bacterial growth on PAO chips 
As inoculum, faecal samples were used from 20 patients that at the time of sampling 
had received SDD treatment for no longer than five days. Three 10-fold serial 
dilutions of the samples, starting at undiluted, were inoculated in duplicate on PAO 
chips on top of GAM and CP agar media, either with or without supplementation of
the SDD antibiotic cocktail. Agar media inoculated at the lowest dilution of faecal 
material and in absence of antibiotics always yielded confluent growth on GAM 
media, whereas on CP media confluent growth was observed on 34 of 40 PAO chips
(Table S6.3). In general, less biomass grew on media if the faecal material was
inoculated at a higher dilution, if the media contained the SDD cocktail of antibiotics, 
and if the faecal material was inoculated on CP media. Growth on most PAO chips
(371 of 480) was confluent as opposed to colonies that could be visually
distinguished (Figure 6.1A). Faecal inocula (in duplicate) and a selection of PAO
chips with bacterial growth, including chips inoculated with undiluted and 100-fold
diluted faecal suspensions, as well as with 10-fold diluted suspensions for three 
samples, were analysed by 16S rRNA gene amplicon sequencing, which amounted 
to a total of 324 samples. The NG-tax pipeline was used to process the sequencing 
data of our samples as well as mock communities with known composition that were 
added to each library [400]. The average Pearson correlation value of OTU-level taxa 
between the included mock communities and their theoretical composition was 0.82 
(min-max 0.77-0.88), supporting the reliability of the applied approach (data not
shown). Samples with 0 reads (n=4) assigned were removed from all further analysis
yielding 319 samples with an average read depth of 40,999 ± 49,592 (s.d.) reads 
(Table S6.4), and 3,832 assigned OTUs. 
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Figure 6.1 A) Close-up photograph of microbial growth on a PAO chip that was placed on top of CP 
agar. The chip was inoculated with 10X diluted cryo-preserved faecal sample from patient 188. The 
area that was inoculated is visualized as a smear in which individual microbial colonies can be 
distinguished. The white dots in the picture represent air bubbles in the agar medium. B) A light 
microscopy picture of the strain corresponding to OTU3088 that was isolated by a targeted approach. 
The strain shares 99% 16S rRNA gene identity with Sellimonas intestinalis BR72T. 
Comparison of bacterial growth communities 
Bacterial diversity 
Averaged across all faecal samples, the most abundant bacterial phyla were 
Firmicutes (60.5% ± 23.5 [s.d.]), Bacteroidetes (33.9% ± 25.3), Proteobacteria 
(2.60% ± 6.40), Actinobacteria (1.56% ± 5.00) and Verrucomicrobia (0.49% ± 1.22) 
(Figure 6.2A). The corresponding growth communities on GAM and CP media were 
dominated by Firmicutes and Bacteroidetes, together comprising on average >80% 
of the bacterial community. On GAM agar without antibiotics the Proteobacteria on 
average constituted 5.1% ± 16.7 of the communities whereas on GAM agar with the 
SDD cocktail (GAM-SDD), proteobacterial relative abundance was 0.033% ± 0.14. 
Similarly, on CP-SDD media the Proteobacteria had reduced relative abundance (a 
decrease from 13.6% ± 27.7 to 9.8% ± 2.92) as compared to CP media without 
antibiotics. Notably, Cyanobacteria were not detected in the faecal samples or on 
GAM media, but they were detected on CP media averaging 0.51% ± 6.40 relative 
abundance. As expected, the average Shannon diversity of faecal samples was 
significantly higher than that of growth communities grouped by medium, addition of 
antibiotics or dilution (two-tailed t-test, p = <0.01 for all comparisons) (Figure 6.2B). 
Lower Shannon diversity values were also observed in growth communities 
inoculated with more diluted faecal sample. However, this difference was only 
significant between communities on CP-SDD agar that were inoculated with undiluted 
10 μm
A) B)
1 mm
and 100-fold diluted faecal sample (two-tailed t-test, p = 0.01). The addition of the
SDD antibiotics significantly reduced the Shannon diversity on GAM media (p = 
<0.01) but not on CP media. Differences in OTU richness and whole-tree 
phylogenetic diversity between the sample groups followed the same trends as
differences in Shannon diversity i.e. higher values were obtained for faecal samples
and lower values were obtained if media were inoculated with more diluted faecal 
material or included antibiotics (Figure S6.1). However, surprisingly, a higher dilution 
of the faecal inoculum did not affect whole-tree phylogenetic diversity on CP media 
without antibiotics (p = 0.81). Canonical correspondence analysis (CCA) of OTU-level 
data from all bacterial communities (faecal inoculates and cultivable fractions)
indicated that cultivation medium and presence/absence of antibiotics could explain 
in total 3.7% of the variation in bacterial composition (p = 0.002) (Figure 6.3). 
However, bacterial growth on CP agar was not found to be significantly affected by 
the addition of the SDD cocktail of antibiotics. The dilution factor of faecal inocula 
was also evaluated as explanatory variable but was found to not affect bacterial 
composition. 
Figure 6.2 A) Bacterial phyla that were detected in the faecal samples of 20 intensive care patients
and in their corresponding growth communities on GAM and CP agar media. Growth on these media
was further subdivided based on the addition of the SDD antibiotics. Phyla with a relative abundance
<0.5% are not shown. The relative abundance values are based on the combined reads of all samples 
in the different experimental groups. B) Boxplots depicting the distribution of Shannon diversity values 
of bacterial communities in the different experimental groups. Asterisks indicate that Shannon values
of bacterial communities in experimental groups were significantly different (p = <0.05) based on the
two-tailed t-test. Medium (i.e. GAM vs. CP) did not significantly affect Shannon values of bacterial
growth communities. Shannon values of faecal samples were in all cases higher than those for growth 
communities, irrespective of medium, dilution and addition of antibiotics (p = <0.01 for all
comparisons).
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Figure 6.1 A) Close-up photograph of microbial growth on a PAO chip that was placed on top of CP 
agar. The chip was inoculated with 10X diluted cryo-preserved faecal sample from patient 188. The 
area that was inoculated is visualized as a smear in which individual microbial colonies can be 
distinguished. The white dots in the picture represent air bubbles in the agar medium. B) A light 
microscopy picture of the strain corresponding to OTU3088 that was isolated by a targeted approach. 
The strain shares 99% 16S rRNA gene identity with Sellimonas intestinalis BR72T. 
Comparison of bacterial growth communities 
Bacterial diversity 
Averaged across all faecal samples, the most abundant bacterial phyla were 
Firmicutes (60.5% ± 23.5 [s.d.]), Bacteroidetes (33.9% ± 25.3), Proteobacteria 
(2.60% ± 6.40), Actinobacteria (1.56% ± 5.00) and Verrucomicrobia (0.49% ± 1.22) 
(Figure 6.2A). The corresponding growth communities on GAM and CP media were 
dominated by Firmicutes and Bacteroidetes, together comprising on average >80% 
of the bacterial community. On GAM agar without antibiotics the Proteobacteria on 
average constituted 5.1% ± 16.7 of the communities whereas on GAM agar with the 
SDD cocktail (GAM-SDD), proteobacterial relative abundance was 0.033% ± 0.14. 
Similarly, on CP-SDD media the Proteobacteria had reduced relative abundance (a 
decrease from 13.6% ± 27.7 to 9.8% ± 2.92) as compared to CP media without 
antibiotics. Notably, Cyanobacteria were not detected in the faecal samples or on 
GAM media, but they were detected on CP media averaging 0.51% ± 6.40 relative 
abundance. As expected, the average Shannon diversity of faecal samples was 
significantly higher than that of growth communities grouped by medium, addition of 
antibiotics or dilution (two-tailed t-test, p = <0.01 for all comparisons) (Figure 6.2B). 
Lower Shannon diversity values were also observed in growth communities 
inoculated with more diluted faecal sample. However, this difference was only 
significant between communities on CP-SDD agar that were inoculated with undiluted 
10 μm
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1 mm
and 100-fold diluted faecal sample (two-tailed t-test, p = 0.01). The addition of the
SDD antibiotics significantly reduced the Shannon diversity on GAM media (p = 
<0.01) but not on CP media. Differences in OTU richness and whole-tree 
phylogenetic diversity between the sample groups followed the same trends as
differences in Shannon diversity i.e. higher values were obtained for faecal samples
and lower values were obtained if media were inoculated with more diluted faecal 
material or included antibiotics (Figure S6.1). However, surprisingly, a higher dilution 
of the faecal inoculum did not affect whole-tree phylogenetic diversity on CP media 
without antibiotics (p = 0.81). Canonical correspondence analysis (CCA) of OTU-level 
data from all bacterial communities (faecal inoculates and cultivable fractions)
indicated that cultivation medium and presence/absence of antibiotics could explain 
in total 3.7% of the variation in bacterial composition (p = 0.002) (Figure 6.3). 
However, bacterial growth on CP agar was not found to be significantly affected by 
the addition of the SDD cocktail of antibiotics. The dilution factor of faecal inocula 
was also evaluated as explanatory variable but was found to not affect bacterial 
composition. 
Figure 6.2 A) Bacterial phyla that were detected in the faecal samples of 20 intensive care patients
and in their corresponding growth communities on GAM and CP agar media. Growth on these media
was further subdivided based on the addition of the SDD antibiotics. Phyla with a relative abundance
<0.5% are not shown. The relative abundance values are based on the combined reads of all samples 
in the different experimental groups. B) Boxplots depicting the distribution of Shannon diversity values 
of bacterial communities in the different experimental groups. Asterisks indicate that Shannon values
of bacterial communities in experimental groups were significantly different (p = <0.05) based on the
two-tailed t-test. Medium (i.e. GAM vs. CP) did not significantly affect Shannon values of bacterial
growth communities. Shannon values of faecal samples were in all cases higher than those for growth 
communities, irrespective of medium, dilution and addition of antibiotics (p = <0.01 for all
comparisons).
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Figure 6.3 Canonical correspondence analysis (CCA) of OTU-level data was used to investigate to 
what extent growth conditions can explain the variation in the composition of bacterial communities. 
Included in the analyses were the faecal samples (inocula) as well as their corresponding growth 
communities on GAM agar and CP agar. Growth on agar media was further distinguished based on 
the addition of the SDD antibiotics. 
Inter-individual differences in communities 
While bacterial communities grouped by experimental variables (i.e. medium or 
addition of antibiotics) showed significant differences, we were also interested in 
potential differences between patients. Hierarchical clustering of OTU-level data 
using Bray-Curtis dissimilarity indicated high dissimilarity between individual faecal 
samples with mutual dissimilarity values being >0.8 in all but two cases (Figure 6.4). 
Growth communities derived from only 9 of 20 patients all clustered together 
indicating that other factors besides inoculum influenced bacterial growth. For 
example, growth communities of patient 131 all clustered together with mutual 
dissimilarity values <0.25 whereas for growth communities of patient 236 dissimilarity 
values exceeded 0.8. Moderate clustering by medium and presence/absence of 
antibiotics confirmed that cultivation conditions affected growth as was shown before 
by CCA. We also evaluated by Pearson correlation to what extent bacterial growth 
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communities resembled the faecal samples from which they were derived (Figure 
S6.2). For different individuals the average Pearson correlations ranged from 0.02 to
0.99, indicating that there were large inter-individual differences in bacterial
cultivability. No trends were discovered between the applied medium, antibiotics
and/or dilution of faecal inoculum, and how well the growth communities resembled 
the faecal samples. 
Effects of media composition and antibiotics on bacterial growth 
In the following, we aimed to identify OTUs that were enriched as a result of specific
cultivation conditions. We fitted linear mixed-effect models on OTU-level data so that 
also differences between individual patients could be taken into account (Table 
S6.5). A total of 35 OTUs were significantly enriched under the different cultivation 
conditions (Table 6.1). Considering Bonferroni-corrected p-values, a total of seven 
OTUs belonging to the families Bacteroidaceae (5 OTUs), Staphylococcaceae (1 
OTU) and Enterococcaceae (1 OTU) were present in significantly higher abundance 
on GAM media as compared to the respective faecal samples. In contrast, on CP 
media, OTUs belonging to the families Halomonadaceae (2 OTUs), Lachnospiraceae
(6 OTUs), Ruminococcaceae (1 OTU), Streptococcaceae (1 OTU), Enterococcaceae
(3 OTUs), Porphyromonadaceae (2 OTUs), and Oxalobacteraceae (1 OTU) were 
enriched. A significantly lower abundance of Ruminococcaceae spp (1 OTU).
Enterobacteriaceae spp (6 OTUs) and Lachnospiraceae spp. (4 OTUs) was detected 
on media supplemented with the SDD antibiotics in comparison to media without 
antibiotics, indicating that the antibiotics inhibited the growth of these bacteria. 
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communities resembled the faecal samples from which they were derived (Figure 
S6.2). For different individuals the average Pearson correlations ranged from 0.02 to
0.99, indicating that there were large inter-individual differences in bacterial
cultivability. No trends were discovered between the applied medium, antibiotics
and/or dilution of faecal inoculum, and how well the growth communities resembled 
the faecal samples. 
Effects of media composition and antibiotics on bacterial growth 
In the following, we aimed to identify OTUs that were enriched as a result of specific
cultivation conditions. We fitted linear mixed-effect models on OTU-level data so that 
also differences between individual patients could be taken into account (Table 
S6.5). A total of 35 OTUs were significantly enriched under the different cultivation 
conditions (Table 6.1). Considering Bonferroni-corrected p-values, a total of seven 
OTUs belonging to the families Bacteroidaceae (5 OTUs), Staphylococcaceae (1 
OTU) and Enterococcaceae (1 OTU) were present in significantly higher abundance 
on GAM media as compared to the respective faecal samples. In contrast, on CP 
media, OTUs belonging to the families Halomonadaceae (2 OTUs), Lachnospiraceae
(6 OTUs), Ruminococcaceae (1 OTU), Streptococcaceae (1 OTU), Enterococcaceae
(3 OTUs), Porphyromonadaceae (2 OTUs), and Oxalobacteraceae (1 OTU) were 
enriched. A significantly lower abundance of Ruminococcaceae spp (1 OTU).
Enterobacteriaceae spp (6 OTUs) and Lachnospiraceae spp. (4 OTUs) was detected 
on media supplemented with the SDD antibiotics in comparison to media without 
antibiotics, indicating that the antibiotics inhibited the growth of these bacteria. 
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Table 6.1 Linear mixed-effect models of OTU-level composition data of bacterial growth were applied 
to investigate which OTUs varied in abundance as a results of cultivation conditions. This table lists 
the taxonomic affiliations of OTUs that were found to be enriched at Bonferroni corrected p-values of 
<0.05. Bacterial communities were cultivated on GAM agar and CP agar, both in the presence and 
absence of the SDD antibiotics.
Taxonomy
Enriched on No. of OTUs Family Genus
GAM agar 5 Bacteroidaceae Bacteroides 
1 Staphylococcaceae Staphylococcus 
1 Enterococcaceae Enterococcus 
CP agar 2 Halomonadaceae Halomonas 
6 Lachnospiraceae Unspecified 
1 Ruminococcaceae Unspecified 
1 Streptococcaceae Streptococcus 
3 Enterococcaceae Enterococcus 
2 Porphyromonadaceae Parabacteroides
1 Oxalobacteraceae Undibacterium
Media (CP and GAM) without antibiotics 1 Ruminococcaceae Unspecified 
6 Enterobacteriaceae Escherichia-Shigella 
4 Lachnospiraceae Unspecified 
CP agar without SDD cocktail of antibiotics 1 Ruminococcaceae Unspecified 
Growth of novel species
We further aimed to investigate whether novel species or members of taxa on the 
most wanted list were present in the cultivable fraction of the faecal samples. Eleven 
high priority most wanted OTUs were detected in the growth communities; however,
none of these OTUs was present at a relative abundance of >0.8% (Table S6.6).
Furthermore, three medium priority most wanted OTUs (OTUs 236, 172 and 288)
were detected in the cultivable fraction with 1-3% relative abundance. Nevertheless, 
members of medium priority OTUs were not considered candidates for isolation 
because they shared 100% identity with strains that were previously isolated. 
Comparison of OTUs with the SILVA database of type strains yielded 16 OTUs with 
>2% relative abundance of which the OTU representative read shared <95% identity 
with the 16S rRNA gene sequence of the closest type strain (Table 6.2). Therefore, 
these OTUs were considered to i) potentially represent novel species, and ii) to be 
sufficiently abundant for isolation by colony picking. Among these 16 OTUs, OTUs
3088, 322, 3797, 2642 and 2024 were considered prime candidates for targeted 
isolation based on their high relative abundance on the PAO chips (>5%) and 
novelty. OTU3088 shared 93.4% identity with the closest type strain, that is,
Ruminococcus torques, and was present on GAM-SDD agar at 49.8% relative 
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Table 6.1 Linear mixed-effect models of OTU-level composition data of bacterial growth were applied 
to investigate which OTUs varied in abundance as a results of cultivation conditions. This table lists 
the taxonomic affiliations of OTUs that were found to be enriched at Bonferroni corrected p-values of 
<0.05. Bacterial communities were cultivated on GAM agar and CP agar, both in the presence and 
absence of the SDD antibiotics.
Taxonomy
Enriched on No. of OTUs Family Genus
GAM agar 5 Bacteroidaceae Bacteroides 
1 Staphylococcaceae Staphylococcus 
1 Enterococcaceae Enterococcus 
CP agar 2 Halomonadaceae Halomonas 
6 Lachnospiraceae Unspecified 
1 Ruminococcaceae Unspecified 
1 Streptococcaceae Streptococcus 
3 Enterococcaceae Enterococcus 
2 Porphyromonadaceae Parabacteroides
1 Oxalobacteraceae Undibacterium
Media (CP and GAM) without antibiotics 1 Ruminococcaceae Unspecified 
6 Enterobacteriaceae Escherichia-Shigella 
4 Lachnospiraceae Unspecified 
CP agar without SDD cocktail of antibiotics 1 Ruminococcaceae Unspecified 
Growth of novel species
We further aimed to investigate whether novel species or members of taxa on the 
most wanted list were present in the cultivable fraction of the faecal samples. Eleven 
high priority most wanted OTUs were detected in the growth communities; however,
none of these OTUs was present at a relative abundance of >0.8% (Table S6.6).
Furthermore, three medium priority most wanted OTUs (OTUs 236, 172 and 288)
were detected in the cultivable fraction with 1-3% relative abundance. Nevertheless, 
members of medium priority OTUs were not considered candidates for isolation 
because they shared 100% identity with strains that were previously isolated. 
Comparison of OTUs with the SILVA database of type strains yielded 16 OTUs with 
>2% relative abundance of which the OTU representative read shared <95% identity 
with the 16S rRNA gene sequence of the closest type strain (Table 6.2). Therefore, 
these OTUs were considered to i) potentially represent novel species, and ii) to be 
sufficiently abundant for isolation by colony picking. Among these 16 OTUs, OTUs
3088, 322, 3797, 2642 and 2024 were considered prime candidates for targeted 
isolation based on their high relative abundance on the PAO chips (>5%) and 
novelty. OTU3088 shared 93.4% identity with the closest type strain, that is,
Ruminococcus torques, and was present on GAM-SDD agar at 49.8% relative 
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abundance (Table S6.6). OTU3088 was also detected on GAM, CP and CP-SDD 
agar media, albeit at a lower relative abundance. We detected three additional OTUs 
(OTUs 3067, 3103 and 3070) at >2% relative abundance of which the closest type 
strain was also Ruminococcus torques. Since these three OTUs were always 
detected in samples that contained OTU3088, and since their representative reads 
shared high nucleotide identity with OTU3088 (>99%), we considered that they may 
be derived from the same bacterial strains. The best hits in the SILVA type strain 
database of strains OTU322 and OTU3797 were Hydrogenoanaerobacterium 
saccharovorans and the chloroplast of the diatom Thalassiosira pseudonana, 
respectively, and both were detected at >10% relative abundance (OTU322, max. 
23.9%; OTU3797, max. 13.2%). Both OTU322 and OTU3797 were only detected at 
>1% relative abundance on CP agar media in the absence of the SDD antibiotics. 
The representative read of OTU2642 shared 94.7% nucleotide identity with the 16S 
rRNA gene of Bacteroides ovatus. OTU2642 was only detected on GAM media at a 
maximum of 7.4% relative abundance. Finally, the closest type strain of OTU2024 
was Oscillibacter ruminantium, and it was detected at >1% relative abundance 
exclusively on CP-SDD media. 
Targeted cultivation 
To provide proof of concept, we aimed to isolate strains corresponding to OTUs 3088 
and 2024 as they were considered prime candidates for isolation based on novelty. 
Furthermore, the fact that these OTUs grew on media containing the SDD antibiotics 
suggested they may be antibiotic resistance reservoir species. We prepared dilution 
series of the growth fractions in which these OTUs were most enriched and 
subsequently inoculated the diluted samples under the exact conditions that 
previously yielded enrichment of the target OTUs. This experiment, however, did not 
yield isolation of the target OTUs. Therefore, the protocol was repeated using the 
original faecal samples as inocula instead of the enriched growth fractions. By this 
method we isolated a member of OTU3088, which was demonstrated by the fact that 
the representative read of OTU3088 shared 100% identity with the 16S rRNA gene 
Sanger read of our isolate (Figure 6.1B). BLASTn of the 16S rRNA gene read of the 
isolate against the NCBI ribosomal 16S RNA sequences database showed that 
closely related strains (98-99% nucleotide identity) have recently been isolated in four 
other laboratories. One closely related strain that was isolated from human faeces 
was recently published as a novel species named Sellimonas intestinalis BR72T
[402]. 
Discussion 
In this investigation, we studied the cultivability of anaerobic human faecal bacteria in 
order to isolate strains that can serve as reservoirs of antibiotic resistance. Therefore,
bacterial growth communities on GAM and CP agar media derived from faeces of 20 
ICU patients receiving SDD therapy were studied. We applied the MicroDish PAO
chip to reduce potential toxicity of agar and to facilitate efficient parallel processing of
a large number of samples. We also applied media supplemented with the SDD 
antibiotics that the patients received upon arrival on the ICU. A first selection of
bacteria was made by comparing the cultivated species with the strains on the most 
wanted list that comprises human-associated bacteria of which the genome has not
yet been sequenced and that are grouped into priority classes based on novelty 
[391]. We did not detect high priority taxa at >1% relative abundance in the growth 
communities. Medium priority taxa were detected at 1-3% relative abundance but 
they shared 100% 16S rRNA gene sequence identity with strains for which the 
genome has been already sequenced. Therefore, due to the low relative abundance 
and/or high similarity to previously genome-sequenced bacteria, the detected 
medium and high priority taxa were not further considered prime candidates for 
isolation. However, comparison of the OTU centroid reads with the strains in the 
SILVA type strain database yielded 16 OTUs with <95% nucleotide identity and >2% 
relative abundance. Based on their novelty, members of these OTUs were 
considered candidates for isolation. Although their prevalence in the gut microbiota is
expected to be <20%, i.e. they are not on the most wanted list, understanding the 
biology of such populations might be highly relevant in a more personalized 
approach, where individual-specific microbiota signatures are considered key to
success [403]. Our results show that novel human-associated bacteria can still be
cultivated using conventional methods. The extent to which novel bacteria can still be 
isolated by conventional methods was shown recently by Browne and co-authors in 
an experiment in which they isolated ~4,000 pure culture bacterial strains from
faeces of six human individuals. The authors found that these isolates comprised as
much as 96% of the bacterial abundance at the genus level and 90% of the bacterial  
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abundance (Table S6.6). OTU3088 was also detected on GAM, CP and CP-SDD 
agar media, albeit at a lower relative abundance. We detected three additional OTUs 
(OTUs 3067, 3103 and 3070) at >2% relative abundance of which the closest type 
strain was also Ruminococcus torques. Since these three OTUs were always 
detected in samples that contained OTU3088, and since their representative reads 
shared high nucleotide identity with OTU3088 (>99%), we considered that they may 
be derived from the same bacterial strains. The best hits in the SILVA type strain 
database of strains OTU322 and OTU3797 were Hydrogenoanaerobacterium 
saccharovorans and the chloroplast of the diatom Thalassiosira pseudonana, 
respectively, and both were detected at >10% relative abundance (OTU322, max. 
23.9%; OTU3797, max. 13.2%). Both OTU322 and OTU3797 were only detected at 
>1% relative abundance on CP agar media in the absence of the SDD antibiotics. 
The representative read of OTU2642 shared 94.7% nucleotide identity with the 16S 
rRNA gene of Bacteroides ovatus. OTU2642 was only detected on GAM media at a 
maximum of 7.4% relative abundance. Finally, the closest type strain of OTU2024 
was Oscillibacter ruminantium, and it was detected at >1% relative abundance 
exclusively on CP-SDD media. 
Targeted cultivation 
To provide proof of concept, we aimed to isolate strains corresponding to OTUs 3088 
and 2024 as they were considered prime candidates for isolation based on novelty. 
Furthermore, the fact that these OTUs grew on media containing the SDD antibiotics 
suggested they may be antibiotic resistance reservoir species. We prepared dilution 
series of the growth fractions in which these OTUs were most enriched and 
subsequently inoculated the diluted samples under the exact conditions that 
previously yielded enrichment of the target OTUs. This experiment, however, did not 
yield isolation of the target OTUs. Therefore, the protocol was repeated using the 
original faecal samples as inocula instead of the enriched growth fractions. By this 
method we isolated a member of OTU3088, which was demonstrated by the fact that 
the representative read of OTU3088 shared 100% identity with the 16S rRNA gene 
Sanger read of our isolate (Figure 6.1B). BLASTn of the 16S rRNA gene read of the 
isolate against the NCBI ribosomal 16S RNA sequences database showed that 
closely related strains (98-99% nucleotide identity) have recently been isolated in four 
other laboratories. One closely related strain that was isolated from human faeces 
was recently published as a novel species named Sellimonas intestinalis BR72T
[402]. 
Discussion 
In this investigation, we studied the cultivability of anaerobic human faecal bacteria in 
order to isolate strains that can serve as reservoirs of antibiotic resistance. Therefore,
bacterial growth communities on GAM and CP agar media derived from faeces of 20 
ICU patients receiving SDD therapy were studied. We applied the MicroDish PAO
chip to reduce potential toxicity of agar and to facilitate efficient parallel processing of
a large number of samples. We also applied media supplemented with the SDD 
antibiotics that the patients received upon arrival on the ICU. A first selection of
bacteria was made by comparing the cultivated species with the strains on the most 
wanted list that comprises human-associated bacteria of which the genome has not
yet been sequenced and that are grouped into priority classes based on novelty 
[391]. We did not detect high priority taxa at >1% relative abundance in the growth 
communities. Medium priority taxa were detected at 1-3% relative abundance but 
they shared 100% 16S rRNA gene sequence identity with strains for which the 
genome has been already sequenced. Therefore, due to the low relative abundance 
and/or high similarity to previously genome-sequenced bacteria, the detected 
medium and high priority taxa were not further considered prime candidates for 
isolation. However, comparison of the OTU centroid reads with the strains in the 
SILVA type strain database yielded 16 OTUs with <95% nucleotide identity and >2% 
relative abundance. Based on their novelty, members of these OTUs were 
considered candidates for isolation. Although their prevalence in the gut microbiota is
expected to be <20%, i.e. they are not on the most wanted list, understanding the 
biology of such populations might be highly relevant in a more personalized 
approach, where individual-specific microbiota signatures are considered key to
success [403]. Our results show that novel human-associated bacteria can still be
cultivated using conventional methods. The extent to which novel bacteria can still be 
isolated by conventional methods was shown recently by Browne and co-authors in 
an experiment in which they isolated ~4,000 pure culture bacterial strains from
faeces of six human individuals. The authors found that these isolates comprised as
much as 96% of the bacterial abundance at the genus level and 90% of the bacterial  
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96 abundance at the species level based on average relative abundance across faecal 
samples of six individuals [86]. 
Almost all of the 16 OTUs detected in the growth communities represented 
novel species that belonged to the Firmicutes (11 OTUs) and Bacteroidetes (4 
OTUs), and these phyla were also detected in highest relative abundance in the 
faecal samples. Notably, a single OTU was detected on CP agar at a maximum
relative abundance of 13.2% that shared 85.9% nucleotide identity with the best hit in 
the SILVA type strain database, namely the chloroplast of Thalassiosira pseudonana. 
Chloroplasts are thought to have originated from cyanobacteria [404], and this finding 
might suggest the growth of a eukaryote capable of photosynthesis. OTU3088, which 
is a novel OTU belonging to the Firmicutes, was detected in samples of nine different 
patients. Furthermore, on one PAO chip OTU3088 was detected in the presence of
the SDD antibiotics at a relative abundance of 49.8%. Therefore, it was selected for 
isolation, which was achieved on GAM-SDD media (Figure 6.1B). After isolation, the 
16S rRNA gene of the isolate turned out to share 99% nucleotide identity with the
recently published Sellimonas intestinalis [402], and high identity (98-99%) with three 
other strains recently isolated from human gut microbiota (accessions KT156811,
LN828944 and AY960564). Therefore, even though a close relative of our isolate has
been recently described, these results demonstrate that high-throughput cultivation-
based screening can be used to isolate novel antibiotic resistant bacteria by a 
targeted approach. The strain in question is a candidate to be further analysed as
resistance reservoir (e.g. by genome sequencing). Besides OTU3088, five other
novel OTUs were found to grow in the presence of the SDD antibiotic cocktail, and as
such are additional candidates for isolation and characterization (Table 6.2).
However, it should be noted that antibiotics may be broken down by adjacent 
bacteria, and that therefore these bacteria may themselves be not resistant. For 
example, cefotaxime may be degraded through the secretion of a β-lactamase [405,
406]. Bacterial isolation in general can also be hampered by the dependence on 
microbe-microbe interactions or host-microbe interactions [87]. Out of the 16 novel
OTUs detected on agar media, only OTU (OTU3088) was detected on both GAM and 
CP media at >2% relative abundance. This indicates that the number of target 
species for isolation might be increased by including different media.  
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96 abundance at the species level based on average relative abundance across faecal 
samples of six individuals [86]. 
Almost all of the 16 OTUs detected in the growth communities represented 
novel species that belonged to the Firmicutes (11 OTUs) and Bacteroidetes (4 
OTUs), and these phyla were also detected in highest relative abundance in the 
faecal samples. Notably, a single OTU was detected on CP agar at a maximum
relative abundance of 13.2% that shared 85.9% nucleotide identity with the best hit in 
the SILVA type strain database, namely the chloroplast of Thalassiosira pseudonana. 
Chloroplasts are thought to have originated from cyanobacteria [404], and this finding 
might suggest the growth of a eukaryote capable of photosynthesis. OTU3088, which 
is a novel OTU belonging to the Firmicutes, was detected in samples of nine different 
patients. Furthermore, on one PAO chip OTU3088 was detected in the presence of
the SDD antibiotics at a relative abundance of 49.8%. Therefore, it was selected for 
isolation, which was achieved on GAM-SDD media (Figure 6.1B). After isolation, the 
16S rRNA gene of the isolate turned out to share 99% nucleotide identity with the
recently published Sellimonas intestinalis [402], and high identity (98-99%) with three 
other strains recently isolated from human gut microbiota (accessions KT156811,
LN828944 and AY960564). Therefore, even though a close relative of our isolate has
been recently described, these results demonstrate that high-throughput cultivation-
based screening can be used to isolate novel antibiotic resistant bacteria by a 
targeted approach. The strain in question is a candidate to be further analysed as
resistance reservoir (e.g. by genome sequencing). Besides OTU3088, five other
novel OTUs were found to grow in the presence of the SDD antibiotic cocktail, and as
such are additional candidates for isolation and characterization (Table 6.2).
However, it should be noted that antibiotics may be broken down by adjacent 
bacteria, and that therefore these bacteria may themselves be not resistant. For 
example, cefotaxime may be degraded through the secretion of a β-lactamase [405,
406]. Bacterial isolation in general can also be hampered by the dependence on 
microbe-microbe interactions or host-microbe interactions [87]. Out of the 16 novel
OTUs detected on agar media, only OTU (OTU3088) was detected on both GAM and 
CP media at >2% relative abundance. This indicates that the number of target 
species for isolation might be increased by including different media.  
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We also investigated bacterial growth not pertinent to the isolation of novel species. 
We showed that the composition of bacterial growth communities was significantly 
impacted by medium and by supplementation of media with antibiotics (Figure 6.3). 
The cocktail used in SDD therapy contains antibiotics that are predominantly active 
against Gram-negative bacteria and fungi [407], and was designed in order to 
eradicate potentially pathogenic bacteria from the gut without harming the anaerobic 
microbiota [392, 396]. Indeed, we found that six OTUs belonging to the genus 
Escherichia, one of the SDD-target taxa, grew in significantly lower relative 
abundance on media containing the SDD cocktail. However, we also found that five 
OTUs belonging to the families Ruminococcaceae and Lachnospiraceae grew to a 
significantly lower relative abundance in the presence of the SDD antibiotics. 
Members from these families are Gram-positive and lack aerobic respiration [408], 
and are therefore collaterally affected by the application of the SDD antibiotics that 
aim to lower the risk of infection with Gram-negative aerobic opportunistic pathogens 
[392]. Remarkably, we found that the correlation of bacterial composition of the faecal 
communities and the growth communities varied extensively between patients. We 
cannot exclude that this may have resulted from differences in viability of cryo-
preserved faecal samples, but it might also be related to the individual-specific 
composition of the gut microbiota. 
In conclusion, we have shown that high-throughput screening of growth 
communities for bacterial resistance can guide targeted isolation of potential reservoir 
species. The fact that a member of one novel antibiotic-resistant OTU (OTU3088) 
was successfully isolated demonstrates the viability of the approach. Follow-up 
isolation and characterization will be required to analyse the role of previously 
uncultivated species in the dissemination of resistance genes in the gut microbiota, 
including the transfer to potential pathogens. 
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Figure S6.1 Boxplots depicting the distribution of no. of OTUs (panel A) and phylogenetic diversity 
values (Panel B) of bacterial communities in different experimental groups. The experimental groups 
are the faecal inocula and their corresponding growth communities on GAM and CP agar media. 
Growth on these media was further subdivided based on the addition of the SDD antibiotics. Asterisks 
indicate that these richness and diversity values of bacterial communities in experimental groups were 
significantly different (p = <0.05) based on the two-tailed t-test. 
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Figure S6.2 The bacterial communities in the faecal samples of 18 intensive care patients were 
compared to the corresponding growth communities on GAM agar and CP agar by calculating the 
Pearson correlation coefficients of OTU-level taxa. Growth on these media was further distinguished 
based on the addition of the SDD antibiotics. Per patient the Pearson coefficients are sorted from 
lower to higher values. 
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Application of antibiotics has resulted in enormous societal benefits in terms of 
improved patient treatment outcomes and more efficient livestock production. Over 
time, however, high antibiotic use contributed to the evolution of antibiotic resistance 
in human pathogens [9], thereby negatively affecting patient treatment outcomes. In 
fact, “superbugs” have emerged that are resistant to virtually all antibiotics, including 
the drugs of last resort [409, 410]. As a result, numerous scientists now believe that 
we are heading towards a post-antibiotic era in which mortality due to infections will 
rise [411-413]. One way by which microorganisms can become resistant is via 
acquisition of resistance-conferring genes from other microorganisms in the 
environment. However, surprisingly little is yet known about the mechanisms and 
frequencies of these resistance dissemination events, even though knowledge 
regarding these topics is crucial to combat antibiotic resistance [40, 45]. 
The main aim of this thesis was to identify resistance reservoirs, which can 
be individual bacterial species or microbial communities in specific environments, and 
to subsequently characterize the resistance determinants and their dissemination in 
the microbial biosphere. Particular focus was given to sponge-associated bacteria 
and to anaerobic bacteria from the human gut microbiota. Sponges often contain 
diverse microbial communities that are rich sources of antimicrobial compounds [118, 
277]. This notion, together with the fact that the sponge microbiota has not yet been 
methodically studied in the context of antibiotic resistance, triggered us to investigate 
their potential role as a reservoir of resistance-conferring genes. Among the 
microorganisms associated with marine sponges, members of the genus 
Pseudovibrio were studied in more detail by comparative genomics. Pseudovibrio 
spp. represent a metabolically versatile group of marine microorganisms that 
potentially play a role as sponge symbionts and hubs of antibiotic resistance. While 
many studies have focused on antibiotic resistance in the human gut microbiota, 
relatively few studies specifically reported on anaerobic uncultivated gut bacteria as a 
reservoir of resistance. To this end, innovative cultivation approaches were applied 
together with state of the art molecular profiling of microbial composition in order to 
identify and better understand the contribution of the anaerobic gut microbiota to the 
antibiotic resistance problem. Finally, this thesis for the first time applied 
metatranscriptomics to study to resistance gene expression in different biological 
niches under natural conditions. Figure 7.1 provides a schematic overview of the 
research described in this thesis. 
Figure 7.1 Schematic representation of the research described in this thesis. Dashed lines group
biological niches that were investigated with particular methods.
Resistance gene expression detected in all investigated niches 
Multiple studies analysing metagenomic data have established that antibiotic
resistance genes are present in most, if not all, biological niches that harbour
complex microbial communities [69, 97]. In Chapter 2, we went one step further and 
showed that resistance genes are not only ubiquitously present, but also being 
expressed in the microbial biosphere. Resistance gene expression was detected in 
bacteria associated with humans, mice, sea bacterioplankton, a marine sponge,
forest soil and sub-seafloor sediment even though these bacteria were unperturbed 
by anthropogenic antibiotic pressure. In human gut metatranscriptomes and 
metagenomes studied so far, the detected resistance genes broadly belonged to the 
same classes, namely tetracycline, macrolide and β-lactam resistance genes [104, 
202]. Interestingly, in gut metagenome data of 162 human individuals the number of 
detected resistance genes ranged from 33 to 89 [202], whereas in our
metatranscriptome data of four human individuals this number ranged from 5 to 20.
Furthermore, quinolone resistance genes were detected exclusively in the 
metagenome data, albeit at low relative abundance. The lower resistance gene 
richness in metatranscriptome data cannot be explained by differences in read depth 
since the metatranscriptome dataset averaged ~6 million non-rRNA reads and the 
metagenome datasets averaged ~5 million reads. As such, these results would
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Application of antibiotics has resulted in enormous societal benefits in terms of 
improved patient treatment outcomes and more efficient livestock production. Over 
time, however, high antibiotic use contributed to the evolution of antibiotic resistance 
in human pathogens [9], thereby negatively affecting patient treatment outcomes. In 
fact, “superbugs” have emerged that are resistant to virtually all antibiotics, including 
the drugs of last resort [409, 410]. As a result, numerous scientists now believe that 
we are heading towards a post-antibiotic era in which mortality due to infections will 
rise [411-413]. One way by which microorganisms can become resistant is via 
acquisition of resistance-conferring genes from other microorganisms in the 
environment. However, surprisingly little is yet known about the mechanisms and 
frequencies of these resistance dissemination events, even though knowledge 
regarding these topics is crucial to combat antibiotic resistance [40, 45]. 
The main aim of this thesis was to identify resistance reservoirs, which can 
be individual bacterial species or microbial communities in specific environments, and 
to subsequently characterize the resistance determinants and their dissemination in 
the microbial biosphere. Particular focus was given to sponge-associated bacteria 
and to anaerobic bacteria from the human gut microbiota. Sponges often contain 
diverse microbial communities that are rich sources of antimicrobial compounds [118, 
277]. This notion, together with the fact that the sponge microbiota has not yet been 
methodically studied in the context of antibiotic resistance, triggered us to investigate 
their potential role as a reservoir of resistance-conferring genes. Among the 
microorganisms associated with marine sponges, members of the genus 
Pseudovibrio were studied in more detail by comparative genomics. Pseudovibrio 
spp. represent a metabolically versatile group of marine microorganisms that 
potentially play a role as sponge symbionts and hubs of antibiotic resistance. While 
many studies have focused on antibiotic resistance in the human gut microbiota, 
relatively few studies specifically reported on anaerobic uncultivated gut bacteria as a 
reservoir of resistance. To this end, innovative cultivation approaches were applied 
together with state of the art molecular profiling of microbial composition in order to 
identify and better understand the contribution of the anaerobic gut microbiota to the 
antibiotic resistance problem. Finally, this thesis for the first time applied 
metatranscriptomics to study to resistance gene expression in different biological 
niches under natural conditions. Figure 7.1 provides a schematic overview of the 
research described in this thesis. 
Figure 7.1 Schematic representation of the research described in this thesis. Dashed lines group
biological niches that were investigated with particular methods.
Resistance gene expression detected in all investigated niches 
Multiple studies analysing metagenomic data have established that antibiotic
resistance genes are present in most, if not all, biological niches that harbour
complex microbial communities [69, 97]. In Chapter 2, we went one step further and 
showed that resistance genes are not only ubiquitously present, but also being 
expressed in the microbial biosphere. Resistance gene expression was detected in 
bacteria associated with humans, mice, sea bacterioplankton, a marine sponge,
forest soil and sub-seafloor sediment even though these bacteria were unperturbed 
by anthropogenic antibiotic pressure. In human gut metatranscriptomes and 
metagenomes studied so far, the detected resistance genes broadly belonged to the 
same classes, namely tetracycline, macrolide and β-lactam resistance genes [104, 
202]. Interestingly, in gut metagenome data of 162 human individuals the number of 
detected resistance genes ranged from 33 to 89 [202], whereas in our
metatranscriptome data of four human individuals this number ranged from 5 to 20.
Furthermore, quinolone resistance genes were detected exclusively in the 
metagenome data, albeit at low relative abundance. The lower resistance gene 
richness in metatranscriptome data cannot be explained by differences in read depth 
since the metatranscriptome dataset averaged ~6 million non-rRNA reads and the 
metagenome datasets averaged ~5 million reads. As such, these results would
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suggest that a considerable number of resistance genes is present while not being 
expressed. 
However, caution should be taken before concluding that absence of 
resistance genes in metatranscriptome data also equals absence of expression. In 
fact, Haas and co-authors found that as much as 5-10 million non-rRNA reads are 
required to detect all but the rarest transcripts of a single bacterium [414]. 
Considering that the human gut has been estimated to contain 100-1,000 bacterial 
species [415-417], it is expected that our datasets of ~6 million non-rRNA reads do 
not even approach the required sequencing depth to capture most transcripts. A case 
in point is the forest soil sample in our study from which both metagenome and 
metatranscriptome datasets of ~1 million reads were available. In the soil 
metatranscriptome dataset macrolide resistance genes were detected whereas in the 
metagenome dataset chloramphenicol, aminoglycoside, tetracycline, and β-lactam 
resistance genes were detected (data not shown). A suitable sequencing depth can 
be selected based on knowledge about relative abundances of resident bacteria 
[418]. Clearly, routinely achieved current metatranscriptome sequencing depths, and 
to a lesser degree metagenome sequencing depths, are not sufficient to fully discern 
the functionality and activity of low-abundance bacteria in microbial communities. 
Therefore, while these technical considerations do not undermine the validity of our 
conclusions based on distinct inter-individual and inter-niche differences in resistance 
transcripts, it should be considered that observations are limited by an inherent 
detection threshold. 
To validate the hypothesis that resistance genes are often present in microbial 
communities without being expressed, it is necessary to at the same time analyse the 
metatranscriptome and metagenome of a sample. The study can include 
communities that have been subjected to antibiotics to study induction of expression 
by antibiotics (sample pre- and post-administration of antibiotics). A similar approach 
can be used to study to what extent other factors such as heat, dietary fibers, 
solvents or non-relevant antibiotics affect resistance gene expression levels. The 
inadequate read depth of traditional metatranscriptome sequencing can be 
circumvented by using a more targeted approach. For example, quantitative PCR can 
be used to detect the presence or expression of specific resistance genes [78, 419]. 
Furthermore, RNA CaptureSeq may be applied to achieve unprecedented depth in 
mining of resistance transcripts [420]. Using this approach, RNA is first transcribed 
into cDNA, after which the cDNA pool is enriched by hybridizing it to arrays that 
contain probes targeting sequences of interest (i.e. resistance gene sequences). 
Finally, the cDNA pool is deep-sequenced. It should be noted that a targeted 
approach can only work if there is prior knowledge on the resistance genes that can 
be present or expressed in a given biological niche. However, at this time, 
comprehensive information about resistance gene presence is only available for 
human gut microbiota. 
It has been proposed that eventually antibiotic therapy will be based on 
resistance potentials of gut microbiota of individuals, as determined by metagenome 
sequencing [104]. Therefore, clinicians need to first screen patient-associated 
bacteria for resistance, after which an antibiotic therapy can be tailored to fit the 
patient’s resistome [421]. In our metatranscriptome study, we showed that there are 
substantial inter-individual differences in the profiles of expressed antibiotic
resistance genes. Information about resistance gene expression could provide 
deeper insights into the immediate resistance potential of bacteria associated with 
patients suffering from bacterial infections, and as such may be relevant in clinical
practice as well. Such individualized treatments could be used to treat non-urgent
infections if meta-level resistome sequencing and downstream data analysis can be 
accomplished in a short time frame [422]. 
Sponges as a reservoir for antibiotic resistance genes 
Chapter 3 and Chapter 4 covered the investigation of antibiotic resistance in sponge 
microbiota. It was hypothesized that sponges are an important resistance reservoir 
because they often contain diverse and complex microbial communities that can 
produce bioactive compounds, including those with antimicrobial activity. The main 
aim was to identify antibiotic resistant bacteria and their resistance genes and 
associated mobile elements, in order to evaluate to what extent sponges may
contribute to emerging resistance. In addition, knowledge about identified resistance 
genes could contribute to the development of compounds that inhibit resistance
mechanisms [423, 424], and could lead to the discovery of novel antibiotic
biosynthesis clusters that are frequently co-localized with resistance genes in 
bacterial genomes [425]. In Chapter 3, we described the isolation of 31 different 
bacterial strains from the sponges A. aerophoba, P. ficiformis, and C. candelabrum
on agar media supplemented with antibiotics. Subsequently, application of functional
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suggest that a considerable number of resistance genes is present while not being 
expressed. 
However, caution should be taken before concluding that absence of 
resistance genes in metatranscriptome data also equals absence of expression. In 
fact, Haas and co-authors found that as much as 5-10 million non-rRNA reads are 
required to detect all but the rarest transcripts of a single bacterium [414]. 
Considering that the human gut has been estimated to contain 100-1,000 bacterial 
species [415-417], it is expected that our datasets of ~6 million non-rRNA reads do 
not even approach the required sequencing depth to capture most transcripts. A case 
in point is the forest soil sample in our study from which both metagenome and 
metatranscriptome datasets of ~1 million reads were available. In the soil 
metatranscriptome dataset macrolide resistance genes were detected whereas in the 
metagenome dataset chloramphenicol, aminoglycoside, tetracycline, and β-lactam 
resistance genes were detected (data not shown). A suitable sequencing depth can 
be selected based on knowledge about relative abundances of resident bacteria 
[418]. Clearly, routinely achieved current metatranscriptome sequencing depths, and 
to a lesser degree metagenome sequencing depths, are not sufficient to fully discern 
the functionality and activity of low-abundance bacteria in microbial communities. 
Therefore, while these technical considerations do not undermine the validity of our 
conclusions based on distinct inter-individual and inter-niche differences in resistance 
transcripts, it should be considered that observations are limited by an inherent 
detection threshold. 
To validate the hypothesis that resistance genes are often present in microbial 
communities without being expressed, it is necessary to at the same time analyse the 
metatranscriptome and metagenome of a sample. The study can include 
communities that have been subjected to antibiotics to study induction of expression 
by antibiotics (sample pre- and post-administration of antibiotics). A similar approach 
can be used to study to what extent other factors such as heat, dietary fibers, 
solvents or non-relevant antibiotics affect resistance gene expression levels. The 
inadequate read depth of traditional metatranscriptome sequencing can be 
circumvented by using a more targeted approach. For example, quantitative PCR can 
be used to detect the presence or expression of specific resistance genes [78, 419]. 
Furthermore, RNA CaptureSeq may be applied to achieve unprecedented depth in 
mining of resistance transcripts [420]. Using this approach, RNA is first transcribed 
into cDNA, after which the cDNA pool is enriched by hybridizing it to arrays that 
contain probes targeting sequences of interest (i.e. resistance gene sequences). 
Finally, the cDNA pool is deep-sequenced. It should be noted that a targeted 
approach can only work if there is prior knowledge on the resistance genes that can 
be present or expressed in a given biological niche. However, at this time, 
comprehensive information about resistance gene presence is only available for 
human gut microbiota. 
It has been proposed that eventually antibiotic therapy will be based on 
resistance potentials of gut microbiota of individuals, as determined by metagenome 
sequencing [104]. Therefore, clinicians need to first screen patient-associated 
bacteria for resistance, after which an antibiotic therapy can be tailored to fit the 
patient’s resistome [421]. In our metatranscriptome study, we showed that there are 
substantial inter-individual differences in the profiles of expressed antibiotic
resistance genes. Information about resistance gene expression could provide 
deeper insights into the immediate resistance potential of bacteria associated with 
patients suffering from bacterial infections, and as such may be relevant in clinical
practice as well. Such individualized treatments could be used to treat non-urgent
infections if meta-level resistome sequencing and downstream data analysis can be 
accomplished in a short time frame [422]. 
Sponges as a reservoir for antibiotic resistance genes 
Chapter 3 and Chapter 4 covered the investigation of antibiotic resistance in sponge 
microbiota. It was hypothesized that sponges are an important resistance reservoir 
because they often contain diverse and complex microbial communities that can 
produce bioactive compounds, including those with antimicrobial activity. The main 
aim was to identify antibiotic resistant bacteria and their resistance genes and 
associated mobile elements, in order to evaluate to what extent sponges may
contribute to emerging resistance. In addition, knowledge about identified resistance 
genes could contribute to the development of compounds that inhibit resistance
mechanisms [423, 424], and could lead to the discovery of novel antibiotic
biosynthesis clusters that are frequently co-localized with resistance genes in 
bacterial genomes [425]. In Chapter 3, we described the isolation of 31 different 
bacterial strains from the sponges A. aerophoba, P. ficiformis, and C. candelabrum
on agar media supplemented with antibiotics. Subsequently, application of functional
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metagenomics, using pooled genomic DNA of the isolates as starting material, 
yielded the identification of functional resistance genes in 15 of these 31 bacteria 
(Chapter 4). In the combined samples of said sponges, 972 OTUs were detected 
based on clustering of 16S rRNA gene amplicon sequences at 97% identity; 
however, none of these OTUs corresponded to the 31 bacteria that were obtained in 
pure culture. This failure to recover OTUs may in part be explained by selective 
growth due to the supplementation of the cultivation media with antibiotics. Since our 
cultured isolates only comprised a small fraction of bacterial sponge residents, we 
decided to also interrogate the sponges culture-independently for the presence of 
functional resistance genes. The metagenomic libraries, which were prepared 
starting with DNA from sponge tissue, yielded only seven unique resistance genes 
even though the cumulative sponge DNA-derived libraries were 2.7 Gbp in size. 
The fraction of clones with eukaryotic DNA in the sponge DNA-derived libraries 
was not investigated, and as such we cannot decidedly link the low number of 
resistant clones to the presence of eukaryotic DNA in these libraries. In our 
sponge DNA-derived libraries we recovered none of the resistance genes that 
were found in our isolate-derived libraries, even though both originated from the 
same sponge samples. Therefore, these results imply that resistance gene 
presence in these sponges is vastly underestimated. Previously, it has been 
shown that expanding the metagenomic library size for a given biological 
niche will increase the number of unique resistance genes that are retrieved [69, 
426-428]. Given that >8,500 sponge species are currently listed in the World 
Porifera Database [429], and given that sponge-associated microbial 
communities are largely sponge-specific [126-128], it may be anticipated that our 
research only offered a first glimpse of an enormous resistance gene diversity 
amongst sponges. The resistance genes that we identified were limited to those 
that could be heterologously expressed in E. coli. Heterologous expression can be 
impeded by differences between bacterial species in cellular machinery 
including promotor recognition, recognition of the ribosome binding site and 
translation of rare codons [427, 430]. Identification of resistance genes was 
further limited by E. coli being intrinsically resistant to several antibiotics, and in 
particular to those that target Gram-positive bacteria [431]. To overcome these 
limitations, an alternative surrogate host may be used such as Bacillus subtilis [432] 
or Lactococcus lactis [433]. For resistant bacteria in pure culture, transposon-
insertion sequencing methods may be used to identify genomic loci that affect 
sensitivity to antibiotics [434]. 
It was remarkable that 11 of our sponge isolates harboured functional 
resistance genes against gentamicin, chloramphenicol, rifampicin, ampicillin and/or
trimethoprim while the strains themselves were not resistant to these antibiotics in the 
phenotypic tests described in Chapter 3. One of the possible explanations, as
speculated in Chapter 3, might be that E. coli cells become resistant due to the high 
copy number of the resistance-gene-harbouring plasmids, thereby increasing the 
concentration of active enzyme. In turn, in the sponge isolate the resistance gene, if
encoded chromosomally, may be present as a single copy, which might generate 
insufficient active enzyme to provide antibiotic resistance to the host. Still, it should 
also be considered that for our sponge isolates MIC values that correspond to the 
upper limit of the wild-type population of a particular species have not been defined. 
Typically, these epidemiological cut-off values are well-defined for human pathogens
but not defined for environmental bacteria [435]. Therefore, it may be that the 
identified resistance genes confer resistance to the original host in its natural 
environment but not at the (artificially high) antibiotic concentration that was used 
during resistance profiling. This phenomenon could especially play a role because 
the antibiotic testing concentrations were set relatively high compared to 
epidemiological cut-off values of common pathogens aiming to reduce the isolation of
bacteria that are intrinsically resistant. To select an antibiotic testing concentration, 
we used the cut-off values from four bacterial taxa (Enterobacteriaceae, P.
aeruginosa, Pseudomonas spp. and Staphylococcus spp.) from the EUCAST and 
CLSI databases [436-438]. The highest antibiotic concentration cut-off for 
“resistance” amongst these four taxa was multiplied by 1.5, rounded off, and
subsequently used as testing concentration. For example, for cefotaxime the 
available epidemiological cut-off values were 2 μg/ml (Enterobacteriaceae, CLSI), 4
μg/ml (Enterobacteriaceae, EUCAST), 32 μg/ml (P. aeruginosa, CLSI) and 64 μg/ml
(Staphylococcus spp., CLSI). The highest value (i.e. 64 μg/ml) was multiplied by 1.5, 
and subsequently rounded off to yield a testing concentration of 100 μg/ml.  
It is interesting to note that the functional resistance genes from sponge-
associated microbiota identified in our study had only limited similarity to resistance 
genes found in human pathogens, or even in human-associated bacteria. This finding 
was supported by an experiment that used qPCR to detect antibiotic resistance 
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metagenomics, using pooled genomic DNA of the isolates as starting material, 
yielded the identification of functional resistance genes in 15 of these 31 bacteria 
(Chapter 4). In the combined samples of said sponges, 972 OTUs were detected 
based on clustering of 16S rRNA gene amplicon sequences at 97% identity; 
however, none of these OTUs corresponded to the 31 bacteria that were obtained in 
pure culture. This failure to recover OTUs may in part be explained by selective 
growth due to the supplementation of the cultivation media with antibiotics. Since our 
cultured isolates only comprised a small fraction of bacterial sponge residents, we 
decided to also interrogate the sponges culture-independently for the presence of 
functional resistance genes. The metagenomic libraries, which were prepared 
starting with DNA from sponge tissue, yielded only seven unique resistance genes 
even though the cumulative sponge DNA-derived libraries were 2.7 Gbp in size. 
The fraction of clones with eukaryotic DNA in the sponge DNA-derived libraries 
was not investigated, and as such we cannot decidedly link the low number of 
resistant clones to the presence of eukaryotic DNA in these libraries. In our 
sponge DNA-derived libraries we recovered none of the resistance genes that 
were found in our isolate-derived libraries, even though both originated from the 
same sponge samples. Therefore, these results imply that resistance gene 
presence in these sponges is vastly underestimated. Previously, it has been 
shown that expanding the metagenomic library size for a given biological 
niche will increase the number of unique resistance genes that are retrieved [69, 
426-428]. Given that >8,500 sponge species are currently listed in the World 
Porifera Database [429], and given that sponge-associated microbial 
communities are largely sponge-specific [126-128], it may be anticipated that our 
research only offered a first glimpse of an enormous resistance gene diversity 
amongst sponges. The resistance genes that we identified were limited to those 
that could be heterologously expressed in E. coli. Heterologous expression can be 
impeded by differences between bacterial species in cellular machinery 
including promotor recognition, recognition of the ribosome binding site and 
translation of rare codons [427, 430]. Identification of resistance genes was 
further limited by E. coli being intrinsically resistant to several antibiotics, and in 
particular to those that target Gram-positive bacteria [431]. To overcome these 
limitations, an alternative surrogate host may be used such as Bacillus subtilis [432] 
or Lactococcus lactis [433]. For resistant bacteria in pure culture, transposon-
insertion sequencing methods may be used to identify genomic loci that affect 
sensitivity to antibiotics [434]. 
It was remarkable that 11 of our sponge isolates harboured functional 
resistance genes against gentamicin, chloramphenicol, rifampicin, ampicillin and/or
trimethoprim while the strains themselves were not resistant to these antibiotics in the 
phenotypic tests described in Chapter 3. One of the possible explanations, as
speculated in Chapter 3, might be that E. coli cells become resistant due to the high 
copy number of the resistance-gene-harbouring plasmids, thereby increasing the 
concentration of active enzyme. In turn, in the sponge isolate the resistance gene, if
encoded chromosomally, may be present as a single copy, which might generate 
insufficient active enzyme to provide antibiotic resistance to the host. Still, it should 
also be considered that for our sponge isolates MIC values that correspond to the 
upper limit of the wild-type population of a particular species have not been defined. 
Typically, these epidemiological cut-off values are well-defined for human pathogens
but not defined for environmental bacteria [435]. Therefore, it may be that the 
identified resistance genes confer resistance to the original host in its natural 
environment but not at the (artificially high) antibiotic concentration that was used 
during resistance profiling. This phenomenon could especially play a role because 
the antibiotic testing concentrations were set relatively high compared to 
epidemiological cut-off values of common pathogens aiming to reduce the isolation of
bacteria that are intrinsically resistant. To select an antibiotic testing concentration, 
we used the cut-off values from four bacterial taxa (Enterobacteriaceae, P.
aeruginosa, Pseudomonas spp. and Staphylococcus spp.) from the EUCAST and 
CLSI databases [436-438]. The highest antibiotic concentration cut-off for 
“resistance” amongst these four taxa was multiplied by 1.5, rounded off, and
subsequently used as testing concentration. For example, for cefotaxime the 
available epidemiological cut-off values were 2 μg/ml (Enterobacteriaceae, CLSI), 4
μg/ml (Enterobacteriaceae, EUCAST), 32 μg/ml (P. aeruginosa, CLSI) and 64 μg/ml
(Staphylococcus spp., CLSI). The highest value (i.e. 64 μg/ml) was multiplied by 1.5, 
and subsequently rounded off to yield a testing concentration of 100 μg/ml.  
It is interesting to note that the functional resistance genes from sponge-
associated microbiota identified in our study had only limited similarity to resistance 
genes found in human pathogens, or even in human-associated bacteria. This finding 
was supported by an experiment that used qPCR to detect antibiotic resistance 
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genes in DNA samples from the three sponges: A. aerophoba, P. ficiformis and C. 
candelabrum. The samples were interrogated with respect to 84 resistance genes 
that are frequently present in the human gut microbiota including those providing 
resistance to aminoglycosides, bacteriocins, β-lactams, macrolides, fosfomycin, 
linezolid, quinolones, tetracycline and vancomycin [396]. None of these clinically 
relevant resistance genes were detected in the sponge samples by qPCR, and 
comparison of the qPCR primers with the resistance genes identified by functional 
metagenomics confirmed that the primers indeed did not sufficiently match with these 
sequences to allow for PCR amplification (data not shown). On the other hand, a 
recent study detected the mecA, mupA, qnrB and tetL genes in the sponge 
Petromica citrina by PCR with gene-specific primers [142]. It is not unexpected that 
clinically relevant resistance genes are rarely detected in the environment as the 
environmental origin of these genes has only been well-established for CTX-M β-
lactamases and qnrA [111-113]. For example, blaKLUA from a member of the genus 
Kluyvera, which are environmental organisms [439], was found to be highly similar to 
various clinically relevant plasmid-encoded CTX-M-type β-lactamases. Mobilization 
of blaKLUA was expected to be probable due to its association with a mobile element, 
and the fact that its surrounding sequences shared high identity with those 
surrounding the clinically relevant CTX-M β-lactamases [111, 440]. The fact that 
clinically relevant resistance genes are rarely detected in other environments is also 
consistent with the notion that different ecological niches contain a core resistome 
that overlaps with resistomes of other niches only to a limited extent [99, 104, 105]. 
Nevertheless, it is clear from functional metagenomics studies that “niche-specific” 
resistance genes can also function outside their natural environments (i.e. in the 
laboratory in E. coli) [79]. Therefore, it has been speculated that mobility, rather than 
functionality, might be the main obstacle preventing resistance gene dissemination 
[99]. It appears that resistance genes typically need to be associated with mobile 
elements before disseminating into the microbial biosphere. Amongst our genes 
identified by functional metagenomics, only 1 of 37 identified genes was associated 
with a mobile element. We also found that resistance genes identified in libraries 
prepared from DNA isolated from sponge tissue were less similar to deposited 
resistance genes than genes identified in libraries prepared from pooled DNA from 
bacterial isolates. This is consistent with a previous functional metagenomics study 
showing that resistance genes are more distant from known resistance genes in 
libraries independent of cultivation [185], most likely reflecting differences in cellular
machineries between cultivable taxa and yet uncultivated taxa.
Even though the resistance genes that were identified by functional 
metagenomics showed limited similarity to resistance genes found in pathogens, we 
did find evidence for resistance gene dissemination between sponges and the 
microbial biosphere. More specifically, a rifampicin resistance gene and an ampicillin 
resistance gene were identified in a Bacillus sp. sponge isolate, and both genes 
shared >99% nucleotide identity with those encoded on genomes of various Bacillus 
megaterium strains. Bacillus megaterium can be found in a wide range of habitats 
such as soil, sea water, sediment, fish and dried food [441]. These findings
complement already existing evidence for resistance dissemination between sponges
and the environment that came from the detection of a tetracycline resistance gene in 
a sponge-associated Bacillus sp. as well as in Bacillus spp. associated with cheese, 
soil and honey bees [139]. Taken together, these results indicate that resistance 
genes can indeed move between sponges and the (non-marine) environment.
Considering that Bacillus spp. are not sponge-specific bacteria [442], it could be 
argued that the resistance genes are merely conserved in Bacillus, and that these 
genes are only transiently present in the filter-feeding sponge. Still, bacteria that are 
transiently present in sponges may serve as vehicles for the dissemination of
sponge-specific resistance genes into the environment. The fact that we identified a 
novel class of β-lactamases exclusive to putative sponge symbiotic Pseudovibrio
spp. suggests that resistance genes exist that evolved in sponges. To what extent
these “sponge-specific” β-lactamases complement those of other classes in terms of 
substrate specificity will require additional experiments that compare functionality. 
In summary, we can conclude that sponges indeed serve as a reservoir for
antibiotic resistance genes that potentially can be transferred to human pathogens.
Even though we have not shown direct transfer of an antibiotic resistance gene from 
a sponge bacterium to a human pathogen, we provided evidence that resistance 
genes should indeed be able to move between sponges and the greater non-marine 
biosphere. Furthermore, 15 novel resistance genes (<90% amino acid identity to 
known genes products) were detected in sponge bacteria indicating that these might
contribute to the current spectrum of resistance genes that can potentially be
harnessed by human pathogens. Considering that resistance genes in sponge 
bacteria are rarely associated with mobile elements, and considering the remote 
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novel class of β-lactamases exclusive to putative sponge symbiotic Pseudovibrio
spp. suggests that resistance genes exist that evolved in sponges. To what extent
these “sponge-specific” β-lactamases complement those of other classes in terms of 
substrate specificity will require additional experiments that compare functionality. 
In summary, we can conclude that sponges indeed serve as a reservoir for
antibiotic resistance genes that potentially can be transferred to human pathogens.
Even though we have not shown direct transfer of an antibiotic resistance gene from 
a sponge bacterium to a human pathogen, we provided evidence that resistance 
genes should indeed be able to move between sponges and the greater non-marine 
biosphere. Furthermore, 15 novel resistance genes (<90% amino acid identity to 
known genes products) were detected in sponge bacteria indicating that these might
contribute to the current spectrum of resistance genes that can potentially be
harnessed by human pathogens. Considering that resistance genes in sponge 
bacteria are rarely associated with mobile elements, and considering the remote 
151
General Discussion
 
 
 
 
 
 
 
 
 
  
 
     
152
Chapter 7 
 
localization of sponges, it is expected that sponge-associated resistance 
determinants only pose a very limited immediate risk to human health [435]. 
Nevertheless, sponges filter large amounts of water [443], and as such the identified 
resistance genes could be derived from marine-specific microorganisms instead of 
sponge-specific, and as such might be closer to humans than anticipated. It might be 
interesting to also explicitly focus on taxa that are considered sponge-specific in 
future studies [444]. To obtain a more exhaustive account of sponges as a resistance 
reservoir, more sponges will need to be examined with respect to resistance gene 
presence. Tracking of resistance genes at the level of individual bacterial strains and 
individual plasmids will be required to obtain an all-inclusive view of their (potential) 
clinical impact [445]. This will require a better understanding of population biology of 
microorganisms, and extensive access to modern molecular techniques (e.g. 
metagenome sequencing). Quantitative knowledge about HGT rates of resistance 
genes under different conditions would be required to identify factors that contribute 
to the emergence of resistance. 
The genus Pseudovibrio as a resistance reservoir 
The hypothesis that Pseudovibrio spp. form a symbiotic relationship with marine 
invertebrates, and especially sponges, is well-supported. Firstly, cultivation studies 
sampling both sponges and the surrounding sea water only yielded Pseudovibrio 
isolates from sponge material [149, 150]. Secondly, research described in Chapter 5 
of this thesis and previous studies have identified symbiosis-related genetic elements 
in genomes of Pseudovibrio spp. [151, 304]. Lastly, by analysing publicly available 
metagenomes (Chapter 5), it was found that the relative abundance of Pseudovibrio 
spp. in sea squirt and sponge 16S rRNA gene datasets (>5%) was substantially 
higher than in sea water and aquatic 16S rRNA gene datasets (<1%). In Chapter 4 
of this thesis we describe the identification of a member of a novel β-lactamase 
family (termed blaPSV-1) from Pseudovibrio ascidiaceicola strain 1D03 that was 
isolated from A. aerophoba. This enzyme conferred resistance to ampicillin and 
penicillin, and the most closely related known β-lactamases belonged to the families 
LEN and SHV, sharing ~50% amino acid identity with blaPSV-1. The closest non-
Pseudovibrio hit in NCBI’s non-redundant protein sequences database is a β-
lactamase from the marine bacterium Ruegeria atlantica with 63% amino acid 
identity. The β-lactamase from Ruegeria was computationally predicted and its 
 
 
functionality has not been experimentally verified. As such, the gene has not been 
assigned to a β-lactamase family. These results show that members of the 
Pseudovibrio genus, which appear to preferentially reside in sponges, contain 
resistance genes that so far have not been identified elsewhere. This may indicate 
that the enzyme converts a substrate that is exclusive to sponges (or sessile marine 
animals), but more importantly, it calls attention to sponges as a reservoir of novel 
resistance genes that can potentially be harnessed by non-sponge associated 
microorganisms including human pathogens. In Chapter 5 we detected proteins that 
were highly similar (>95% amino acid identity) to blaPSV-1 in 21 distinct P. 
ascidiaceicola strains that were isolated from the coast of Portugal, the coast of 
Spain, and in the Limski channel of Croatia. We speculate that the gene was 
acquired by an ancestral Pseudovibrio sp. strain in the Mediterranean region and that 
the gene since then has been conserved. 
Exchange of antibiotic resistance between aquatic niches and 
other, non-aquatic environments 
In the following we discuss important routes through which antibiotic resistance 
exchanges between the aquatic environment and the greater microbial biosphere. A 
distinction is made between the marine environment i.e. those habitats that depend 
on salt water from the sea, and the aquatic environment, which also includes 
freshwater habitats. 
Remarkably, blaTEM-1, encoding the canonical TEM β-lactamase, which is 
notoriously found in human pathogens [446-448] and soil bacteria [449], was found to 
be prevalent in the marine environment. The gene was identified previously in the 
ocean [102], and we found this gene being expressed in the sponge Crambe crambe 
and in sea bacterioplankton (Chapter 2 of this thesis). Functional TEM β-lactamases 
have also been detected in river samples [103]. BlaTEM-1 was originally detected in E. 
coli isolated from a blood culture of a patient named Temoniera [450] and is often 
found on plasmids [448, 451, 452]. TEM-1 β-lactamases are widespread in the 
microbial biosphere, and as such their presence in the aquatic environment could 
have resulted from them spreading into the aquatic environment as a result of 
veterinary- or clinical antibiotic usage. However, blaTEM-1 could also have a functional 
role in the aquatic environment as discussed in Chapter 2 of this thesis. 
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notoriously found in human pathogens [446-448] and soil bacteria [449], was found to 
be prevalent in the marine environment. The gene was identified previously in the 
ocean [102], and we found this gene being expressed in the sponge Crambe crambe 
and in sea bacterioplankton (Chapter 2 of this thesis). Functional TEM β-lactamases 
have also been detected in river samples [103]. BlaTEM-1 was originally detected in E. 
coli isolated from a blood culture of a patient named Temoniera [450] and is often 
found on plasmids [448, 451, 452]. TEM-1 β-lactamases are widespread in the 
microbial biosphere, and as such their presence in the aquatic environment could 
have resulted from them spreading into the aquatic environment as a result of 
veterinary- or clinical antibiotic usage. However, blaTEM-1 could also have a functional 
role in the aquatic environment as discussed in Chapter 2 of this thesis. 
153
General Discussion
154
Chapter 7 
 
In the aquatic environment, resistance genes have been detected in bacterial 
communities associated with microbialites [453], aquatic animals [454, 455], rivers 
[103, 456], the ocean [102], an estuary [457] and marine sediment [190]. All of these 
niches are in contact with sponges and can therefore serve as vehicles for resistance 
exchange between sponges and other biological niches. Resistance genes in aquatic 
bacteria have been predicted either to serve as defense against locally or self-
produced antimicrobials, or to have functional roles unrelated to resistance [295]. 
Alternatively, it cannot be excluded that the genes do not have a function in the 
natural environment, in which case resistance gene presence can be the result of 
prior anthropogenic antibiotic pressure. Resistance in the aquatic environment due to 
human activity can evolve as a result of antibiotic run-off or by dissemination of 
resistant bacteria from other niches [102]. In the latter case the resistance genes are 
expected to be present in non-marine taxa at least initially, but may spread to marine 
taxa via HGT. For example, it has been shown that downstream of a waste water 
treatment plant, the relative abundance of resistance determinants was higher as 
compared to upstream [103, 458]. In general, waste water treatment plants are 
considered hubs for HGT of resistance genes that can spread into the environment 
via effluent wastewater [99, 445, 459]. Furthermore, gulls have been proposed as an 
important reservoir for resistance gene dissemination due to their close association 
with humans and the fact that they may acquire resistant microorganisms by visiting 
farms or lagoons [460, 461]. Hasan and co-authors showed that E. coli isolates were 
resistant to more antibiotics if they were isolated from gulls that lived in an area with 
more human activity (e.g. more clinics, poultry farms and shrimp hatcheries) [462]. 
Gulls are often found at beaches and therefore can also carry resistance to the 
marine environment. Another study found elevated levels of antibiotic resistant 
bacteria in surface- and groundwater downstream of a swine facility [463]. Manure 
has been found to enrich antibiotic resistance in soil [101, 419, 464], and by the 
same token groundwater might become enriched for resistance [33, 445]. In addition, 
it has been shown that administration of tetracyclines to cattle increased the 
abundance of tetracycline-resistance-genes in associated waste water lagoons [465]. 
Yet another study indicated that faecal contamination of beaches might contribute to 
resistance in the marine environment [466]. Application of antibiotics in the aquatic 
environment is limited to the use of prophylactic antibiotics in aquaculture. Industrial 
aquaculture is rapidly growing [467], which is expected to concurrently increase 
antibiotic resistance frequencies in the marine environment [468-470]. For example, 
in sediment of the Northern Yellow Sea, the concentration of sulfonamides, which are 
highly persistent antibiotics that are used in local aquaculture, was found to be 
correlated with the relative abundance of resistance genes [471].  
Taken together, these results show that the aquatic environment is a 
resistance reservoir of increasing importance in which the indigenous resistance
gene diversity is being supplemented by resistance due to human activity. This may 
affect all biological niches in the marine environment, including sponges. Humans are 
directly exposed to these reservoirs via in situ bathing and via consumption of marine 
flora and fauna. Whether these routes of resistance dissemination pose an important 
threat to human health will require further research [472, 473]. 
The human gut microbiota as antibiotic resistance reservoir 
An important reservoir from which pathogenic bacteria can acquire antibiotic 
resistance are human-associated bacteria, and particularly those residing in the gut 
[80, 474]. Close contact between pathogens and the gut microbiota, especially in the 
densely populated large intestine, facilitates genetic exchange [426]. Mobilizable 
antibiotic resistance to clinical antibiotics in gut bacteria is mainly attributed to prior 
antibiotic usage [9], where resistance to new antibiotics usually develops within a few 
years after introduction [475, 476]. In addition, gut bacteria harbour antibiotic
resistance that is unrelated to the application of anthropogenic antibiotics [179-181]. 
Therefore, it is paramount to decipher the role of the human gut microbiota in the 
emergence of antibiotic resistance in pathogens. To comprehensively catalogue and 
characterize antibiotic resistance in human-associated bacteria, it is necessary to 
grow the bacteria up to pure culture. Metagenomic sequencing alone can never 
completely replace cultivation because it cannot be used to study all aspects of 
resistance and HGT mechanisms. However, a problem when attempting to obtain gut 
bacteria in pure culture is that a large fraction of them remains recalcitrant to 
cultivation [92, 477]. Another obstacle is that the gut of each individual human is
expected to comprise ~100-1,000 different species [415-417], and that there are 
large inter-individual differences in terms of bacterial presence [416]. Therefore, 
exploring all microbial diversity will require considerable effort. Furthermore, it should 
also be taken into account that even if a strain of a certain species does not harbour
resistance genes, it might be that another strain belonging to a subpopulation of the 
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directly exposed to these reservoirs via in situ bathing and via consumption of marine 
flora and fauna. Whether these routes of resistance dissemination pose an important 
threat to human health will require further research [472, 473]. 
The human gut microbiota as antibiotic resistance reservoir 
An important reservoir from which pathogenic bacteria can acquire antibiotic 
resistance are human-associated bacteria, and particularly those residing in the gut 
[80, 474]. Close contact between pathogens and the gut microbiota, especially in the 
densely populated large intestine, facilitates genetic exchange [426]. Mobilizable 
antibiotic resistance to clinical antibiotics in gut bacteria is mainly attributed to prior 
antibiotic usage [9], where resistance to new antibiotics usually develops within a few 
years after introduction [475, 476]. In addition, gut bacteria harbour antibiotic
resistance that is unrelated to the application of anthropogenic antibiotics [179-181]. 
Therefore, it is paramount to decipher the role of the human gut microbiota in the 
emergence of antibiotic resistance in pathogens. To comprehensively catalogue and 
characterize antibiotic resistance in human-associated bacteria, it is necessary to 
grow the bacteria up to pure culture. Metagenomic sequencing alone can never 
completely replace cultivation because it cannot be used to study all aspects of 
resistance and HGT mechanisms. However, a problem when attempting to obtain gut 
bacteria in pure culture is that a large fraction of them remains recalcitrant to 
cultivation [92, 477]. Another obstacle is that the gut of each individual human is
expected to comprise ~100-1,000 different species [415-417], and that there are 
large inter-individual differences in terms of bacterial presence [416]. Therefore, 
exploring all microbial diversity will require considerable effort. Furthermore, it should 
also be taken into account that even if a strain of a certain species does not harbour
resistance genes, it might be that another strain belonging to a subpopulation of the 
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species actually does harbour resistance [478]. The high frequency at which HGT 
events occur in the gut microbiota should also be considered when studying 
resistance spread [47, 60]. While conjugation is the main HGT mechanism through 
which resistance is transferred, transduction and transformation have also been 
implicated in resistance spread, and should not be neglected [47, 479]. Even though 
it is generally acknowledged that gut bacteria are (currently) largely uncultivable in 
vitro, recent studies provided evidence to the contrary. A study by Browne and 
colleagues, in which ~4,000 colonies from faecal samples of six healthy humans 
were re-streaked to purity, the cultured bacterial diversity comprised 96% and 90% of 
the bacterial abundance at the genus level and species level, respectively, based on 
average relative abundance across the six subjects [86]. Another study based on 
faecal material from two individuals retrieved 95% of order-level and 88% of family-
level taxonomic groups when growth across 10 different media was combined [390]. 
However, in case of the latter study it should be considered that bacteria may have 
relied on biotic factors from nearby bacteria to grow, as cultivation success was 
assessed based on growth on original plates containing large numbers of colonies 
[87]. In Chapter 6, we found that the faecal microbiota of 6 out of 18 human 
individuals correlated well with their respective growth communities on GAM and CP 
media with Pearson correlation values of >0.6. Growth communities derived from 
faeces from one individual even scored Pearson correlation values of >0.95. The less 
representative bacterial growth derived from faeces of the 12 remaining individuals 
may have resulted from a low viability of the samples due to cryo-preservation of 
faecal material in glycerol stocks before inoculation. Indeed, in the previously-
mentioned studies that showed more representative bacterial growth [86, 390], fresh 
faecal material was inoculated within one hour after sample collection. In our study it 
was unpractical to use fresh faecal material because we were interested in analysing 
faecal material of a large number of intensive care patients. One hurdle in the 
isolation of novel taxa is their typically low relative abundance. Isolation of novel 
bacteria from the more abundant taxa will result in isolation of bacteria from novel 
taxa becoming progressively harder, thereby increasing the need for targeted 
approaches. A targeted approach can be implemented if cultivation conditions can be 
custom-designed based on genomic data. Genomic data can be obtained by culture-
independent genome sequencing of specific sub-populations or even single cells 
(e.g. after cell sorting [480]), or by extracting genomic data from metagenomic data 
by taking advantage of differences in genome coverage between bacteria (i.e.
differential coverage binning) [94, 481]. If researchers simply aim to isolate members 
of novel taxa or novel bacteria with a specific phenotype, then the first step can be to 
analyse bacterial growth at the community level on different media that include 
selective conditions such as supplementation of the medium with antibiotics [390] or 
treatment of samples with ethanol [86]. If the screen yields novel taxa of interest, 
such initial screening can be followed-up by re-plating and subsequently picking a 
large number of colonies e.g. with the help of automated colony pickers [482]. This is
also the approach that was used in this thesis to isolate an antibiotic resistant 
member of a taxon of which no members have yet been genome sequenced. The 
closest member of this bacterium is the recently described Sellimonas intestinalis
BR72T [402], and its moderate prevalence in human gut microbiota of ca. 20% merits 
further investigation into this strain as potential antibiotic resistance reservoir (Figure 
7.2). Recently, a group of bacteria comprising >15% of groundwater bacteria was 
described and called the candidate phyla radiation [483], which taken together
constitute a collection of >35 phyla that lack isolated representatives, and many of 
which would escape detection by 16S rRNA targeted approaches due to mismatches
Figure 7.2 Using a targeted approach, a bacterium (OTU3088) was isolated on the MicroDish platform 
that shared 99% 16S rRNA gene identity with Sellimonas intestinalis BR72T. Relative abundance of
this strain was derived from available 16S rRNA gene amplicon datasets in the SRA database. The
analysis was performed by the IMNGS platform (https://www.imngs.org/about/), which divides the 
datasets in 105 categories according to which biological niche was sampled. For detection, a nearly 
full-length (1,399 bp) 16S rRNA gene sequence of OTU3088 was used as query. The similarity 
threshold was set at 99% nucleotide identity. All metagenome categories are shown in which the
bacterium was detected at >1,5% relative abundance.
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species actually does harbour resistance [478]. The high frequency at which HGT 
events occur in the gut microbiota should also be considered when studying 
resistance spread [47, 60]. While conjugation is the main HGT mechanism through 
which resistance is transferred, transduction and transformation have also been 
implicated in resistance spread, and should not be neglected [47, 479]. Even though 
it is generally acknowledged that gut bacteria are (currently) largely uncultivable in 
vitro, recent studies provided evidence to the contrary. A study by Browne and 
colleagues, in which ~4,000 colonies from faecal samples of six healthy humans 
were re-streaked to purity, the cultured bacterial diversity comprised 96% and 90% of 
the bacterial abundance at the genus level and species level, respectively, based on 
average relative abundance across the six subjects [86]. Another study based on 
faecal material from two individuals retrieved 95% of order-level and 88% of family-
level taxonomic groups when growth across 10 different media was combined [390]. 
However, in case of the latter study it should be considered that bacteria may have 
relied on biotic factors from nearby bacteria to grow, as cultivation success was 
assessed based on growth on original plates containing large numbers of colonies 
[87]. In Chapter 6, we found that the faecal microbiota of 6 out of 18 human 
individuals correlated well with their respective growth communities on GAM and CP 
media with Pearson correlation values of >0.6. Growth communities derived from 
faeces from one individual even scored Pearson correlation values of >0.95. The less 
representative bacterial growth derived from faeces of the 12 remaining individuals 
may have resulted from a low viability of the samples due to cryo-preservation of 
faecal material in glycerol stocks before inoculation. Indeed, in the previously-
mentioned studies that showed more representative bacterial growth [86, 390], fresh 
faecal material was inoculated within one hour after sample collection. In our study it 
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bacteria from the more abundant taxa will result in isolation of bacteria from novel 
taxa becoming progressively harder, thereby increasing the need for targeted 
approaches. A targeted approach can be implemented if cultivation conditions can be 
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differential coverage binning) [94, 481]. If researchers simply aim to isolate members 
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treatment of samples with ethanol [86]. If the screen yields novel taxa of interest, 
such initial screening can be followed-up by re-plating and subsequently picking a 
large number of colonies e.g. with the help of automated colony pickers [482]. This is
also the approach that was used in this thesis to isolate an antibiotic resistant 
member of a taxon of which no members have yet been genome sequenced. The 
closest member of this bacterium is the recently described Sellimonas intestinalis
BR72T [402], and its moderate prevalence in human gut microbiota of ca. 20% merits 
further investigation into this strain as potential antibiotic resistance reservoir (Figure 
7.2). Recently, a group of bacteria comprising >15% of groundwater bacteria was 
described and called the candidate phyla radiation [483], which taken together
constitute a collection of >35 phyla that lack isolated representatives, and many of 
which would escape detection by 16S rRNA targeted approaches due to mismatches
Figure 7.2 Using a targeted approach, a bacterium (OTU3088) was isolated on the MicroDish platform 
that shared 99% 16S rRNA gene identity with Sellimonas intestinalis BR72T. Relative abundance of
this strain was derived from available 16S rRNA gene amplicon datasets in the SRA database. The
analysis was performed by the IMNGS platform (https://www.imngs.org/about/), which divides the 
datasets in 105 categories according to which biological niche was sampled. For detection, a nearly 
full-length (1,399 bp) 16S rRNA gene sequence of OTU3088 was used as query. The similarity 
threshold was set at 99% nucleotide identity. All metagenome categories are shown in which the
bacterium was detected at >1,5% relative abundance.
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with commonly used “universal” primers and probes. They were identified by filtering 
groundwater samples through ≤0.2 μm filters, followed by metagenomic sequencing 
of the filtrate. It was shown that they have limited metabolic capacity e.g. they can 
have incomplete tricarboxylic acid cycles, incomplete nucleotide biosynthesis 
pathways, or incomplete amino acid biosynthesis pathways. It is predicted that also 
human gut microbiota contain rare bacteria that could be hard to cultivate or are not 
detected by conventional 16S rRNA profiling [484]. These rare bacteria may also be 
relevant with regards to the emergence of antibiotic resistance. 
Future outlook and main conclusion 
It has been predicted that the global annual death toll of antibiotic resistance will 
grow from 700,000 nowadays to 10 million in 2050, superseding the death toll of road 
traffic accidents (1.2 million) and even cancer (8.2 million) [411]. The gravity of the 
situation demands that all viable strategies to combat emerging antibiotic resistance 
need to be treated with equal consideration, including development of novel 
antibiotics [485, 486], antibiotic stewardship programs [487, 488], restriction of 
agricultural antibiotic use [489, 490] and antibiotic cycling [491]. In this thesis we 
studied how the environment, and in particular sponge microbiota and anaerobic 
human gut microbiota, may contribute to the antibiotic crisis as a resistance reservoir. 
We applied complementary cultivation dependent and molecular methods to 
investigate antibiotic resistance at the community-level i.e. metatranscriptomics and 
functional metagenomics, and methods to investigate resistance at the level of 
individual species i.e. isolation of resistant bacteria and comparative genomics 
(Figure 7.1). The identification of a sponge-specific β-lactamase (blaPSV-1) indicated 
that sponges may uniquely contribute to resistance in the environment. Furthermore, 
we conclude that the human gut microbiota potentially harbours numerous antibiotic 
resistance reservoir species that can be accessed by conventional cultivation, 
although their isolation should be preferably attempted with selective or targeted 
cultivation campaigns. To what extent the marine environment contributes to 
resistance in the clinics remains unknown; therefore, before considering intervention, 
marine resistance genes will need to be further catalogued, and their exchange 
mechanisms and factors that contribute to environmental spread will need to be 
studied in-depth.  
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Summary
One of the major threats to human health in the 21st century is the emergence of 
pathogenic bacteria that are resistant to multiple antibiotics, thereby limiting treatment 
options. An important route through which pathogens become resistant is via 
acquisition of resistance genes from environmental and human-associated bacteria. 
Yet, it is poorly understood to what extent and by what mechanisms these so-called 
reservoirs contribute to emerging resistance. Therefore, the work described in this 
thesis focussed on generating novel insights into different niches as sources of 
resistance, with a particular focus on the human gut microbiota as well as on 
microbial communities associated with marine sponges, especially because the latter 
have been described as one of the richest sources of bioactive secondary
metabolites, including a broad range of antimicrobials. Cultivation-based methods 
were complemented with culture-independent approaches in order to study bacterial 
taxa that are not readily cultivated. 
Using metatranscriptomics it was found that clinically relevant antibiotic 
resistance genes are expressed in a broad range of environmental niches including 
human, mouse and pig gut microbiota, sea bacterioplankton, a marine sponge, forest 
soil and sub-seafloor sediment. The diversity of resistance gene transcripts differed 
greatly per niche indicating that the environment contains a rich reservoir of 
functional resistance that could be accessible by pathogens. Even though resistance 
gene expression might be linked to the presence of natural antibiotics, we did not
detect expression of the corresponding secondary metabolite biosynthesis clusters.
Thirty-one antibiotic-resistant bacteria, amongst which three belonging to
potentially novel Flavobacteriaceae spp., were isolated from the Mediterranean 
sponges Aplysina aerophoba, Corticium candelabrum and Petrosia ficiformis. 
Isolates were identified in a high throughput manner by double-barcoded 16S rRNA 
gene amplicon sequencing. Furthermore, analysis of sponge tissue-derived bacterial 
biomass growing on agar media showed that many novel bacterial taxa can still be
isolated by conventional cultivation methods. Genomic DNA from the 31 antibiotic-
resistant bacteria was interrogated with respect to the presence of active resistance 
genes by functional metagenomics. In addition, we also screened metagenomic
libraries prepared from DNA directly isolated from sponge tissue in order to 
circumvent the need for cultivation. In total, 37 unique resistance genes were 
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identified, and the predicted gene products of 15 of these shared <90% amino acid 
identity with known gene products. One resistance gene (blaPSV-1), which was 
classified into a new β-lactamase family, was found to be exclusive to the marine-
specific genus Pseudovibrio. These findings raised questions as to the functional 
roles of these genes in sponges, but more importantly, the functionality of these 
genes in E. coli shows that they can potentially be harnessed by phylogenetically 
distinct bacteria in other environments, including human pathogens. As such, it is a 
wake-up call as to the significance of marine resistance reservoirs. 
Pseudovibrio, a genus of α-Proteobacteria, was studied in more detail by 
comparative genomics as it comprises bacteria that potentially play a role as sponge 
symbionts and marine hubs of antibiotics resistance. Based on gene content, 
members of the genus Pseudovibrio were found to cluster by sponge sampling 
location indicating geographic speciation. Furthermore, Pseudovibrio spp. isolated 
from sponges near the Spanish coast clustered by sponge, suggesting host-specific 
colonization or adaptation. Strong support for Pseudovibrio spp. forming symbiotic 
relations with sponges came from the presence of a plethora of (predicted) 
conserved symbiosis-related functions in their genomes. 
A final study aimed to isolate novel antibiotic resistant reservoir species from 
the human gut microbiota using a targeted approach. Faecal samples from 
hospitalized patients that received Selective Digestive Decontamination (SDD), a 
prophylactic treatment with a cocktail of different antibiotics (tobramycin, polymyxin E, 
amphotericin B and cefotaxime), were inoculated anaerobically on agar media, after 
which bacterial biomass was analysed by 16S rRNA gene amplicon sequencing. Six 
novel taxa were identified that, based on their growth on media supplemented with 
the SDD antibiotics, could serve as clinically relevant reservoirs of antibiotic 
resistance. For one of these six taxa a member was obtained in pure culture by 
targeted isolation. The abundance of antibiotic resistant uncultivated taxa in the 
human gut microbiota warrants further research as to their potential roles in 
resistance dissemination.  
In conclusion, this thesis provides deeper insights into different environmental 
niches as reservoirs of antibiotic resistance. The results can serve to prime and 
inspire future research. 
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Nederlandse Samenvatting 
Eén van de grootste bedreigingen voor de volksgezondheid in de 21ste eeuw is de 
opkomst van pathogene bacteriën die resistent zijn tegen meerdere antibiotica, 
waardoor infecties moeilijker te behandelen worden. Deze pathogenen kunnen onder 
andere resistent worden door het overnemen van resistentiegenen van bacteriën uit 
het milieu of van bacteriën die zich van nature met mensen associëren. Het is 
grotendeels nog onduidelijk in welke mate en via welke mechanismen deze 
zogenoemde resistentie reservoirs bijdragen aan de opkomende resistentie in 
pathogenen. Om die reden heeft het onderzoek in dit proefschrift zich gericht op het 
verkrijgen van nieuwe inzichten met betrekking tot de rol van verschillende resistentie 
reservoirs in de resistentieproblematiek, waarbij de nadruk is gelegd op de microbiota 
in menselijke darmen en sponsdieren. Bacteriën in sponsdieren zijn onderzocht 
omdat ze een grote verscheidenheid aan bioactieve stoffen kunnen produceren 
waaronder ook stoffen met een antibacteriële werking. Onderzoeksmethodieken die 
afhankelijk zijn van bacteriële cultivatie, zijn gecomplementeerd met cultivatie-
onafhankelijke methodieken, zodat we ook resistentie kunnen bestuderen in 
bacteriën die we nog niet kunnen cultiveren. 
Met behulp van een metatranscriptome analyse was ontdekt dat klinisch 
relevante antibiotica-resistentiegenen tot expressie komen in een grote 
verscheidenheid aan ecologische niches waaronder de microbiota in de darmen van 
mensen, muizen en varkens, plankton in de zee en bacteriën in een sponsdier, 
bosgrond en sediment in de zeebodem. We vonden dat per niche verschillende 
resistentiegenen tot expressie kwamen, wat aangeeft dat het milieu een rijk reservoir 
is van functionele resistentiegenen waar pathogenen mogelijk een beroep op kunnen 
doen. We onderzochten ook of de expressie van resistentiegenen kon worden gelinkt 
aan de lokale productie van antibiotica aan de hand van de expressie van relevante 
biosynthese clusters, maar hiervoor werd geen bewijs gevonden. 
Eenendertig antibioticaresistente bacteriën waren geïsoleerd uit de 
Mediterrane sponsdieren Aplysina aerophoba, Corticium candelabrum en Petrosia 
ficiformis. Hieronder zaten drie stammen die mogelijk nieuwe soorten zijn binnen de 
familie van Flavobacteriaceae. De 31 isolaten waren verkregen uit een groot 
cultivatie experiment waarin de bacteriën werden geïdentificeerd door middel van 
high throughput 16S rRNA amplicon onderzoek met dubbele barcodes. Op basis van 
een analyse van bacteriële groei vanuit spons samples op agar kweekmedium werd 
geconcludeerd dat veel nieuwe bacteriesoorten nog steeds gecultiveerd kunnen 
worden met conventionele methodieken. Functionele metagenomics werd toegepast 
om te onderzoeken of de genomen van de 31 antibioticaresistente spons bacteriën 
functionele resistentiegenen bevatten. We onderzochten met deze methodiek ook 
DNA dat was geïsoleerd uit sponsdieren, teneinde de noodzaak van cultivatie te 
omzeilen. In totaal werden 37 unieke resistentiegenen geïdentificeerd en de 
bijbehorende eiwitsequenties van 15 hiervan deelden <90% aminozuur identiteit met 
bekende eiwitten. Eén resistentiegen (blaPSV-1) werd geclassificeerd in een nieuwe 
familie die tot zover alleen is gevonden in Pseudovibrio. Leden van het bacteriële 
genus Pseudovibrio vindt men exclusief in aquatische zoutwateromgevingen en ze
worden veelvuldig geïsoleerd uit sponsdieren. Deze vindingen roepen vragen op wat
betreft de functie van resistentiegenen in sponzen, maar belangrijker is dat de 
functionaliteit van deze genen in E. coli aantoont dat ze ingezet kunnen worden door
bacteriën in andere taxa en dus ook pathogenen. Derhalve zijn deze resultaten een 
wekroep voor wat betreft de significantie van marine resistentie reservoirs. 
Het genus Pseudovibrio was bestudeerd in detail in dit proefschrift door de 
genoominformatie van 31 Pseudovibrio stammen te vergelijken. De hypothese was
dat Pseudovibrio symbionten zijn van sponsdieren en tevens was er een vermoeden
dat ze dienen als hub voor de verspreiding van antibiotica resistentie. Er werd 
geconcludeerd dat leden van dit genus meer genetische overeenkomsten 
vertoonden wanneer ze waren geïsoleerd op dezelfde geografische locatie. Dit duidt 
op geografische speciatie. Er waren ook aanwijzingen voor spons-specifieke 
kolonisatie of adaptatie doordat Pseudovibrio stammen in een gebied nabij de
Spaanse kust meer overeenkomsten vertoonden wanneer ze waren geïsoleerd uit
dezelfde sponssoort. Veel steun voor de hypothese dat Pseudovibrio symbionten zijn 
van sponzen werd geleverd doordat de genomen codeerden voor een veelzijdigheid 
aan symbiosis gerelateerde genen die ook nog eens sterk geconserveerd waren.
Het doel van de laatste studie was om door middel van een gerichte aanpak
nieuwe soorten bacteriën uit de menselijke darmen te isoleren die zouden kunnen 
dienen als reservoirs voor antibiotica resistentie. Daarvoor werden monsters van 
faeces van intensive care patiënten die profylactische antibiotica (tobramycine, 
polymyxine E, amphotericine B en cefotaxime) toegediend kregen anaerobisch
uitgeplaat op agar kweekmedia, waarna de bacteriële groei werd geanalyseerd
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middels 16S rRNA gen amplicon sequenties. Er werden zes nieuwe bacteriële taxa 
geïdentificeerd die groeiden op agar kweekmedia waaraan de 
profylactische antibiotica waren toegevoegd en zodoende zouden deze bacteriën 
kunnen dienen als klinisch relevante resistentie reservoirs. Een lid van één van 
deze zes taxa werd vervolgens gericht geïsoleerd. De grote hoeveelheid 
antibioticaresistente taxa in de menselijke darmen, waarvan nog geen leden 
zijn gecultiveerd, verantwoordt vervolgonderzoek naar hun mogelijke rol in 
de verspreiding van antibiotica resistentie. 
Samenvattend, de kennis besloten in dit proefschrift verschaft nieuwe 
inzichten over de rol van verschillende ecologisch niches als antibiotica resistentie 
reservoirs. De resultaten kunnen dienen als leidraad en inspiratie voor 
vervolgonderzoek. 
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